Sogen Data · Datasets · 数据专题

结直肠癌数据集锦

甲基化 · accessibility

本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。

人源甲基化

Human · Methylation

  1. 01 GSE97693 对结直肠癌患者肿瘤组织的多区域样本(包括表面和中心区域)进行单细胞多组学测序,涵盖RNA和DNA甲基组分析。其中,5例患者肿瘤样本在化疗前采集,1例(CRC01)在化疗后采集。比较不同区域及化疗前后状态下的基因表达与甲基化差异。 人源 · 2503 例 · GPL20301 · 2018/11/29

    设计对结直肠癌患者肿瘤组织的多区域样本(包括表面和中心区域)进行单细胞多组学测序,涵盖RNA和DNA甲基组分析。其中,5例患者肿瘤样本在化疗前采集,1例(CRC01)在化疗后采集。比较不同区域及化疗前后状态下的基因表达与甲基化差异。

    摘要Although genomic instability, epigenetic abnormality, and gene expression dysregulation are hallmarks of colorectal cancer, these features have not been simultaneously analyzed at single-cell resolution. Using optimized single-cell multi-omics sequencing together with multi-regional sampling of the primary tumor, lymphatic and distant metastases, we provide insights beyond intratumoral heterogeneity. Genome-wide DNA methylation levels were relatively consistent within a single genetic sub-lineage. The genome-wide DNA demethylation patterns of cancer cells were consistent in all 10 sequenced patients. Our work demonstrates the feasibility of reconstructing genetic lineages, and tracing their epigenomic and transcriptomic dynamics with single-cell multi-omics sequencing.

  2. 02 GSE97923 对773名结直肠癌患者血清中的循环肿瘤DNA(ctDNA)进行高通量测序,分析其甲基化特征并与正常血液样本的细胞游离DNA(cfDNA)进行比较。 人源 · 773 例 · GPL16791 · 2020/01/01

    设计对773名结直肠癌患者血清中的循环肿瘤DNA(ctDNA)进行高通量测序,分析其甲基化特征并与正常血液样本的细胞游离DNA(cfDNA)进行比较。

    摘要To identify diagnostic and prognostic biomarkers, we compared methylation profiles of COAD tissues and normal blood at 485,000 CpG markers and identified a marker panel differently methylated in COAD. We developed diagnostic and prognostic prediction models with the selected panel and compared their efficacy in ctDNA to current available approaches. Our data indicate that cfDNA methylation patterns provide reliable biomarkers in the diagnosis, surveillance, and prognosis of COAD.

  3. 03 GSE208713 对原发(PR)和肝转移(LM)结直肠癌(CRC)样本进行全基因组 DNA 甲基化分析,使用 Illumina Infinium MethylationEPIC Beadchip 平台检测约 850,000 个 CpG 位点的甲基化状态,比较不同组织类型间的甲基化差异。 人源 · 568 例 · GPL21145 · 2023/01/31

    设计对原发(PR)和肝转移(LM)结直肠癌(CRC)样本进行全基因组 DNA 甲基化分析,使用 Illumina Infinium MethylationEPIC Beadchip 平台检测约 850,000 个 CpG 位点的甲基化状态,比较不同组织类型间的甲基化差异。

    摘要Genome wide DNA methylation profiling of primary (PR) and liver metastasis (LM) colorectal cancer (CRC). The Illumina Infinium MethylationEPIC Beadchip was used to obtain DNA methylation profiles across approximately 850,000 CpGs in human and xenogratfs derived samples. Raw data were processed using R minfi package. The main goal of this study is to develop a methylation-based classifier and predictor for metastatic CRC (mCRC), in order to find specific patients stratification for anti-EGFR targeted therapy (cetuximab) and bring the promise to shed new light on the role of methylation in driving colorectal cancer progression in different groups of patients.

  4. 04 GSE136089 开发并验证 RETrace 方法:在同一单细胞中同时捕获微卫星位点与甲基化信息胞嘧啶,微卫星经线性扩增以降低体外扩增噪声,并偶联单细胞简化代表性亚硫酸氢盐测序(scRRBS)检测 CpG 甲基化。材料为 HCT116 结肠癌细胞系克隆、U87MG 细胞系及成人死后脑组织单个核;HCT116 各克隆分别以 1000、100、10、5 个细胞及单细胞(SC)输入,脑组织按脑区(小脑、皮层、海马)与 NeuN+/- 分选单个核。共处理 138 个 HCT116、67 个 U87MG 与 137 个成人死后单细胞/单个核,并各自配套 bulk 样本,比较不同输入量、克隆、脑区与 NeuN 状态的谱系与甲基化特征。 人源 · 453 例 · GPL15520;16791 · 2020/02/23

    设计开发并验证 RETrace 方法:在同一单细胞中同时捕获微卫星位点与甲基化信息胞嘧啶,微卫星经线性扩增以降低体外扩增噪声,并偶联单细胞简化代表性亚硫酸氢盐测序(scRRBS)检测 CpG 甲基化。材料为 HCT116 结肠癌细胞系克隆、U87MG 细胞系及成人死后脑组织单个核;HCT116 各克隆分别以 1000、100、10、5 个细胞及单细胞(SC)输入,脑组织按脑区(小脑、皮层、海马)与 NeuN+/- 分选单个核。共处理 138 个 HCT116、67 个 U87MG 与 137 个成人死后单细胞/单个核,并各自配套 bulk 样本,比较不同输入量、克隆、脑区与 NeuN 状态的谱系与甲基化特征。

    摘要Retrospective lineage tracing harnesses naturally occurring mutations in cells to elucidate single cell development. Common single cell phylogenetic fate mapping methods have utilized highly mutable microsatellite loci found within the human genome. Such methods were limited by the introduction of in vitro noise through polymerase slippage inherent in DNA amplification, which we characterized to be approximately 10-100 higher than in vivo replication mutation rate. Here, we present RETrace, a method for simultaneously capturing both microsatellites and methylation-informative cytosines to characterize both lineage and cell type, respectively, from the same single cell. An important unique feature of RETrace was the introduction of linear amplification of microsatellites in order to reduce in vitro amplification noise. We further coupled microsatellite capture with single-cell reduced representation bisulfite sequencing (scRRBS), to measure the CpG methylation status on the same cell for cell type inference. When compared to existing retrospective lineage tracing methods, RETrace achieved higher accuracy (88% triplet accuracy from an ex vivo HCT116 tree) at a higher cell division resolution (lowering the required number of cell division difference between single cells by approximately 100 divisions). Simultaneously, RETrace demonstrated the ability to capture on average 150,000 unique CpGs per single cell in order to accurately determine cell type. We further formulated additional developments that would allow high-resolution mapping on microsatellite stable cells or tissues with RETrace. Overall, we present RETrace as a foundation for multi-omics lineage mapping and cell typing of single cells.

  5. 05 GSE124600 采用 MCTA-Seq(甲基化 CpG 串联扩增测序)对血浆样本进行基因组尺度 DNA 甲基化分析,样本来自 147 例结直肠癌(CRC)患者与 134 例健康对照,其中 5 例 CRC、2 例对照未通过质控被排除;同时对 33 例 CRC 肿瘤组织与 33 例癌旁黏膜组织进行甲基化检测。样本按疾病状态(CRC 患者/健康个体)、CRC 分期(Stage_I–Stage_IV)与组织来源(肿瘤组织、癌旁黏膜、血浆)标注。研究旨在筛选血液中可用于 CRC 无创检测的甲基化 CpG 岛标记,并评估区分早期 CRC 与肝细胞癌(HCC)的能力。 人源 · 340 例 · GPL20795 · 2019/05/31

    设计采用 MCTA-Seq(甲基化 CpG 串联扩增测序)对血浆样本进行基因组尺度 DNA 甲基化分析,样本来自 147 例结直肠癌(CRC)患者与 134 例健康对照,其中 5 例 CRC、2 例对照未通过质控被排除;同时对 33 例 CRC 肿瘤组织与 33 例癌旁黏膜组织进行甲基化检测。样本按疾病状态(CRC 患者/健康个体)、CRC 分期(Stage_I–Stage_IV)与组织来源(肿瘤组织、癌旁黏膜、血浆)标注。研究旨在筛选血液中可用于 CRC 无创检测的甲基化 CpG 岛标记,并评估区分早期 CRC 与肝细胞癌(HCC)的能力。

    摘要Aberrant DNA hypermethylation of CpG islands occurs frequently throughout the genome in human colorectal cancer (CRC). A genome-scale DNA hypermethylation analysis technique using plasma is attractive for the noninvasive early detection of CRC. The methylated CpG tandems amplification and sequencing (MCTA-Seq) method was applied to plasma samples from 147 CRC patients and 134 controls in which 5 from the CRC patients and 2 from the control subjects failed to pass a quality control value and were excluded from further analysis. The capacity of the method for discriminating CRC and hepatocellular carcinoma (HCC) was assessed. We identified many DNA methylation markers including known (e.g., SEPT9 and IKZF1) and novel (e.g., EMBP1, KCNQ5 and CHST11) CpG islands for detecting CRC in blood. A panel of 80 markers significantly discriminated early stage CRC and controls with a sensitivity of 78% and a specificity of 90%. This method can efficiently distinguish between early stage CRC and HCC. MCTA-Seq is a promising method for the noninvasive detection of CRC that also shows great potential for identifying the tissue of origin of cancer.

  6. 06 GSE57342 对63株人类乳腺、结直肠和卵巢癌细胞系分别进行5-azacitidine处理,采集处理后不同时间点的样本进行甲基化分析,比较处理组与对照组的基因表达差异。 人源 · 338 例 · GPL13534 · 2014/05/08

    设计对63株人类乳腺、结直肠和卵巢癌细胞系分别进行5-azacitidine处理,采集处理后不同时间点的样本进行甲基化分析,比较处理组与对照组的基因表达差异。

    摘要Epigenetic therapy is emerging as a potential therapy for solid tumors. To investigate its mechanism of action, we performed integrative expression and methylation analysis of 63 cancer cell lines (breast, colorectal, and ovarian) after treatment with the DNA methyltransferase inhibitor 5-azacitidine (AZA). Gene Set Enrichment Analysis demonstrated significant enrichment for immunomodulatory pathways in all three cancers (14.4-31.3%) including interferon signaling, antigen processing and presentation, and cytokines/chemokines. Strong upregulation of cancer testis antigens was also observed. An AZA IMmune gene set (AIMs) derived from the union of these immunomodulatory pathway genes classified primary tumors from all three types, into “high” and “low” AIM gene expression subsets in tumor expression data from both TCGA and GEO (GSE42284, GSE10893, and GSE26712 for the colon, breast, and ovarian samples, respectively). Samples from selected patient biopsies showed upregulation of AIM genes after treatment with epigenetic therapy. These results point to a broad immune stimulatory role for DNA demethylating drugs in multiple cancers.

  7. 07 GSE149438 收集结直肠癌(CRC)、胃癌(GC)、食管鳞状细胞癌(ESCC)、食管腺癌(EAC)、肝细胞癌(HCC)和胰腺导管腺癌(PDAC)患者的血浆样本及健康对照样本,行靶向 DNA 甲基化测序,检测细胞游离 DNA(cf-DNA)的甲基化模式。通过分析 1940 例肿瘤组织与相邻正常组织的 DNA 甲基化数据,识别不同胃肠癌与相邻正常组织间的差异甲基化区域(DMRs),并整合所有显著 DMRs 设计出包含 25.6 Mb 基因组区域的 67,832 个组织特异性 DMRs 靶向测序平台(SeqCap Epi)。随后在 300 份 cf-DNA 样本中验证这些 DMRs,并应用机器学习算法开发出三种 DMR 面板:1)针对特定胃肠癌的癌症特异性生物标志物面板;2)可检测所有胃肠癌的泛胃肠癌(pan-GI)面板;3)多癌种预测面板 EpiPanGI Dx。 人源 · 300 例 · GPL24676 · 2021/08/27

    设计收集结直肠癌(CRC)、胃癌(GC)、食管鳞状细胞癌(ESCC)、食管腺癌(EAC)、肝细胞癌(HCC)和胰腺导管腺癌(PDAC)患者的血浆样本及健康对照样本,行靶向 DNA 甲基化测序,检测细胞游离 DNA(cf-DNA)的甲基化模式。通过分析 1940 例肿瘤组织与相邻正常组织的 DNA 甲基化数据,识别不同胃肠癌与相邻正常组织间的差异甲基化区域(DMRs),并整合所有显著 DMRs 设计出包含 25.6 Mb 基因组区域的 67,832 个组织特异性 DMRs 靶向测序平台(SeqCap Epi)。随后在 300 份 cf-DNA 样本中验证这些 DMRs,并应用机器学习算法开发出三种 DMR 面板:1)针对特定胃肠癌的癌症特异性生物标志物面板;2)可检测所有胃肠癌的泛胃肠癌(pan-GI)面板;3)多癌种预测面板 EpiPanGI Dx。

    摘要Owing to high cancer-specificity, DNA methylation alterations have emerged as front-runners in cell-free DNA (cf-DNA) biomarker development. However, much effort to date has focused on single cancers and have not explored the possibility of developing a pan-cancer diagnostic assay. Here, we undertook a genome-wide DNA methylation analysis for multiple gastrointestinal (GI) cancers, to develop a panGI diagnostic assay. By analyzing the DNA methylation data from 1940 tumor and adjacent normal tissues from TCGA and GSE72872 datasets, we first identified the differentially methylated regions (DMRs) between individual GI cancers and adjacent normal tissues, as well as across all GI cancers. We next prioritized a list of 67,832 tissue DMRs encompassing a 25.6 Mb genomic region by incorporating all significant DMRs across various GI cancers to design a custom SeqCap Epi, targeted bisulfite sequencing platform. Subsequent investigation of these tissue-specific DMRs in 300 cf-DNA specimens and applying machine learning algorithms led to the development of three distinct categories of DMR panels: 1) Cancer-specific biomarker panels with an AUC values of 0.98 (Colorectal cancer, CRC), 0.94 (Esophageal squamous cell carcinoma, ESCC), 0.90 (Esophageal adenocarcinoma, EAC), 0.90 (Gastric cancer, GC), 0.98 (Hepatocellular carcinoma, HCC), and 0.85 (Pancreatic ductal adenocarcinoma, PDAC); 2) A pan-GI panel that detected all GI cancers with an AUC of 0.90; and 3) A multi-cancer prediction panel, EpiPanGI Dx, with a prediction accuracy around 0.85-0.95 for most GI cancers. Utilizing a novel biomarker discovery approach, we provide first evidence for a cell-free DNA methylation biomarker assay that offer a robust diagnostic accuracy for all gastrointestinal cancers.

  8. 08 GSE52272 收集结直肠癌患者肿瘤组织与配对癌旁黏膜样本,行全基因组规模 DNA 甲基化谱检测,比较肿瘤与癌旁组织的甲基化模式差异。 人源 · 280 例 · GPL13534;11154 · 2016/01/08

    设计收集结直肠癌患者肿瘤组织与配对癌旁黏膜样本,行全基因组规模 DNA 甲基化谱检测,比较肿瘤与癌旁组织的甲基化模式差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  9. 09 GSE101764 对结直肠癌患者及其相邻黏膜组织进行全基因组 DNA 甲基化分析,采集 149 份黏膜组织和 112 份肿瘤组织样本,包含 105 对肿瘤-黏膜配对样本,其中一名患者有 3 个来自不同芯片的重复样本。 人源 · 261 例 · GPL13534 · 2017/09/13

    设计对结直肠癌患者及其相邻黏膜组织进行全基因组 DNA 甲基化分析,采集 149 份黏膜组织和 112 份肿瘤组织样本,包含 105 对肿瘤-黏膜配对样本,其中一名患者有 3 个来自不同芯片的重复样本。

    摘要Within the ColoCare Project we obtained genome-wide DNA methylation profiles from 149 mucosa and 112 colorectal cancer tissues using Illumina HumanMethylation450k BeadChips. DNA methylation profiles were analysed by patient characteristics, lifestyle and exposures.

  10. 10 GSE27130 研究纳入118例已检测抗癌药物反应的结肠癌患者,采集其肿瘤组织与配对癌旁正常组织,另含HCT15、RKO、KM12C、CaCo2、LoVo、DLD1、WiDr、AMC5、HCT116、HT29、SW48、SW480等细胞系样本,共248例。提取基因组DNA,经重亚硫酸盐转化后以Illumina Infinium 27k Human Methylation Beadchip v1.2检测约27,000个CpG位点甲基化水平,比较肿瘤与配对正常组织,并关联抗癌药物反应组与非反应组。 人源 · 248 例 · GPL8490 · 2011/12/31

    设计研究纳入118例已检测抗癌药物反应的结肠癌患者,采集其肿瘤组织与配对癌旁正常组织,另含HCT15、RKO、KM12C、CaCo2、LoVo、DLD1、WiDr、AMC5、HCT116、HT29、SW48、SW480等细胞系样本,共248例。提取基因组DNA,经重亚硫酸盐转化后以Illumina Infinium 27k Human Methylation Beadchip v1.2检测约27,000个CpG位点甲基化水平,比较肿瘤与配对正常组织,并关联抗癌药物反应组与非反应组。

    摘要Genome wide DNA methylation profiling of normal and colon cancer and assosiation study between anti-cancer drug respond group and non-respond group. The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 27,000 CpGs in 118 paired anti-cancer drug response tested colon cancer and adjacent normal tissues

  11. 11 GSE131013 对96例结直肠腺癌患者配对的肿瘤组织与相邻正常黏膜样本、以及48例健康供体的结肠黏膜样本进行甲基化分析,采用Illumina Infinium Human Methylation 450K BeadChip平台检测,比较肿瘤组织与相邻正常黏膜的甲基化差异及肿瘤组织与健康黏膜的差异。 人源 · 240 例 · GPL13534 · 2020/05/10

    设计对96例结直肠腺癌患者配对的肿瘤组织与相邻正常黏膜样本、以及48例健康供体的结肠黏膜样本进行甲基化分析,采用Illumina Infinium Human Methylation 450K BeadChip平台检测,比较肿瘤组织与相邻正常黏膜的甲基化差异及肿瘤组织与健康黏膜的差异。

    摘要Methylation profiles of paired normal adjacent mucosa and tumor samples from 96 individuals and 48 healthy colon mucosae, were obtained through Illumina Infinium Human Methylation 450K BeadChip. This dataset is in the context of the COLONOMICS project and to query additional information you can visit the project website www.colonomics.org.

  12. 12 GSE199057 收集结直肠癌患者肿瘤组织、配对癌旁黏膜及非结直肠癌患者的正常结直肠黏膜样本,行全基因组 DNA 甲基化阵列谱检测。具体包括 76 例 CRC 患者肿瘤组织、78 例 CRC 患者癌旁黏膜及 68 例非 CRC 患者正常结直肠黏膜样本,采用亚硫酸盐转化 DNA 技术,将样本杂交至 Illumina MethylationEPIC BeadChip v1.0 平台,覆盖约 85 万个 CpG 位点,比较三组间 DNA 甲基化模式差异。 人源 · 229 例 · GPL21145 · 2022/03/23

    设计收集结直肠癌患者肿瘤组织、配对癌旁黏膜及非结直肠癌患者的正常结直肠黏膜样本,行全基因组 DNA 甲基化阵列谱检测。具体包括 76 例 CRC 患者肿瘤组织、78 例 CRC 患者癌旁黏膜及 68 例非 CRC 患者正常结直肠黏膜样本,采用亚硫酸盐转化 DNA 技术,将样本杂交至 Illumina MethylationEPIC BeadChip v1.0 平台,覆盖约 85 万个 CpG 位点,比较三组间 DNA 甲基化模式差异。

    摘要Genome wide DNA methylation profiling of normal healthy patients and tumor and non-tumor samples of patients with colorectal cancer (CRC). The Illumina Infinium MethylationEPIC BeadChip was used to obtain DNA methylation across ~850,000 CpG sites. Samples include 78 normal sample from CRC patients, 76 tumor samples from CRC patients, and 68 samples from non-CRC patients

  13. 13 GSE43369 对92例结直肠癌患者的肿瘤组织及其相邻正常黏膜进行亚硫酸氢盐处理,提取DNA后使用Illumina GoldenGate Methylation Cancer Panel I芯片进行甲基化分析,其中5对肿瘤组织与正常黏膜样本作为重复样本进行分析以确保可重复性,共包含194个样本。部分样本因信号-噪声比未达标或甲基化模式异常被排除,但保留于原始数据矩阵中。 人源 · 194 例 · GPL9183 · 2013/05/27

    设计对92例结直肠癌患者的肿瘤组织及其相邻正常黏膜进行亚硫酸氢盐处理,提取DNA后使用Illumina GoldenGate Methylation Cancer Panel I芯片进行甲基化分析,其中5对肿瘤组织与正常黏膜样本作为重复样本进行分析以确保可重复性,共包含194个样本。部分样本因信号-噪声比未达标或甲基化模式异常被排除,但保留于原始数据矩阵中。

    摘要DNA methylation in colorectal cancer diagnosis. The Illumina GoldenGate Methylation Cancer Panel I was used to select a set of candidates markers informative of colorectal cancer diagnosis from 807 cancer-related genes. In the discovery phase, tumor tissue and paired adjacent normal mucosa from 92 colorectal patients were analyzed.

  14. 14 GSE77718 收集结直肠癌患者的新鲜冷冻结肠活检组织,每位患者取肿瘤组织与配对正常组织,共94对匹配组织(对应192份样本)。从组织提取并纯化基因组DNA,经亚硫酸氢盐转化后与Illumina Infinium HumanMethylation 450 Beadchip杂交,检测全基因组甲基化水平,比较各患者肿瘤组织与配对正常组织的甲基化差异。样本特征记录性别及结肠分段(盲肠、升结肠、横结肠、肝曲、脾曲、降结肠、乙状结肠、直肠乙状结肠等)。 人源 · 192 例 · GPL13534 · 2017/04/26

    设计收集结直肠癌患者的新鲜冷冻结肠活检组织,每位患者取肿瘤组织与配对正常组织,共94对匹配组织(对应192份样本)。从组织提取并纯化基因组DNA,经亚硫酸氢盐转化后与Illumina Infinium HumanMethylation 450 Beadchip杂交,检测全基因组甲基化水平,比较各患者肿瘤组织与配对正常组织的甲基化差异。样本特征记录性别及结肠分段(盲肠、升结肠、横结肠、肝曲、脾曲、降结肠、乙状结肠、直肠乙状结肠等)。

    摘要DNA methylation was analysed using the Illumina Infinium HumanMethylation 450 Beadchip in 94 matched tissue pairs of colorectal cancer patients.

  15. 15 GSE133928 收集结直肠癌患者肿瘤组织与配对癌旁黏膜样本,以及结直肠癌细胞系(HCT116、SW480、RKO、LS174T)和正常结直肠细胞系(FHC)样本,行全基因组 DNA 甲基化谱检测。通过 Bisulfite-Seq 技术测定 DNA 甲基化状态,覆盖全基因组 CpG 位点。研究对象包括肿瘤组织、癌旁黏膜和细胞系样本,分组为肿瘤组织 vs 癌旁黏膜、细胞系 vs 正常细胞系,比较不同组别间的甲基化模式差异。 人源 · 175 例 · GPL18573;16791;24676 · 2020/08/24

    设计收集结直肠癌患者肿瘤组织与配对癌旁黏膜样本,以及结直肠癌细胞系(HCT116、SW480、RKO、LS174T)和正常结直肠细胞系(FHC)样本,行全基因组 DNA 甲基化谱检测。通过 Bisulfite-Seq 技术测定 DNA 甲基化状态,覆盖全基因组 CpG 位点。研究对象包括肿瘤组织、癌旁黏膜和细胞系样本,分组为肿瘤组织 vs 癌旁黏膜、细胞系 vs 正常细胞系,比较不同组别间的甲基化模式差异。

    摘要To understand how nuclear architecture is altered in cancer, we profiled genome topology along with DNA methylation, chromatin modifications and the DNA binding factors CTCF in primary colon tumors, normal colon and colon cancer cell lines.

  16. 16 GSE25062 对125例结直肠肿瘤样本和29例相邻正常组织样本进行全基因组DNA甲基化分析,使用Illumina Infinium DNA甲基化检测平台,检测27,578个CpG位点的甲基化状态。研究通过模型聚类分析将结直肠癌分为四个基于DNA甲基化的亚型,每个亚型具有特征性的遗传和临床特征。 人源 · 154 例 · GPL8490 · 2011/06/03

    设计对125例结直肠肿瘤样本和29例相邻正常组织样本进行全基因组DNA甲基化分析,使用Illumina Infinium DNA甲基化检测平台,检测27,578个CpG位点的甲基化状态。研究通过模型聚类分析将结直肠癌分为四个基于DNA甲基化的亚型,每个亚型具有特征性的遗传和临床特征。

    摘要To characterize DNA methylation-based subgroups in colorectal cancer, we performed genome-scale DNA methylation profiling of 125 colorectal tumor samples and 29 histologically normal-adjacent colonic tissue samples using the Illumina Infinium DNA methylation assay, which assesses the DNA methylation status of 27,578 CpG sites located at the promoter regions of 14,495 protein-coding genes. We identified four DNA methylation-based subgroups of CRC using model-based cluster analyses. Each subtype shows characteristic genetic and clinical features, indicating that they represent biologically distinct subgroups.

  17. 17 GSE237522 收集人类结直肠癌肿瘤组织与配对相邻正常组织样本,采用Digital Restriction Enzyme Analysis of Methylation (DREAM)技术进行甲基化谱检测,比较肿瘤组织与相邻正常组织的甲基化模式差异。 人源 · 148 例 · GPL24676;16791 · 2024/06/12

    设计收集人类结直肠癌肿瘤组织与配对相邻正常组织样本,采用Digital Restriction Enzyme Analysis of Methylation (DREAM)技术进行甲基化谱检测,比较肿瘤组织与相邻正常组织的甲基化模式差异。

    摘要We report the association between CpG islander methylator phenotype (CIMP) and the gut microbiome in human colorectal cancer tumor and adjacent normal tissue.

  18. 18 GSE64114 采集人类结直肠癌患者正常邻近黏膜与肿瘤组织样本,采用 SNP array 技术进行甲基化分析和基因组变异检测,未明确分组比较关系。 人源 · 148 例 · GPL3720;4091;9183 · 2015/09/02

    设计采集人类结直肠癌患者正常邻近黏膜与肿瘤组织样本,采用 SNP array 技术进行甲基化分析和基因组变异检测,未明确分组比较关系。

    摘要This SuperSeries is composed of the SubSeries listed below.

  19. 19 GSE48684 对人类结直肠黏膜组织、腺瘤和结直肠癌样本进行全基因组甲基化分析,比较正常组织、腺瘤与癌症之间的甲基化模式差异。研究包含41例正常结直肠黏膜样本、42例腺瘤样本和64例结直肠癌样本,按DNA甲基化特征分为正常-H、正常-C、腺瘤及癌症组。检测采用基因组tiling阵列技术,分析全基因组异常甲基化位点的分布特征。 人源 · 147 例 · GPL13534 · 2014/09/08

    设计对人类结直肠黏膜组织、腺瘤和结直肠癌样本进行全基因组甲基化分析,比较正常组织、腺瘤与癌症之间的甲基化模式差异。研究包含41例正常结直肠黏膜样本、42例腺瘤样本和64例结直肠癌样本,按DNA甲基化特征分为正常-H、正常-C、腺瘤及癌症组。检测采用基因组tiling阵列技术,分析全基因组异常甲基化位点的分布特征。

    摘要Genetic and epigenetic alterations are a fundamental aspect of colorectal cancer formation. There is considerable heterogeneity between colorectal cancers regarding the mutations and methylated genes they carry, and this heterogeneity may arise early in the polyp-cancer sequence. However, our understanding of the epigenetic alterations and gene mutations in colon adenomas and their relation to colorectal cancer is incomplete. Thus, we have assessed the methylome in normal colon mucosa, tubular adenomas, and colorectal adenocarcinomas and have determined the relationship of these findings between adenomas and cancer in the colon. Genome-wide alterations in DNA methylation were found in the normal colon mucosa adjacent to colorectal cancer, tubular adenomas, and colorectal cancer. Three subgroups of CRCs and two subgroups of adenomas were identified on the basis of their DNA methylation patterns. The adenomas separated into a high-frequency methylation class (Adenoma-H) and a low-frequency methylation class. The adenoma-H polyps have a methylated DNA signature similar to non-CIMP CRCs, whereas those of the Adenoma-L class have a similar methylation pattern to normal colon mucosa. The CpGs that account for these signatures are located in intragenic/intergenic regions, which suggests that these two groups of adenomas arise from different stem cell populations.

  20. 20 GSE164811 对146例结直肠癌患者的肿瘤组织进行DNA甲基化分析,其中124例为CMS2型,22例为CMS3型。采用Infinium HumanMethylation450 BeadChip平台获取甲基化图谱,通过自适应组正则化逻辑回归模型筛选甲基化标记物,比较CMS2与CMS3型肿瘤的甲基化特征差异。 人源 · 146 例 · GPL13534 · 2021/12/08

    设计对146例结直肠癌患者的肿瘤组织进行DNA甲基化分析,其中124例为CMS2型,22例为CMS3型。采用Infinium HumanMethylation450 BeadChip平台获取甲基化图谱,通过自适应组正则化逻辑回归模型筛选甲基化标记物,比较CMS2与CMS3型肿瘤的甲基化特征差异。

    摘要INTRODUCTION. Consensus molecular subtypes (CMSs) can guide precision treatment of colorectal cancer (CRC). Currently available dedicated assays can identify CMS1 and CMS4 cases very well while a dedicated test to distinguish CMS2 and 3 is lacking. This study aimed to identify a panel of methylation markers to distinguish between CMS2 and 3 in patients with CRC. METHODS. Fresh-frozen tumor tissue of 239 patients with stage I-III CRC who underwent surgery between 2007 and 2014 was included. CMS classification was performed on RNA-seq data using the single-sample prediction parameter from the “CMSclassifier” package. Methylation profiles were gathered/obtained using the Infinium HumanMethylation450 BeadChip for 146 samples (124 CMS2 and 22 CMS3) . We performed adaptive group-regularised logistic ridge regression with post-hoc group-weighted elastic net marker selection to build prediction models for classification of CMS2 and CMS3 based on 15, 10 or 5 methylation markers. Data from the Cancer Genome Atlas project was used for independent validation of our obtained models. RESULTS. Overall methylation profiles differed between CMS2 and CMS3 tumors. Group-regularisation of the methylation probes was done based on their location either relative to a CpG island or relative to a gene present in the CMS classifier. This resulted in two different prediction models and subsequently different marker panels. For both panels, even when using only 5 markers, the sensitivity, specificity, and accuracy were >90%. Independent validation of the fixed models in TCGA data showed comparable performances. CONCLUSION. Our highly sensitive and specific methylation marker panel can be used to distinguish CMS2 and 3. This enables future development of a qPCR DNA methylation assay in patients with CRC to provide a specific and non-invasive classification tool.

  21. 21 GSE47592 对人类结直肠癌样本及正常结肠组织进行甲基化分析,采集样本包括肿瘤组织、远离肿瘤的正常结肠组织和靠近肿瘤的正常结肠组织,同时涉及 HCT116 人结直肠癌细胞系的 shRNA 敲低 TET2 或 TET2+TET3 的处理组与对照组,采用 MeDIP-Seq 和 ChIP-Seq 技术检测 5-羟甲基胞嘧啶(5hmC)和 TET2 的结合情况,比较不同组别间的甲基化差异。 人源 · 137 例 · GPL6102;8490;10999;15456;13534 · 2015/02/03

    设计对人类结直肠癌样本及正常结肠组织进行甲基化分析,采集样本包括肿瘤组织、远离肿瘤的正常结肠组织和靠近肿瘤的正常结肠组织,同时涉及 HCT116 人结直肠癌细胞系的 shRNA 敲低 TET2 或 TET2+TET3 的处理组与对照组,采用 MeDIP-Seq 和 ChIP-Seq 技术检测 5-羟甲基胞嘧啶(5hmC)和 TET2 的结合情况,比较不同组别间的甲基化差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  22. 22 GSE79277 对人类结直肠癌患者和正常人的循环游离DNA进行甲基化分析,使用亚硫酸氢盐测序方法,比较不同疾病状态的甲基化模式。 人源 · 134 例 · GPL16791;15520 · 2017/02/19

    设计对人类结直肠癌患者和正常人的循环游离DNA进行甲基化分析,使用亚硫酸氢盐测序方法,比较不同疾病状态的甲基化模式。

    摘要Adjacent CpG sites in mammalian genomes tend to be co-methylated due to the processivity of enzymes responsible for adding or removing the methyl group. Yet discordant methylation patterns have also be observed, and found to be related to stochastic or uncoordinated molecular processes. Here we focused on a systematic search and investigation of regions in the human genome that exhibit highly coordinated methylation. By examining the co-methylation patterns of multiple adjacent CpG sites, termed methylation haplotypes, in single bisulfite sequencing reads, we applied a greedy-searching strategy to defined blocks of tightly coupled CpG sites, called Methylation Haplotype Blocks (MHBs), based on 53 sets of whole genome bisulfite sequencing (WGBS) data, including 43 published sets from human adult tissues, ESC and in vitro differentiated cell lines, as well as 10 sets from human adult tissues generated in this study. The MHBs were then further validated with 101 sets of RRBS ENCODE data, and 637 sets of Illumina 450k methylation array data from TCGA tumor and normal samples. Globally, MHBs are enriched in but only partially overlap with several well-known genomic features, including CpG islands, promoters, enhancers and VMRs. To perform quantitative analysis of the MHBs, we defined a metric called Methylation Haplotype Load (MHL), which is covered both average methylation level and methylation complexity and therefore more informative than average methylation level or Shannon entropy. Using a feature selection strategy, we identified a set of tissue-specific MHBs that cluster by developmental germ-layers. Interestingly, examination of these MHBs revealed two distinct mechanisms for fate commitment during development: epigenetic silencing of pluripotent genes, such as NANOG, for mesoderm induction; and epigenetic induction (or de-suppression) of lineage-specific factors for ectoderm commitment.

  23. 23 GSE68060 对西班牙和芬兰来源的结直肠癌样本及正常组织进行甲基化芯片分析,比较不同组织类型和国家来源样本的甲基化特征。采用Infinium Human Methylation 450K BeadChip平台检测450,000个CpG位点,包含36例Serrated肿瘤样本、34例Conventional肿瘤样本、15例Serrated正常组织样本及15例MSI正常组织样本,按国家和组织类型分组检测,分析不同组别间的甲基化差异。 人源 · 120 例 · GPL13534 · 2015/06/21

    设计对西班牙和芬兰来源的结直肠癌样本及正常组织进行甲基化芯片分析,比较不同组织类型和国家来源样本的甲基化特征。采用Infinium Human Methylation 450K BeadChip平台检测450,000个CpG位点,包含36例Serrated肿瘤样本、34例Conventional肿瘤样本、15例Serrated正常组织样本及15例MSI正常组织样本,按国家和组织类型分组检测,分析不同组别间的甲基化差异。

    摘要Serrated adenocarcinoma (SAC) is a recently recognized colorectal cancer (CRC) subtype accounting for 7.5 - 8.7% of CRCs. It has been shown that SAC has a worse prognosis and has different molecular and immunohistochemical features compared to conventional carcinoma (CC) but, to date, there is no study analysing its methylome profile. We have investigated the methylation status of 450,000 CpG sites using the Infinium Human Methylation 450 BeadChip array in 103 colorectal specimens from Spanish and Finnish patients. The comparison between the epigenetic signature of 36 SACs and 34 matched CCs was established with the aim of identifying the functions which characterize SAC biology and also the most differentially methylated genes for subsequent validatation by pyrosequencing, methylation-specific PCR, qPCR and immunohistochemistry, including additional cases. Microarray data showed a higher representation of morphogenesis-, neurogenesis-, cytoskeleton- and vesicle-transport-related functions and also significant differential methylation of 15 genes, including the iodothyronine deiodinase DIO3 and the forkhead family transcription factor FOXD2 genes which were validated at the CpG, mRNA and protein level. A quantification study of the methylation status of CpG sequences in FOXD2 demonstrated a novel region controlling gene expression. Moreover, differences in these markers were also evident when comparing SAC with CRC showing molecular and histological features of high level microsatellite instability. This methylome study demonstrates that SAC has a distinct epigenetic regulation pattern resulting in different biological functions and that DIO3 and FOXD2 might be molecular targets for a specific histology-oriented treatment of CRC.

  24. 24 GSE39446 收集结直肠癌患者肿瘤组织与配对癌旁正常结肠黏膜样本,行DNA甲基化阵列谱检测,覆盖1,505个CpG位点,比较肿瘤组织与癌旁正常组织的甲基化模式差异。 人源 · 119 例 · GPL9183 · 2012/07/18

    设计收集结直肠癌患者肿瘤组织与配对癌旁正常结肠黏膜样本,行DNA甲基化阵列谱检测,覆盖1,505个CpG位点,比较肿瘤组织与癌旁正常组织的甲基化模式差异。

    摘要The Illumina GoldenGate® methylation array was used to evaluate DNA methylation at 1,505 CpG sites in 807 cancer-related genes in 91 consecutive CRC samples and 28 matched normal colonic mucosa.

  25. 25 GSE193535 对54例结直肠癌患者的肿瘤组织与配对癌旁正常组织各取一份,共108份样本,提取基因组DNA并经重亚硫酸盐转化后,使用Illumina Infinium Human Methylation 450K BeadChip(覆盖全基因组485,577个CpG位点)进行全基因组甲基化谱检测,比较同一患者肿瘤与配对正常组织的甲基化差异。 人源 · 108 例 · GPL13534 · 2022/01/17

    设计对54例结直肠癌患者的肿瘤组织与配对癌旁正常组织各取一份,共108份样本,提取基因组DNA并经重亚硫酸盐转化后,使用Illumina Infinium Human Methylation 450K BeadChip(覆盖全基因组485,577个CpG位点)进行全基因组甲基化谱检测,比较同一患者肿瘤与配对正常组织的甲基化差异。

    摘要Genome-wide methylation profilling on 54 paired of CRCs and their adjacent normal tissues using the Infinium Human Methylation 450K beadchip, which covers 485,577 CpG di-nucleotide sites distributed over the whole genome

  26. 26 GSE77955 收集结直肠癌患者不同组织类型的样本,包括腺瘤、癌、转移灶及配对的正常组织,如正常隐窝上皮、正常表面上皮、正常结肠邻近腺瘤/癌、正常肝脏邻近肝转移等,行全基因组规模 DNA 甲基化阵列谱检测,同时对总 RNA 进行全基因组规模表达谱分析,比较不同组织类型间的甲基化与表达模式差异。 人源 · 106 例 · GPL96;13534 · 2016/05/13

    设计收集结直肠癌患者不同组织类型的样本,包括腺瘤、癌、转移灶及配对的正常组织,如正常隐窝上皮、正常表面上皮、正常结肠邻近腺瘤/癌、正常肝脏邻近肝转移等,行全基因组规模 DNA 甲基化阵列谱检测,同时对总 RNA 进行全基因组规模表达谱分析,比较不同组织类型间的甲基化与表达模式差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  27. 27 GSE240324 对结直肠癌(CRC)患者与正常对照的外周血单核细胞(PBMCs)进行全基因组DNA甲基化分析,使用Illumina Infinium 850k Human Methylation Beadchip检测约82万个CpG位点,共包含50例CRC样本和50例正常样本,所有样本均采用Qiagen DNeasy Kit提取基因组DNA,数据通过BeadStudio软件v3.2处理,比较两组间DNA甲基化特征差异。 人源 · 100 例 · GPL23976 · 2023/08/10

    设计对结直肠癌(CRC)患者与正常对照的外周血单核细胞(PBMCs)进行全基因组DNA甲基化分析,使用Illumina Infinium 850k Human Methylation Beadchip检测约82万个CpG位点,共包含50例CRC样本和50例正常样本,所有样本均采用Qiagen DNeasy Kit提取基因组DNA,数据通过BeadStudio软件v3.2处理,比较两组间DNA甲基化特征差异。

    摘要Genome wide DNA methylation profiling of peripheral blood mononuclear cells(PBMCs) in normal and CRC samples. The Illumina Infinium 850k Human DNA methylation Beadchip was used to obtain DNA methylation profiles across approximately 820,000 CpGs in PBMC samples. Samples included 50 newly diagnosed CRC patients and 50 normal controls. NOTE:Patients numbered "CRC" and "E-CRC" are from two wards of the same hospital and do not need to be treated differently in data analysis.

  28. 28 GSE119526 本研究使用Infinium MethylationEPIC芯片分析早期结直肠癌患者肿瘤组织及邻近正常组织的全基因组DNA甲基化情况,纳入23例疾病复发患者和22例无复发患者的样本,共96个样本,比较两组间甲基化模式的差异。 人源 · 96 例 · GPL21145 · 2023/04/19

    设计本研究使用Infinium MethylationEPIC芯片分析早期结直肠癌患者肿瘤组织及邻近正常组织的全基因组DNA甲基化情况,纳入23例疾病复发患者和22例无复发患者的样本,共96个样本,比较两组间甲基化模式的差异。

    摘要The current risk stratification system defined by clinicopathological features do not accurately identify the risk of disease recurrence in patients with stage I-II colorectal cancer (CRC). We aimed to investigate whether the CpG sites from newly established genome-wide methylation profiles could serve as biomarkers to improve prognosis prediction.

  29. 29 GSE208596 对结直肠癌患者与健康个体的细胞游离DNA进行甲基化测序,比较两组间GC含量、CpG位点富集程度及甲基化状态差异,评估肿瘤负担并监测治疗反应。 人源 · 95 例 · GPL15520;24676 · 2022/07/21

    设计对结直肠癌患者与健康个体的细胞游离DNA进行甲基化测序,比较两组间GC含量、CpG位点富集程度及甲基化状态差异,评估肿瘤负担并监测治疗反应。

    摘要Genome-wide analysis of cell-free DNA (cfDNA) methylation profile has been recognized as a promising approach for sensitive and specific detection of many cancers. However, scaling such genome-wide assays for clinical translation is impractical due to the high cost of whole genome bisulfite sequencing. We have shown that the small fraction of GC-rich genome is highly enriched in CpG sites and disproportionately harbors the majority of cancer-specific methylation signature. Here, we report on the simple but effective Heat enrichment of CpG-rich regions for Bisulfite Sequencing (Heatrich-BS) platform that allows for focused methylation profiling in these highly informative regions. Our novel method and bioinformatics algorithm enable accurate tumor burden estimation with high sensitivity and quantitative tracking of colorectal cancer patient’s response to treatment, at much reduced sequencing cost suitable for frequent monitoring. We also show, for the first time, tumor epigenetic subtyping from cfDNA using Heatrich-BS, which could enable patient stratification from non-invasive liquid biopsy. As such, Heatrich-BS holds great potential for highly scalable screening and regular monitoring of cancer using liquid biopsy.

  30. 30 GSE79794 对结直肠癌患者及正常人的结直肠组织进行DNA甲基化和转录组分析,样本分为测试队列和验证队列,采用福尔马林固定石蜡包埋处理,比较不同疾病状态及队列间的差异。 人源 · 90 例 · GPL13534;14951 · 2017/07/21

    设计对结直肠癌患者及正常人的结直肠组织进行DNA甲基化和转录组分析,样本分为测试队列和验证队列,采用福尔马林固定石蜡包埋处理,比较不同疾病状态及队列间的差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  31. 31 GSE47071 研究对象为结直肠组织样本,包括正常组织(远离肿瘤、靠近肿瘤)和肿瘤组织(腺瘤、腺癌),采用甲基化分析检测基因组 DNA 的甲基化水平,使用 GPL8490 平台,比较正常组织与肿瘤组织中启动子区域的 5-hmC 标记及甲基化变化特征。 人源 · 89 例 · GPL8490 · 2015/02/03

    设计研究对象为结直肠组织样本,包括正常组织(远离肿瘤、靠近肿瘤)和肿瘤组织(腺瘤、腺癌),采用甲基化分析检测基因组 DNA 的甲基化水平,使用 GPL8490 平台,比较正常组织与肿瘤组织中启动子区域的 5-hmC 标记及甲基化变化特征。

    摘要The discovery of cytosine hydroxymethylation (5-hmC) as a mechanism that potentially controls DNA methylation changes typical of neoplasia prompted us to investigate its behavior in colon cancer. 5-hmC is globally reduced in proliferating cells such as colon tumors and the gut crypt progenitors, from which tumors can arise. Here, we show that colorectal tumors and cancer cells express Ten-Eleven Translocation (TET) transcripts at levels similar to normal tissues. Genome-wide analyses show that promoters marked by 5-hmC in normal tissue, and those identified as TET2 targets in colorectal cancer cells, are resistant to methylation gain in cancer. In vitro studies of TET2 in cancer cells confirm that these promoters are resistant to methylation gain independently of sustained TET2 expression. We also find that a considerable number of the methylation gain-resistant promoters marked by 5-hmC in normal colon overlap with those that are marked with poised bivalent histone modifications in embryonic stem cells. Together our results indicate that promoters that acquire 5-hmC upon normal colon differentiation are innately resistant to neoplastic hypermethylation by mechanisms that do not require high levels of 5-hmC in tumors. Our study highlights the potential of cytosine modifications as biomarkers of cancerous cell proliferation.

  32. 32 GSE220197 对88例未经药物处理的人源结直肠癌细胞系进行DNA甲基化分析,采用EPIC微阵列平台获取甲基化信号并计算beta值,排除性染色体及chrM位点后整合多组学数据,比较不同细胞系的甲基化模式差异。 人源 · 88 例 · GPL21145 · 2024/05/31

    设计对88例未经药物处理的人源结直肠癌细胞系进行DNA甲基化分析,采用EPIC微阵列平台获取甲基化信号并计算beta值,排除性染色体及chrM位点后整合多组学数据,比较不同细胞系的甲基化模式差异。

    摘要Multiple strategies are continuously being explored to expand the drug target repertoire in solid tumors. We devised a novel computational workflow for transcriptome-wide gene expression outlier analysis that allows the systematic identification of both overexpression and underexpression events in cancer cells. Here, it was applied to expression values obtained through RNA sequencing in 226 colorectal cancer (CRC) cell lines that were also characterized by whole-exome sequencing and microarray-based DNA methylation profiling. We found cell models displaying an abnormally high or low expression level for 3533 and 965 genes, respectively. Gene expression abnormalities that have been previously associated with clinically relevant features of CRC cell lines were confirmed. Moreover, by integrating multi-omics data, we identified both genetic and epigenetic alternations underlying outlier expression values. Importantly, our atlas of CRC gene expression outliers can guide the discovery of novel drug targets and biomarkers. As a proof of concept, we found that CRC cell lines lacking expression of the MTAP gene are sensitive to treatment with a PRMT5-MTA inhibitor (MRTX1719). Finally, other tumor types may also benefit from this approach.

  33. 33 GSE35508 收集结直肠癌患者肿瘤组织与配对癌旁正常结肠组织样本,以及人类结直肠癌细胞系,行全基因组规模 DNA 甲基化阵列谱检测,比较肿瘤组织与癌旁正常组织的甲基化模式差异,并关联临床病理特征与拷贝数变异。 人源 · 88 例 · GPL15182 · 2012/08/31

    设计收集结直肠癌患者肿瘤组织与配对癌旁正常结肠组织样本,以及人类结直肠癌细胞系,行全基因组规模 DNA 甲基化阵列谱检测,比较肿瘤组织与癌旁正常组织的甲基化模式差异,并关联临床病理特征与拷贝数变异。

    摘要The concept of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC) is widely accepted, though the timing of its occurrence and its interaction with other genetic defects are not fully understood. Our aim in this study was to unravel the molecular development of CIMP cancers by dissecting their genetic and epigenetic signatures in precancerous and malignant colorectal lesions.

  34. 34 GSE256033 将 HCT116 结肠癌上皮细胞中 Doxycycline-inducible shRNA 靶向 UHRF1 或 DNMT1 的细胞系分别设置为 Knockdown 组和 Recovery 组,通过 Bisulfite-Seq 和 ChIP-Seq 技术检测 CpG 甲基化状态及组蛋白修饰变化,比较 Knockdown 与 Recovery 组的甲基化差异。 人源 · 79 例 · GPL21145;24676;20795 · 2024/10/23

    设计将 HCT116 结肠癌上皮细胞中 Doxycycline-inducible shRNA 靶向 UHRF1 或 DNMT1 的细胞系分别设置为 Knockdown 组和 Recovery 组,通过 Bisulfite-Seq 和 ChIP-Seq 技术检测 CpG 甲基化状态及组蛋白修饰变化,比较 Knockdown 与 Recovery 组的甲基化差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  35. 35 GSE226221 将转移性结直肠癌患者按 2:1 比例随机分为接受 guadecitabine 联合 irinotecan 的治疗组与接受 regorafenib 或 TAS-102 的标准治疗对照组,采集肿瘤组织进行甲基化分析,比较治疗前与治疗后甲基化状态的差异。 人源 · 76 例 · GPL21145 · 2023/03/31

    设计将转移性结直肠癌患者按 2:1 比例随机分为接受 guadecitabine 联合 irinotecan 的治疗组与接受 regorafenib 或 TAS-102 的标准治疗对照组,采集肿瘤组织进行甲基化分析,比较治疗前与治疗后甲基化状态的差异。

    摘要A phase II study of guadecitabien combined with irinotecan vs regorafenib or TAS-102 in previously treated metastatic colorectal cancer patients

  36. 36 GSE88821 对八例结直肠癌患者的多个肿瘤区域及对应正常黏膜组织进行基因组DNA分离,采用亚硫酸氢盐处理后杂交至 Illumina HumanMethylation450 BeadChip 平台,分析肿瘤组织与正常组织的甲基化差异及肿瘤内部异质性。 人源 · 75 例 · GPL13534 · 2016/10/18

    设计对八例结直肠癌患者的多个肿瘤区域及对应正常黏膜组织进行基因组DNA分离,采用亚硫酸氢盐处理后杂交至 Illumina HumanMethylation450 BeadChip 平台,分析肿瘤组织与正常组织的甲基化差异及肿瘤内部异质性。

    摘要Understanding intratumor heterogeneity is clinically important because it could cause therapeutic failure by fostering evolutionary adaptation. To this end, we profiled the genome and epigenome in multiple regions within each of eight colorectal tumors. Extensive intertumor heterogeneity is observed, from which we inferred the evolutionary history of the tumors. First, clonally shared alterations appeared, in which C>T transitions at CpG site and CpG island hypermethylation were relatively enriched. Correlation between mutation counts and patients’ ages suggests that the early-acquired alterations resulted from aging. In the late phase, a parental clone was branched into numerous subclones. Known driver alterations were observed frequently in the early-acquired alterations, but rarely in the late-acquired alterations. Consistently, our computational simulation of the branching evolution suggests that extensive intratumor heterogeneity could be generated by neutral evolution. Collectively, we propose a new model of colorectal cancer evolution, which is useful for understanding and confronting this heterogeneous disease.

  37. 37 GSE141878 从结直肠癌患者中分离出肿瘤反应性 CD8+ 肿瘤浸润淋巴细胞(TILs)、旁观者 CD8+ TILs 以及幼稚型和效应记忆型 CD8+ T 细胞亚型作为对照,分别进行全基因组甲基化分析和转录组测序,比较不同亚型的转录组和甲基化特征。 人源 · 73 例 · GPL24676 · 2019/12/12

    设计从结直肠癌患者中分离出肿瘤反应性 CD8+ 肿瘤浸润淋巴细胞(TILs)、旁观者 CD8+ TILs 以及幼稚型和效应记忆型 CD8+ T 细胞亚型作为对照,分别进行全基因组甲基化分析和转录组测序,比较不同亚型的转录组和甲基化特征。

    摘要Tumor-reactive CD8+ tumor infiltrating lymphocytes (TILs) represent a subtype of T cells that could recognize and destroy tumor specifically. Understanding the regulatory mechanism of tumor-reactive CD8+ T cells has important therapeutic implications. Yet the DNA methylation status of this T cell subtype has not been elucidated. In this study, we segregated tumor-reactive and bystander CD8+ TILs, as well as naïve and effector memory CD8+ T cell subtypes as controls from colorectal cancer (CRC) patients, to compare their transcriptome and methylome characteristics. Transcriptome profiling confirmed previous conclusion that tumor-reactive TILs have an exhausted tissue-resident memory signature. Whole-genome methylation profiling identified a distinct methylome pattern of tumor-reactive CD8+ T cells, with tumor-reactive markers (CD39 and CD103) being specifically demethylated. In addition, dynamic changes were observed during the transition of naïve T cells into tumor-reactive CD8+ T cells. Transcription factor (TF) binding motif enrichment analysis identified several immune-related TFs, including three exhaustion-related genes (NR4A1, BATF and EGR2) and VDR, that potentially play important regulatory role in tumor-reactive CD8+ T cells. Our study supports the involvement of DNA methylation in shaping tumor-reactive and bystander CD8+ TILs, and provides a valuable resource for the development of novel DNA methylation markers and future therapeutics.

  38. 38 GSE129364 将72例结直肠腺瘤样本(含无复发腺瘤30例、有复发腺瘤29例、匹配对样本10例[每例包含原发腺瘤与对应复发腺瘤]及正常黏膜3例)的基因组DNA进行亚硫酸盐转化,采用Illumina HumanMethylation 450K BeadChip阵列检测全基因组甲基化状态,比较复发腺瘤与匹配原发腺瘤、腺瘤与正常黏膜的差异。 人源 · 72 例 · GPL13534 · 2019/06/01

    设计将72例结直肠腺瘤样本(含无复发腺瘤30例、有复发腺瘤29例、匹配对样本10例[每例包含原发腺瘤与对应复发腺瘤]及正常黏膜3例)的基因组DNA进行亚硫酸盐转化,采用Illumina HumanMethylation 450K BeadChip阵列检测全基因组甲基化状态,比较复发腺瘤与匹配原发腺瘤、腺瘤与正常黏膜的差异。

    摘要Aberrant methylation of DNA is supposed to be a major and early driver of colonic adenoma development and may also lead to colorectal cancer (CRC) formation. While gene methylation assays are used already for CRC screening, differential epigenetic alterations of recurring and non-recurring colorectal adenomas have yet not been systematically investigated. Here, we collected a sample set (n=72) of formalin-fixed paraffin-embedded (FFPE) primary colorectal adenomas without recurrence (n=30), primary adenomas with recurrence at the same location (n=19), so-called “matched pair samples” (n=10; comprising the primary adenoma and the recurrent adenoma) and normal mucosa specimens (n=3). We aimed to unveil differentially methylated CpG positions (DMPs) across the methylome of the selected samples using the Illumina HumanMethylation 450K BeadChip array. Unsupervised hierarchical clustering exhibited a significant association of methylation patterns with the histological subtypes. No significant DMPs were identified comparing primary adenomas with and without recurrence. Despite that, a total of 5,094 DMPs (FDR<0.05, fold change>10%) were identified in the comparisons of recurrent adenomas vs. (non-) matched primary adenomas with recurrence (674; 98% hypermethylated), recurrent adenomas vs. primary adenomas with and without recurrence (241; 99% hypermethylated) and adenomas vs. normal mucosae (4,179; 46% hypermethylated). DMPs in CpG islands were frequently hypermethylated whereas open sea and shelves exhibited hypomethylation. Gene ontological analysis demonstrated enrichment of genes associated with the immune system, inflammatory processes, and cancer-pathways. We conclude that methylation data is helpful to contribute to a more stable and reproducible histological adenoma classification which is a prerequisite to establishing profound surveillance guidelines

  39. 39 GSE95656 对结直肠癌患者和健康个体的结肠组织进行全基因组 DNA 甲基化分析,比较不同疾病状态(健康、II-IV 期结肠癌)下的正常隐窝、相邻正常结肠组织和肿瘤组织的甲基化差异。采用 Bisulfite-Seq 技术,样本通过激光捕获显微切割获取,每组至少分离 1 mm² 组织(约 10,000 个细胞)。部分样本设置技术重复(如 165S1 和 165S2)。 人源 · 71 例 · GPL16791 · 2018/01/23

    设计对结直肠癌患者和健康个体的结肠组织进行全基因组 DNA 甲基化分析,比较不同疾病状态(健康、II-IV 期结肠癌)下的正常隐窝、相邻正常结肠组织和肿瘤组织的甲基化差异。采用 Bisulfite-Seq 技术,样本通过激光捕获显微切割获取,每组至少分离 1 mm² 组织(约 10,000 个细胞)。部分样本设置技术重复(如 165S1 和 165S2)。

    摘要This SuperSeries is composed of the SubSeries listed below.

  40. 40 GSE39068 对结直肠癌(colorectal cancer)肿瘤组织和匹配的正常结肠组织进行全基因组 DNA 甲基化分析,采用 MethylCap-seq 方法捕获甲基化 DNA 并进行高通量测序。同时,将 MethylCap-seq 数据与 HCT116 细胞系的 RNA-seq 和 ChIP-seq 数据进行比较,以分析甲基化与基因表达调控的关系。 人源 · 68 例 · GPL10999 · 2012/10/26

    设计对结直肠癌(colorectal cancer)肿瘤组织和匹配的正常结肠组织进行全基因组 DNA 甲基化分析,采用 MethylCap-seq 方法捕获甲基化 DNA 并进行高通量测序。同时,将 MethylCap-seq 数据与 HCT116 细胞系的 RNA-seq 和 ChIP-seq 数据进行比较,以分析甲基化与基因表达调控的关系。

    摘要In our study we applied a genome-wide DNA methylation analysis approach, MethylCap-seq, to map the differentially methylated regions in 24 tumor and matched normal colon samples. In total, 2687 frequently hypermethylated and 468 frequently hypomethylated regions were identified, which include potential biomarkers for CRC diagnosis. Hypermethylation in the tumor samples was enriched at CpG islands and gene promoters, while hypomethylation was distributed throughout the genome. Using epigenetic data from human embryonic stem cells, we show that frequent differentially methylated regions (DMRs) coincide with bivalent loci in human embryonic stem cells. DNA methylation is commonly thought to lead to cancer gene related silencing, however integration of publically available expression analysis shows that 75% of the frequently hypermethylation genes were most likely already lowly or not expressed in normal tissue. Collectively, our study provides genome-wide DNA methylation maps of colon cancer, comprehensive lists of DMRs, and gives further clues on the role of aberrant DNA methylation in CRC formation.

  41. 41 GSE42752 对结直肠癌患者及非患者来源的结肠组织样本进行全基因组 DNA 甲基化检测,采集结肠腺癌组织(22 个)、癌症无关正常结肠组织(22 个)及癌症相关正常结肠组织样本(共 63 个),采用 Illumina HumanMethylation450 BeadChip 平台检测约 485000 个 CpG 位点,比较不同组织类型间的甲基化差异。 人源 · 63 例 · GPL13534 · 2012/12/06

    设计对结直肠癌患者及非患者来源的结肠组织样本进行全基因组 DNA 甲基化检测,采集结肠腺癌组织(22 个)、癌症无关正常结肠组织(22 个)及癌症相关正常结肠组织样本(共 63 个),采用 Illumina HumanMethylation450 BeadChip 平台检测约 485000 个 CpG 位点,比较不同组织类型间的甲基化差异。

    摘要Genome-wide DNA methylation profiles were obtained from colon adenocarcinoma samples (22), corresponding normal colon tissue (22) and cancer-unrelated normal colon tissue using Illumina HumanMethylation450 BeadChips. Approximately 485000 CpG sites were measured in every sample.

  42. 42 GSE236026 研究采用结直肠癌甲基化分析,使用人类结直肠癌细胞系 HCT116 及其衍生的 WT 和 DKO(DNMT1 超突变和 DNMT3B 敲除)细胞系,通过 auxin-inducible degron(AID)技术实现 UHRF1 和 DNMT1 的特异性降解。在含 doxycycline 和 auxin 的培养基中,对细胞进行 0、2、4、6、8、12 天时间点的处理,采集全基因组 DNA 进行亚硫酸氢盐测序,比较不同基因型(WT、UHRF1-AID、DNMT1-AID、UHRF1-AID/DNMT1-AID)在 auxin 处理前后的甲基化动态变化。 人源 · 62 例 · GPL20795 · 2024/02/12

    设计研究采用结直肠癌甲基化分析,使用人类结直肠癌细胞系 HCT116 及其衍生的 WT 和 DKO(DNMT1 超突变和 DNMT3B 敲除)细胞系,通过 auxin-inducible degron(AID)技术实现 UHRF1 和 DNMT1 的特异性降解。在含 doxycycline 和 auxin 的培养基中,对细胞进行 0、2、4、6、8、12 天时间点的处理,采集全基因组 DNA 进行亚硫酸氢盐测序,比较不同基因型(WT、UHRF1-AID、DNMT1-AID、UHRF1-AID/DNMT1-AID)在 auxin 处理前后的甲基化动态变化。

    摘要DNA methylation is an essential epigenetic mark in mammals. It controls gene expression and genome stability. Global DNA methylation pattern is abnormal in cancers. Ubiquitin like with PHD and RING finger domains 1 (UHRF1) is a key epigenetic regulator that recruits and activates DNA methyltransferase 1 (DNMT1), the methylation maintenance enzyme. UHRF1 is a proven oncogene and its overexpression transforms cells in vitro and causes cancer in animal models. Therefore, UHRF1 provides a unique entry point into the links between epigenetics and cancer. However, it is still not fully clear how UHRF1 works in cancer cells. To understand UHRF1 functions in cancer, we employed experimental strategy to use an advanced chemical/genetic system, the auxin-inducible degron (AID) technology, whereby the degron-fused protein can be totally and rapidly degraded upon the addition of a small molecule, auxin. We chose the human CRC cell line HCT116 as our model and successfully generated UHRF1-AID and DNMT1-AID. Through this study, we made the significant discovery that UHRF1 not only regulates DNMT1, but also influences the activities of de novo methyltransferases DNMT3A and DNMT3B, as well as the active demethylase TET2.

  43. 43 GSE139404 对人类结直肠癌前病变组织及正常组织进行全基因组 DNA 甲基化检测,比较低级别腺瘤(18 例)、高级别腺瘤(22 例)与正常组织(20 例)的甲基化差异。采用亚硫酸盐转化 DNA 技术,将样本 DNA 杂交至 Illumina Infinium 450k 甲基化芯片,旨在识别早期诊断的潜在生物标志物。 人源 · 60 例 · GPL13534 · 2020/04/23

    设计对人类结直肠癌前病变组织及正常组织进行全基因组 DNA 甲基化检测,比较低级别腺瘤(18 例)、高级别腺瘤(22 例)与正常组织(20 例)的甲基化差异。采用亚硫酸盐转化 DNA 技术,将样本 DNA 杂交至 Illumina Infinium 450k 甲基化芯片,旨在识别早期诊断的潜在生物标志物。

    摘要Abnormal DNA methylation is a hallmark of human cancers and may be a promising biomarker for early diagnosis of human cancers1. However, the majority of DNA methylation biomarkers that have been identified are based on the hypothesis that early differential methylation regions (DMRs) are maintained throughout carcinogenesis and could be detected at all stages of cancer. In this study, we identified potential early biomarkers of colorectal cancer (CRC) development by genome-wide DNA methylation assay (Illumina infinium450, 450K) to normal (N=20) and pre-colorectal cancer samples including 18 low-grade adenoma (LGA) and 22 high-grade adenoma (HGA).

  44. 44 GSE210018 收集来自健康个体和Lynch综合征(LS)患者的左、右结肠正常类器官样本,采用Illumina EPIC甲基化芯片对两类样本行全基因组DNA甲基化谱检测,比较健康对照与LS类器官的甲基化模式差异。 人源 · 58 例 · GPL23976 · 2023/06/01

    设计收集来自健康个体和Lynch综合征(LS)患者的左、右结肠正常类器官样本,采用Illumina EPIC甲基化芯片对两类样本行全基因组DNA甲基化谱检测,比较健康对照与LS类器官的甲基化模式差异。

    摘要Approximately 15% of colorectal cancer (CRC) patients present with high levels of microsatellite instability (MSI-H), which is driven by defective mismatch repair (dMMR). While about 20% of MSI-H tumors are associated with the hereditary condition, Lynch syndrome (LS), the majority develop through non-hereditary mechanisms. In recent years, the molecular processes underpinning tumor development in LS patients has been debated, with the longstanding view that dMMR is a secondary process in CRC development of LS patients being questioned. Here, we performed the first multi-omic analysis of normal colon organoids developed from LS and healthy patients to address questions regarding the development of dMMR in LS colon epithelial cells from cancer-free individuals.

  45. 45 GSE64112 收集32例散发性结直肠原发肿瘤及同一患者匹配的癌旁正常黏膜,提取基因组DNA并经亚硫酸盐处理后,使用Illumina HumanMethylation450 BeadChip(GPL9183)进行甲基化谱检测,以匹配正常黏膜为参照,比较肿瘤与正常组织的全基因组甲基化状态,并结合UPD/UPP与拷贝数变异进行整合分析。 人源 · 58 例 · GPL9183 · 2015/09/02

    设计收集32例散发性结直肠原发肿瘤及同一患者匹配的癌旁正常黏膜,提取基因组DNA并经亚硫酸盐处理后,使用Illumina HumanMethylation450 BeadChip(GPL9183)进行甲基化谱检测,以匹配正常黏膜为参照,比较肿瘤与正常组织的全基因组甲基化状态,并结合UPD/UPP与拷贝数变异进行整合分析。

    摘要The aim of this study is to establish an integrative profiling of recurrent UPDs/UPPs, CNAs and genome-wide methylation status in sporadic CRC. Our results indicate that regions showing high frequencies of UPDs/UPPs mostly coincide with regions typically involved in genomic losses such as chromosome arms 1p, 5q, 8p, 14q, 17p, 18q, 20p, and 22q. Of these, chromosome arms 5q, 14q, 17p, and 20p preferentially showed UPDs/UPPs over genomic losses suggesting that tumor cells must maintain the disomic state of certain genes to favor cellular fitness. A meta-analysis using over 300 samples from The Cancer Genome Atlas confirmed our findings. In addition, the genes CSPG2, FLT4, SFRP1, DLK1, and GAS7 were frequently involved in regions of UPDs/UPPs and showed high levels of methylation revealing that UPDs/UPPs can result in the duplication of hypermethylated inactive genes.

  46. 46 GSE256028 将 HCT116 人结直肠癌上皮细胞中 UHRF1 和 DNMT1 的基因敲低及恢复处理进行比较,采集不同时间点的基因组 DNA 进行甲基化分析,评估 UHRF1 和 DNMT1 的泛素信号对低密度 CpG 甲基化维持的影响。 人源 · 57 例 · GPL21145 · 2024/10/23

    设计将 HCT116 人结直肠癌上皮细胞中 UHRF1 和 DNMT1 的基因敲低及恢复处理进行比较,采集不同时间点的基因组 DNA 进行甲基化分析,评估 UHRF1 和 DNMT1 的泛素信号对低密度 CpG 甲基化维持的影响。

    摘要The E3 ubiquitin ligase UHRF1 is an established cofactor for replication-coupled DNA methylation inheritance. The current model posits a stepwise pathway in which UHRF1 engages nucleosomes through histone and DNA binding. This multivalent nucleosome readout directs UHRF1 ubiquitin ligase activity toward several lysines on N-terminal tails of histone H3, binding sites for DNMT1 through tandem ubiquitin interacting motifs (UIM1 and UIM2). While this elegant chromatin regulatory mechanism is now taking shape, the extent to which ubiquitin signaling through UHRF1 contributes to DNMT1-dependent DNA methylation maintenance genome-wide is not known. Here, we present comparative, genome-scale analysis of DNA methylation inheritance in human colon cancer cells with compromised UHRF1 ubiquitin ligase and DNMT1 ubiquitin reading activities. We reveal that DNA methylation maintenance in contexts of low CpG density is particularly vulnerable to disruption of UHRF1 ubiquitin ligase activity. This low CpG density hypomethylation signature, a common feature of partially methylated domains (PMDs) in human cancers, is also seen when DNMT1 ubiquitin reading activity through UIM1 is disrupted. Notably, disrupting UIM2 function affects DNA methylation inheritance to a similar extent as a catalytically dead form of the enzyme. Collectively, these studies demonstrate that DNMT1-dependent DNA methylation inheritance is a ubiquitin-regulated process and suggest that a disrupted UHRF1-DNMT1 ubiquitin signaling axis contributes to the development of PMDs in human cancers.

  47. 47 GSE171550 对56例结直肠癌患者 colorectal tumor adjacent normal tissue 进行亚硫酸氢盐处理后,采用Illumina Infinium Human MethylationEPIC Beadchip芯片检测DNA甲基化状态,比较肿瘤组织与邻近正常组织在化疗相关手足综合征发生与否的差异。 人源 · 56 例 · GPL21145 · 2021/08/27

    设计对56例结直肠癌患者 colorectal tumor adjacent normal tissue 进行亚硫酸氢盐处理后,采用Illumina Infinium Human MethylationEPIC Beadchip芯片检测DNA甲基化状态,比较肿瘤组织与邻近正常组织在化疗相关手足综合征发生与否的差异。

    摘要Background: Capecitabine-based adjuvant chemotherapy is the first-line treatment for patients with colorectal cancer (CRC). Although this therapy generally reduces the incidence of CRC recurrence and mortality, it can cause various chemotherapy-related adverse events (CRAEs), one of the most frequent of which is hand-foot syndrome (HFS). Most of the currently available HFS prediction markers focus on the pharmacokinetic parameters of drugs or their metabolites, yet our understanding of the biomolecular mechanism of HFS remains limited. Methods: We conducted an integrated multi-omics analysis of 63 Chinese patients with colorectal cancer (CRC) who had chemotherapy related adverse effect (CRAE) records during adjuvant chemotherapy. The metabolomic profiles for each of plasma, urine, and colorectal tissue as well as profiles for colorectal-tissue transcriptomics and genome methylation were analyzed based on samples collected before and during surgery. Results: Susceptibility to HFS was found to be associated with profibrotic changes in several aspects of cellular biochemistry and physiology, characterized by reduced nucleotide salvage (indicating potential tissue damage, elevated spermine release, increased M2 macrophage polarization, and hypermethylation of genes for collagen formation. All these aspects were found to promote fibrosis, even before patients received chemotherapeutic drugs or developed any HFS symptoms. Additionally, we developed and validated relevant biomarkers with reasonably good discrimination performance and a high AUROC (area under the receiver operating characteristic curve) value, i.e., from 0.848 to 1.000. Conclusions: Our results demonstrate that a profibrotic phenotype characterized by multi-omics variation in colorectal tissue, plasma, and urine is closely related to the susceptibility to chemotherapy-induced HFS. Our findings provide a better understanding of the molecular mechanism underlying HFS.

  48. 48 GSE79740 以结直肠印戒细胞癌为对象,取结直肠癌患者手术切除的福尔马林固定石蜡包埋组织,用 Maxwell 16 FFPE Plus LEV DNA Purification Kit 提取基因组 DNA,以 Illumina Infinium 450k 甲基化芯片检测 DNA 甲基化。样本分为发现(test)队列 26 例与验证(validation)队列 18 例,按 disease state 分为 normal 与 tumour,比较肿瘤与正常组织及两队列间的甲基化差异,用于识别印戒细胞癌的甲基化分子亚型。 人源 · 54 例 · GPL13534 · 2017/07/21

    设计以结直肠印戒细胞癌为对象,取结直肠癌患者手术切除的福尔马林固定石蜡包埋组织,用 Maxwell 16 FFPE Plus LEV DNA Purification Kit 提取基因组 DNA,以 Illumina Infinium 450k 甲基化芯片检测 DNA 甲基化。样本分为发现(test)队列 26 例与验证(validation)队列 18 例,按 disease state 分为 normal 与 tumour,比较肿瘤与正常组织及两队列间的甲基化差异,用于识别印戒细胞癌的甲基化分子亚型。

    摘要Identification of molecular subtypes of colorectal signet ring cell carcinoma based on differences in DNA methylation.

  49. 49 GSE107352 对12例constitutional MLH1表观突变携带者、61例林奇综合征患者及41名健康对照的FFPE结直肠癌组织和正常黏膜样本进行Infinium Human Methylation 450K芯片分析,结合靶向分子技术研究MLH1表观突变特征及其遗传模式,比较突变携带者与对照组在EPM2AIP1-MLH1 CpG岛的甲基化差异。 人源 · 51 例 · GPL13534 · 2017/11/28

    设计对12例constitutional MLH1表观突变携带者、61例林奇综合征患者及41名健康对照的FFPE结直肠癌组织和正常黏膜样本进行Infinium Human Methylation 450K芯片分析,结合靶向分子技术研究MLH1表观突变特征及其遗传模式,比较突变携带者与对照组在EPM2AIP1-MLH1 CpG岛的甲基化差异。

    摘要Background: Constitutional MLH1 epimutations are characterized by monoallelic methylation of the MLH1 promoter throughout normal tissues, accompanied by allele-specific silencing. The mechanism underlying primary MLH1 epimutations is currently unknown. The aim of this study was to perform an in-depth characterization of constitutional MLH1 epimutations targeting the aberrantly methylated region around MLH1 and other genomic loci. Methods: Twelve MLH1 epimutation carriers, 61 Lynch syndrome patients and 41 healthy controls, were analyzed by Infinium Human Methylation 450K beadchip, and targeted molecular techniques were used to characterize the MLH1 epimutation in carriers and their inheritance pattern. Results: No nucleotide or structural variants were identified in-cis on the epimutated allele in ten carriers, in which intergenerational methylation erasure was demonstrated in two, suggesting primary type of epimutation. CNVs outside the MLH1 locus were found in two cases. EPM2AIP1-MLH1 CpG island was identified as the sole differentially methylated region in MLH1 epimutation carriers compared to controls. Conclusion: Primary constitutional MLH1 epimutations arise as a focal epigenetic event at the EPM2AIP1-MLH1 CpG island in the absence of cis-acting genetic variants. Further molecular characterization is needed to elucidate the mechanistic basis of MLH1 epimutations and their heritability/reversibility.

  50. 50 GSE118972 对人类结直肠癌细胞系 HCT116 和 RKO 的基因组 DNA 进行甲基化分析,通过敲除内源性 UHRF1 并补充不同突变形式的外源性 UHRF1,比较各组细胞的甲基化状态及与野生型的差异。 人源 · 50 例 · GPL21145;10332 · 2019/02/28

    设计对人类结直肠癌细胞系 HCT116 和 RKO 的基因组 DNA 进行甲基化分析,通过敲除内源性 UHRF1 并补充不同突变形式的外源性 UHRF1,比较各组细胞的甲基化状态及与野生型的差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  51. 51 GSE166212 对人类结直肠肿瘤及配对正常结肠组织的基因组 DNA 进行甲基化芯片检测。肿瘤组织 DNA 来自经 EDTA 洗脱释放的数百个肿瘤腺体;21 个肿瘤分别取相对的 A 侧与 B 侧(共 42 份肿瘤样本),另有 6 份与之配对的正常结肠组织,合计 48 份样本。肿瘤类型涵盖腺瘤及 1–4 期癌,患者年龄 41–93 岁、男女均有。主要比较同一肿瘤相对两侧之间以及肿瘤与配对正常结肠组织之间的甲基化差异。 人源 · 48 例 · GPL21145 · 2021/02/05

    设计对人类结直肠肿瘤及配对正常结肠组织的基因组 DNA 进行甲基化芯片检测。肿瘤组织 DNA 来自经 EDTA 洗脱释放的数百个肿瘤腺体;21 个肿瘤分别取相对的 A 侧与 B 侧(共 42 份肿瘤样本),另有 6 份与之配对的正常结肠组织,合计 48 份样本。肿瘤类型涵盖腺瘤及 1–4 期癌,患者年龄 41–93 岁、男女均有。主要比较同一肿瘤相对两侧之间以及肿瘤与配对正常结肠组织之间的甲基化差异。

    摘要Methylation is measured from opposite tumor sides of human colorectal cancers

  52. 52 GSE184494 采集结直肠癌患者手术切除的肿瘤组织及对应正常组织,提取基因组DNA,使用Illumina 450K甲基化芯片(GPL13534)检测甲基化谱,按不同疾病分期将每位患者的肿瘤组织与对应正常组织配对比较甲基化差异。 人源 · 48 例 · GPL13534 · 2021/12/15

    设计采集结直肠癌患者手术切除的肿瘤组织及对应正常组织,提取基因组DNA,使用Illumina 450K甲基化芯片(GPL13534)检测甲基化谱,按不同疾病分期将每位患者的肿瘤组织与对应正常组织配对比较甲基化差异。

    摘要Colorectal cancer tissues

  53. 53 GSE29490 对结直肠癌患者肿瘤组织与对应周围健康结肠黏膜进行全基因组DNA甲基化芯片分析,采用Illumina Infinium 27k Human DNA甲基化芯片v1.2检测27,578个CpG位点覆盖的14,475个基因,每名患者提供1对配对样本共48个GSM记录。 人源 · 48 例 · GPL8490 · 2012/05/23

    设计对结直肠癌患者肿瘤组织与对应周围健康结肠黏膜进行全基因组DNA甲基化芯片分析,采用Illumina Infinium 27k Human DNA甲基化芯片v1.2检测27,578个CpG位点覆盖的14,475个基因,每名患者提供1对配对样本共48个GSM记录。

    摘要Genome wide DNA methylation profiling of tumor and surrounding healthy colonic mucosa from patients with colorectal carcinoma. The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across 27,578 CpG loci covering 14,475 genes.

  54. 54 GSE33181 对结直肠癌患者的结肠肿瘤及周围健康组织,分别采用新鲜冷冻(FF)和福尔马林固定石蜡包埋(FFPE)样本,使用Thirwell改良的DNA修复协议处理FFPE样本,提取基因组DNA后进行Infinium甲基化芯片检测,比较FF与FFPE样本中肿瘤特异性差异甲基化位点(DML)的定位和一致性。 人源 · 48 例 · GPL8490 · 2014/10/23

    设计对结直肠癌患者的结肠肿瘤及周围健康组织,分别采用新鲜冷冻(FF)和福尔马林固定石蜡包埋(FFPE)样本,使用Thirwell改良的DNA修复协议处理FFPE样本,提取基因组DNA后进行Infinium甲基化芯片检测,比较FF与FFPE样本中肿瘤特异性差异甲基化位点(DML)的定位和一致性。

    摘要Formalin-fixed paraffin-embedded (FFPE) samples are a highly desirable resource for epigenetic studies, but there is no suitable platform to assay genome-wide methylation in these widely available resources. Recently, Thirwell et al. (2010) have reported a modified ligation-based DNA repair protocol to prepare FFPE DNA for the Infinium methylation assay. In this study, we have tested the accuracy of methylation data obtained with this modification by comparing paired fresh-frozen (FF) and FFPE colon tissue from colorectal cancer patients. We report locus-specific correlation and concordance of tumor-specific differentially-methylated loci (DML), both of which were not previously assessed.

  55. 55 GSE47075 收集结直肠癌患者肿瘤组织与配对癌旁黏膜样本,采用甲基化阵列谱检测技术分析 DNA 甲基化模式。研究同时对 H3K27me3 和 H3K4me3 标记进行染色质免疫沉淀(ChIP)分析,使用 NimbleGen 人类 CpG 岛/启动子微阵列进行检测。所有实验均针对同一批配对样本同步进行,涵盖 15 位患者(编号 1-15)的肿瘤与癌旁组织,其中患者 6、8、12、13 的样本被特别标注。检测包括 MIRA 技术用于 5mC 模式分析,以及使用 H3K27me3 和 H3K4me3 抗体进行 ChIP 分析,最终通过微阵列平台进行信号读取。 人源 · 48 例 · GPL13118 · 2013/12/31

    设计收集结直肠癌患者肿瘤组织与配对癌旁黏膜样本,采用甲基化阵列谱检测技术分析 DNA 甲基化模式。研究同时对 H3K27me3 和 H3K4me3 标记进行染色质免疫沉淀(ChIP)分析,使用 NimbleGen 人类 CpG 岛/启动子微阵列进行检测。所有实验均针对同一批配对样本同步进行,涵盖 15 位患者(编号 1-15)的肿瘤与癌旁组织,其中患者 6、8、12、13 的样本被特别标注。检测包括 MIRA 技术用于 5mC 模式分析,以及使用 H3K27me3 和 H3K4me3 抗体进行 ChIP 分析,最终通过微阵列平台进行信号读取。

    摘要We used NimbleGen human CpG/promoter microarrays for profiling epigenetic changes (DNA methylation, H3K27me3 and H3K4me3 marks) in colon tumors (Duke's stage II) and matching mucosa samples from patients.

  56. 56 GSE77954 对48例结直肠癌患者不同组织类型的DNA进行全基因组甲基化分析,比较正常结肠组织与腺瘤、癌及转移灶的甲基化差异。采用IlluminaHumanMethylation450 Beadchip平台检测,样本包含腺瘤、癌、转移灶及邻近正常组织。 人源 · 48 例 · GPL13534 · 2016/05/13

    设计对48例结直肠癌患者不同组织类型的DNA进行全基因组甲基化分析,比较正常结肠组织与腺瘤、癌及转移灶的甲基化差异。采用IlluminaHumanMethylation450 Beadchip平台检测,样本包含腺瘤、癌、转移灶及邻近正常组织。

    摘要Colorectal tumorigenesis proceedes through well defined clinical stages assoicated with charateristic mutations. Besides genetic alterations, epi-driver genes that are aberrantly expressed in cancers in a fashion that confers a seletive growth advantage can also contribute to tumor evolution. To gain a global view of methylation patterns in normal and maliganant colorectal epithelia, we performed genome-wide DNA methylation analysis on DNAs from 48 fresh frozen CRC samples at different stages of CRC progression. We used IlluminaHumanMethylation450 Beadchip to get a broad view of genome-wide DNA methylationdata during CRC progression and identified significantly differentially methylated genes during CRC progression

  57. 57 GSE158011 对结直肠癌细胞系 HCT116 和 DKO1 的基因组 DNA 进行 Hi-C 和 WGBS 测序,分析 DNA 甲基化对高阶基因组结构的影响,比较不同细胞周期阶段的染色质相互作用模式及甲基化状态差异。 人源 · 46 例 · GPL20795;16791;24676;26167 · 2021/09/21

    设计对结直肠癌细胞系 HCT116 和 DKO1 的基因组 DNA 进行 Hi-C 和 WGBS 测序,分析 DNA 甲基化对高阶基因组结构的影响,比较不同细胞周期阶段的染色质相互作用模式及甲基化状态差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  58. 58 GSE39958 对45例直肠癌患者肿瘤组织进行全基因组甲基化分析,根据其对术前化疗放疗(CRT)的反应分组(完全反应、主导反应、有效反应),采用Infinium® Methylation Assay检测甲基化状态,比较不同反应类型样本的甲基化特征。 人源 · 45 例 · GPL13534 · 2014/08/01

    设计对45例直肠癌患者肿瘤组织进行全基因组甲基化分析,根据其对术前化疗放疗(CRT)的反应分组(完全反应、主导反应、有效反应),采用Infinium® Methylation Assay检测甲基化状态,比较不同反应类型样本的甲基化特征。

    摘要The identification of surrogate methylation markers that can predict responses to preoperative chemoradiotherapy (CRT) in rectal cancer patients. Genome-wide association studies in clinical populations are theoretically capable of identifying markers that are capable of tumor regression after CRT. We used Infinium® Methylation Assay to detail methylation status of patient’s group showing differential responsiveness to preoperative CRT and profiled SNP biomarkers. The chemoradiosensitivity of tumor tissue from the initial cohort of 45 patients was assessed using clinical responses of tumor regression grade (TRG). TRG was clinically categorized as complete response (CR) as TRG 1, dominant response (ER or finally as DR) as TRG 1 and 2, and efficient response (RYN or finally as ER) as TRG 1, 2, and 3 (TRG grade from Mandard et al, 1994).

  59. 59 GSE159898 对21名中国结直肠癌患者及其配对正常组织的甲基化谱型进行分析,使用Illumina Infinium MethylationEPIC 850K芯片检测亚硫酸盐转化DNA,比较肿瘤组织与正常组织的甲基化差异以识别诊断标志物和化疗毒性相关标志物。 人源 · 44 例 · GPL21145 · 2021/08/01

    设计对21名中国结直肠癌患者及其配对正常组织的甲基化谱型进行分析,使用Illumina Infinium MethylationEPIC 850K芯片检测亚硫酸盐转化DNA,比较肿瘤组织与正常组织的甲基化差异以识别诊断标志物和化疗毒性相关标志物。

    摘要Background: Colorectal cancer (CRC) remains a major concern with high morbidity and mortality worldwide. DNA methylation alteration plays a pivotal role in cancer development. We aimed to screen novel biomarkers for CRC diagnosis and chemotherapy-related adverse event (CRAE) prediction using the advanced Illumina Infinium MethylationEPIC (850K) BeadChip. Methods: We analyzed the methylation profiles of paired tumor and normal tissues from 21 Chinese CRC patients. After normalization by potential confounders, three types of methylation profiles (differentially methylated probes, differentially methylated regions, and gene-function-differentially methylated regions) were further studied by functional annotation and pathway enrichment analysis. At last, integrated-methylation-marker systems for CRC diagnosis and CRAE prediction were developed based on genes within the mostly related pathways and LASSO regression. Findings: Tumor-related methylation was characterized with hypermethylated promoter islands and hypomethylated intragenic openseas. CRAE-related methylation was characterized with hyper- (or hypo-) methylated intragenic (or intergenic) regions. The two most important susceptible factors for various types of CARE were inactive regeneration functions and active immune response. Differentially methylated genes were significantly enriched in neuronal system, metabolism of RNA, and extracellular matrix organization. All of the integrated-methylation-marker systems demonstrated high discriminative accuracy in both CRC diagnosis (AUROC = 1) and CRAE prediction (AUROC = 0.817-1). Interpretation: In this study, we provided new insights on the formation of CRC diagnosis and CRAE based on three types of methylation profile. The integrated-methylation-marker systems combining multiple DMPs were found to have potentially diagnostic and predictive values. Hence, our findings have important clinical implications, and further validation is warranted.

  60. 60 GSE17648 研究使用基于beadchip阵列的甲基化分析技术,检测27,578个CpG位点在结直肠癌组织及相邻正常黏膜中的甲基化状态,比较两者的差异,并通过pyrosequencing验证部分位点的甲基化情况。 人源 · 44 例 · GPL8490 · 2009/08/18

    设计研究使用基于beadchip阵列的甲基化分析技术,检测27,578个CpG位点在结直肠癌组织及相邻正常黏膜中的甲基化状态,比较两者的差异,并通过pyrosequencing验证部分位点的甲基化情况。

    摘要Determination of the profile of genes commonly aberrantly methylated in colorectal cancer (CRC) has substantial potential value for diagnostic and therapeutic application. However, our knowledge of the DNA methylation pattern in CRC is currently limited. Therefore, we analyzed the methylation profile of 27,578 CpG sites spanning more than 14,000 genes in CRC and in adjacent normal mucosa using beadchip array-based technology. We identified 621 CpG sites located in promoter region and CpG islands that were significantly hypermethylated in CRC compared to normal mucosa. Genes on chromosome 18 showed promoter hypermethylation most frequently. According to gene ontology analysis, the most common biologically relevant class of genes affected by methylation was the class associated with the cadherin signaling pathway. In comparison with genome-wide expression array, mRNA expression was more like to be down-regulated in the genes demonstrating promoter hypermethylation, although this was not statistically significant. We validated 10 CpG sites that were shown to be hypermethylated in the array studies (ADHFE1, BOLL, SLC6A15, ADAMTS5, TFPI2, EYA4, NPY, TWIST1, LAMA1, GAS7) and 2 CpG sites showing hypomethylaion (MAEL, SFT2D3) in CRC compared to normal mucosa using pyrosequencing. The methylation status measured by pyrosequencing was consistent with the methylation array data. In conclusion, we have shown that methylation profiling based on beadchip arrays is an effective method for screening for aberrantly methylated genes in CRC. In addition, we identified novel methylated genes that are candidate diagnostic or prognostic markers for CRC.

  61. 61 GSE284238 以40–74岁初次接受筛查结肠镜检查的成人为对象,纳入24例确诊结直肠腺瘤者与20例全结肠镜无异常的健康对照,取下段直肠(Houston瓣与齿状线之间)外观正常黏膜活检,每处取两块、立即冻存于-80℃,提取基因组DNA并经亚硫酸盐处理后,用Illumina Infinium MethylationEPIC v2.0 BeadChip(935K)进行DNA甲基化谱检测;以线性回归模型(校正性别、年龄、肥胖、糖尿病、当前吸烟与规律饮酒)考察各CpG位点甲基化与腺瘤发生的关系,并对含显著关联CpG位点的基因做GO与KEGG富集分析,比较腺瘤组与正常对照组背景黏膜的甲基化差异。 人源 · 44 例 · GPL33022 · 2025/12/31

    设计以40–74岁初次接受筛查结肠镜检查的成人为对象,纳入24例确诊结直肠腺瘤者与20例全结肠镜无异常的健康对照,取下段直肠(Houston瓣与齿状线之间)外观正常黏膜活检,每处取两块、立即冻存于-80℃,提取基因组DNA并经亚硫酸盐处理后,用Illumina Infinium MethylationEPIC v2.0 BeadChip(935K)进行DNA甲基化谱检测;以线性回归模型(校正性别、年龄、肥胖、糖尿病、当前吸烟与规律饮酒)考察各CpG位点甲基化与腺瘤发生的关系,并对含显著关联CpG位点的基因做GO与KEGG富集分析,比较腺瘤组与正常对照组背景黏膜的甲基化差异。

    摘要Background: Colorectal adenoma is the primary precursor in colorectal cancer development, partially driven by epigenetic alteration occurring at a very early stage. While aberrant DNA-methylations have been observed in mucosa adjacent to primary tumors, this study aimed to investigate whether such alterations exist in distant background mucosa as global defect rather than local transition, and identify adenoma-related CpG sites which may serve as potential targets for early intervention. Methods: DNA methylation in normal rectal mucosal biopsies from 24 individuals with colorectal adenoma and 20 normal controls were profiled utilizing the Illumina Infinium MethylationEPIC v2.0 BeadChip (935K). Linear regression model was employed to investigate the relationship between adenoma incidence and DNA methylation at each CpG site, adjusted for demographic characteristics. GO and KEGG enrichment analysis were conducted using genes containing CpG sites significantly associated with adenoma. A sensitivity analysis was conducted with individuals who had one or more known risk factors for colorectal adenoma. Results: Twenty-seven CpG sites with aberrant DNA-methylation were significantly correlated with the incidence of adenoma (P<1×10-5, |Δβ|≧0.2). Through GO and KEGG enrichment analysis and lookups in EWAS atlas, a group of CpG sites and genes were identified as potential intervention targets. Conclusions: A group of adenoma-related CpG sites and genes with aberrant DNA-methylation was identified in normal-appearing rectal mucosa. Further extensive validation of the adenoma-related loci as targets for molecular intervention could pave the way for colorectal cancer prevention.

  62. 62 GSE40055 对人类结直肠组织样本进行全基因组 DNA 甲基化分析,包含 6 例正常结肠上皮组织、6 例腺瘤和 30 例结直肠腺癌,采用 Illumina Infinium 27k Human DNA Methylation BeadChip v1.2 平台检测约 27,000 个 CpG 位点,比较不同组织类型及非 CpG 岛启动子与 CpG 岛启动子的甲基化差异。 人源 · 42 例 · GPL8490 · 2013/06/15

    设计对人类结直肠组织样本进行全基因组 DNA 甲基化分析,包含 6 例正常结肠上皮组织、6 例腺瘤和 30 例结直肠腺癌,采用 Illumina Infinium 27k Human DNA Methylation BeadChip v1.2 平台检测约 27,000 个 CpG 位点,比较不同组织类型及非 CpG 岛启动子与 CpG 岛启动子的甲基化差异。

    摘要We used Illumina Infinium 27k Human DNA Methylation BeadChip v1.2 to assess genome-wide DNA methylation profiling of normal colon epithelial, adenomas and colorectal adenocarcinomas across approximately 27,000 CpGs in fresh frozen colorectal tissue samples. We found that cancer-associated methylation changes with impact on transcription occur nearly as frequent at non-CpG island as CpG island promoters in colorectal cancer (CRC).

  63. 63 GSE67775 收集结直肠癌患者及其肝转移样本的基因组 DNA,使用 Illumina HumanExome-12 v1.0 和 v1.2 BeadChip 进行全基因组甲基化谱检测,分析不同肿瘤组织与肝转移样本的甲基化模式差异。研究对象包括结直肠癌原发灶与肝转移灶,样本来源涵盖 CRC 和 CRC-liver-metastasis,测定方法为 genome tiling array 类型的甲基化谱检测,数据归一化采用 BMIQ 函数并执行多轮过滤,最终保留符合质量标准的甲基化位点。 人源 · 42 例 · GPL18809;18544;20019 · 2016/02/29

    设计收集结直肠癌患者及其肝转移样本的基因组 DNA,使用 Illumina HumanExome-12 v1.0 和 v1.2 BeadChip 进行全基因组甲基化谱检测,分析不同肿瘤组织与肝转移样本的甲基化模式差异。研究对象包括结直肠癌原发灶与肝转移灶,样本来源涵盖 CRC 和 CRC-liver-metastasis,测定方法为 genome tiling array 类型的甲基化谱检测,数据归一化采用 BMIQ 函数并执行多轮过滤,最终保留符合质量标准的甲基化位点。

    摘要This SuperSeries is composed of the SubSeries listed below.

  64. 64 GSE52573 对同步性结直肠癌患者与配对的单发性结直肠癌患者进行全基因组 DNA 甲基化分析,比较两组肿瘤的甲基化差异,并验证部分 CpG 位点的甲基化结果。 人源 · 41 例 · GPL8490 · 2014/09/01

    设计对同步性结直肠癌患者与配对的单发性结直肠癌患者进行全基因组 DNA 甲基化分析,比较两组肿瘤的甲基化差异,并验证部分 CpG 位点的甲基化结果。

    摘要Background an Aim: Epigenetics are thought to play a major role in the carcinogenesis of patients that develop multiple colorectal cancers (CRC) in the non-hereditary setting. Previous studies have suggested concordant DNA hypermethylation between tumor pairs. However, only a few methylation markers have been analyzed. This study was aimed at describing the underlying epigenetic signature that differentiates multiple from solitary colorectal cancer tumors using a genome-scale DNA methylation profiling. Patients and Methods: We used a population-based cohort (EPICOLON II) of 12 patients with synchronous CRC and 29 age- sex- and tumor location-paired solitary CRC patients. DNA methylation profiling was performed using the Illumina Infinium HM27 DNA methylation assay. The most significantly hypermethylated CpG sites results were validated by Methylight. Tumors samples were also analyzed for the CpG Island Methylator Phenotype (CIMP) using the Infinium DNA methylation data; KRAS and BRAF mutations; microsatellite instability; and immunohistochemistry for MLH1/MSH2/MSH6/PMS2. Functional annotation clustering of differentially methylated genes between multiple and solitary CRCs was performed. Results: We identified 102 CpG sites that showed significant DNA hypermethylation in multiple versus solitary tumors (difference in β value >0.1 and p<0.05). Methylight assays validated the array results for 4 selected significantly hypermethylated genes (MAP1B, HTRA1, ALOX15, TIMP3) identified in the profiling (p=0.0002). Based on the Infinium data, 8/12 (66.6%) of multiple tumors were classified as CIMP-high, as compared to 5/29 (17%) solitary tumors (p=0.004). CIMP-high tumors displayed significant hypermethylation in 301 CpG sites (difference in β value >0.1; p value <0.05). Interestingly, 76/102 (74.5%) of the hypermethylated CpG sites found in multiple vs. solitary tumors were also seen to be hypermethylated in CIMP-H tumors. Functional analysis of hypermethylated genes found in multiple vs. solitary tumors showed the presence and enrichment of genes involved in different tumorigenic functions. Conclusions: Multiple colorectal cancers are associated with a distinct methylation phenotype, with a close association between tumor multiplicity and CIMP-high. Our results may be important to unravel the underlying mechanism of tumor multiplicity in the non-hereditary scenario, and provide novel potential biomarkers for identifying high-risk patients and tailoring surveillance strategies.

  65. 65 GSE213402 对结直肠癌患者配对原发肿瘤与肝转移组织进行甲基化和基因表达联合分析,采集40个样本(20对配对样本)开展Reduced Representation Bisulfite Sequencing (RRBS)和RNA-Seq测序,比较原发肿瘤与肝转移组织的DNA甲基化状态及基因表达差异。 人源 · 40 例 · GPL16791 · 2023/08/22

    设计对结直肠癌患者配对原发肿瘤与肝转移组织进行甲基化和基因表达联合分析,采集40个样本(20对配对样本)开展Reduced Representation Bisulfite Sequencing (RRBS)和RNA-Seq测序,比较原发肿瘤与肝转移组织的DNA甲基化状态及基因表达差异。

    摘要We generated reduced representation bisulfite sequencing (RRBS) and RNA sequencing (RNA-Seq) data of 20 samples (paired primary and liver metastases from 10 CRC patients) to understand key molecular events involved in tumor progression and metastasis.

  66. 66 GSE39334 对19例结直肠癌患者及其配对正常组织样本的基因组DNA进行Agilent 244k CpG岛微阵列甲基化分析,比较癌症与正常组织的甲基化模式差异。 人源 · 40 例 · GPL9767 · 2013/01/22

    设计对19例结直肠癌患者及其配对正常组织样本的基因组DNA进行Agilent 244k CpG岛微阵列甲基化分析,比较癌症与正常组织的甲基化模式差异。

    摘要Profiling of CpG island methylation in 19 primary colon cancer and paired normal samples

  67. 67 GSE95654 对结直肠癌患者和健康个体的结肠组织进行RRBS分析,比较原发肿瘤与匹配的正常结肠组织、异常隐窝灶与匹配的正常隐窝的DNA甲基化差异。采用激光捕获显微切割技术分离组织样本,每份样本获取约10,000个细胞。研究包含10对肿瘤/正常结肠组织及10对异常隐窝灶/正常隐窝样本,共40份基因组DNA材料。 人源 · 40 例 · GPL16791 · 2018/01/23

    设计对结直肠癌患者和健康个体的结肠组织进行RRBS分析,比较原发肿瘤与匹配的正常结肠组织、异常隐窝灶与匹配的正常隐窝的DNA甲基化差异。采用激光捕获显微切割技术分离组织样本,每份样本获取约10,000个细胞。研究包含10对肿瘤/正常结肠组织及10对异常隐窝灶/正常隐窝样本,共40份基因组DNA材料。

    摘要Colorectal cancer (CRC) is characterized by genome-wide alterations to DNA methylation that influence gene expression and genomic stability. Less is known about the extent to which methylation is disrupted in the earliest stages of CRC development. In this study we have combined laser-capture microdissection (LCM) with reduced representation bisulfite sequencing (RRBS) to identify cancer associated DNA methylation changes in human aberrant crypt foci (ACF), the earliest putative precursor to CRC. Using this approach, methylation profiles have been generated for 10 KRAS-mutant ACF and 10 CRCs harboring a KRAS mutation, as well as matched samples of normal mucosa. Of 811 differentially methylated regions (DMRs) identified in ACF, 537 (66%) were hypermethylated and 274 (34%) were hypomethylated. DMRs located within intergenic regions were heavily enriched for AP-1 transcription factor binding sites and were frequently hypomethylated. Furthermore, gene ontology (GO) analysis demonstrated that DMRs associated with promoters were enriched for genes involved in intestinal development, including homeobox genes and targets of the Polycomb repressive complex 2 (PRC2).Consistent with their role in the earliest stages of colonic neoplasia, 75% of the methylation changes identified in ACF were also present in the CRC samples. Together, these data demonstrate that DNA methylation changes, including significant hypomethylation, occur more frequently in early colonic neoplasia than previously believed, and identify epigenomic features of ACF that may provide new targets for cancer chemoprevention or lead to the development of new biomarkers for CRC risk.

  68. 68 GSE77635 对11例横向扩散肿瘤(LSTs)及其配对的正常结直肠黏膜进行DNA甲基化和基因表达分析,比较病变组织与正常组织的表观遗传学及转录组差异。采用MBD-Seq和RNA-Seq技术检测,样本包含患者1-5、GNG及81-85的病变与正常组织,每例患者均包含病变与正常样本。检测方式为基于MBD2蛋白结合域的甲基化测序及cDNA转录组测序,材料来源为基因组DNA和转录组RNA。 人源 · 39 例 · GPL11154;10999 · 2016/11/12

    设计对11例横向扩散肿瘤(LSTs)及其配对的正常结直肠黏膜进行DNA甲基化和基因表达分析,比较病变组织与正常组织的表观遗传学及转录组差异。采用MBD-Seq和RNA-Seq技术检测,样本包含患者1-5、GNG及81-85的病变与正常组织,每例患者均包含病变与正常样本。检测方式为基于MBD2蛋白结合域的甲基化测序及cDNA转录组测序,材料来源为基因组DNA和转录组RNA。

    摘要Laterally spreading tumors (LSTs) are colorectal adenomas that develop into extremely large lesions but rarely become malignant. Elucidating their molecular profiles, and how these contrast with colorectal cancer (CRC), offers the opportunity to understand their biology and how they are able to grow to such large lesions without progressing to cancer. Profiling of 11 LSTs with multiple genome-wide approaches showed mutation rates comparable with microsatellite stable CRCs at 2.4 versus 2.6 mutations per megabase respectively, however copy number alterations are infrequent (averaging 1.5 per LST). Only 28.5% of genes with promoter CpG island hypermethylation showed >2-fold downregulation of expression in LST tissue relative to paired normal mucosa. Integration of genetic and epigenetic data identified driver genes not previously implicated in colorectal neoplasia (ANO5, MED12L, EPB41L4A, RGMB, SLITRK1, NRXN1, ANK2), including genes targeted by both genetic and epigenetic alterations. Alterations to pathways commonly mutated in CRCs, namely the p53, PI3K and TGFb pathways, are rare. Instead LST-altered genes converge on axonal guidance, Wnt and actin cytoskeleton signalling. Non-granular morphology, which is associated with an elevated risk of cancer, correlates with low frequencies of epigenetic inactivation and KRAS mutations and the hyperactivation of CXCR4 signalling. These data show that mutation load is a poor predictor of invasive potential and that genomic structural aberrations or alterations in key pathways is important in progression to cancer. By integrating genetic, epigenetic and transcriptional data this study identifies novel genes important in early colorectal neoplasia.

  69. 69 GSE128067 本研究纳入Lynch样综合征(LLS)患者,即肿瘤存在错配修复(MMR)缺陷但无致病性胚系MMR基因突变的个体,旨在通过遗传与表观遗传分析阐明其MMR缺陷的体质性基础。整体研究共分析115例高加索LLS患者,全部采集血液DNA,并在可获得时纳入正常结肠黏膜与结直肠癌组织的FFPE石蜡块;当前数据集(GSE128067)仅包含FFPE样本,共37例,血液样本另见同组关联数据集。被测材料为FFPE来源的基因组DNA,组织类型包括正常结肠黏膜(FFPE_normal colon mucosa)与结直肠癌组织(FFPE_CRC tissue),部分患者同时具有同一编号的血液及FFPE正常结肠或FFPE CRC样本。检测方式为Infinium HumanMethylation450K BeadChip全基因组甲基化芯片分析,DNA经QIAmp DNA FFPE Tissue Kit提取,数据用GenomeStudio(Methylation Module)处理。主要比较为LLS患者与Lynch综合征患者及健康个体之间的甲基化差异,并检测体质性MLH1表观突变等差异甲基化区域。 人源 · 37 例 · GPL13534 · 2019/03/09

    设计本研究纳入Lynch样综合征(LLS)患者,即肿瘤存在错配修复(MMR)缺陷但无致病性胚系MMR基因突变的个体,旨在通过遗传与表观遗传分析阐明其MMR缺陷的体质性基础。整体研究共分析115例高加索LLS患者,全部采集血液DNA,并在可获得时纳入正常结肠黏膜与结直肠癌组织的FFPE石蜡块;当前数据集(GSE128067)仅包含FFPE样本,共37例,血液样本另见同组关联数据集。被测材料为FFPE来源的基因组DNA,组织类型包括正常结肠黏膜(FFPE_normal colon mucosa)与结直肠癌组织(FFPE_CRC tissue),部分患者同时具有同一编号的血液及FFPE正常结肠或FFPE CRC样本。检测方式为Infinium HumanMethylation450K BeadChip全基因组甲基化芯片分析,DNA经QIAmp DNA FFPE Tissue Kit提取,数据用GenomeStudio(Methylation Module)处理。主要比较为LLS患者与Lynch综合征患者及健康个体之间的甲基化差异,并检测体质性MLH1表观突变等差异甲基化区域。

    摘要Background: In ~50% of Lynch syndrome (LS)-suspected patients (also called Lynch-like syndrome, LLS), the causal mechanism for cancer predisposition remains unknown. Our aim was to elucidate the constitutional basis of mismatch repair (MMR) deficiency in LLS patients throughout a comprehensive genetic and epigenetic analysis. Methods: One hundred and fifteen LLS patients harboring MMR deficient tumors and no pathogenic germline MMR gene mutations were included in this study. Mutational analysis of 26 colorectal cancer associated genes was performed by using a customized multigene panel and massively parallel sequencing. Pathogenicity of MMR variants was assessed by mRNA analysis and multifactorial likelihood calculations. Genome-wide methylome analysis was perfomed by using the Infinium HumanMethylation450K BeadChip. Results: The multigene panel analysis revealed the presence of two MMR gene truncating mutations not found in previous analysis. Of a total of 15 MMR variants of unknown significance identified, five - present in 6 unrelated individuals- were reclassified as pathogenic. In addition, 13 predicted deleterious variants in other CRC-predisposing genes (MSH3, MUTYH, POLD1, APC, EPCAM, BUB1, FAN1, EXO1 or PSM1) were found in 12 probands. Methylome analysis detected one constitutional MLH1 epimutation in an individual diagnosed with CRC at age 42, but no additional differentially methylated regions were identified in LLS compared to LS patients or healthy individuals. Conclusions: In conclusion, the use of an ad-hoc designed gene panel combined with pathogenicity assessment of variants allows the identification of deleterious MMR mutations as well as new LLS candidate genes. Moreover, constitutional epimutations in non-LS-associated genes are not responsible for the MMR-deficient phenotype observed in LLS patients.

  70. 70 GSE132668 对局部晚期直肠癌(LARC)患者术前活检样本的DNA甲基化状态进行分析,比较11例病理完全缓解(pCR)组、21例不完全缓解(pIR)组及5例正常直肠组织(NT)的差异。采用EPIC BeadChip平台检测基因组DNA甲基化,通过差异甲基化CpGs构建预测分类器,用于区分不同响应状态。样本量为37,包含32例LARC病例和5例正常组织。 人源 · 37 例 · GPL23976 · 2021/06/08

    设计对局部晚期直肠癌(LARC)患者术前活检样本的DNA甲基化状态进行分析,比较11例病理完全缓解(pCR)组、21例不完全缓解(pIR)组及5例正常直肠组织(NT)的差异。采用EPIC BeadChip平台检测基因组DNA甲基化,通过差异甲基化CpGs构建预测分类器,用于区分不同响应状态。样本量为37,包含32例LARC病例和5例正常组织。

    摘要Locally advanced rectal cancer (LARC) patients have been treated with a pre-operative multimodal regimen based on 5-fluorouracil and radiotherapy (nCRT) followed by surgery. Patients that achieve pathological complete response (pCR) present better overall survival and lower rates of recurrence. Substantial evidence indicate that these patients could be spared of surgery, while near 70% of cases present incomplete response (pIR), varying from partial response to stable-disease/progression. Markers capable of distinguishing pIR from pCR have the potential to address alternative treatment strategies. Herein, we evaluated the ability of predicting response to nCRT by DNA methylation analysis in pre-treatment biopsies of LARC.

  71. 71 GSE148766 对36例转移性结直肠癌样本进行甲基化分析,其中24例为一线原发耐药亚型(first-line primary-resistant mCRC)且12例为药物敏感亚型(drug-sensitive mCRC),采用亚硫酸氢盐转化DNA杂交至Illumina Infinium 850K Human Methylation Beadchip v1.2平台,比较两组间差异甲基化图谱及功能甲基化基因表达特征。 人源 · 36 例 · GPL21145 · 2021/04/15

    设计对36例转移性结直肠癌样本进行甲基化分析,其中24例为一线原发耐药亚型(first-line primary-resistant mCRC)且12例为药物敏感亚型(drug-sensitive mCRC),采用亚硫酸氢盐转化DNA杂交至Illumina Infinium 850K Human Methylation Beadchip v1.2平台,比较两组间差异甲基化图谱及功能甲基化基因表达特征。

    摘要Epigenetic remodeling is responsible for tumor progression and drug resistance in human colorectal carcinoma (CRC). This study addressed the hypothesis that DNA methylation profiling may identify metastatic CRC (mCRC) subtypes with defined clinical characters. Global differential methylation profile was comparatively analyzed between 24 first-line primary-resistant and 12 drug-sensitive mCRCs, two subgroups with significantly different outcome. Gene expression and methylation data from the TCGA mCRCs cohort were used to identify, among differentially methylated genes, a prognostic signature of functionally methylated genes. Twelve functionally methylated genes yielded a hierarchical clustering of patients in two well-defined subgroups with hypermethylated tumors characterized by a significantly worst relapse-free and overall survival compared to hypomethylated cancers. Interestingly, the poor prognosis cluster was enriched of CIMP-high and MSI-like cases. Furthermore, methylation events were enriched in genes located on arms q of chromosomes 13 and 20, this suggesting that epigenetic remodeling may involve selective genomic regions. Finally, the expression of the 12-genes signature and MSI-enriching genes was confirmed in two independent oxaliplatin- and irinotecan-resistant CRC cell lines. These data provide the proof of concept that the hypermethylation of specific sets of genes may provide prognostic informations being able to identify a subgroup of mCRCs with poor prognosis

  72. 72 GSE152640 收集结直肠癌细胞系 HCT116 和 DKO8 的 PCR 产物及 MNase 消化的 DNA 片段,设置空载体对照组(EV)、DNMT3B3 表达组(D3B3)及其 R740E、R743E、R745D、R749E 突变体分组,采用亚硫酸氢盐测序(Bisulfite-Seq)和 MNase 测序(MNase-Seq)双策略进行 DNA 甲基化谱检测,比较不同 DNMT3A2/3B3 蛋白变体处理下 DNA 甲基化模式的差异。 人源 · 36 例 · GPL21145;17769 · 2020/06/17

    设计收集结直肠癌细胞系 HCT116 和 DKO8 的 PCR 产物及 MNase 消化的 DNA 片段,设置空载体对照组(EV)、DNMT3B3 表达组(D3B3)及其 R740E、R743E、R745D、R749E 突变体分组,采用亚硫酸氢盐测序(Bisulfite-Seq)和 MNase 测序(MNase-Seq)双策略进行 DNA 甲基化谱检测,比较不同 DNMT3A2/3B3 蛋白变体处理下 DNA 甲基化模式的差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  73. 73 GSE279921 收集 HCT116 结直肠癌细胞系,设置未处理对照组与转染 EAL、CRISPRoff (CROF) 处理组,行 DNA 甲基化阵列谱检测,比较不同处理条件下基因启动子区域 DNA 甲基化状态差异。 人源 · 36 例 · GPL34295 · 2026/10/01

    设计收集 HCT116 结直肠癌细胞系,设置未处理对照组与转染 EAL、CRISPRoff (CROF) 处理组,行 DNA 甲基化阵列谱检测,比较不同处理条件下基因启动子区域 DNA 甲基化状态差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  74. 74 GSE87096 收集了12例结直肠癌患者的肿瘤组织与对应的正常结肠组织样本,行MeDIP-seq检测全基因组DNA甲基化水平,hMeDIP-seq检测全基因组DNA羟甲基化水平,RNA-seq检测全转录组表达水平。通过比较肿瘤组织与正常组织的甲基化、羟甲基化及表达差异,识别出差异甲基化区域(DMR)、差异羟甲基化区域(DhMR)和差异表达基因(DEG)。进一步整合DMR、DhMR与DEG信息,筛选出7个潜在的表观遗传标志物。研究发现HADHB基因的超甲基化与转录下调在结直肠癌中持续存在,可能提示其作为肿瘤抑制基因(TSG)的功能。该差异在额外的结直肠癌患者中得到验证,并通过功能分析发现HADHB表达水平降低可显著抑制癌细胞迁移和侵袭能力。 人源 · 36 例 · GPL11154 · 2018/12/31

    设计收集了12例结直肠癌患者的肿瘤组织与对应的正常结肠组织样本,行MeDIP-seq检测全基因组DNA甲基化水平,hMeDIP-seq检测全基因组DNA羟甲基化水平,RNA-seq检测全转录组表达水平。通过比较肿瘤组织与正常组织的甲基化、羟甲基化及表达差异,识别出差异甲基化区域(DMR)、差异羟甲基化区域(DhMR)和差异表达基因(DEG)。进一步整合DMR、DhMR与DEG信息,筛选出7个潜在的表观遗传标志物。研究发现HADHB基因的超甲基化与转录下调在结直肠癌中持续存在,可能提示其作为肿瘤抑制基因(TSG)的功能。该差异在额外的结直肠癌患者中得到验证,并通过功能分析发现HADHB表达水平降低可显著抑制癌细胞迁移和侵袭能力。

    摘要DNA methylation (5-mC) and hydroxymethylation (5-hmC) are regarded as important epigenetic hallmarks in the carcinogenesis of colorectal cancer by transcriptional regulation. 5hmC is an intermediate during active demethylation and maintains the equilibrium of DNA methylation. Previous studies on DNA methylation don’t differentiate 5-hmC from 5-mC. Here, in order to elucidate the epigenetic mechanisms of carcinogenesis of colorectal cancer, we integrate genome wide levels of 5-mC, 5-hmC and Transcriptional expression. 12 samples, including six colorectal tumor tissues and corresponding normal colonic tissues were recruited after surgery. Genome-wide DNA methylation was determined by methylated DNA immune- precipitation sequencing (MeDIP-seq), and hydroxymethylation by hydroxyl- methylated DNA immune-precipitation sequencing (hMedip-seq). Transcriptional expression was determined by RNA-seq. Group-wise different methylation region (DMR), different hydroxyl methylation region (DhMR) and different expressed gene (DEG) were identified. Epigenetic biomarkers were screened by integrating DMR, DhMR and DEG. We found that a genome-scale distinct hydroxymethylation pattern could be used as epigenetic biomarker for clearly differentiating colorectal cancer from normal tissues. 59249 differentially methylated regions (DMR), 187172 differentially hydroxymethylated region (DhMR) and 948 differentially expressed genes (DEGs) were identified. After cross-matched genes containing DMRs or DhMRs with DEGs, seven genes were screened. Furthermore, hypermethylation of HADHB was persistently found to be correlated with its down-regulation of transcription in CRC, potentially suggesting its role as TSG. The differences of methylation, hydroxymethylation and transcriptional expression in HADHB between cancerous and normal tissues were validated among additional colorectal cancer patients. To further validate this assumption, we also performed functional analysis and found that the expression of HADHB obviously reduced cancer cells migration and invasiveness. This study provided valuable basic data for screening epigenetic biomarkers and elucidated the epigenetic mechanisms of carcinogenesis of colorectal cancer.

  75. 75 GSE137812 对人类结直肠癌细胞系 HCT116 及其 DNMT1/DNMT3B 缺失突变体进行 5-aza-2-deoxycytidine 处理,采集不同时间点的基因组 DNA 通过 RRBS 技术检测甲基化状态,比较处理组与未处理对照组的 CpG 岛甲基化差异。 人源 · 34 例 · GPL18573 · 2020/11/24

    设计对人类结直肠癌细胞系 HCT116 及其 DNMT1/DNMT3B 缺失突变体进行 5-aza-2-deoxycytidine 处理,采集不同时间点的基因组 DNA 通过 RRBS 技术检测甲基化状态,比较处理组与未处理对照组的 CpG 岛甲基化差异。

    摘要The aberrant gain of DNA methylation at CpG islands (CGIs) is frequently observed in colorectal tumours and may silence the expression of tumour suppressors such as MLH1. Current models propose that these CGIs are targeted by de novo DNA methyltransferases (DNMTs) in a sequence-specific manner but this has not been tested. Using ectopically integrated CGIs, we find that aberrantly methylated CGIs are subject to low levels of de novo DNMT activity in colorectal cancer cells. By delineating DNMT targets, we find that instead de novo DNMT activity is targeted primarily to CGIs marked by the histone modification H3K36me3, a mark associated with transcriptional elongation. These H3K36me3 marked CGIs are heavily methylated in colorectal tumours and the normal colon suggesting that de novo DNMT activity at CGIs in colorectal cancer is focused on similar targets to normal tissues and not greatly remodelled by tumourigenesis.

  76. 76 GSE38142 对结直肠癌及转移灶组织进行甲基化分析,采用甲基化DNA免疫沉淀(mDIP)富集处理,比较富集组与输入组的甲基化状态差异,分析不同组织类型的甲基化模式。 人源 · 34 例 · GPL4126;10878 · 2014/03/26

    设计对结直肠癌及转移灶组织进行甲基化分析,采用甲基化DNA免疫沉淀(mDIP)富集处理,比较富集组与输入组的甲基化状态差异,分析不同组织类型的甲基化模式。

    摘要De novo methylation of CpG islands is seen in many tumors, but the general rules governing this process are not known. By analyzing DNA from tumors, as well as normal tissues, and by utilizing a wide range of published data, we have been able to identify a well-defined set of tumor targets, each of which has its own “coefficient” of methylation that is largely determined by its inherent relative ability to recruit the polycomb complex. This pattern is initially formed by a slow process of de novo methylation that occurs during aging and then undergoes expansion early in tumorigenesis, where it may play a role as an inhibitor of development-associated gene activation. We also demonstrate that DNA methylation patterns can be used to diagnose the primary tissue source of tumor metastases.

  77. 77 GSE111689 对结直肠癌细胞系 HCT116 及其 DNMT3B 敲除突变株进行 shRNA 干扰实验,采集基因组 DNA 和转录组 RNA 采用甲基化芯片和 RNA 测序检测,比较不同 shRNA 处理(shNT 对照、shZBTB24、DNMT3B 敲除)与相应基因型(野生型、3BKO)间的表观遗传和转录组差异。 人源 · 33 例 · GPL23976;11154;16791 · 2018/07/31

    设计对结直肠癌细胞系 HCT116 及其 DNMT3B 敲除突变株进行 shRNA 干扰实验,采集基因组 DNA 和转录组 RNA 采用甲基化芯片和 RNA 测序检测,比较不同 shRNA 处理(shNT 对照、shZBTB24、DNMT3B 敲除)与相应基因型(野生型、3BKO)间的表观遗传和转录组差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  78. 78 GSE77247 对结直肠癌细胞系 HCT116 和 RKO 进行遗传和 shRNA 耗竭处理,包括 DNMT1shRNA(第4、12天)、DNMT3A/3B CRISPR 敲除、DNMT1hypomorph 突变及 DNMT1/3A/3B 双敲除,采集基因组 DNA 进行甲基化分析,比较不同处理组在全基因组位点(含启动子和增强子)的甲基化差异及 DNMT1 在维持异常甲基化中的作用。 人源 · 33 例 · GPL13534 · 2017/01/13

    设计对结直肠癌细胞系 HCT116 和 RKO 进行遗传和 shRNA 耗竭处理,包括 DNMT1shRNA(第4、12天)、DNMT3A/3B CRISPR 敲除、DNMT1hypomorph 突变及 DNMT1/3A/3B 双敲除,采集基因组 DNA 进行甲基化分析,比较不同处理组在全基因组位点(含启动子和增强子)的甲基化差异及 DNMT1 在维持异常甲基化中的作用。

    摘要Maximizing DNA methyltransferase (DNMT’s) inhibition for cancer therapy requires defining the roles and interactions between these enzymes for maintaining the widespread DNA methylation abnormalities in cancer. Combining genetic and shRNA depletion in colon and other cancer cells reveals that DNMT1 is extremely dominant in this maintenance, with DNMT’s 3A and 3B playing minor roles, at all genomic loci including promoters and enhancers. Reducing DNMT1 below a deep threshold level, especially at promoters, is required for reversing abnormal DNA methylation and re-expressing key tumor suppressor genes. Current DNMT inhibitors (DNMTis) are challenged, at tolerable patient doses, for achieving such reductions. We introduce a new approach in which reducing levels of the DNMT targeting protein, UHRF1, complements low DNMTi doses to DNA demethylate and reactivate expression of such genes.

  79. 79 GSE309002 对结直肠癌原发肿瘤与相邻正常结肠组织进行甲基化分析,使用Infinium MethylationEPIC Assay检测基因组DNA甲基化状态,比较两组间甲基化差异。 人源 · 32 例 · GPL21145 · 2026/09/25

    设计对结直肠癌原发肿瘤与相邻正常结肠组织进行甲基化分析,使用Infinium MethylationEPIC Assay检测基因组DNA甲基化状态,比较两组间甲基化差异。

    摘要Dysregulation of cellular metabolism is one of the hallmarks of cancer. Tumor cells would enhance glycolysis to fuel the phenotypes of rapid proliferation and invasion. This study aims to explore epigenetic reprogramming of glycolysis pathway in colorectal cancer (CRC). CRCs and the adjacent normal colon tissues were profiled by using a comprehensive methylation array (Illumina Methylation EPIC Beadchips) to comprehensively analyze the methylation alterations in the glycolysis pathway. Differentially methylated genes (DMGs) were identified by using β value difference (≧ 0.2 or ≦ -0.2) and Wilcoxon rank-sum test (p < 0.05), and the common DMG in open datasets (GSE42752, GSE25062 and TCGA). Pyrosequencing was executed to validate the DMGs. Hexokinase domain containing 1 (HKDC1), the major hypomethylated gene we found, was overexpressed in colon cancer cells. Cells were treated with an HKDC1 inhibitor to elucidate the role of HKDC1. We found hypomethylation of HKDC1 was the only shared hypomethylated DMG in glycolysis pathway after comparing our methylation profiles of CRC to 3 public datasets. The RT-qPCR study in our cohort supported HDKC1 expression is methylation-regulated. Overexpression of HKDC1 in colon cancer cells resulted in increased proliferation of colon cancer cells and decreased cytotoxicity by an HKDC1 inhibitor. RNA sequencing revealed significant up-regulation of glycolysis and cell cycle pathways and their targets in HKDC1 overexpressed cells. In summary, hypomethylation of HKDC1 is common in CRC and may regulate cellular metabolism to promote proliferation of colon cancer cells through upregulation of glycolysis and cell cycle pathways.

  80. 80 GSE118970 研究对象为人类结直肠癌细胞系 HCT116 和 RKO,采用亚硫酸氢盐处理基因组 DNA 后进行甲基化芯片分析。样本分为 Mock 细胞、UHRF1 敲除细胞及不同结构域突变补救细胞,包括 TTD、PHD、SRA 和 RING 域突变体。检测方式为甲基化状态分析,比较各处理组间 DNA 甲基化差异及对肿瘤特性的影响。 人源 · 30 例 · GPL21145 · 2019/02/28

    设计研究对象为人类结直肠癌细胞系 HCT116 和 RKO,采用亚硫酸氢盐处理基因组 DNA 后进行甲基化芯片分析。样本分为 Mock 细胞、UHRF1 敲除细胞及不同结构域突变补救细胞,包括 TTD、PHD、SRA 和 RING 域突变体。检测方式为甲基化状态分析,比较各处理组间 DNA 甲基化差异及对肿瘤特性的影响。

    摘要UHRF1 is essential for targeting DNA methyltransferases (DNMT’s) to replicating DNA to establish de novo DNA methylation and maintain it. While, UHRF1 domains are defined, including requirement for an E3 ligase region, for de novo methylation, those essential for maintenance have been difficult to outline. Herein, via a new assay, chromatin histone-binding and a hemimethylated DNA reader domains, but not the ligase domain are found essential for cancer-specific DNA methylation maintenance in human colorectal cancer (CRC) cells. Disrupting each essential domain phenocopies UHRF1 depletion for global DNA demethylation, reactivation of tumor suppressor genes (TSGs), and reduction in CRC invasion and metastatic properties. Moreover, there is strong negative correlation between high UHRF1 expression, low TSG expression, and abnormal methylation with CRC progression and overall survival. Our battery of findings suggest the value of targeting specific domains of UHRF1 for cancer therapy and adding a precision medicine approach through use of the biomarker associations we define.

  81. 81 GSE84400 对Colo320DM和HCT116人结直肠癌细胞系进行TET1敲低及5-aza-dC处理,采集基因组DNA与总RNA进行甲基化和表达检测,比较转染TET1敲低载体与阴性对照质粒的细胞在处理前后的差异。 人源 · 30 例 · GPL16699;13534 · 2017/01/01

    设计对Colo320DM和HCT116人结直肠癌细胞系进行TET1敲低及5-aza-dC处理,采集基因组DNA与总RNA进行甲基化和表达检测,比较转染TET1敲低载体与阴性对照质粒的细胞在处理前后的差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  82. 82 GSE186381 将结直肠癌甲基化研究中无肿瘤(NCF、BEN、NAA)和高级肿瘤(D-AA、P-AA、CRC-I/II、CRC-III/IV)的血清 cfDNA 分别混池,采用 Infinium MethylationEPIC BeadChip 平台进行甲基化分析,比较两组 cfDNA 的甲基化模式差异。 人源 · 28 例 · GPL21145 · 2023/10/01

    设计将结直肠癌甲基化研究中无肿瘤(NCF、BEN、NAA)和高级肿瘤(D-AA、P-AA、CRC-I/II、CRC-III/IV)的血清 cfDNA 分别混池,采用 Infinium MethylationEPIC BeadChip 平台进行甲基化分析,比较两组 cfDNA 的甲基化模式差异。

    摘要We explored the differential methylation patterns found in cfDNA between no neoplasia (NN; individuals with no colorectal findings, benign pathologies and non-advanced adenomas) and patients with advanced neoplasia (AN; advanced adenomas and colorectal cancer) using pooled samples, for the discovery of non-invasive methylation biomarkers for CRC screening. cfDNA was extracted from serum samples and methylation measurements were assessed with the Infinium MethylationEPIC BeadChip. Data was mainly preprocessed and analyzed with R/Bioconductor packages.

  83. 83 GSE222612 对结直肠癌相关细胞系 HCT116 和 NCM460 进行多组学分析,采用 RNA-Seq、ChIP-Seq 和 Bisulfite-Seq 技术检测转录组、组蛋白修饰和 DNA 甲基化状态。研究对象包含野生型、LSD1 敲除、LSD1 过表达及负对照四类基因型细胞,分别提取总 RNA 和基因组 DNA,通过染色质免疫沉淀技术结合 H3K4me1/H3K4me3 抗体分析组蛋白修饰,同时检测双价基因启动子区域的 DNA 甲基化变化,比较不同基因型下 DNA 甲基化与组蛋白修饰的关联性。 人源 · 28 例 · GPL16791 · 2023/01/11

    设计对结直肠癌相关细胞系 HCT116 和 NCM460 进行多组学分析,采用 RNA-Seq、ChIP-Seq 和 Bisulfite-Seq 技术检测转录组、组蛋白修饰和 DNA 甲基化状态。研究对象包含野生型、LSD1 敲除、LSD1 过表达及负对照四类基因型细胞,分别提取总 RNA 和基因组 DNA,通过染色质免疫沉淀技术结合 H3K4me1/H3K4me3 抗体分析组蛋白修饰,同时检测双价基因启动子区域的 DNA 甲基化变化,比较不同基因型下 DNA 甲基化与组蛋白修饰的关联性。

    摘要Background: DNA hypermethylation at promoter CpG islands (CGIs) is a hallmark of cancers and could lead to dysregulation of gene expression in the development of cancers, however, its dynamics and regulatory mechanisms remain elusive. Bivalent genes, that direct development and differentiation of stem cells, are found to be frequent targets of hypermethylation in cancers. Results: Here we performed comprehensive analysis across multiple cancer types and identified that the decrease in H3K4me1 levels coincides with DNA hypermethylation at the bivalent promoter CGIs during tumorigenesis. Removal of DNA hypermethylation leads to increment of H3K4me1 at promoter CGIs with preference for bivalent genes. Nevertheless, the alteration of H3K4me1 by overexpressing or knockout LSD1, the demethylase of H3K4, doesn't change the level or pattern of DNA methylation. Moreover, LSD1 was found to regulate the expression of a bivalent gene OVOL2 to promote tumorigenesis. Knockdown of OVOL2 in LSD1 knockout HCT116 cells restored the cancer cell phenotype. Conclusion: In summary, our work identified a universal indicator that can pre-mark DNA hypermethylation in cancer cells, and dissected the interplay between H3K4me1 and DNA hypermethylation in detail. Current study also reveals a novel mechanism underlying the oncogenic role of LSD1, providing clues for cancer therapies.

  84. 84 GSE54840 对NCCIT人胚胎癌细胞及HCT116人结直肠癌细胞系进行siRNA处理,分别针对DNMT1、DNMT3B、DNMT3A、DNMT3L等甲基转移酶开展急性耗竭实验,同步分析基因型变异(如DNMT1敲除、DNMT3B敲除、过表达等)对DNA甲基化模式的影响。采用Infinium HumanMethylation450 BeadChip检测技术,包含19个NCCIT细胞处理样本(NTC-1为对照,NTC-2作为siDNMT1、siDNMT3B、si3B+3L条件的对照),6个HCT116细胞系样本(WT为对照),以及2个NCCIT细胞分化状态样本(UD为对照)。检测对象为基因组DNA,通过生物重复验证不同甲基转移酶组合对基因体甲基化和羟甲基化调控的差异。 人源 · 27 例 · GPL13534 · 2014/10/20

    设计对NCCIT人胚胎癌细胞及HCT116人结直肠癌细胞系进行siRNA处理,分别针对DNMT1、DNMT3B、DNMT3A、DNMT3L等甲基转移酶开展急性耗竭实验,同步分析基因型变异(如DNMT1敲除、DNMT3B敲除、过表达等)对DNA甲基化模式的影响。采用Infinium HumanMethylation450 BeadChip检测技术,包含19个NCCIT细胞处理样本(NTC-1为对照,NTC-2作为siDNMT1、siDNMT3B、si3B+3L条件的对照),6个HCT116细胞系样本(WT为对照),以及2个NCCIT细胞分化状态样本(UD为对照)。检测对象为基因组DNA,通过生物重复验证不同甲基转移酶组合对基因体甲基化和羟甲基化调控的差异。

    摘要Global patterns of DNA methylation, mediated by the DNA methyltransferases (DNMTs), are disrupted in all cancers by mechanisms that remain largely unknown, hampering their development as therapeutic targets. Combinatorial acute depletion of all DNMTs in a pluripotent human tumor cell line, followed by epigenome and transcriptome analysis, revealed DNMT functions in unprecedented detail. DNMT3B occupancy regulates methylation during differentiation, while an unexpected interplay was discovered in which DNMT1 and DNMT3B antithetically regulate methylation and hydroxymethylation in gene bodies, a finding confirmed in other cell types. DNMT3B mediated nonCpG methylation, while DNMT3L influenced the activity of DNMT3B toward nonCpG versus CpG site methylation. Taken together, these data reveal new functional targets of each DNMT suggesting that isoform selective inhibition would be therapeutically advantageous.

  85. 85 GSE144213 收集来自美国典型培养物收藏中心(ATCC)的25例人类癌源类器官的基因组DNA,行全基因组规模的DNA甲基化谱检测,比较不同癌症类型类器官的甲基化模式。 人源 · 25 例 · GPL21145 · 2020/03/30

    设计收集来自美国典型培养物收藏中心(ATCC)的25例人类癌源类器官的基因组DNA,行全基因组规模的DNA甲基化谱检测,比较不同癌症类型类器官的甲基化模式。

    摘要Study of the DNA methylation profile of different human cancer organoids.

  86. 86 GSE45334 对结直肠癌细胞系(包括 HCT116 及其 DNMT1/3b 双敲除细胞、HT29、RKO、LS513、Colo205、Colo320、SW480、SW1398)在不同时间点(5h、6h、7h、8h、9h、10h、11h)采集样本,提取总 RNA、polyA RNA 和甲基化 DNA,采用 RNA-Seq 和 MBD-Seq 技术进行双向测序,比较不同时间点及基因型间的转录组和甲基化模式差异。 人源 · 25 例 · GPL10999 · 2013/10/01

    设计对结直肠癌细胞系(包括 HCT116 及其 DNMT1/3b 双敲除细胞、HT29、RKO、LS513、Colo205、Colo320、SW480、SW1398)在不同时间点(5h、6h、7h、8h、9h、10h、11h)采集样本,提取总 RNA、polyA RNA 和甲基化 DNA,采用 RNA-Seq 和 MBD-Seq 技术进行双向测序,比较不同时间点及基因型间的转录组和甲基化模式差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  87. 87 GSE149282 对结直肠癌组织及正常相邻结肠组织的开放染色质甲基化状态进行比较分析,采用Infinium DNA MethylationEPIC芯片检测全基因组 CpG 位点甲基化水平,通过ChAMP Bioconductor识别差异甲基化区域,比较两组间开放染色质的甲基化差异。 人源 · 24 例 · GPL21145 · 2020/04/25

    设计对结直肠癌组织及正常相邻结肠组织的开放染色质甲基化状态进行比较分析,采用Infinium DNA MethylationEPIC芯片检测全基因组 CpG 位点甲基化水平,通过ChAMP Bioconductor识别差异甲基化区域,比较两组间开放染色质的甲基化差异。

    摘要The methylome of open chromatins was investigated in colorectal cancer (CRC) to explore cancer-specific methylation and potential biomarkers. Epigenome-wide methylome of open chromatins was studied in colorectal cancer tissues using Infinium DNA MethylationEPIC assay. Differentially methylated regions were identified using the ChAMP Bioconductor. Our stringent analysis led to the discovery of 2187 significant differentially methylated open chromatins in CRCs. More hypomethylated probes were observed and the trend was similar across all chromosomes. Majority of hyper- and hypomethylated probes in open chromatin were in chromosome 1. Our unsupervised hierarchical clustering analysis showed that 40 significant differentially methylated open chromatins were able to segregate CRC from normal colonic tissues. Receiver operating characteristic analyses from the top 40 probes revealed several significant, highly discriminative, specific and sensitive probes such as OPLAH cg26256223, EYA4 cg01328892, and CCNA1 cg11513637, among others. OPLAH cg26256223 hypermethylation is associated with reduced gene expression in the CRC. This study reports many open chromatin loci with novel differential methylation statuses, some of which with the potential as candidate markers for diagnostic purposes.

  88. 88 GSE159670 对结直肠癌患者和健康个体的肿瘤及正常组织进行全基因组 DNA 甲基化芯片分析,比较肿瘤组织与正常组织的甲基化特征以识别新的风险分层标志物。 人源 · 24 例 · GPL21145 · 2026/10/31

    设计对结直肠癌患者和健康个体的肿瘤及正常组织进行全基因组 DNA 甲基化芯片分析,比较肿瘤组织与正常组织的甲基化特征以识别新的风险分层标志物。

    摘要The current risk stratification system defined by clinicopathological features do not accurately identify the risk of disease recurrence in patients with stage I-II colorectal cancer (CRC). We aimed to investigate whether the CpG sites from newly established genome-wide methylation profiles could serve as biomarkers to improve prognosis prediction.

  89. 89 GSE26020 收集 HCT116 野生型细胞与 HCT116 DNMT1-/- DNMT3b -/- 双敲除细胞的基因组 DNA,以及人支气管上皮细胞(HBEC)经 hTERT 和 CDK4 基因永生化处理后的基因组 DNA,进行甲基化敏感扩增(MIRA)和染色质免疫沉淀(ChIP)实验。实验包括对 HBEC 经非编码 siRNA 或 SETD2 siRNA 转染后的基因组 DNA 进行 MIRA 和 ChIP,检测 H3K9me3、H3K36me3 等组蛋白修饰标记与基因体 DNA 甲基化之间的关联。所有样本均采用 LM-PCR 技术进行扩增,检测方式为甲基化敏感扩增(MIRA)和染色质免疫沉淀-芯片(ChIP-chip)实验,主要比较不同处理条件下 DNA 甲基化与组蛋白修饰的差异。 人源 · 24 例 · GPL5188;6244;5175;11313 · 2011/03/31

    设计收集 HCT116 野生型细胞与 HCT116 DNMT1-/- DNMT3b -/- 双敲除细胞的基因组 DNA,以及人支气管上皮细胞(HBEC)经 hTERT 和 CDK4 基因永生化处理后的基因组 DNA,进行甲基化敏感扩增(MIRA)和染色质免疫沉淀(ChIP)实验。实验包括对 HBEC 经非编码 siRNA 或 SETD2 siRNA 转染后的基因组 DNA 进行 MIRA 和 ChIP,检测 H3K9me3、H3K36me3 等组蛋白修饰标记与基因体 DNA 甲基化之间的关联。所有样本均采用 LM-PCR 技术进行扩增,检测方式为甲基化敏感扩增(MIRA)和染色质免疫沉淀-芯片(ChIP-chip)实验,主要比较不同处理条件下 DNA 甲基化与组蛋白修饰的差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  90. 90 GSE271438 从结直肠癌组织及邻近癌组织中提取原代成纤维细胞,分别作为CAF与NF组,采集基因组DNA进行850K甲基化芯片分析,比较两组DNA甲基化谱的差异。 人源 · 24 例 · GPL21145 · 2026/07/01

    设计从结直肠癌组织及邻近癌组织中提取原代成纤维细胞,分别作为CAF与NF组,采集基因组DNA进行850K甲基化芯片分析,比较两组DNA甲基化谱的差异。

    摘要To investigate the DNA methylation landscape differences between CAFs and NFs in colorectal cancer, we extracted primary fibroblasts from colorectal cancer tissue and para-cancerous tissue for 850K chip analysis.

  91. 91 GSE287214 对结直肠癌肿瘤起始细胞(CICs)与分化后的肿瘤细胞系(FBS)进行全基因组 DNA 甲基化分析,使用 Illumina Infinium Methylation EPIC v1.0 BeadChip 平台生成 idat 文件,通过 RnBeads R 包分析,保留 782,939 个探针进行差异甲基化比较。研究比较 CICs 与 FBS 细胞系在 CpG 位点及区域水平的差异,包括 tiling(5 kb)、基因、启动子和 CpG 岛,识别 3529 个差异甲基化位点,并基于 500 个最佳区域筛选差异甲基化基因(n=79)和启动子(n=31)。检测覆盖 24 个 GSM 样本,包含多个 CIC 细胞系(如 1076 CSC、1247 CSC、14583 CSC)和 FBS 细胞系(如 1076 col.、1247 col.、1872 col.)。 人源 · 24 例 · GPL21145 · 2025/02/26

    设计对结直肠癌肿瘤起始细胞(CICs)与分化后的肿瘤细胞系(FBS)进行全基因组 DNA 甲基化分析,使用 Illumina Infinium Methylation EPIC v1.0 BeadChip 平台生成 idat 文件,通过 RnBeads R 包分析,保留 782,939 个探针进行差异甲基化比较。研究比较 CICs 与 FBS 细胞系在 CpG 位点及区域水平的差异,包括 tiling(5 kb)、基因、启动子和 CpG 岛,识别 3529 个差异甲基化位点,并基于 500 个最佳区域筛选差异甲基化基因(n=79)和启动子(n=31)。检测覆盖 24 个 GSM 样本,包含多个 CIC 细胞系(如 1076 CSC、1247 CSC、14583 CSC)和 FBS 细胞系(如 1076 col.、1247 col.、1872 col.)。

    摘要We conducted a genome wide DNA methylation profiling of primary CICs-CRC and differentiated tumor cell lines-CRC, including autologous pairs. The Illumina Infinium Methylation EPIC v1.0 BeadChip Array was used to obtain DNA methylation profiles. Idat files generated by Infinium MethylationV.1 BeadChip were analyzed using the RnBeads R package. In total, 782939 probes were retained for further differential DNA methylation analysis. Differential methylation analysis between CIC and FBS cell lines was conducted using limmaR package at the CpG sites and region levels, defined as tiling (5 kb), genes, promoters, and CpG islands. For differential methylation measures, a combined rank a total of 3529 differentially methylated sites were identified. A combined rank among the 500 best ranking regions was applied to identify differentially methylated genes (n=79) and promoters (n=31) in CRC-CICs vs. FBS cell lines. N=48 and 31 genes were hypomethylated and hypermethylated, respectively while, at the promoter levels, N=9 and 22 were hypomethylated and hypermethylated, respectively in CRC-CIC as compared to FBS cell lines (p-value ≤0.11). CICs exhibited distinct methylation patterns, compared to differentiated tumor cells (p<0.05 or 0.01). Following the data quality control and normalization,

  92. 92 GSE36380 对结直肠癌患者相邻正常组织与肿瘤组织的富集甲基化 DNA 进行基因组平铺阵列甲基化分析,比较相邻正常组织与肿瘤组织的甲基化差异,并与公共参考 DNA 进行间接比较。 人源 · 24 例 · GPL4126 · 2012/03/10

    设计对结直肠癌患者相邻正常组织与肿瘤组织的富集甲基化 DNA 进行基因组平铺阵列甲基化分析,比较相邻正常组织与肿瘤组织的甲基化差异,并与公共参考 DNA 进行间接比较。

    摘要Methylation profiling in colorectal cancer : adjacent normal tissue vs colon tumor tissue

  93. 93 GSE75550 对结直肠癌患者直肠肿瘤组织与相邻正常组织进行DNA甲基化和基因表达谱联合分析,比较两组组织的表观遗传与转录组差异。 人源 · 24 例 · GPL13534;10558 · 2015/12/02

    设计对结直肠癌患者直肠肿瘤组织与相邻正常组织进行DNA甲基化和基因表达谱联合分析,比较两组组织的表观遗传与转录组差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  94. 94 GSE249157 收集结直肠癌脑转移样本的基因组DNA,行全基因组规模DNA甲基化阵列谱检测,分析其甲基化模式。 人源 · 23 例 · GPL21145 · 2023/12/17

    设计收集结直肠癌脑转移样本的基因组DNA,行全基因组规模DNA甲基化阵列谱检测,分析其甲基化模式。

    摘要Genome wide DNA methylation profiling of brain metastasis from colorectal and lung cancer. The Illumina Infinium MethylationEPIC was used to obtain DNA methylation profiles across approximately 850,000 CpGs in brain metastasis samples. Samples included 1 breast ductal invasive carcinoma, 4 colon adenocarcinoma, 1 melanoma, 1 multiple mieloma, 7 non small cell lung cancer adenocarcinoma, 3 non small cell lung cancer G3, 4 non small cell lung cancer SCC, 1 prostate cancer adenocarcinoma and 1 serous carcinoma.

  95. 95 GSE50610 对HCT116结直肠癌细胞及其DNMT1KO、DNMT3BKO、DNMT1KO/DNMT3BKO双敲除变种进行全基因组CTCF占据分析和DNaseI超敏反应检测,同时对HCT116细胞开展甲基化分析。此外,对K562 erythroleukemia细胞设置对照组和5-aza-2’-deoxycytidine处理组,采集细胞进行ChIP-seq分析,比较不同处理条件下转录因子占据与甲基化状态差异。 人源 · 23 例 · GPL11154;10999 · 2014/02/28

    设计对HCT116结直肠癌细胞及其DNMT1KO、DNMT3BKO、DNMT1KO/DNMT3BKO双敲除变种进行全基因组CTCF占据分析和DNaseI超敏反应检测,同时对HCT116细胞开展甲基化分析。此外,对K562 erythroleukemia细胞设置对照组和5-aza-2’-deoxycytidine处理组,采集细胞进行ChIP-seq分析,比较不同处理条件下转录因子占据与甲基化状态差异。

    摘要This data includes regulatory factor profiling using DNase and ChIP-seq and methylation profiling using bisulfite-seq.

  96. 96 GSE56269 对SN38和奥沙利铂耐药的结直肠癌细胞系模型及14例对XELOX治疗无反应的临床结直肠转移样本进行RRBS分析,比较不同耐药细胞系的甲基化特征差异及临床样本中与耐药表型相关的甲基化位点多样性。 人源 · 23 例 · GPL11154 · 2015/04/01

    设计对SN38和奥沙利铂耐药的结直肠癌细胞系模型及14例对XELOX治疗无反应的临床结直肠转移样本进行RRBS分析,比较不同耐药细胞系的甲基化特征差异及临床样本中与耐药表型相关的甲基化位点多样性。

    摘要Purpose: Irinotecan (SN38) and oxaliplatin are chemotherapeutic agents used in the treatment of colorectal cancer. However, the frequent development of resistance to these drugs represents a considerable challenge in the clinic. Alus as retrotransposons comprise 11% of the human genome. Genomic toxicity induced by carcinogens or drugs can reactivate Alus by altering DNA methylation. Whether or not reactivation of Alus occurs in SN38 and oxaliplatin resistance remains unknown. Methods: We applied reduced representation bisulfite sequencing (RRBS) to investigate the DNA methylome in SN38- or oxaliplatin-resistant colorectal cancer cell line models. Moreover, we extended the RRBS analysis to tumor tissue from 14 patients with colorectal cancer who either did or did not benefit from capecitabine + oxaliplatin treatment. For the clinical samples, we applied a concept of DNA methylation entropy to estimate the diversity of DNA methylation states of the identified resistance phenotype-associated methylation loci observed in the cell line models. Results: We identified different loci being characteristic for the different resistant cell lines. Interestingly, 53% of the identified loci were Alu sequences -- especially the Alu Y subfamily. Furthermore, we identified an enrichment of Alu Y sequences that likely results from increased integration of new copies of Alu Y sequence in the drug-resistant cell lines. In the clinical samples, SOX1 and other SOX gene family members were shown to display variable DNA methylation states in their gene regions. The Alu Y sequences showed remarkable variation in DNA methylation states across the clinical samples. Our findings imply a crucial role of Alu Y in colorectal cancer drug resistance. Our study underscores the complexity of colorectal cancer aggravated by mobility of Alu elements and stresses the importance of personalized strategies, using a systematic and dynamic view, for effective cancer therapy.

  97. 97 GSE244517 对人类结直肠癌细胞系 HCT116 及其 DNMT3B 敲除或表达不同突变体的衍生细胞进行全基因组亚硫酸盐测序,分析不同基因型下 DNA 甲基化水平差异。 人源 · 22 例 · GPL21697 · 2024/01/22

    设计对人类结直肠癌细胞系 HCT116 及其 DNMT3B 敲除或表达不同突变体的衍生细胞进行全基因组亚硫酸盐测序,分析不同基因型下 DNA 甲基化水平差异。

    摘要The correct establishment of DNA methylation patterns is vital for mammalian development and is achieved by the de novo DNA methyltransferases DNMT3A and DNMT3B. DNMT3B localises to H3K36me3 at actively transcribing gene bodies through its PWWP domain. It also functions at heterochromatin through an unknown recruitment mechanism. Here we find that knockout of DNMT3B causes losses of methylation predominantly at H3K9me3-marked heterochromatin and that DNMT3B PWWP domain mutations or deletion result in striking increases of methylation in H3K9me3-marked heterochromatin. Removal of the N-terminal region of DNMT3B affects its ability to methylate H3K9me3-marked regions. This region of DNMT3B directly interacts with HP1-alpha and facilitates the bridging of DNMT3B with H3K9me3-marked nucleosomes in vitro. Our results suggest that DNMT3B is recruited to H3K9me3 marked heterochromatin in a PWWP-independent manner that is facilitated by the protein's N-terminus through an interaction with a key heterochromatin protein. More generally, we suggest that DNMT3B plays a role in DNA methylation homeostasis at heterochromatin, a process which is disrupted in cancer, aging and Immunodeficiency, Centromeric Instability and Facial Anomalies (ICF) syndrome.

  98. 98 GSE29290 收集结直肠癌细胞系 HCT116 的野生型与 DNMT1/DNMT3B 双敲除组基因组 DNA,行全基因组规模 DNA 甲基化阵列谱检测,比较两组甲基化模式。同时包含乳腺癌肿瘤组织与配对正常乳腺组织样本,行相同检测方式,比较肿瘤与正常组织的甲基化差异。 人源 · 22 例 · GPL13534 · 2011/12/15

    设计收集结直肠癌细胞系 HCT116 的野生型与 DNMT1/DNMT3B 双敲除组基因组 DNA,行全基因组规模 DNA 甲基化阵列谱检测,比较两组甲基化模式。同时包含乳腺癌肿瘤组织与配对正常乳腺组织样本,行相同检测方式,比较肿瘤与正常组织的甲基化差异。

    摘要Genome-wide DNA methylation profiling of HCT116 WT, HCT116 DNMT1 and DNMT3B double KO, and breast cancer tumors by next generation Infinium assay

  99. 99 GSE51810 对结直肠癌细胞系HCT116及其DNMT3B基因敲除变种,分别设置5-Aza-CdR处理组与对照组,在多个时间点采集基因组DNA进行亚硫酸盐处理,使用Illumina Infinium HM450芯片检测甲基化状态,比较处理组与对照组的基因体甲基化差异。 人源 · 22 例 · GPL13534 · 2014/08/01

    设计对结直肠癌细胞系HCT116及其DNMT3B基因敲除变种,分别设置5-Aza-CdR处理组与对照组,在多个时间点采集基因组DNA进行亚硫酸盐处理,使用Illumina Infinium HM450芯片检测甲基化状态,比较处理组与对照组的基因体甲基化差异。

    摘要Demethylation treatment reduce gene body methylation as well as gene expression

  100. 100 GSE77965 采集 6 例结直肠癌患者的肿瘤组织与配对正常结肠组织(个体 CRC_1–CRC_6),另纳入 HCT116 与 HCT15 来源的异种移植瘤各 1 例,以及 KG1 与 KG1a 急性髓系白血病细胞系,各设 5-aza-2'-deoxycytidine 处理组与相应对照组,共 22 个样本。各样本提取基因组 DNA 后以 Illumina Infinium 450k 芯片检测全基因组 DNA 甲基化,比较肿瘤与配对正常组织、药物处理与对照细胞系之间的甲基化差异,用于筛选位点以评估位点特异性 DNA 甲基化检测方法。 人源 · 22 例 · GPL13534 · 2016/05/20

    设计采集 6 例结直肠癌患者的肿瘤组织与配对正常结肠组织(个体 CRC_1–CRC_6),另纳入 HCT116 与 HCT15 来源的异种移植瘤各 1 例,以及 KG1 与 KG1a 急性髓系白血病细胞系,各设 5-aza-2'-deoxycytidine 处理组与相应对照组,共 22 个样本。各样本提取基因组 DNA 后以 Illumina Infinium 450k 芯片检测全基因组 DNA 甲基化,比较肿瘤与配对正常组织、药物处理与对照细胞系之间的甲基化差异,用于筛选位点以评估位点特异性 DNA 甲基化检测方法。

    摘要Genome-scale DNA methylation data obtained with the Infinium 450k assay. These data were used to support target selection for benchmarking of locus-specific DNA methylation assays

  101. 101 GSE37740 将结直肠癌组织与正常相邻结直肠组织按甲基化表型分为高甲基化(HME)、中间甲基化(IME)、低甲基化(LME)及对照组(Control),通过Illumina Infinium HumanMethylation27芯片检测各组DNA甲基化状态,比较不同表型间的甲基化差异。 人源 · 21 例 · GPL8490 · 2013/03/08

    设计将结直肠癌组织与正常相邻结直肠组织按甲基化表型分为高甲基化(HME)、中间甲基化(IME)、低甲基化(LME)及对照组(Control),通过Illumina Infinium HumanMethylation27芯片检测各组DNA甲基化状态,比较不同表型间的甲基化差异。

    摘要We performed comprehensive genome-scale DNA methylation profiling by Illumina Infinium HumanMethylation27 of 18 DNA pools that represent 84 colorectal cancer (CRC) samples divided according to their high-, intermediate-, and low-methylation epigenotypes (HME, IME, and LME, respectively) and 3 pools representing 70 normal-adjacent colonic tissues.

  102. 102 GSE59134 收集结直肠癌患者肿瘤组织与配对的患者来源异种移植瘤(PDX)模型,采用亚硫酸盐转化DNA后行 Illumina Infinium 450k Human DNA Methylation BeadChip 谱级甲基化检测,比较两组全基因组 CpG 位点甲基化模式差异。 人源 · 21 例 · GPL13534 · 2014/11/26

    设计收集结直肠癌患者肿瘤组织与配对的患者来源异种移植瘤(PDX)模型,采用亚硫酸盐转化DNA后行 Illumina Infinium 450k Human DNA Methylation BeadChip 谱级甲基化检测,比较两组全基因组 CpG 位点甲基化模式差异。

    摘要Illumina Infinium 450k Human DNA Methylation BeadChip was used to obtain DNA methylation profiles across approximately 450,000 CpGs in Osteosarcoma and Colon Cancer PDXs

  103. 103 GSE67772 对21例结直肠癌细胞系进行基因组甲基化分析,其中6例源自肝转移组织。检测基因组DNA甲基化状态并比较原发与肝转移衍生细胞系的DNA拷贝数变异,分析BRAF突变状态(BRAF-WT与BRAF-V600E)相关的甲基化特征,同时结合基因表达数据比较甲基化状态与基因表达的相关性。 人源 · 21 例 · GPL18809 · 2016/02/29

    设计对21例结直肠癌细胞系进行基因组甲基化分析,其中6例源自肝转移组织。检测基因组DNA甲基化状态并比较原发与肝转移衍生细胞系的DNA拷贝数变异,分析BRAF突变状态(BRAF-WT与BRAF-V600E)相关的甲基化特征,同时结合基因表达数据比较甲基化状态与基因表达的相关性。

    摘要Background: In vitro models are an essential tool towards understanding the molecular characteristics of colorectal cancer (CRC) and the testing of therapies for CRC. To this end we established 21 novel CRC cell lines of which six were derived from liver metastases. Extensive genetic, genomic, transcriptomic and methylomic profiling was performed in order to characterize these new cell lines and all data is made publically available. Additionally, sensitivity of oxaliplatin was tested as a measure for chemotherapy resistance. Results: DNA copy-number alterations (CNA) were compared between primary and metastasis derived cell lines. In concordance with previous studies copy-number gain of chr20, and loss of chr8p were found highly specific for liver metastases. Previously reported BRAF-mutation associated DNA methylation profiles could be validated on the genome-wide DNA methylation profiles of these cell lines. 47.6% of the loci previously reported to associate with BRAF mutation status were reproduced in this dataset. When examining the gene expression profiles in conjunction with these DNA methylation results, we identified 20 genes of which the gene expression correlated with the DNA methylation status, including MEIS1, LRAT and STC2. These genes have previously been reported to be subject to transcriptional regulation through DNA hypermethylation, validating our approach. Conclusions: By combining mutation profiles with CNA and gene expression profiles we constructed an overview of the alterations in the major CRC-related signalling pathways. The mutation profiles, along with the genome, transcriptome and methylome data of these cell lines will be made publically available . This combined dataset puts these cell lines among the best characterized CRC cell lines, allowing researchers to select appropriate cell line models for their particular experiment, making optimal use of these novel cell lines as in vitro model for CRC.

  104. 104 GSE92945 对正常、结肠炎和结直肠癌患者的结直肠相关成纤维细胞进行RNA-seq和MBD-seq测序,比较不同疾病状态下细胞的基因表达和甲基化模式差异。 人源 · 21 例 · GPL11154 · 2022/12/29

    设计对正常、结肠炎和结直肠癌患者的结直肠相关成纤维细胞进行RNA-seq和MBD-seq测序,比较不同疾病状态下细胞的基因表达和甲基化模式差异。

    摘要The colon cancer associated fibroblasts are part of the tumor microenvironment and has been shown to facilitate colon cancer progression by secretion of various signaling molecules and growth hormones. Similarly, the fibroblasts associated with colitic colons secrete pro-inflammatory cytokines that promote inflammation of the colon. However, the molecular mechanisms that underlie these gene expression changes in these fibroblasts is unclear. To characterize the epigenetic mechanisms that may contribute to the gene expression changes in these fibroblasts, we performed RNA-seq and MBD-isolated genome sequencing (MiGS or MBD-seq) on colon associated fibroblasts isolated from normal, colitis and cancer patients.

  105. 105 GSE144357 收集人源结直肠癌细胞系 HCT-116 的单细胞和克隆样本,行单细胞转录组分析(使用 MARS-seq 和 10x 平台)及批量转录组分析(使用 MARS-seq),同时对单细胞和克隆样本行全基因组 DNA 甲基化分析(使用 PBAT 技术)及针对结直肠癌设计的捕获型 PBAT 甲基化分析。研究还分析了 HCT116 单细胞克隆在培养 148 天内的纵向单细胞转录组,并对携带 DNMT1 和 DNMT3B 敲除突变的 HCT116 克隆进行转录组和甲基化分析。 人源 · 20 例 · GPL18573 · 2020/01/29

    设计收集人源结直肠癌细胞系 HCT-116 的单细胞和克隆样本,行单细胞转录组分析(使用 MARS-seq 和 10x 平台)及批量转录组分析(使用 MARS-seq),同时对单细胞和克隆样本行全基因组 DNA 甲基化分析(使用 PBAT 技术)及针对结直肠癌设计的捕获型 PBAT 甲基化分析。研究还分析了 HCT116 单细胞克隆在培养 148 天内的纵向单细胞转录组,并对携带 DNMT1 和 DNMT3B 敲除突变的 HCT116 克隆进行转录组和甲基化分析。

    摘要We performed single-cell transcriptome analysis (using MARS-seq and 10x) of four human cell lines, as well as bulk tracscriptome analysis of hundreds of single-cell clones, derived from the same cells population. Additionally, we performed methylation analysis of HCT116 single cells (using whole-genome PBAT) and of the same clones whose transcriptome was analysed (using capture-PBAT). We also analyse longitudinal single cell transcriptomes of six selected HCT116 clones grown for up to 148 days in our lab, and analysed cells and clones of HCT116 cells harbouring knock-out mutations in DNMT1 and DNMT3B (DKO).

  106. 106 GSE25221 对19例结直肠癌样本及正常结肠组织的甲基化状态进行比较分析,采用甲基-CpG免疫沉淀(MCIp)技术富集甲基化DNA,通过基因组平铺阵列检测 CpG 岛甲基化模式,比较癌组织与正常组织的差异。 人源 · 19 例 · GPL8544 · 2012/11/01

    设计对19例结直肠癌样本及正常结肠组织的甲基化状态进行比较分析,采用甲基-CpG免疫沉淀(MCIp)技术富集甲基化DNA,通过基因组平铺阵列检测 CpG 岛甲基化模式,比较癌组织与正常组织的差异。

    摘要To globally define methylation-’prone’ and -’protected’ CpG islands in cancer, we analyzed the methylation status of 23,000 CpG islands of the human genome in 19 colorectal carcinoma samples as well as normal colon using our previously described methyl-CpG immunoprecipitation (MCIp) technique (Gebhard et al. 2006; Schilling and Rehli 2007). This method enriches for highly CpG methylated DNA that can be directly applied to fluorescent labeling and oligonucleotide microarray hybridization without an additional amplification step.

  107. 107 GSE116699 对14例肺源性肠腺癌(PEAD)及4例结直肠癌肺转移样本的DNA甲基化模式进行比较分析,采用Illumina Infinium MethylationEPIC BeadChip平台检测,通过机器学习算法区分PEAD与转移性结直肠癌。所有样本均为人类基因组DNA,来源包括肺切除、肺活检和肺转移切除,未明确分组处理方式。 人源 · 18 例 · GPL21145 · 2019/01/04

    设计对14例肺源性肠腺癌(PEAD)及4例结直肠癌肺转移样本的DNA甲基化模式进行比较分析,采用Illumina Infinium MethylationEPIC BeadChip平台检测,通过机器学习算法区分PEAD与转移性结直肠癌。所有样本均为人类基因组DNA,来源包括肺切除、肺活检和肺转移切除,未明确分组处理方式。

    摘要Pulmonary enteric adenocarcinoma (PEAD) is a rare non-small cell lung cancer subtype. It is poorly characterized and cannot be distinguished from metastatic colorectal or upper gastrointestinal adenocarcinomas (ADCs) by means of routine pathological methods. As DNA methylation patterns are known to be highly tissue specific, we aimed to develop a methylation-based algorithm to differentiate these entities. To this end, genome wide methylation profiles of 600 primary pulmonary, colorectal and upper gastrointestinal ADCs obtained from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) database were used as a reference cohort to train a machine learning algorithm. The resulting classifier correctly classified all samples from a validation cohort consisting of 680 primary pulmonary, colorectal and upper gastrointestinal ADCs from TCGA and the GEO database, demonstrating the ability of the algorithm to reliably distinguish these three entities. We then analyzed DNA methylation data of 15 PEADs as well as four pulmonary metastases and four primary colorectal ADCs with the algorithm. All 15 PEADs were reliably classified as primary pulmonary tumors and all four metastases as well as all four primary colorectal ADC samples were identified as primary colorectal ADCs. In a t-distributed stochastic neighbor embedding analysis, the PEAD samples did not form a separate methylation subclass but rather diffusely intermixed with other pulmonary ADCs. Additional characterization of the PEAD series using fluorescence in-situ hybridization, next generation sequencing and copy number analysis revealed KRAS mutations in nine of 15 samples (60%) and a high number of structural chromosomal changes. Except for an unusually high rate of chromosome 20 gain (66.7%) the molecular data was mostly reminiscent of standard pulmonary ADCs. In conclusion, we provide sound evidence of the pulmonary origin of PEAD and in addition provide a publicly available machine learning based algorithm to reliably distinguish PEAD from metastatic colorectal cancer and upper gastrointestinal adenocarcinomas.

  108. 108 GSE278681 对 HCT116 结直肠癌细胞系设置 UHRF1 敲除组、DNMT1 敲除组及双敲除组,与野生型对照组共同接受 auxin 处理,分别在 0、2、4、6、8 天时间点采集样本,行全基因组规模亚硫酸氢盐测序(Bisulfite-Seq)甲基化谱检测,比较各组 DNA 甲基化模式变化。 人源 · 18 例 · GPL20795 · 2025/05/19

    设计对 HCT116 结直肠癌细胞系设置 UHRF1 敲除组、DNMT1 敲除组及双敲除组,与野生型对照组共同接受 auxin 处理,分别在 0、2、4、6、8 天时间点采集样本,行全基因组规模亚硫酸氢盐测序(Bisulfite-Seq)甲基化谱检测,比较各组 DNA 甲基化模式变化。

    摘要Aberrant DNA methylation patterns are a hallmark of human cancers, prompting targeting of DNA methylation machinery to be explored as an anti-tumor strategy. DNA methyltransferase 1 (DNMT1) and ubiquitin like With PHD and Ring finger domains 1 (UHRF1) are crucial enzymes for DNA methylation maintenance. Unlike DNMT1, UHRF1 is overexpressed in most cancers and is a proven oncogene in vivo. Our previous work revealed that the degree of DNA methylation loss induced by UHRF1 depletion is more severe than DNMT1 depletion in colorectal cancer cells, indicating that targeting UHRF1 may be a more effective approach. Using an advanced chemical/genetic system, the auxin-inducible degron (AID) technology, we monitored the long-term effects of removing UHRF1 and/or DNMT1 in cancer cells, deciphering the mechanistic basis through bioinformatic tools. We found that chronic DNA demethylation triggers cancer cells to undergo cellular senescence. The loss of UHRF1 results in a more rapid and profound senescence phenotype than DNMT1 loss. Intriguingly, this senescence is not accompanied by DNA damage and functions independently of canonical senescence pathways such as p53 and p16/pRB. Non-canonical pathway investigations revealed that cytosolic p21 accumulation contributes to antiapoptosis during senescence. The suppression of cyclic GMP-AMP synthase (cGAS) also alleviates the senescence-associated secretory phenotype (SASP) and lysosomal activity, and this process is independent of stimulator of interferon genes (STING). Finally, xenograft experiments verified our findings in vivo. Our results highlight how DNA methylation protects cancer cells from non-canonical senescence and demonstrate the potential of targeting UHRF1 as a novel avenue for anticancer treatments.

  109. 109 GSE37872 对两名结直肠癌患者的原发肿瘤(CRC)、癌相关黏膜(CAM)和血液样本进行基因组 DNA 提取与亚硫酸氢盐转化,杂交至 Illumina Infinium 27k 甲基化芯片 v1.2,比较不同样本类型间的 DNA 甲基化差异。 人源 · 18 例 · GPL8490 · 2019/03/22

    设计对两名结直肠癌患者的原发肿瘤(CRC)、癌相关黏膜(CAM)和血液样本进行基因组 DNA 提取与亚硫酸氢盐转化,杂交至 Illumina Infinium 27k 甲基化芯片 v1.2,比较不同样本类型间的 DNA 甲基化差异。

    摘要DNA methylation profiling of matched primary tumor (CRC), cancer-associated mucosa (CAM) and blood from two colorectal cancer patients to identify cancer-specific methylation targets.

  110. 110 GSE26040 收集人类支气管上皮细胞(HBEC)与结直肠癌细胞系 HCT116 及其 DNMT1-/- DNMT3b -/- 双敲除株(HCT116-DKO)的输入 DNA,对 HBEC 和 HCT116-DKO 行 DNA 甲基化状态分析,采用 MIRA 和 UnmethylCollector(UMC)方法;同时对 HBEC、HCT116 及 HCT116-DKO 行组蛋白修饰 H3K9me3、H3K36me3、H3K27me3、H4K20me3 和 H3K4me3 的 ChIP-ChIP 测定,采用基因组 tiling array 平台;HBEC 经非编码 siRNA 或 SETD2 siRNA 转染后,行 DNA 甲基化与 H3K36me3 的 ChIP-ChIP 测定。 人源 · 17 例 · GPL11313 · 2011/03/31

    设计收集人类支气管上皮细胞(HBEC)与结直肠癌细胞系 HCT116 及其 DNMT1-/- DNMT3b -/- 双敲除株(HCT116-DKO)的输入 DNA,对 HBEC 和 HCT116-DKO 行 DNA 甲基化状态分析,采用 MIRA 和 UnmethylCollector(UMC)方法;同时对 HBEC、HCT116 及 HCT116-DKO 行组蛋白修饰 H3K9me3、H3K36me3、H3K27me3、H4K20me3 和 H3K4me3 的 ChIP-ChIP 测定,采用基因组 tiling array 平台;HBEC 经非编码 siRNA 或 SETD2 siRNA 转染后,行 DNA 甲基化与 H3K36me3 的 ChIP-ChIP 测定。

    摘要Analysis of cross talk of epigenetic marks in HBEC by using tilling arrays chr19. In Human Bronchial epithelia cells (HBEC), H3K9me3, H4K20me3, H3K4me3, H3K27me3, H3K36me3 and DNA methylation were profiled. In these cells, DNA methylation status was analyzed by MIRA and UnmethylCollector (UMC). Study of epigenetic changes in HCT116 DNMT1-/- and DNMT3b -/- (HCT116-DKO) in comparison to intact HCT116. In HCT116 and HCT116-DKO, H3K9me3, H3K36me3 and DNA methylation were profiled. In these cells, DNA methylation status was analyzed by MIRA. Analysis of epigenetic changes caused by siRNA for SED2 transcript in HBEC. In HBEC and SETD2 siRNA HBEC, H3K36me3 and DNA methylation were profiled. In these cells, DNA methylation status was analyzed by MIRA.

  111. 111 GSE47590 收集人类结直肠癌原发肿瘤组织与配对癌旁黏膜样本,采用 hmeDIP-seq 技术对全基因组 5-羟基甲基胞嘧啶含量进行测序分析,比较肿瘤组织与癌旁黏膜的 5-hmC 分布特征。研究包含 5 例正常结直肠组织(距肿瘤 20cm 与近肿瘤区域)和 4 例配对肿瘤组织样本,所有样本均来自人源,采用 MeDIP-Seq 和 ChIP-Seq 测定策略,使用 anti-5-hmC 抗体和 anti-TET2 抗体进行免疫沉淀,检测材料为基因组 DNA,测序数据通过 Illumina 平台生成,未涉及细胞模型或治疗干预。 人源 · 17 例 · GPL10999;15456 · 2015/02/03

    设计收集人类结直肠癌原发肿瘤组织与配对癌旁黏膜样本,采用 hmeDIP-seq 技术对全基因组 5-羟基甲基胞嘧啶含量进行测序分析,比较肿瘤组织与癌旁黏膜的 5-hmC 分布特征。研究包含 5 例正常结直肠组织(距肿瘤 20cm 与近肿瘤区域)和 4 例配对肿瘤组织样本,所有样本均来自人源,采用 MeDIP-Seq 和 ChIP-Seq 测定策略,使用 anti-5-hmC 抗体和 anti-TET2 抗体进行免疫沉淀,检测材料为基因组 DNA,测序数据通过 Illumina 平台生成,未涉及细胞模型或治疗干预。

    摘要The discovery of cytosine hydroxymethylation (5-hmC) as a mechanism that potentially controls DNA methylation changes typical of neoplasia prompted us to investigate its behavior in colon cancer. 5-hmC is globally reduced in proliferating cells such as colon tumors and the gut crypt progenitors, from which tumors can arise. Here, we show that colorectal tumors and cancer cells express Ten-Eleven Translocation (TET) transcripts at levels similar to normal tissues. Genome-wide analyses show that promoters marked by 5-hmC in normal tissue, and those identified as TET2 targets in colorectal cancer cells, are resistant to methylation gain in cancer. In vitro studies of TET2 in cancer cells confirm that these promoters are resistant to methylation gain independently of sustained TET2 expression. We also find that a considerable number of the methylation gain-resistant promoters marked by 5-hmC in normal colon overlap with those that are marked with poised bivalent histone modifications in embryonic stem cells. Together our results indicate that promoters that acquire 5-hmC upon normal colon differentiation are innately resistant to neoplastic hypermethylation by mechanisms that do not require high levels of 5-hmC in tumors. Our study highlights the potential of cytosine modifications as biomarkers of cancerous cell proliferation.

  112. 112 GSE123367 对来自8位结直肠癌患者的CR-CSC系及其对应的异种移植来源CR-XenoCSC进行DNA甲基化分析,比较不同来源细胞的甲基化模式。样本经亚硫酸盐转化后使用Infinium HumanMethylationEPIC BeadChip检测,共包含16个GSM记录。 人源 · 16 例 · GPL21145 · 2020/01/15

    设计对来自8位结直肠癌患者的CR-CSC系及其对应的异种移植来源CR-XenoCSC进行DNA甲基化分析,比较不同来源细胞的甲基化模式。样本经亚硫酸盐转化后使用Infinium HumanMethylationEPIC BeadChip检测,共包含16个GSM记录。

    摘要Colorectal cancer stem cells (CR-CSCs) are implicated in tumor development, metastasis, and therapy resistance, however little is known about their epigenetic features. Here we describe the DNA methylation profiles of eight CR-CSC lines and their distinctive patterns, which are maintained following in vivo passages in immune-compromised mice.

  113. 113 GSE14526 收集结直肠癌患者临床样本与正常结直肠组织,行甲基化免疫沉淀芯片分析,比较不同甲基化表型与基因突变、肿瘤位置等特征的关联。研究使用 HCT116 和 SW480 两种结直肠癌细胞系,分别进行甲基化免疫沉淀芯片分析,同时对临床样本进行 MALDI-TOF 质谱检测,分析 44 个新选甲基化标记与 16 个已知标记的甲基化水平。通过无监督的双向层次聚类,将结直肠癌样本分为高甲基化、中甲基化和低甲基化表型。甲基化标记被分为两组:Group-1 标记在高甲基化表型中富集,包含除 NEUROG1 外的所有 CIMP 相关标记;Group-2 标记在高甲基化和中甲基化表型中富集。研究开发了两个标记面板用于区分不同表型,其中 Group-1 标记用于识别高甲基化表型,Group-2 标记与 SLC30A10 用于区分中甲基化与低甲基化表型。 人源 · 16 例 · GPL570;5082 · 2010/01/05

    设计收集结直肠癌患者临床样本与正常结直肠组织,行甲基化免疫沉淀芯片分析,比较不同甲基化表型与基因突变、肿瘤位置等特征的关联。研究使用 HCT116 和 SW480 两种结直肠癌细胞系,分别进行甲基化免疫沉淀芯片分析,同时对临床样本进行 MALDI-TOF 质谱检测,分析 44 个新选甲基化标记与 16 个已知标记的甲基化水平。通过无监督的双向层次聚类,将结直肠癌样本分为高甲基化、中甲基化和低甲基化表型。甲基化标记被分为两组:Group-1 标记在高甲基化表型中富集,包含除 NEUROG1 外的所有 CIMP 相关标记;Group-2 标记在高甲基化和中甲基化表型中富集。研究开发了两个标记面板用于区分不同表型,其中 Group-1 标记用于识别高甲基化表型,Group-2 标记与 SLC30A10 用于区分中甲基化与低甲基化表型。

    摘要Aberrant DNA methylation, one of the major epigenetic alterations in cancer, has been reported to accumulate in a subset of colorectal cancer (CRC), so-called CpG island methylator phenotype (CIMP), which was known to correlate with microsatellite instability (MSI)-high CRC. To select new methylation markers genome-widely and epigenotype CRC by DNA methylation comprehensively, we performed methylated DNA immunoprecipitation-on-chip analysis using MSI-high CRC cell line HCT116 and microsatellite-stable SW480, and re-expression array analysis by 5-aza-2-deoxycytidine/Trichostatin A. Methylation levels of 44 new markers selected and 16 previously reported markers were analyzed quantitatively in 149 clinical CRC samples using MALDI-TOF mass spectrometry. By unsupervised two-way hierarchical clustering, CRC was clustered into high-, intermediate-, and low-methylation epigenotypes. Methylation markers were clustered into two groups: Group-1 showing methylation in high-methylation epigenotype and including all the 11 CIMP-related markers except NEUROG1, and Group-2 showing methylation in high- and intermediate-methylation epigenotypes. Marker panel deciding methylation epigenotypes with the highest accuracy was developed: 1st-Panel consisting of Group-1 genes (CACNA1G, LOX, SLC30A10) to extract high-methylation epigenotype, and 2nd-Panel consisting of Group-2 genes (ELMO1, FBN2, THBD, HAND1) and SLC30A10 again to divide the remains into intermediate- and low-methylation epigenotypes. High-methylation epigenotype correlated significantly with BRAF mutation, MSI, proximal tumor location, and mucinous component, in concordance with reported CIMP. Intermediate- and low-methylation epigenotypes significantly correlated with KRAS-mutation(+) and KRAS-mutation(-), respectively. KRAS-mutation(+) intermediate-methylation epigenotype showed worse prognosis than KRAS-mutation(-) low-methylation epigenotype (p=0.030). These three epigenotypes with different genetic characteristics suggested different molecular CRC genesis, and the markers might be useful to predict prognosis.

  114. 114 GSE220160 将结直肠癌组织与息肉组织样本进行全基因组甲基化分析,使用Illumina Infinium EPIC Human Methylation BeadChip芯片检测差异甲基化位点,比较两组组织的甲基化特征差异。 人源 · 16 例 · GPL21145 · 2024/01/01

    设计将结直肠癌组织与息肉组织样本进行全基因组甲基化分析,使用Illumina Infinium EPIC Human Methylation BeadChip芯片检测差异甲基化位点,比较两组组织的甲基化特征差异。

    摘要Colorectal polyp is known a precursor of colorectal cancer (CRC) that holds an increased risk for progression to CRC. Circulating cell-free DNA(cfDNA) methylation has shown favorable performance in the detection and monitoring the malignant progression in a variety of cancers. Here, we conducted a study to discovery cfDNA methylation markers for the diagnosis of CRC. We first performed a genome-wide analysis using the Infinium HumanMethylationEPIC BeadChip array to identify differentially methylated CpGs (DMCs) between 8 CRC and 8 polyp tissues. Then, we validated DMCs in a larger tissue cohort and four methylation markers (cg04486886, cg06712559, cg13539460 and cg27541454) were selected as the methylation markers in tissue by LASSO and random forest models. A diagnosis prediction model was bulit based on the four markers and the methylaion diagnosis score (md-score) can effectively discriminate patients with CRC from polyp tissues. Finally, a single cfDNA methylation marker, cg27541454, was confirmed hypermethylated in CRC in the plasma validation cohort. Together, our findings suggested that the md-score derived from tissue could robustly detect CRC from polpy patients, and cg27541454 may be a promising candidate non-invasive biomarker for CRC early diagnosis.

  115. 115 GSE284325 对早期发病结直肠癌(EOCRC)患者及正常相邻结肠黏膜组织进行全基因组亚硫酸盐测序,比较其表观遗传景观差异及特定种族/民族群体的甲基化特征。 人源 · 16 例 · GPL24676 · 2025/01/29

    设计对早期发病结直肠癌(EOCRC)患者及正常相邻结肠黏膜组织进行全基因组亚硫酸盐测序,比较其表观遗传景观差异及特定种族/民族群体的甲基化特征。

    摘要Background. The incidence of early-onset colorectal cancer (EOCRC) has been rising at an alarming rate in the United States, and EOCRC disproportionately affects racial/ethnic minorities. Here, we construct comprehensive profiles of EOCRC DNA methylomes at base-pair resolution for a cohort of Hispanic and African American patients. Results. We show the epigenetic landscape of these EOCRC patients differs from that of late-onset colorectal cancer (LOCRC) patients, and methylation canyons in EOCRC tumor tissue preferentially overlapped genes in cancer-related pathways. Furthermore, we identify epigenetic alterations in metabolic genes that are specific to our racial/ethnic minority EOCRC cohort but not Caucasian patients from TCGA. Top genes differentially methylated between these cohorts included the obesity-protective MFAP2 gene as well as cancer risk susceptibility genes APOL3 and RNASEL. Conclusions. In this study, we provide to the scientific community high-resolution DNA methylomes for a cohort of EOCRC patients from underrepresented populations. Our exploratory findings in this cohort highlight epigenetic mechanisms underlying the pathogenesis of EOCRC and nominate novel biomarkers for EOCRC in underrepresented populations.

  116. 116 GSE47413 对16例结直肠癌患者的肿瘤组织与匹配的正常组织进行甲基化分析,采用甲基-CpG免疫沉淀结合CpG岛微阵列技术,比较两者甲基化状态的差异。 人源 · 16 例 · GPL9767 · 2013/12/31

    设计对16例结直肠癌患者的肿瘤组织与匹配的正常组织进行甲基化分析,采用甲基-CpG免疫沉淀结合CpG岛微阵列技术,比较两者甲基化状态的差异。

    摘要To identify new markers for colorectal cancer we scrutinized the methylation status by methyl-CpG immunoprecipitation followed by global methylation profiling on a CpG island microarray, as altered expression could drive genomic and chromosomal instability observed in these tumors. We show for the first time hypermethylation of MMP9, DNMT3A, and LIG4 in CRC which was confirmed in two independent ethnic CRC patients groups. Hypermethylation of the LIG4 promoter is a new mechanism to control ligase IV expression. It may represent a new epigenetic marker for colorectal cancer independent of known markers.

  117. 117 GSE5326 采用MMASS方法评估结直肠癌细胞系HCT116基因组DNA的CpG岛甲基化状态,通过优化的甲基化敏感酶组合(BstUI/HhaI/HpaII或McrBC)分别制备甲基化与未甲基化序列表示,使用GPL2040微阵列平台进行杂交分析,比较MMASS-v2方法与Nouzova等人的方法在统计效力上的差异。 人源 · 16 例 · GPL2040 · 2006/10/31

    设计采用MMASS方法评估结直肠癌细胞系HCT116基因组DNA的CpG岛甲基化状态,通过优化的甲基化敏感酶组合(BstUI/HhaI/HpaII或McrBC)分别制备甲基化与未甲基化序列表示,使用GPL2040微阵列平台进行杂交分析,比较MMASS-v2方法与Nouzova等人的方法在统计效力上的差异。

    摘要We describe an optimized microarray method for identifying genome-wide CpG island methylation called Microarray-based Methylation Assessment of Single Samples (MMASS) which directly compares methylated to unmethylated sequences within a single sample. To improve previous methods we used bioinformatic analysis to predict an optimised combination of methylation-sensitive enzymes that had the highest utility for CpG-island probes and different methods to produce unmethylated representations of test DNA for more sensitive detection of differential methylation by hybridization. Subtraction or methylation-dependent digestion with McrBC was used with optimized (MMASS-v2) or previously described (MMASS-v1, MMASS-sub) methylation-sensitive enzyme combinations and compared to a published McrBC method. Comparison was performed using DNA from the cell line HCT116. We show that the distribution of methylation microarray data is inherently skewed and requires exogenous spiked controls for normalization and that analysis of digestion of methylated and unmethylated control sequences together with linear fit models of replicate data showed superior statistical power for the MMASS-v2 method. Comparison to previous methylation data for HCT116 and validation of CpG islands from PXMP4, SFRP2, DCC, RARB and TSEN2 confirmed the accuracy of MMASS-v2 results. The MMASS-v2 method offers improved sensitivity and statistical power for high-throughput microarray identification of differential methylation. Keywords: Methylation genomic hybridizations.

  118. 118 GSE98531 对结直肠腺癌组织及其配对正常黏膜组织进行全基因组 DNA 甲基化分析,比较肿瘤与对应正常组织的甲基化差异,识别与 CIMP 相关的遗传驱动型 CpG 高甲基化特征。 人源 · 16 例 · GPL8490 · 2019/12/18

    设计对结直肠腺癌组织及其配对正常黏膜组织进行全基因组 DNA 甲基化分析,比较肿瘤与对应正常组织的甲基化差异,识别与 CIMP 相关的遗传驱动型 CpG 高甲基化特征。

    摘要Promoter hypermethylation divides colon cancers into subtypes with and without a CpG island methylator phenotype (CIMP). Here, we performed genome-wide DNA methylation profiling of colonic normal and tumor tissues to dissect development of CpG hypermethylation in colon carcinogenesis. This identified age-environment related versus genetically driven CpG hypermethylation, the latter being associated with CIMP cancers. We found a strong association between BRAFV600E mutation and downregulation of the DNA demethylases TET1 and TET2. Expression of BRAFV600E in CIMP cancer cells suppressed TET1 transcription, which was sufficient to establish hypermethylation at CIMP genes promoters, including that of TET2. This phenotype was reverted by the BRAFV600E inhibitor vemurafenib. Thus, BRAFV600E, via impairment of cytosine de-methylation, is a genetic driver of CIMP in colon tumorigenesis. Genome-wide DNA methylation profiling of adjacent non-tumor colon tissue and colon adenocarcinoma samples. The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 27,000 CpGs. Samples included 8 colon cancer tissues and their associated healthy mucosa (CAM).

  119. 119 GSE151318 对5名结直肠癌患者的匹配正常邻近组织、原发肿瘤和淋巴结转移样本进行全基因组DNA甲基化分析,使用Bisulfite-Seq技术在Illumina HiSeq 2500平台上进行50bp单端测序,比较各组与正常相邻组织的差异。 人源 · 15 例 · GPL16791 · 2020/11/02

    设计对5名结直肠癌患者的匹配正常邻近组织、原发肿瘤和淋巴结转移样本进行全基因组DNA甲基化分析,使用Bisulfite-Seq技术在Illumina HiSeq 2500平台上进行50bp单端测序,比较各组与正常相邻组织的差异。

    摘要Genome-wide DNA methylation of colorectal cancer patients with lymph node metastases showed global loss of DNA methylation in CG-poor, non-CpG island (CGI) regions. Overall CGI methylation was increased in tumour samples. Differential methylation analysis of CGIs identified 60 putative biomarkers, with >20% increase in DNA methylation in both primary tumour and metastasis samples compared to normal adjacent tissue.

  120. 120 GSE273176 对人类结直肠癌细胞系 HCT116 的肿瘤组织进行 DNA 甲基化分析,样本接受三种不同 LNP 处理:LNP、LNP-mSTELLA 和 LNP-mSTELLA-Swap1。同时包含 A549 和 MDA-MB-231 人癌细胞系稳定过表达 hSTELLA 或 mSTELLA 蛋白的样本,以及空载体对照。所有样本采用 Infinium MethylationEPIC v2.0 芯片检测,共包含 15 个 GSM 样本。 人源 · 15 例 · GPL33022 · 2024/07/28

    设计对人类结直肠癌细胞系 HCT116 的肿瘤组织进行 DNA 甲基化分析,样本接受三种不同 LNP 处理:LNP、LNP-mSTELLA 和 LNP-mSTELLA-Swap1。同时包含 A549 和 MDA-MB-231 人癌细胞系稳定过表达 hSTELLA 或 mSTELLA 蛋白的样本,以及空载体对照。所有样本采用 Infinium MethylationEPIC v2.0 芯片检测,共包含 15 个 GSM 样本。

    摘要Genome-wide DNA methylation profiling of non-small cell lung cancer (NSCLC) cell line A549 and breast cancer cell line MDA-MB-231 stably expressing hSTELLA and mSTELLA, as well as the HCT116 xenograft tumor tissues from the mice treated by the indicated LNP formulations. The Infinium MethylationEPIC v2.0 array was used to obtain DNA methylation profiles across more than 935,000 CpGs in 15 samples. Samples included 3 stable NSCLC cells and 3 stable breast cancer cells expressing the STELLA orthologs, and 9 xenograft tumors from the mice with the indicated treatments.

  121. 121 GSE34068 对11例增生性息肉病综合征(HPS)患者与4例正常结肠对照的结肠组织提取基因组DNA,采用Illumina甲基化芯片(GPL8490)进行全基因组DNA甲基化谱分析。HPS样本按息肉类型(HP/SSA、SSA、MP、MVHP)、大小、部位(横结肠、升结肠、脾曲、降结肠、乙状结肠)、BRAF/KRAS突变状态等临床特征记录,对照为正常结肠组织。比较HPS息肉组织与正常结肠组织的启动子甲基化模式,以探讨癌前病变阶段的CpG岛甲基化表型特征。 人源 · 15 例 · GPL8490 · 2014/12/01

    设计对11例增生性息肉病综合征(HPS)患者与4例正常结肠对照的结肠组织提取基因组DNA,采用Illumina甲基化芯片(GPL8490)进行全基因组DNA甲基化谱分析。HPS样本按息肉类型(HP/SSA、SSA、MP、MVHP)、大小、部位(横结肠、升结肠、脾曲、降结肠、乙状结肠)、BRAF/KRAS突变状态等临床特征记录,对照为正常结肠组织。比较HPS息肉组织与正常结肠组织的启动子甲基化模式,以探讨癌前病变阶段的CpG岛甲基化表型特征。

    摘要Hyperplastic Polyposis Syndrome (HPS) is a condition associated with multiple serrated polyps, and an increased risk of colorectal cancer (CRC). The majority of CRCs arising in HPS show a CpG island methylator phenotype (CIMP) that encompasses several common tumor suppressor genes, including regulators of DNA mismatch repair, and negative regulators of Wnt signaling. However, little is currently known about the CIMP status of premalignant polyp tissue in HPS or the temporal changes in CIMP profile associated with transition to malignancy. Using genomescale DNA methylation analysis of HPS polyp and disease-free tissue, we identified widespread coordinated DNA methylation changes, common to all HPS polyps examined. The majority of consistent changes involve low-intermediate (10-50%) methylation and include several tumour suppressor genes, including multiple negative regulators of Wnt signalling (SFRP-1, -2, -4, -5) and cell cycle regulation (eg. RASSF1). We also confirmed selective methylation of the RUNX1, CHFR, CDKN2A, and MLH-1 promoters previously described in HPS, but found no evidence for methylation of DNA mismatch repair genes MGMT or MSH-2 in premalignant polyps. Consistent and widespread methylation of the WT-1 tumour suppressor gene also appears to be a common feature of HPS. Interestingly, where tested the majority of methylation identified was localised to a single allele within the polyp tissue. These findings reveal that premalignant HPS is associated with coordinated, widespread intermediate levels of gene promoter methylation in several TS genes implicated in CRC, primarily restricted to one of two alleles. Transition to malignancy appears to be associated with widespread elevation of methylation at these sites. These findings warrant a further investigation of the potential for future development of novel methylation-based molecular assays for the prediction of HPS cases likely to transition to malignancy.

  122. 122 GSE79211 收集结直肠癌患者肿瘤组织与配对癌旁黏膜的 DNA 甲基化数据,采用全基因组规模的 WGBS 测定方法,分析相邻 CpG 位点的共甲基化模式,定义为甲基化等位块(Methylation Haplotype Blocks, MHBs)。研究进一步利用 RRBS 数据和 Illumina 450k 甲基化芯片数据对 MHBs 进行验证,比较肿瘤与正常组织的甲基化特征,并探讨其与发育命运决定机制的关系。 人源 · 15 例 · GPL11154 · 2017/02/19

    设计收集结直肠癌患者肿瘤组织与配对癌旁黏膜的 DNA 甲基化数据,采用全基因组规模的 WGBS 测定方法,分析相邻 CpG 位点的共甲基化模式,定义为甲基化等位块(Methylation Haplotype Blocks, MHBs)。研究进一步利用 RRBS 数据和 Illumina 450k 甲基化芯片数据对 MHBs 进行验证,比较肿瘤与正常组织的甲基化特征,并探讨其与发育命运决定机制的关系。

    摘要Adjacent CpG sites in mammalian genomes tend to be co-methylated due to the processivity of enzymes responsible for adding or removing the methyl group. Yet discordant methylation patterns have also be observed, and found to be related to stochastic or uncoordinated molecular processes. Here we focused on a systematic search and investigation of regions in the human genome that exhibit highly coordinated methylation. By examining the co-methylation patterns of multiple adjacent CpG sites, termed methylation haplotypes, in single bisulfite sequencing reads, we applied a greedy-searching strategy to defined blocks of tightly coupled CpG sites, called Methylation Haplotype Blocks (MHBs), based on 53 sets of whole genome bisulfite sequencing (WGBS) data, including 43 published sets from human adult tissues, ESC and in vitro differentiated cell lines, as well as 10 sets from human adult tissues generated in this study. The MHBs were then further validated with 101 sets of RRBS ENCODE data, and 637 sets of Illumina 450k methylation array data from TCGA tumor and normal samples. Globally, MHBs are enriched in but only partially overlap with several well-known genomic features, including CpG islands, promoters, enhancers and VMRs. To perform quantitative analysis of the MHBs, we defined a metric called Methylation Haplotype Load (MHL), which is covered both average methylation level and methylation complexity and therefore more informative than average methylation level or Shannon entropy. Using a feature selection strategy, we identified a set of tissue-specific MHBs that cluster by developmental germ-layers. Interestingly, examination of these MHBs revealed two distinct mechanisms for fate commitment during development: epigenetic silencing of pluripotent genes, such as NANOG, for mesoderm induction; and epigenetic induction (or de-suppression) of lineage-specific factors for ectoderm commitment.

  123. 123 GSE90966 对结直肠癌细胞系HCT116、HCT8和DLD1分别以0、500、1000 nM浓度处理,其中0和1000 nM浓度组设置技术重复,提取总RNA进行bisulfite测序,比较不同浓度处理下重复元件的表达差异。 人源 · 15 例 · GPL15520 · 2017/08/01

    设计对结直肠癌细胞系HCT116、HCT8和DLD1分别以0、500、1000 nM浓度处理,其中0和1000 nM浓度组设置技术重复,提取总RNA进行bisulfite测序,比较不同浓度处理下重复元件的表达差异。

    摘要There is tremendous excitement for the potential of epigenetic therapies in cancer, but the ability to predict and monitor response to these drugs remains elusive. This is in part due to the inability to differentiate the direct cytotoxic and the immunomodulatory effects of these drugs on cancers. The DNA hypomethylating agent 5-azacytdine (AZA) has shown these distinct effects in a variety of cancers, and appears to be linked to the de-repression of repetitive element RNA. Although AZA generally induces global de-repression of repeats, we have found that there is significant diversity of repeat behavior that has not been well characterized in cancer. LINE and HERV are two of the largest classes of repeat elements in the human genome, and despite many commonalities, we find there is heterogeneity in behavior amongst different subtypes of repeats. Specifically, the LINE-1 and HERV-H subtypes were found to be abundant across colon cancers by RNA-seq and RNA in situ hybridization, but had distinct expression patterns, which suggested that these repeats are correlated to transcriptional programs marking different biological states in cancer cells. We find that low LINE-1 expression correlates with global DNA hypermethylation, wildtype TP53 status, and responsiveness to AZA. HERV-H repeats were not concordant with LINE-1 expression, but were found to be linked with differences in FOXP3+ regulatory T-cell tumor infiltrates. Together, distinct repeat RNA expression patterns define new molecular classifications of colon cancer and provide biomarkers that better distinguish cytotoxic from immunomodulatory effects by epigenetic drugs.

  124. 124 GSE274189 对12个未经处理的结直肠癌患者来源类器官的基因组DNA进行甲基化芯片分析,以评估其DNA甲基化特征。 人源 · 12 例 · GPL21145 · 2024/09/18

    设计对12个未经处理的结直肠癌患者来源类器官的基因组DNA进行甲基化芯片分析,以评估其DNA甲基化特征。

    摘要Background: Liquid biopsy based on cell free DNA (cfDNA) analysis holds significant promise as a minimally invasive approach for the diagnosis, genotyping and monitoring of solid malignancies. Human tumors release cfDNA in the bloodstream through a combination of events, including cell death, active and passive release. However, the precise mechanisms leading to cfDNA shedding remain to be characterized. Addressing this question in patients is confounded by several factors, such as tumor burden extent, anatomical and vasculature barriers, release of nucleic acids from normal cells. In this work, we exploited cancer models to dissect basic mechanisms of DNA release. Methods: We measured cell loss ratio, doubling time and cfDNA release in the supernatant of a colorectal cancer (CRC) cell line collection (N=76) representative of the molecular subtypes previously identified in cancer patients. Association analyses between quantitative parameters of cfDNA release, cell proliferation and molecular features were evaluated. Functional experiments were performed to test the impact of modulating DNA methylation on cfDNA release. Results: Higher levels of supernatant cfDNA were significantly associated with slower cell cycling and increased cellular crashes. In addition, a higher cfDNA shedding was found in non-CpG Island Methylator Phenotype (CIMP) models. These results indicate a positive correlation between lower methylation and increased cfDNA levels. To explore this further, we exploited methylation microarrays to identify a subset of probes significantly associated with cfDNA shedding and derive a methylation signature capable of discriminating high from low cfDNA releasers. We applied this signature to an independent set of 176 CRC cell lines and patient derived organoids to select 14 models predicted to be low or high releasers. The methylation profile successfully predicted the amount of cfDNA released in the supernatant. At the functional level, genetic ablation of DNA methyl-transferases increased chromatin accessibility and DNA fragmentation, leading to increased cfDNA release in isogenic CRC cell lines. Furthermore, in vitro treatment of five low releaser CRC cells with a demethylating agent was able to induce a significant increase in cfDNA shedding. Conclusion: Methylation status of cancer cell lines contributes to the variability of cfDNA shedding in vitro. Changes in methylation pattern are associated with cfDNA release levels and might be exploited to increase sensitivity of liquid biopsy assays.

  125. 125 GSE75546 对6例直肠癌患者的肿瘤组织与配对癌旁正常组织(共12个样本)提取基因组DNA,经重亚硫酸盐转化后使用Illumina Human Methylation 450K BeadChip检测约485,000个CpG位点的甲基化水平,比较同一患者直肠癌组织与相邻正常组织的甲基化差异。样本临床信息包括性别、年龄、T/N/M分期、淋巴结转移状态、分期(如IIA、IIIB)与分化程度(如中度、低分化)。 人源 · 12 例 · GPL13534 · 2015/12/02

    设计对6例直肠癌患者的肿瘤组织与配对癌旁正常组织(共12个样本)提取基因组DNA,经重亚硫酸盐转化后使用Illumina Human Methylation 450K BeadChip检测约485,000个CpG位点的甲基化水平,比较同一患者直肠癌组织与相邻正常组织的甲基化差异。样本临床信息包括性别、年龄、T/N/M分期、淋巴结转移状态、分期(如IIA、IIIB)与分化程度(如中度、低分化)。

    摘要DNA methylation was suggested as the promising biomarker for rectal cancer diagnosis. However, it remains a great challenge to search for the optimal methylation biomarkers to obtain ideal diagnostic performance. We aimed to identify new molecular markers for rectal cancer by evaluating their epigenomic and transcriptomic profiles. Genome-wide methylation analysis revealed 18568 probes with significant methylation differences between the six rectal cancer and paired normal samples. Transcriptome profiling presented 773 low-expressed and 1,161 over-expressed genes. After merging the DNA methylation with gene expression data, we identified a panel of 36 genes with an inverse correlation between methylation and gene expression levels. A genome-wide DNA methylation approach merged with array-based gene expression profiles allowed identifying a number of novel, epigenetically regulated candidate tumor-related genes in rectal carcinogenesis, which can be a good strategy to discover optimal DNA methylation diagnostic panels. Genome wide DNA methylation profiling of paired rectal cancers and adjacent normal tissues. The Illumina Human Methylation 450K BeadChip was used to obtain DNA methylation profiles across approximately 485,000 CpGs in all samples. Samples included six pairs of rectal cancers and adjacent normal tissues.

  126. 126 GSE81006 将HCT-8人结直肠癌野生型细胞(HCT8/WT)及其5-FU诱导的耐药细胞系(HCT8/5-FU)分别在0小时和72小时处理条件下进行甲基化分析,每个处理条件包含三个生物重复,比较两组细胞在不同处理时间的甲基化差异。 人源 · 12 例 · GPL13534 · 2017/03/15

    设计将HCT-8人结直肠癌野生型细胞(HCT8/WT)及其5-FU诱导的耐药细胞系(HCT8/5-FU)分别在0小时和72小时处理条件下进行甲基化分析,每个处理条件包含三个生物重复,比较两组细胞在不同处理时间的甲基化差异。

    摘要Complete growth medium RPMI-1640 which contains 10% FCS, 1% Penicillin-Streptomycin Solution was used for cell culture. Both cell lines were maintained at 37 °C in a humidified atmosphere containing 5% CO2. MTT assay was performed to determine the 5 ‑ FU resistance in both of HCT-8/WT and HCT-8/5-FU cell line.

  127. 127 GSE23693 对结直肠癌相关细胞系 HCT116、SW480、RKO 及正常淋巴细胞进行甲基化分析和基因表达检测,比较 5-Aza-CdR 处理组与未处理对照组的基因沉默情况,以及甲基化状态与基因表达水平的关系。 人源 · 11 例 · GPL1708;8490 · 2013/08/30

    设计对结直肠癌相关细胞系 HCT116、SW480、RKO 及正常淋巴细胞进行甲基化分析和基因表达检测,比较 5-Aza-CdR 处理组与未处理对照组的基因沉默情况,以及甲基化状态与基因表达水平的关系。

    摘要This SuperSeries is composed of the SubSeries listed below.

  128. 128 GSE60106 对HCT116野生型细胞系与DNA甲基转移酶双敲除细胞系DKO1进行全基因组亚硫酸盐测序(WGBS)和染色质免疫沉淀测序(ChIP-seq),同时采集DKO1细胞的RNA进行转录组测序(RNA-seq),比较两组细胞在DNA甲基化、组蛋白H3K27ac/H3K4me3修饰及RNA聚合酶II结合状态与基因表达水平的差异。DKO1 RNA-seq包含2个独立重复,其余测序数据均来自单个样本。 人源 · 11 例 · GPL11154 · 2014/09/10

    设计对HCT116野生型细胞系与DNA甲基转移酶双敲除细胞系DKO1进行全基因组亚硫酸盐测序(WGBS)和染色质免疫沉淀测序(ChIP-seq),同时采集DKO1细胞的RNA进行转录组测序(RNA-seq),比较两组细胞在DNA甲基化、组蛋白H3K27ac/H3K4me3修饰及RNA聚合酶II结合状态与基因表达水平的差异。DKO1 RNA-seq包含2个独立重复,其余测序数据均来自单个样本。

    摘要We used HCT116 colorectal cancer cells with and without mutations in DNA methyltransferases (resulting in a 95% reduction in global DNA methylation levels) to study the relationship between DNA methylation, histone modifications, and gene expression. (The double knockout cell line is called DKO1)

  129. 129 GSE68027 将HCT116结直肠癌细胞系转染随机23-mer寡核苷酸或miR-155 RNA,采用Bisulfite-Seq和RNA-Seq检测DNA甲基化及mRNA谱型,比较两种转染条件下的差异。 人源 · 11 例 · GPL9115 · 2015/04/21

    设计将HCT116结直肠癌细胞系转染随机23-mer寡核苷酸或miR-155 RNA,采用Bisulfite-Seq和RNA-Seq检测DNA甲基化及mRNA谱型,比较两种转染条件下的差异。

    摘要Mammalian cells contain copious amounts of RNA including both coding and non-coding RNA (ncRNA). Generally the ncRNAs function to regulate gene expression at the transcriptional and post-transcriptional level. Among ncRNA, the long ncRNA and small ncRNA can affect histone modification, DNA methylation targeting and gene silencing. Here we show that endogenous DNA methyltransferase 1 (DNMT1) co-purifies with inhibitory ncRNAs. MicroRNAs (miRNAs) binds directly to DNMT1 with high affinity. The binding of miRNAs, such as miR-155, leads to inhibition of DNMT1 enzyme activity. Exogenous miR-155 in cells induces aberrant DNA methylation of the genome, resulting in hypomethylation of low to moderately methylated regions. And small shift of hypermethylation of previously hypomethylated region was also observed. Furthermore, hypomethylation led to activation of genes. Based on these observations, we propose that overexpression of specific miRNAs in human cancer may lead to aberrant DNA methylation and altered gene-expression.

  130. 130 GSE17512 对10例结直肠癌患者的结直肠组织与3例正常结肠组织进行甲基化分析,采用甲基-CpG免疫沉淀(MCIp)技术富集甲基化DNA,比较两组间CpG岛甲基化状态差异。 人源 · 10 例 · GPL8544 · 2010/03/31

    设计对10例结直肠癌患者的结直肠组织与3例正常结肠组织进行甲基化分析,采用甲基-CpG免疫沉淀(MCIp)技术富集甲基化DNA,比较两组间CpG岛甲基化状态差异。

    摘要To globally define methylation-’prone’ and -’protected’ CpG islands in colorectal carcinoma we analyzed the methylation status of 23,000 CpG islands of the human genome in ten coleorectal carcinoma samples as well as normal colon using our previously described methyl-CpG immunoprecipitation (MCIp) technique (Gebhard et al. 2006; Schilling and Rehli 2007). This method enriches for highly CpG methylated DNA that can be directly applied to fluorescent labeling and oligonucleotide microarray hybridization without an additional amplification step. Keywords: MCIp-on-Chip; comparative genomic hybridization

  131. 131 GSE84171 本研究比较了三对匹配的福尔马林固定石蜡包埋(FFPE)与新鲜冷冻(FF)转移性结直肠癌肿瘤组织,以及两个细胞系(SW480、SW620)的重复样本。采用靶向测序方法结合亚硫酸氢盐测序(Bisulfite-Seq)技术,对样本进行DNA甲基化分析,评估FFPE与FF组织间的甲基化一致性,并比较细胞系重复样本的差异。 人源 · 10 例 · GPL16791 · 2017/07/08

    设计本研究比较了三对匹配的福尔马林固定石蜡包埋(FFPE)与新鲜冷冻(FF)转移性结直肠癌肿瘤组织,以及两个细胞系(SW480、SW620)的重复样本。采用靶向测序方法结合亚硫酸氢盐测序(Bisulfite-Seq)技术,对样本进行DNA甲基化分析,评估FFPE与FF组织间的甲基化一致性,并比较细胞系重复样本的差异。

    摘要DNA methylation controls gene expression and is altered in many types of disease, including metastatic colorectal cancer. Studying this phenomenon in archival material such as formalin-fixed paraffin embedded (FFPE) tumour biopsies would represent a significant step in unlocking a previously unavailable source of data. Methylation at base-pair resolution has not been fully described in FFPE samples in the context of matched fresh frozen (FF) tumour material using a targeted next-generation sequencing approach. Here, we used three pairs of matched FFPE and FF samples, along with two cell lines in duplicate, to determine the extent of their similarity. We identified a “bowing” pattern in FFPE samples showing lower CpG proportion at the start of sequence reads, but found no evidence that this significantly affected methylation calls. We also found no significant increase in deamination, measured by C > T transitions, previously considered a result of cross-linking DNA by formalin fixation and a barrier to FFPE use in methylation studies. Finally, our method has shown sensitivity of between 60-70% based on positions also methylated in cell lines. This level is not affected by coverage, and we believe that FFPE material is useful as a tissue source for similar methylation studies.

  132. 132 GSE268513 将HT-29结直肠癌细胞分为对照组(DMSO处理)和实验组(MG132 0.2μM处理),在第14代和第21代分别进行DNA甲基化检测,比较不同处理条件下甲基化谱型的差异。 人源 · 9 例 · GPL33022 · 2025/02/27

    设计将HT-29结直肠癌细胞分为对照组(DMSO处理)和实验组(MG132 0.2μM处理),在第14代和第21代分别进行DNA甲基化检测,比较不同处理条件下甲基化谱型的差异。

    摘要Proteasome is an essential organelle in guarding cellular protein homeostasis. Here, we report that inhibition of proteasome alters the profile of DNA methylation in colorectal cancer (CRC) by blocking the synthesis of DNA methyltransferases (DNMTs). We found that treating CRC cells with proteasome inhibitors (PIs) suppress the translation of DNMT1 and DNMT3B by inactivating AKT and mammalian target of rapamycin (mTOR), dependent on the accumulation of p300, an acetyltransferase inactivating AKT by mediating its acetylation modification. Furthermore, we demonstrated downregulation of DNMT1 and DNMT3B protects cancer cells against PI treatment, potentially by reprogramming the transcriptome of CRC cells; highlighting the key role of DNMTs in response to proteostasis disturbance

  133. 133 GSE58050 收集 HCT116 结直肠癌细胞在正常培养、低氧和低糖条件下的基因组 DNA,通过甲基化免疫沉淀和全基因组扩增后,使用 Affymetrix Human promoter 1.0R 阵列进行三重杂交检测,比较各处理组与对照组的 DNA 甲基化模式差异。 人源 · 9 例 · GPL5082 · 2014/07/07

    设计收集 HCT116 结直肠癌细胞在正常培养、低氧和低糖条件下的基因组 DNA,通过甲基化免疫沉淀和全基因组扩增后,使用 Affymetrix Human promoter 1.0R 阵列进行三重杂交检测,比较各处理组与对照组的 DNA 甲基化模式差异。

    摘要DNA hypomethylation is an important epigenetic modification found to occur in many different cancer types, leading to the upregulation of previously silenced genes and loss of genomic stability. We previously demonstrated that hypoxia and hypoglycaemia (ischemia), two common micro-environmental changes in solid tumors, decrease DNA methylation through the downregulation of DNMTs in human colorectal cancer cells. Here, we utilized a genome-wide cross-platform approach to identify genes hypomethylated and upregulated by ischemia. Following exposure to hypoxia or hypoglycaemia, methylated DNA from human colorectal cancer cells (HCT116) was immunoprecipitated and analysed with an Affymetrix promoter array. Additionally, RNA was isolated and analysed in parallel with an Affymetrix expression array. Ingenuity pathway analysis software revealed that a significant proportion of the genes hypomethylated and upregulated were involved in cellular movement, including PLAUR and CYR61. A Matrigel invasion assay revealed that indeed HCT116 cells grown in hypoxic or hypoglycaemic conditions have increased mobility capabilities. Confirmation of upregulated expression of cellular movement genes was performed with qPCR. The correlation between ischemia and metastasis is well established in cancer progression, but the molecular mechanisms responsible for this common observation have not been clearly identified. Our novel results suggest that hypoxia and hypoglycaemia may be driving changes in DNA methylation through downregulation of DNMTs. This is the first report to our knowledge that provides an explanation for the increased metastatic potential seen in ischemic cells; i.e. that ischemia could be driving DNA hypomethylation and increasing expression of cellular movement genes.

  134. 134 GSE104998 将SW48衍生的YB5结肠癌细胞系分为HH1处理组与DMSO对照组,每组采用生物三复孔设计,另设生物双复孔未处理组。处理组以10微摩尔浓度HH1单次给药后持续培养四天,第三天更换无药培养基。通过减少表征双硫代亚硫酸盐测序(RRBS)检测DNA甲基化状态,比较HH1处理组与DMSO对照组的甲基化差异。 人源 · 8 例 · GPL16791 · 2018/07/31

    设计将SW48衍生的YB5结肠癌细胞系分为HH1处理组与DMSO对照组,每组采用生物三复孔设计,另设生物双复孔未处理组。处理组以10微摩尔浓度HH1单次给药后持续培养四天,第三天更换无药培养基。通过减少表征双硫代亚硫酸盐测序(RRBS)检测DNA甲基化状态,比较HH1处理组与DMSO对照组的甲基化差异。

    摘要YB5 is a colon cancer cell line derived from the SW48 colon cancer cell line and contains a DNA methylated and silenced CMV promoter driving expression of a GFP reporter. The cells were treated with 10 micromolar concentration of the HH1 compound or with DMSO as a control. Reduced representation bisulfite sequencing (RRBS) was performed after the treatment to analyze DNA methylation at CpG sites.

  135. 135 GSE123830 对HCT116结直肠癌细胞系进行全基因组甲基化分析,比较不同转染条件下的基因组DNA甲基化差异。转染条件包括:dCas9-noED与HER2 gRNAs 1,2+3;Ezh2-dCas9、DNMT3A-dCas9、DNMT3L与HER2 gRNAs 1,2+3;KRAB-dCas9、DNMT3A-dCas9、DNMT3L与HER2 gRNAs 1,2+3。样本在17天和24天后收集,每组独立重复两次。 人源 · 8 例 · GPL21145 · 2019/05/07

    设计对HCT116结直肠癌细胞系进行全基因组甲基化分析,比较不同转染条件下的基因组DNA甲基化差异。转染条件包括:dCas9-noED与HER2 gRNAs 1,2+3;Ezh2-dCas9、DNMT3A-dCas9、DNMT3L与HER2 gRNAs 1,2+3;KRAB-dCas9、DNMT3A-dCas9、DNMT3L与HER2 gRNAs 1,2+3。样本在17天和24天后收集,每组独立重复两次。

    摘要Rewriting of the epigenome has risen as a promising alternative to gene editing for precision medicine. In nature, epigenetic silencing can result in complete attenuation of target gene expression over multiple mitotic divisions. However, persistent repression has been difficult to achieve using targeted systems. Here, we report that robust and persistent epigenetic memory required both a DNA methyltransferase (DNMT3A-dCas9) and a histone methyltransferase (Ezh2-dCas9 or KRAB-dCas9). DNMT3A-dCas9 was dependent on full-length DNMT3L for maximal activity. Co-targeting with Ezh2-dCas9, DNMT3A-dCas9 and DNMT3L induced long-term HER2 repression over at least 50 days and maintained a heterochromatic environment. Interestingly, substitution of Ezh2-dCas9 for KRAB-dCas9 enabled long-term repression at some target genes (e.g., SNURF) but not at HER2, at which H3K9me3 and DNA methylation were transiently acquired and subsequently lost. Off-target DNA hypermethylation occurred at many individual CpG sites but rarely at multiple CpGs in a single promoter, consistent with no detectable effect on transcription at the loci tested. Conversely, robust hypermethylation was observed at HER2. These data demonstrate that targeting different combinations of histone and DNA methyltransferases is required to achieve maximal repression at different loci in the same cell, or the same locus in different cells.

  136. 136 GSE136931 对人类结直肠癌相关细胞系 HeLa 和 HCT116 的 LSH 敲除(KO)与野生型(WT)细胞进行 Reduced Representation Bisulfite Sequencing(RRBS)和 RNA-Seq 分析,比较 KO 与 WT 组的 DNA 甲基化差异。 人源 · 8 例 · GPL9052 · 2020/12/01

    设计对人类结直肠癌相关细胞系 HeLa 和 HCT116 的 LSH 敲除(KO)与野生型(WT)细胞进行 Reduced Representation Bisulfite Sequencing(RRBS)和 RNA-Seq 分析,比较 KO 与 WT 组的 DNA 甲基化差异。

    摘要Accumulative studies indicate that DNA maintenance methylation by DNMT1 is initiated by binding of UHRF1 to replication fork. However, how UHRF1 gains access to chromatin in S phase is poorly understood. Here we report that LSH, a SNF2 family chromatin remodeler, facilitates DNA methylation in somatic cells primarily by promoting DNA methylation by DNMT1. We show that knockout of LSH in various somatic cells resulted in substantial reduction of DNA methylation, whereas knockout of DNMT3A and DNMT3B only moderately reduced the level of DNA methylation. Consistent with a role in maintenance methylation, genome-wide analysis of DNA methylation revealed a widespread reduction of DNA methylation in all genomic elements in LSH null cells. Mechanistically, we demonstrate that LSH interacts with UHRF1 but not DNMT1 and facilitates UHRF1 chromatin association, UHRF1-catalyzed H3 ubiquitination, and subsequent DNMT1 recruitment to replication fork. Notably, UHRF1 also enhances LSH association with replication fork. Thus, our study identifies LSH as an essential factor for maintenance methylation and provides novel insight into how LSH facilitates maintenance methylation.

  137. 137 GSE23789 将结直肠癌样本(HTB-38细胞系,女性供体)与B-Lymphocyte样本(NA 10923,男性供体)按五种不同比例(100:0、90:10、75:25、50:50、0:100)混合,制备混合样本,使用甲基化芯片平台GPL8490进行检测,比较不同混合比例下的甲基化特征差异。 人源 · 8 例 · GPL8490 · 2010/12/01

    设计将结直肠癌样本(HTB-38细胞系,女性供体)与B-Lymphocyte样本(NA 10923,男性供体)按五种不同比例(100:0、90:10、75:25、50:50、0:100)混合,制备混合样本,使用甲基化芯片平台GPL8490进行检测,比较不同混合比例下的甲基化特征差异。

    摘要Two samples with known methylation differences. Sample A is NA 10923 from Coriell Institute for Medical Research. It is a B-Lymphocyte sample from a male donor. Sample B is HTB-38 cell line from ATCC (http://www.atcc.org). It is a colon cancer sample from a female donor. Sample A and B were normalized into the same concentration, and then mixed in five different titration ratios: 100:0, 90:10, 75:25, 50:50 and 0:100

  138. 138 GSE26826 对结直肠癌相关 HCT116 细胞系及其 DNMT1-/-、DNMT3B-/-、DNMT1-/-;DNMT3B-/- 双敲除基因型进行靶向亚硫酸氢盐测序,比较不同基因型细胞系的 DNA 甲基化差异。采用溶液杂交选择技术富集 CpG 岛和启动子区域,使用 Illumina GA IIx 测序平台获取单碱基分辨率甲基化数据,检测对象为基因组 DNA。 人源 · 8 例 · GPL10999 · 2011/08/01

    设计对结直肠癌相关 HCT116 细胞系及其 DNMT1-/-、DNMT3B-/-、DNMT1-/-;DNMT3B-/- 双敲除基因型进行靶向亚硫酸氢盐测序,比较不同基因型细胞系的 DNA 甲基化差异。采用溶液杂交选择技术富集 CpG 岛和启动子区域,使用 Illumina GA IIx 测序平台获取单碱基分辨率甲基化数据,检测对象为基因组 DNA。

    摘要We applied the solution hybrid selection approach to the enrichment of CpG islands (CGIs) and promoter sequences from the human genome for targeted high-throughput bisulfite sequencing. A single lane of Illumina sequences allowed accurate and quantitative analysis of 1 million CpGs in more than 21,408 CGIs and 15,946 transcriptional regulatory regions. More than 85% of capture probes successfully yielded quantitative DNA methylation information of targeted regions. In this study, we generated genome-wide, single-base resolution DNA methylation maps in three of the most commonly used breast cancer cell lines.Differentially methylated regions (DMRs) were identified in the 5?-end regulatory regions, as well as the intra- and intergenic regions, particularly in the X chromosome among the three cell lines. The single CpG resolution methylation maps of many known tumor suppressor genes were also established in the three cell lines.

  139. 139 GSE45333 对8种结直肠癌细胞系分别提取甲基化DNA并采用超声波打断,使用MBD2蛋白结合方法进行MBD测序,分析各细胞系的甲基化特征。 人源 · 8 例 · GPL10999 · 2013/10/01

    设计对8种结直肠癌细胞系分别提取甲基化DNA并采用超声波打断,使用MBD2蛋白结合方法进行MBD测序,分析各细胞系的甲基化特征。

    摘要Genome-wide view of the interplay between methylation and RNA expression in this colorectal cancer model was obtained.

  140. 140 GSE98990 对人类结直肠癌组织、癌旁正常结肠组织、HeLa宫颈癌细胞系、DNMT1与DNMT3b双敲除(DKO)的HCT116细胞系以及经M.SssI处理的DKO细胞系,连同Illumina对照,共8个样本,提取基因组DNA并经亚硫酸氢盐转化后,使用Illumina Infinium MethylationEPIC BeadChip(GPL21145)检测约85,000个CpG位点的DNA甲基化谱,比较肿瘤与癌旁正常组织的甲基化差异,并以HeLa、DKO及M.SssI处理的DKO细胞系和对照样本作为参照。 人源 · 8 例 · GPL21145 · 2017/05/17

    设计对人类结直肠癌组织、癌旁正常结肠组织、HeLa宫颈癌细胞系、DNMT1与DNMT3b双敲除(DKO)的HCT116细胞系以及经M.SssI处理的DKO细胞系,连同Illumina对照,共8个样本,提取基因组DNA并经亚硫酸氢盐转化后,使用Illumina Infinium MethylationEPIC BeadChip(GPL21145)检测约85,000个CpG位点的DNA甲基化谱,比较肿瘤与癌旁正常组织的甲基化差异,并以HeLa、DKO及M.SssI处理的DKO细胞系和对照样本作为参照。

    摘要Genome wide DNA methylation profiling of normal and tumor colorectal cancer samples, HCT116 DKO (DNMT1 (-/-) and DNMT3b (-/-)), M.sssI treated DKO cell lines, and human cervical cancer cell line HeLa. The Illumina Infinium Human DNA methylation EPIC Beadchip was used to obtain DNA methylation profiles across approximately 85,000 CpGs in the above samples.

  141. 141 GSE104271 对结直肠癌细胞系 HCT116-CSC 的全基因组 DNA 甲基化状态进行检测,比较 Vector、FIBP 敲低及 FIBP/GSK3b 敲低三种基因型细胞的甲基化差异。研究对象为携带 FIBP 敲低或 GSK3β 敲低的 HCT116-CSC 细胞,样本按基因型分为三组,每组包含 2 个独立重复,共 6 个样本。检测采用 Illumina HumanMethylation450 BeadChip 平台,通过亚硫酸盐处理基因组 DNA 后进行甲基化分析。 人源 · 6 例 · GPL13534 · 2017/09/27

    设计对结直肠癌细胞系 HCT116-CSC 的全基因组 DNA 甲基化状态进行检测,比较 Vector、FIBP 敲低及 FIBP/GSK3b 敲低三种基因型细胞的甲基化差异。研究对象为携带 FIBP 敲低或 GSK3β 敲低的 HCT116-CSC 细胞,样本按基因型分为三组,每组包含 2 个独立重复,共 6 个样本。检测采用 Illumina HumanMethylation450 BeadChip 平台,通过亚硫酸盐处理基因组 DNA 后进行甲基化分析。

    摘要To validate how FIBP influences stemness, we obtained the genome-wide methylation in HCT116-CSCs by an Illumina HumanMethylation450 BeadChip.

  142. 142 GSE196027 将人类结直肠癌细胞系DLD1分为两组,分别转染空载体和APOBEC3A过表达质粒,提取基因组DNA进行全基因组甲基化分析,比较两种处理条件下DNA甲基化模式的差异。 人源 · 6 例 · GPL21145 · 2025/02/03

    设计将人类结直肠癌细胞系DLD1分为两组,分别转染空载体和APOBEC3A过表达质粒,提取基因组DNA进行全基因组甲基化分析,比较两种处理条件下DNA甲基化模式的差异。

    摘要APOBEC-induced genomic mutation a major driver of cancer evolution. Here, we show that genomic DNA methylation is reshaped following the APOBEC-induced genomic mutation.

  143. 143 GSE196028 对 ALKBH5 敲低与非靶向转染的 HCT116 人类结直肠癌细胞系行全基因组甲基化阵列谱检测,比较不同处理条件下基因组 DNA 甲基化模式的差异。研究对象为人类结直肠癌细胞系,被测材料为基因组 DNA,采用 genome tiling array 技术进行全基因组甲基化谱分析,包含 ALKBH5-sh1、ALKBH5-sh2 和 sh_NC 三个分组。 人源 · 6 例 · GPL21145 · 2025/02/03

    设计对 ALKBH5 敲低与非靶向转染的 HCT116 人类结直肠癌细胞系行全基因组甲基化阵列谱检测,比较不同处理条件下基因组 DNA 甲基化模式的差异。研究对象为人类结直肠癌细胞系,被测材料为基因组 DNA,采用 genome tiling array 技术进行全基因组甲基化谱分析,包含 ALKBH5-sh1、ALKBH5-sh2 和 sh_NC 三个分组。

    摘要ALKBH5 has been recognized as a major RNA m6A demethylase in human cells. Here, we show that genomic DNA methylation is reshaped following the transcriptomic m6a demethylation. ALKBH5-KD human colon cancer cell line HCT116 was constructed. The genomic DNA was extracted to profile the genome-wide methylation.

  144. 144 GSE237662 将 HCT-116 人结直肠癌细胞系分别用 30 nM 和 300 nM 两种剂量的 5-aza-2’-deoxycytidine (DAC) 处理,并用 DMSO 作为溶剂对照,每个处理在生物重复条件下进行 72 小时。处理后,细胞被固定并进行 H3K27me3 染色质免疫沉淀,随后通过 Enzymatic Methyl-seq (EM-seq) 分析纯化 DNA 片段的甲基化状态,以比较不同处理组的 DNA 甲基化差异。 人源 · 6 例 · GPL24676 · 2024/02/26

    设计将 HCT-116 人结直肠癌细胞系分别用 30 nM 和 300 nM 两种剂量的 5-aza-2’-deoxycytidine (DAC) 处理,并用 DMSO 作为溶剂对照,每个处理在生物重复条件下进行 72 小时。处理后,细胞被固定并进行 H3K27me3 染色质免疫沉淀,随后通过 Enzymatic Methyl-seq (EM-seq) 分析纯化 DNA 片段的甲基化状态,以比较不同处理组的 DNA 甲基化差异。

    摘要DNA methyltransferase inhibitors (DNMTi) are FDA-approved for various hematological malignancies but have limited efficacy in solid tumors. DNA hypomethylation with these drugs is associated with elevated lysine 27 tri-methylation on histone H3 (H3K27me3). We hypothesized that this EZH2-dependent repressive mark limits the full potential of DNMTi. Here, we show in cell line and tumoroid models of colorectal cancer, that low-dose DNMTi sensitizes cells to selective EZH2 inhibitors (EZH2i) that have limited single agent toxicity, and that EZH2i enhances DNMTi-driven molecular and therapeutic effects. Through integrative epigenomic analyses, we reveal that DNMTi induces H3K27me3 accumulation at genomic regions poised with EZH2. Unexpectedly, combined treatment alters the epigenome landscape to promote transcriptional upregulation of the Calcium-Calcineurin-NFAT signaling pathway. Blocking this pathway limits the transcriptional activating effects of the drug combination, including expression of transposable elements and innate immune response genes within a viral defense pathway. Consistently, we demonstrate positive correlations between DNMTi- and viral infection-associated transcription profiles and Calcium signal activation in colon cancer patient samples. Collectively, our study demonstrates that compensatory EZH2 activity following DNA hypomethylation presents a barrier to the therapeutic action of DNMTi in colon cancer, reveals a new application of EZH2i beyond cancers associated with PRC2 hyperactivity, and links Calcium-Calcineurin-NFAT signaling to epigenetic therapy-induced viral mimicry.

  145. 145 GSE33545 对3例结直肠癌患者新鲜冷冻的癌组织及其对应非肿瘤邻近组织进行全基因组甲基化分析,采用基于MIRA的微阵列检测57,723个CpG二核苷酸覆盖的4,010个基因。通过组合亚硫酸盐限制分析验证候选基因,比较癌组织与非癌组织的甲基化差异,并评估PHOX2B、FGF12、GAD2等3个新发现基因与Vimentin、SEPT9等已知基因在区分癌组织与正常组织中的表现。 人源 · 6 例 · GPL14835 · 2011/11/14

    设计对3例结直肠癌患者新鲜冷冻的癌组织及其对应非肿瘤邻近组织进行全基因组甲基化分析,采用基于MIRA的微阵列检测57,723个CpG二核苷酸覆盖的4,010个基因。通过组合亚硫酸盐限制分析验证候选基因,比较癌组织与非癌组织的甲基化差异,并评估PHOX2B、FGF12、GAD2等3个新发现基因与Vimentin、SEPT9等已知基因在区分癌组织与正常组织中的表现。

    摘要To identify novel hypermethylated genes in colorectal cancer (CRC) and to test their potential application in CRC early diagnosis, we performed a genome-wide screening of 57,723 CpG dinucleotides covering 4,010 genes in paired DNA samples extracted from 3 fresh frozen CRC tissues and their matching non-tumor adjacent tissues from a cohort of 3 CRC patients undergoing curative surgery using MIRA-based microarray. We also validated candidate hypermethylated genes screened by MIRA-based microarray in independent CRC samples using combined bisulfite restriction analysis. A total of 297 CpG dinucleotides in CRC covering 211 genes were found to be hypermethylated in CRC tissues. From these 211 candidate methylated genes, seven novel methylated genes were picked up for validation and three genes were confirmed to be methylated in cancer samples but not in non-cancer samples.We also compared the methylation levels of these three novel hypermethylated genes with those of Vimentin and SEPT9, well-known hypermethylated genes in CRC, and found that methylated PHOX2B, FGF12 and GAD2 were better than methylated Vimentin and SEPT9 in differentiating CRC cancer tissue from normal tissue. Significant enrichment analysis of GO terms of the hypermethylated genes showed that a high proportion of hypermethylated genes in tumor tissues are involved in regulation of transcription.

  146. 146 GSE63421 将HCT116细胞系分为三组:空载体对照组(TET_KD_Plk)、shRNA敲低TET2组(TET_KD_2C)及同时敲低TET2和TET3组(TET_KD_2.3),每组设2个生物重复。采用Methylation450 Array平台对各组基因组DNA进行甲基化芯片分析,比较不同TET2/TET3表达水平下启动子区域的甲基化状态变化。检测对象为结直肠癌相关启动子,重点关注5-hmC标记的启动子在肿瘤细胞中对甲基化增益的抵抗性。 人源 · 6 例 · GPL13534 · 2015/02/03

    设计将HCT116细胞系分为三组:空载体对照组(TET_KD_Plk)、shRNA敲低TET2组(TET_KD_2C)及同时敲低TET2和TET3组(TET_KD_2.3),每组设2个生物重复。采用Methylation450 Array平台对各组基因组DNA进行甲基化芯片分析,比较不同TET2/TET3表达水平下启动子区域的甲基化状态变化。检测对象为结直肠癌相关启动子,重点关注5-hmC标记的启动子在肿瘤细胞中对甲基化增益的抵抗性。

    摘要The discovery of cytosine hydroxymethylation (5-hmC) as a mechanism that potentially controls DNA methylation changes typical of neoplasia prompted us to investigate its behavior in colon cancer. 5-hmC is globally reduced in proliferating cells such as colon tumors and the gut crypt progenitors, from which tumors can arise. Here, we show that colorectal tumors and cancer cells express Ten-Eleven Translocation (TET) transcripts at levels similar to normal tissues. Genome-wide analyses show that promoters marked by 5-hmC in normal tissue, and those identified as TET2 targets in colorectal cancer cells, are resistant to methylation gain in cancer. In vitro studies of TET2 in cancer cells confirm that these promoters are resistant to methylation gain independently of sustained TET2 expression. We also find that a considerable number of the methylation gain-resistant promoters marked by 5-hmC in normal colon overlap with those that are marked with poised bivalent histone modifications in embryonic stem cells. Together our results indicate that promoters that acquire 5-hmC upon normal colon differentiation are innately resistant to neoplastic hypermethylation by mechanisms that do not require high levels of 5-hmC in tumors. Our study highlights the potential of cytosine modifications as biomarkers of cancerous cell proliferation.

  147. 147 GSE75964 对人类结直肠癌细胞系 HCT1116 的 RNA-Seq 和 Bisulfite-Seq 测序分析,包含 H2O2 处理组与未处理对照组,每组按总样本数 6 个估计为 3 个独立重复,比较两种处理条件下的基因表达与甲基化差异。 人源 · 6 例 · GPL11154 · 2016/05/01

    设计对人类结直肠癌细胞系 HCT1116 的 RNA-Seq 和 Bisulfite-Seq 测序分析,包含 H2O2 处理组与未处理对照组,每组按总样本数 6 个估计为 3 个独立重复,比较两种处理条件下的基因表达与甲基化差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  148. 148 GSE84397 对结直肠癌 Colo320DM 细胞进行 TET1 敲低处理与阴性对照比较,采集基因组 DNA 采用 HumanMethylation450 BeadChip 检测甲基化状态,比较 TET1 敲低组与阴性对照组的差异。 人源 · 6 例 · GPL13534 · 2017/01/01

    设计对结直肠癌 Colo320DM 细胞进行 TET1 敲低处理与阴性对照比较,采集基因组 DNA 采用 HumanMethylation450 BeadChip 检测甲基化状态,比较 TET1 敲低组与阴性对照组的差异。

    摘要We aimed to analyze the relationship between TET1 and aberrant CpG methylation in colorectal cancer (CRC). We established three stable TET1 knockdown clones and negative control clones of Colo320DM cells, and carried out DNA methylation analysis with HumanMethylation450 BeadChip.

  149. 149 GSE86402 对人类结直肠癌 RKO 细胞系进行 DIP2C 基因敲除处理,采集基因组 DNA 采用 Illumina HumanMethylation 450k 芯片分析甲基化模式。研究包含亲本细胞、两个同源敲除(DIP2C-/-)和两个杂合敲除(DIP2C+/-)细胞系,比较不同基因型细胞的 DNA 甲基化差异。 人源 · 6 例 · GPL13534 · 2017/07/31

    设计对人类结直肠癌 RKO 细胞系进行 DIP2C 基因敲除处理,采集基因组 DNA 采用 Illumina HumanMethylation 450k 芯片分析甲基化模式。研究包含亲本细胞、两个同源敲除(DIP2C-/-)和两个杂合敲除(DIP2C+/-)细胞系,比较不同基因型细胞的 DNA 甲基化差异。

    摘要Aim: The disco-interacting protein 2 homolog C (DIP2C) gene is an uncharacterized gene found mutated in breast and lung cancers. We want to understand the role of DIP2C in tumor development. Methods: We engineered human DIP2C knockout cell systems by genome editing, and studied these to identify cellular processes affected by gene knockout. We used the Illumina HumanMethylation 450k beadchip array to identify methylation sites affected by the loss of DIP2C. Results: Inactivation of DIP2C triggered changes in cell morhpology, growth, gene expression and DNA methylation. Differential methylation at promoters was found inversly correlated with gene expression changes.

  150. 150 GSE151862 以人结直肠癌细胞系 HCT116 为对象,先用慢病毒 shRNA 敲低内源性 UHRF1(shUHRF1,嘌呤霉素筛选),再经慢病毒导入并经 FACS 分选稳定表达外源 UHRF1:野生型 WT、乙酰化位点突变体 K490R、K490Q,并设 shNC 加 GFP 空载体(EV)对照及 shUHRF1 加 EV 对照。提取各组基因组 DNA,经 Zymo 试剂盒亚硫酸氢盐转化后,用 Illumina EPIC 甲基化芯片(GPL21145)检测全基因组 CpG 位点甲基化水平(以 β 值表示 0%~100% 甲基化率),比较 K490R、K490Q 突变体与 WT UHRF1 及各载体对照的甲基化谱差异。共 5 个样本,每组 1 例。 人源 · 5 例 · GPL21145 · 2020/06/06

    设计以人结直肠癌细胞系 HCT116 为对象,先用慢病毒 shRNA 敲低内源性 UHRF1(shUHRF1,嘌呤霉素筛选),再经慢病毒导入并经 FACS 分选稳定表达外源 UHRF1:野生型 WT、乙酰化位点突变体 K490R、K490Q,并设 shNC 加 GFP 空载体(EV)对照及 shUHRF1 加 EV 对照。提取各组基因组 DNA,经 Zymo 试剂盒亚硫酸氢盐转化后,用 Illumina EPIC 甲基化芯片(GPL21145)检测全基因组 CpG 位点甲基化水平(以 β 值表示 0%~100% 甲基化率),比较 K490R、K490Q 突变体与 WT UHRF1 及各载体对照的甲基化谱差异。共 5 个样本,每组 1 例。

    摘要UHRF1 is a key regulator of DNA methylation maintenance. In this study, we investigated whether acetylation of UHRF1 affects its hemimethylated DNA binding affinity and alters genome-wide DNA methylation pattern. We show that cells with mutation in K490 of UHRF1 have distinct methylation profile versus wildtype UHRF1 expressing cells.

  151. 151 GSE32276 将SW48结直肠癌细胞系分为DMSO对照组、AKBA处理组(20 μM,6天)和DAC处理组(2.5 μM,6天),提取总RNA和基因组DNA,采用基因表达与甲基化芯片分析,比较各处理组与对照组的差异。 人源 · 5 例 · GPL6947;8490 · 2012/12/01

    设计将SW48结直肠癌细胞系分为DMSO对照组、AKBA处理组(20 μM,6天)和DAC处理组(2.5 μM,6天),提取总RNA和基因组DNA,采用基因表达与甲基化芯片分析,比较各处理组与对照组的差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  152. 152 GSE124915 对Colorectal腺癌细胞系Colo320稳定表达致癌性BRAFV600E或GFP的细胞进行全基因组DNA甲基化检测,比较两组间CpG岛甲基化表型差异。采用病毒转导建立稳定表达系,感染14天后提取基因组DNA,经亚硫酸盐转化后在Illumina HumanMethylation850 BeadChip(EPIC芯片)上检测,数据经preprocessQuantile方法标准化。 人源 · 4 例 · GPL23976 · 2019/12/18

    设计对Colorectal腺癌细胞系Colo320稳定表达致癌性BRAFV600E或GFP的细胞进行全基因组DNA甲基化检测,比较两组间CpG岛甲基化表型差异。采用病毒转导建立稳定表达系,感染14天后提取基因组DNA,经亚硫酸盐转化后在Illumina HumanMethylation850 BeadChip(EPIC芯片)上检测,数据经preprocessQuantile方法标准化。

    摘要Promoter hypermethylation divides colon cancers into subtypes with and without a CpG island methylator phenotype (CIMP). Here, we performed genome-wide DNA methylation profiling of colonic normal and tumor tissues to dissect development of CpG hypermethylation in colon carcinogenesis. This identified age-environment related versus genetically driven CpG hypermethylation, the latter being associated with CIMP cancers. We found a strong association between BRAFV600E mutation and downregulation of the DNA demethylases TET1 and TET2. Expression of BRAFV600E in CIMP cancer cells suppressed TET1 transcription, which was sufficient to establish hypermethylation at CIMP genes promoters, including that of TET2. This phenotype was reverted by the BRAFV600E inhibitor vemurafenib. Thus, BRAFV600E, via impairment of cytosine de-methylation, is a genetic driver of CIMP in colon tumorigenesis.

  153. 153 GSE140265 将结直肠癌细胞系Sw620分为对照组和DM-aKG处理组,各2个样本,进行甲基化微阵列分析,比较两组的差异。 人源 · 4 例 · GPL23976 · 2020/03/23

    设计将结直肠癌细胞系Sw620分为对照组和DM-aKG处理组,各2个样本,进行甲基化微阵列分析,比较两组的差异。

    摘要Genetic-driven deregulation of the Wnt pathway is crucial but not sufficient for colorectal cancer (CRC) tumourigenesis. Here, we show that environmental glutamine restriction further augments Wnt signaling in APC mutant intestinal organoids to promote stemness and leads to adenocarcinoma formation in vivo via decreasing intracellular alpha-ketoglutarate (aKG) levels. aKG supplementation is sufficient to rescue low-glutamine induced stemness and Wnt hyperactivation. Mechanistically, we found that aKG promotes hypomethylation of DNA and histone H3K4me3, leading to an upregulation of differentiation-associated genes and downregulation of Wnt target genes, respectively. Using CRC patient-derived organoids and several in vivo CRC tumour models, we show that aKG supplementation suppresses Wnt signaling and promotes cellular differentiation, thereby significantly restricting tumour growth and extending survival. Together, our results reveal how the low glutamine metabolic microenvironment impacts Wnt signaling and identify aKG as a potent antineoplastic metabolite for potential differentiation therapy for CRC patients.

  154. 154 GSE158010 对结直肠癌细胞系 HCT116 及其 DNMT1/DNMT3B 双敲除低甲基化 DKO1 系统进行 Hi-C 和单细胞 Repli-Seq 测定,比较两种基因型细胞的复制时间点与三维基因组结构差异。按总单位数与组数估计分组。 人源 · 4 例 · GPL20795 · 2021/09/21

    设计对结直肠癌细胞系 HCT116 及其 DNMT1/DNMT3B 双敲除低甲基化 DKO1 系统进行 Hi-C 和单细胞 Repli-Seq 测定,比较两种基因型细胞的复制时间点与三维基因组结构差异。按总单位数与组数估计分组。

    摘要DNA replication timing and 3D chromatin organisation are associated with epigenomic changes across large domains during human differentiation and cancer progression. However, it is unclear if epigenome changes, in particular cancer-associated DNA hypomethylation, is a consequence or cause of changes observed in higher order genome architecture. Here, we compare replication timing profiles and three dimensional (3D) genome organisation, using Hi-C and single cell Repli-Seq in the DNMT1 and DNMT3B DNA methyltransferases double knockout hypomethylated DKO1 colorectal cancer cell line and its parental HCT116 cell line. We find that the hypomethylated cells show a profound loss of replication timing precision, gain of single cell replication timing heterogeneity and loss of chromatin conformation integrity. Discrete regions, that undergo a large change in replication timing in the hypomethylated cells, are associated with a loss of allelic replication timing and shrinking of late replicating Partially Methylated Domain (PMD) boundaries. In contrast, conservation of replication timing after DNA methylation depletion at PMDs is associated with the formation of new H3K9me3/H3K4me3 bivalent domains which may serve to prevent ectopic transcription and maintain cell viability. Together our results show that a loss of global methylation, a common hallmark of cancer, directly impacts on the precision of replication timing and contribute to deregulation of the 3D chromatin architecture.

  155. 155 GSE222611 对人结直肠癌细胞系 HCT116 和 NCM460 的 DNA 甲基化状态进行分析,比较 LSD1 敲除与野生型、LSD1 过表达与阴性对照组的基因型差异,采用亚硫酸氢盐测序技术检测全基因组 DNA 甲基化水平,观察 bivalent 基因启动子区的甲基化变化与 H3K4me1 水平的关系。 人源 · 4 例 · GPL16791 · 2023/01/12

    设计对人结直肠癌细胞系 HCT116 和 NCM460 的 DNA 甲基化状态进行分析,比较 LSD1 敲除与野生型、LSD1 过表达与阴性对照组的基因型差异,采用亚硫酸氢盐测序技术检测全基因组 DNA 甲基化水平,观察 bivalent 基因启动子区的甲基化变化与 H3K4me1 水平的关系。

    摘要Background: DNA hypermethylation at promoter CpG islands (CGIs) is a hallmark of cancers and could lead to dysregulation of gene expression in the development of cancers, however, its dynamics and regulatory mechanisms remain elusive. Bivalent genes, that direct development and differentiation of stem cells, are found to be frequent targets of hypermethylation in cancers. Results: Here we performed comprehensive analysis across multiple cancer types and identified that the decrease in H3K4me1 levels coincides with DNA hypermethylation at the bivalent promoter CGIs during tumorigenesis. Removal of DNA hypermethylation leads to increment of H3K4me1 at promoter CGIs with preference for bivalent genes. Nevertheless, the alteration of H3K4me1 by overexpressing or knockout LSD1, the demethylase of H3K4, doesn't change the level or pattern of DNA methylation. Moreover, LSD1 was found to regulate the expression of a bivalent gene OVOL2 to promote tumorigenesis. Knockdown of OVOL2 in LSD1 knockout HCT116 cells restored the cancer cell phenotype. Conclusion: In summary, our work identified a universal indicator that can pre-mark DNA hypermethylation in cancer cells, and dissected the interplay between H3K4me1 and DNA hypermethylation in detail. Current study also reveals a novel mechanism underlying the oncogenic role of LSD1, providing clues for cancer therapies.

  156. 156 GSE26433 对结直肠癌相关 RKO 细胞系进行全基因组 DNA 甲基化分析,采用非靶向 siRNA 或 SRCAP siRNA 预处理 24 小时后,再分别给予 PBS 或 1uM 5-Aza-CdR 处理 72 小时,提取基因组 DNA 并通过 Illumina Infinium 27k 甲基化芯片检测 27,578 个 CpG 位点的甲基化状态,比较不同处理组合下的甲基化差异。 人源 · 4 例 · GPL8490 · 2013/01/01

    设计对结直肠癌相关 RKO 细胞系进行全基因组 DNA 甲基化分析,采用非靶向 siRNA 或 SRCAP siRNA 预处理 24 小时后,再分别给予 PBS 或 1uM 5-Aza-CdR 处理 72 小时,提取基因组 DNA 并通过 Illumina Infinium 27k 甲基化芯片检测 27,578 个 CpG 位点的甲基化状态,比较不同处理组合下的甲基化差异。

    摘要Genome wide DNA methylation profiling of RKO cells with combination treatments of non-target siRNA or SRCAP siRNA and PBS or 1uM 5-Aza-CdR treatment. The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across 27,578 CpGs in treated RKO cells. Samples included cells under 4 different treatments. The sample treated with non target siRNA and PBS serves as control sample.

  157. 157 GSE341873 对SW620结直肠癌细胞进行全基因组DNA甲基化分析,比较shCtrl和shDNMT3A组的差异。每组包含2个独立生物重复,采用Infinium MethylationEPIC BeadChip数组检测,甲基化水平以β值量化,差异甲基化区域通过调整后P值<0.05和|Δβ|>0.10判定。 人源 · 4 例 · GPL33022 · 2026/08/05

    设计对SW620结直肠癌细胞进行全基因组DNA甲基化分析,比较shCtrl和shDNMT3A组的差异。每组包含2个独立生物重复,采用Infinium MethylationEPIC BeadChip数组检测,甲基化水平以β值量化,差异甲基化区域通过调整后P值<0.05和|Δβ|>0.10判定。

    摘要DNA methyltransferase 3A (DNMT3A) contributes to tumor immune evasion by regulating TNF signaling and cholesterol biosynthesis in colorectal cancer cells. To characterize DNMT3A-dependent changes in the DNA methylation landscape, genome-wide DNA methylation profiling was performed in control and DNMT3A-knockdown SW620 colorectal cancer cells using the Infinium MethylationEPIC BeadChip array. Comparative analysis identified 14,390 differentially methylated regions, of which 12,059 were annotated to known genes. These methylation alterations were predominantly localized to promoter-associated regions, including TSS1500, TSS200, and 5′ untranslated regions. DNMT3A loss reduced promoter methylation at genes involved in TNFα- and IFNγ-related signaling pathways, including TNFRSF1A and TNFRSF1B. These data define the DNMT3A-dependent DNA methylation landscape in SW620 cells and support a role for DNMT3A-mediated promoter methylation in the transcriptional regulation of tumor immune signaling pathways.

  158. 158 GSE50511 取人结直肠癌细胞系 HCT116、RKO、SW480 与正常淋巴细胞,提取基因组 DNA;正常淋巴细胞 DNA 经 Sss1 体外甲基化处理作为对照。四份 DNA 均经亚硫酸氢盐转化后,用 Illumina Infinium 甲基化芯片(GPL8490)检测 CpG 甲基化,以 beta 值表示各位点甲基化水平,比较三种结直肠癌细胞系与体外甲基化正常淋巴细胞 DNA 的甲基化谱。 人源 · 4 例 · GPL8490 · 2013/08/30

    设计取人结直肠癌细胞系 HCT116、RKO、SW480 与正常淋巴细胞,提取基因组 DNA;正常淋巴细胞 DNA 经 Sss1 体外甲基化处理作为对照。四份 DNA 均经亚硫酸氢盐转化后,用 Illumina Infinium 甲基化芯片(GPL8490)检测 CpG 甲基化,以 beta 值表示各位点甲基化水平,比较三种结直肠癌细胞系与体外甲基化正常淋巴细胞 DNA 的甲基化谱。

    摘要Methylation analysis of normal lymphocytes, HCT116, RKO and SW480

  159. 159 GSE84399 对结直肠癌 HCT116 细胞进行 TET1 敲低处理,采集基因组 DNA 进行甲基化分析。将 HCT116 细胞转染 TET1 敲低载体或阴性对照质粒,筛选 G418 抗性克隆,分离 GFP 阳性细胞株,采用 HumanMethylation450 BeadChip 检测 DNA 甲基化状态,比较 TET1 敲低组与对照组的甲基化差异。 人源 · 4 例 · GPL13534 · 2017/01/01

    设计对结直肠癌 HCT116 细胞进行 TET1 敲低处理,采集基因组 DNA 进行甲基化分析。将 HCT116 细胞转染 TET1 敲低载体或阴性对照质粒,筛选 G418 抗性克隆,分离 GFP 阳性细胞株,采用 HumanMethylation450 BeadChip 检测 DNA 甲基化状态,比较 TET1 敲低组与对照组的甲基化差异。

    摘要We aimed to analyze the relationship between TET1 and aberrant CpG methylation in colorectal cancer (CRC). We established two stable TET1 knockdown clones and negative control clones of HCT116 cells, and carried out DNA methylation analysis with HumanMethylation450 BeadChip.

  160. 160 GSE85529 对四个 DLD1 结直肠癌细胞系的基因组 DNA 进行甲基化分析,包括父代上皮型细胞系及三种间质型衍生细胞系(SA、SPH、METS),分别来自软琼脂克隆、结肠球体和肺转移异种移植。采用 Illumina Infinium 450k 人类甲基化芯片检测约 45 万个 CpG 位点的甲基化状态,比较不同来源细胞系的甲基化差异。 人源 · 4 例 · GPL13534 · 2017/03/28

    设计对四个 DLD1 结直肠癌细胞系的基因组 DNA 进行甲基化分析,包括父代上皮型细胞系及三种间质型衍生细胞系(SA、SPH、METS),分别来自软琼脂克隆、结肠球体和肺转移异种移植。采用 Illumina Infinium 450k 人类甲基化芯片检测约 45 万个 CpG 位点的甲基化状态,比较不同来源细胞系的甲基化差异。

    摘要DNA methylation profiling of four DLD1 colorectal cancer cell derivatives that recapitulate EMT/MET transitions during metastasis. The Illumina Infinium 450k Human DNA methylation Beadchip was used to obtain DNA methylation profiles across approximately 450,000 CpGs.

  161. 161 GSE9267 对人类结直肠癌细胞系 HCT116 的野生型与 DNMT1/3b 双敲除(DKO)细胞株进行甲基化检测,采用甲基化 DNA 免疫沉淀(MeDIP)结合启动子微阵列分析方法,比较两组细胞全基因组范围内 CpG 岛的甲基化状态变化。研究对象为 HCT116 结直肠癌细胞系,被测材料为甲基化 DNA 免疫沉淀物与总基因组 DNA,检测方式为基于全基因组 tiling 数组的甲基化谱分析,主要比较 DNMT1/3b 双敲除细胞与野生型细胞的 CpG 岛甲基化模式差异。 人源 · 4 例 · GPL4089;4090 · 2008/01/01

    设计对人类结直肠癌细胞系 HCT116 的野生型与 DNMT1/3b 双敲除(DKO)细胞株进行甲基化检测,采用甲基化 DNA 免疫沉淀(MeDIP)结合启动子微阵列分析方法,比较两组细胞全基因组范围内 CpG 岛的甲基化状态变化。研究对象为 HCT116 结直肠癌细胞系,被测材料为甲基化 DNA 免疫沉淀物与总基因组 DNA,检测方式为基于全基因组 tiling 数组的甲基化谱分析,主要比较 DNMT1/3b 双敲除细胞与野生型细胞的 CpG 岛甲基化模式差异。

    摘要CpG island promoter hypermethylation of tumor suppressor genes is a common hallmark of human cancer, and new large-scale epigenomic technologies might be useful in our attempts to define the complete DNA hypermethylome of tumor cells. Here we report a functional search for hypermethylated CpG islands using the colorectal cancer cell line HCT-116, in which two major DNA methyltransferases, DNMT1 and DNMT3b, have been genetically disrupted (DKOcells). Using methylated DNA immunoprecipitation (MeDIP) methodology in conjunction with promoter microarray analyses we found that DKO cells experience a significant loss of hypermethylated CpG islands. Further characterization of these candidate sequences demonstrates CpG island promoter hypermethylation and silencing of genes with potentially important roles in tumorigenesis, such as the Ras guanine-nucleotide release factor RASGRF2, the apoptosis-associated basic helixloop transcription factor BHLHB9, and the homeobox gene HOXD1. Hypermethylation of these genes occurs already in premalignant lesions and accumulates during tumorigenesis. Thus, our results demonstrate the usefulness of DNMT genetic disruption strategies combined with MeDIP in searching for unknown hypermethylated candidate genes in human cancer that might aid our understanding of the biology of the disease and be of potential translational use. Keywords: Human Proximal Promoter Array; DNA Methylation

  162. 162 GSE98533 研究对象为结直肠腺癌细胞系Caco2,材料为基因组DNA。将Caco2细胞分为稳定表达致癌性BRAF(BRAFV600E)和GFP两组,每组按2个样本估计,提取基因组DNA后进行DNA甲基化分析,比较两组在CIMP基因启动子区域的甲基化差异。 人源 · 4 例 · GPL13534 · 2019/12/18

    设计研究对象为结直肠腺癌细胞系Caco2,材料为基因组DNA。将Caco2细胞分为稳定表达致癌性BRAF(BRAFV600E)和GFP两组,每组按2个样本估计,提取基因组DNA后进行DNA甲基化分析,比较两组在CIMP基因启动子区域的甲基化差异。

    摘要Promoter hypermethylation divides colon cancers into subtypes with and without a CpG island methylator phenotype (CIMP). Here, we performed genome-wide DNA methylation profiling of colonic normal and tumor tissues to dissect development of CpG hypermethylation in colon carcinogenesis. This identified age-environment related versus genetically driven CpG hypermethylation, the latter being associated with CIMP cancers. We found a strong association between BRAFV600E mutation and downregulation of the DNA demethylases TET1 and TET2. Expression of BRAFV600E in CIMP cancer cells suppressed TET1 transcription, which was sufficient to establish hypermethylation at CIMP genes promoters, including that of TET2. This phenotype was reverted by the BRAFV600E inhibitor vemurafenib. Thus, BRAFV600E, via impairment of cytosine de-methylation, is a genetic driver of CIMP in colon tumorigenesis.

  163. 163 GSE106437 本研究针对结直肠癌 DLD1 细胞系,设置 UHRF1 敲除组与对照组,分别采用 control siRNA 和 UHRF1 siRNA1 进行转染处理。转染后细胞在含 10% 热灭活胎牛血清的 DMEM 培养基中培养 48 小时,随后接受 mock(乙醇)或 300 nM Trichostatin A(TSA)处理 24 小时。研究对象为基因组 DNA,采用全基因组规模的 DNA 甲基化阵列谱检测,比较不同处理条件下细胞的甲基化模式变化。 人源 · 3 例 · GPL13534 · 2019/05/21

    设计本研究针对结直肠癌 DLD1 细胞系,设置 UHRF1 敲除组与对照组,分别采用 control siRNA 和 UHRF1 siRNA1 进行转染处理。转染后细胞在含 10% 热灭活胎牛血清的 DMEM 培养基中培养 48 小时,随后接受 mock(乙醇)或 300 nM Trichostatin A(TSA)处理 24 小时。研究对象为基因组 DNA,采用全基因组规模的 DNA 甲基化阵列谱检测,比较不同处理条件下细胞的甲基化模式变化。

    摘要UHRF1 is a major regulator of epigenetic mechanism and is overexpressed in various human malignancies. In this study, we examined the involvement of UHRF1 in aberrant DNA methylation in colorectal cancer (CRC). In CRC cells, transient UHRF1 knockdown rapidly induced DNA demethylation across entire genomic regions, including CpG islands, gene bodies and repetitive elements. Nonetheless, UHRF1 depletion only minimally reversed CpG island hypermethylation-associated gene silencing. However, the combination of UHRF1 depletion and histone deacetylase (HDAC) inhibition synergistically reactivated the silenced genes and strongly suppressed CRC cell proliferation. Our results suggest that (i) maintenance of DNA methylation in CRC cells is highly dependent on UHRF1; (ii) UHRF1 depletion rapidly induces DNA demethylation, though it is insufficient to fully reactivate the silenced genes; and (iii) dual targeting of UHRF1 and HDAC may be an effective new therapeutic strategy.

  164. 164 GSE106438 将结直肠癌 RKO 细胞分为三组:control siRNA 加 mock 处理、UHRF1 siRNA1 加 mock 处理、UHRF1 siRNA1 加 TSA 处理,采集基因组 DNA 进行基因组 tiling 阵列甲基化分析,比较不同处理条件下 DNA 甲基化状态差异。 人源 · 3 例 · GPL13534 · 2019/05/21

    设计将结直肠癌 RKO 细胞分为三组:control siRNA 加 mock 处理、UHRF1 siRNA1 加 mock 处理、UHRF1 siRNA1 加 TSA 处理,采集基因组 DNA 进行基因组 tiling 阵列甲基化分析,比较不同处理条件下 DNA 甲基化状态差异。

    摘要UHRF1 is a major regulator of epigenetic mechanism and is overexpressed in various human malignancies. In this study, we examined the involvement of UHRF1 in aberrant DNA methylation in colorectal cancer (CRC). In CRC cells, transient UHRF1 knockdown rapidly induced DNA demethylation across entire genomic regions, including CpG islands, gene bodies and repetitive elements. Nonetheless, UHRF1 depletion only minimally reversed CpG island hypermethylation-associated gene silencing. However, the combination of UHRF1 depletion and histone deacetylase (HDAC) inhibition synergistically reactivated the silenced genes and strongly suppressed CRC cell proliferation. Our results suggest that (i) maintenance of DNA methylation in CRC cells is highly dependent on UHRF1; (ii) UHRF1 depletion rapidly induces DNA demethylation, though it is insufficient to fully reactivate the silenced genes; and (iii) dual targeting of UHRF1 and HDAC may be an effective new therapeutic strategy.

  165. 165 GSE147518 对HCT116结直肠癌细胞系进行shRNA敲低处理,分别靶向LIG1、UHRF1或luciferase(作为对照),病毒转染后12天采集亚硫酸氢盐转化的基因组DNA,通过Illumina MethylationEPIC BeadChip平台进行甲基化分析,比较不同shRNA处理组间的DNA甲基化差异。 人源 · 3 例 · GPL21145 · 2020/03/26

    设计对HCT116结直肠癌细胞系进行shRNA敲低处理,分别靶向LIG1、UHRF1或luciferase(作为对照),病毒转染后12天采集亚硫酸氢盐转化的基因组DNA,通过Illumina MethylationEPIC BeadChip平台进行甲基化分析,比较不同shRNA处理组间的DNA甲基化差异。

    摘要In HCT116 colorectal cancer cells, UHRF1, LIG1, or luciferase was knocked down by shRNA followed by selection with puromycin for 2 days. DNA was analyzed 12 days after viral transduction.

  166. 166 GSE62086 对3例患者来源的结直肠癌样本(不同CIMP谱型)进行全基因组DNA甲基化分析,采用Illumina HumanMethylation450 BeadChip芯片检测约450,000个CpG位点的甲基化状态,比较不同CIMP类型样本的甲基化特征差异。 人源 · 3 例 · GPL13534 · 2015/08/27

    设计对3例患者来源的结直肠癌样本(不同CIMP谱型)进行全基因组DNA甲基化分析,采用Illumina HumanMethylation450 BeadChip芯片检测约450,000个CpG位点的甲基化状态,比较不同CIMP类型样本的甲基化特征差异。

    摘要Genome wide DNA methylation profiling of 3 patient-derived colorectal cancer samples with different CIMP profiles. The Illumina Infinium 450k Human DNA methylation Beadchip was used to obtain DNA methylation profiles across approximately 450,000 CpGs

  167. 167 GSE98532 对三种结直肠癌细胞系(Caco2、Co115、Sw620)的基因组DNA进行甲基化分析,使用Illumina Infinium 450k Human Methylation BeadChip检测,比较BRAFV600E突变型与野生型细胞系的甲基化差异。 人源 · 3 例 · GPL13534 · 2019/12/18

    设计对三种结直肠癌细胞系(Caco2、Co115、Sw620)的基因组DNA进行甲基化分析,使用Illumina Infinium 450k Human Methylation BeadChip检测,比较BRAFV600E突变型与野生型细胞系的甲基化差异。

    摘要Promoter hypermethylation divides colon cancers into subtypes with and without a CpG island methylator phenotype (CIMP). Here, we performed genome-wide DNA methylation profiling of colonic normal and tumor tissues to dissect development of CpG hypermethylation in colon carcinogenesis. This identified age-environment related versus genetically driven CpG hypermethylation, the latter being associated with CIMP cancers. We found a strong association between BRAFV600E mutation and downregulation of the DNA demethylases TET1 and TET2. Expression of BRAFV600E in CIMP cancer cells suppressed TET1 transcription, which was sufficient to establish hypermethylation at CIMP genes promoters, including that of TET2. This phenotype was reverted by the BRAFV600E inhibitor vemurafenib. Thus, BRAFV600E, via impairment of cytosine de-methylation, is a genetic driver of CIMP in colon tumorigenesis.

  168. 168 GSE192833 将人类结直肠癌肿瘤组织接种至NPG小鼠建立PDX模型,分为DAC处理组与非处理对照组,于28天后连续5天腹腔注射DAC(20 μg/次),第七天收集肿瘤组织进行全基因组亚硫酸氢盐测序(WGBS)和RNA测序,比较两组甲基化状态及基因表达差异。 人源 · 2 例 · GPL21290 · 2022/01/03

    设计将人类结直肠癌肿瘤组织接种至NPG小鼠建立PDX模型,分为DAC处理组与非处理对照组,于28天后连续5天腹腔注射DAC(20 μg/次),第七天收集肿瘤组织进行全基因组亚硫酸氢盐测序(WGBS)和RNA测序,比较两组甲基化状态及基因表达差异。

    摘要PD-1 blockade has demonstrated impressive clinical outcomes in colorectal cancers that have high microsatellite instability. However, the therapeutic efficacy for patients with tumors with low microsatellite instability or stable microsatellites needs further improvement. Here, we have demonstrated that low-dose decitabine could increase the expression of immune-related genes such as major histocompatibility complex genes and cytokine-related genes as well as the number of lymphocytes at the tumor site in CT26 colorectal cancer-bearing mice. A more significant inhibition of tumor growth and a prolongation of survival were observed in the CT26 mouse model after treatment with a combination of PD-1 blockade and decitabine than in mice treated with decitabine or PD-1 blockade alone. The anti-tumor effect of the PD-1 blockade was enhanced by low-dose decitabine. The results of RNA sequencing and whole-genome bisulfite sequencing of decitabine-treated CT26 cells and tumor samples with microsatellite stability from the patient tumor-derived xenograft model have shown that many immune-related genes, including antigen processing and antigen-presenting genes, were upregulated, whereas the promoter demethylation was downregulated after decitabine exposure. Therefore, decitabine-based tumor microenvironment re-modulation could improve the effect of the PD-1 blockade. The application of decitabine in PD-1 blockade-based immunotherapy may elicit more potent immune responses, which can provide clinical benefits to the colorectal cancer patients with low microsatellite instability or stable microsatellites.

  169. 169 GSE249602 以人结直肠癌SW480细胞系(结肠来源上皮细胞)为对象,设置野生型(WT)与稳定表达致癌lncRNA PCAT2转基因盒(PCAT2-KI)两组细胞,均培养于含10% FBS的RPMI培养基、37℃、5% CO2条件,测序分析前未对细胞施加其他处理。提取高分子量基因组DNA,进行全基因组亚硫酸氢盐测序(Bisulfite-Seq),在NovaSeq 6000 S1平台以双端模式测序,比较两组细胞基因组DNA甲基化谱的差异,以探讨PCAT2转基因表达对该细胞系染色体位点表观遗传状态的影响。 人源 · 2 例 · GPL24676 · 2025/06/23

    设计以人结直肠癌SW480细胞系(结肠来源上皮细胞)为对象,设置野生型(WT)与稳定表达致癌lncRNA PCAT2转基因盒(PCAT2-KI)两组细胞,均培养于含10% FBS的RPMI培养基、37℃、5% CO2条件,测序分析前未对细胞施加其他处理。提取高分子量基因组DNA,进行全基因组亚硫酸氢盐测序(Bisulfite-Seq),在NovaSeq 6000 S1平台以双端模式测序,比较两组细胞基因组DNA甲基化谱的差异,以探讨PCAT2转基因表达对该细胞系染色体位点表观遗传状态的影响。

    摘要Maintaining genome integrity is crucial for the proper functioning and development of organisms. One intriguing aspect of genome integrity is the formation and function of neocentromeres at non-centromeric sites. The centromere-specific protein CENP-A plays a vital role in centromere identification and function. However, in many cancers, CENP-A is often found to be ectopically misplaced when overexpressed. Moreover, the deposition of CENP-A at the centromere depends on the transcription of centromeric non-coding RNAs. Consequently, ectopic CENP-A is found at transcriptionally active and frequent breakpoint regions. To further explore the ectopic CENP-A localization, we engineered a stable ectopic CENP-A site at a naïve chromosome by overexpressing a non-centromeric oncogenic lncRNA capable of recruiting CENP-A to its transcription site. We tracked cells carrying the stable transgene to understand the stability and longevity of the induced ectopic CENP-A site and the harboring chromosome. Our findings revealed that the induced epigenetic memory was eventually lost by suppression of the transgene through competing epigenetic silencing mechanisms. This epigenetic restoration naturally reversed the ectopic CENP-A level to its previous levels at the engineered site. Our observations suggest that cells may have evolved failsafe mechanisms to prevent neocentromere formation at ectopic sites unless otherwise favored by selection involving multiple components.

  170. 170 GSE297777 对结直肠癌细胞系 HCT116 及其 DNMT1 敲除细胞进行全基因组亚硫酸盐测序(WGBS)、repli-seq 和 ChIP-seq 分析,比较野生型与 DNMT1 敲除细胞的 DNA 甲基化模式差异。 人源 · 2 例 · GPL21697 · 2026/03/26

    设计对结直肠癌细胞系 HCT116 及其 DNMT1 敲除细胞进行全基因组亚硫酸盐测序(WGBS)、repli-seq 和 ChIP-seq 分析,比较野生型与 DNMT1 敲除细胞的 DNA 甲基化模式差异。

    摘要Loss of DNA methylation is a hallmark of cancer that is proposed to promote carcinogenesis through gene expression alterations, retrotransposon activation and induction of genomic instability. Cancer-associated hypomethylation does not occur across the whole genome but leads to the formation of partially methylated domains (PMDs). However, the mechanisms underpinning PMD formation remain unclear. PMDs replicate late in S-phase leading to the proposal that they become hypomethylated due to incomplete re-methylation by the maintenance methyltransferase DNMT1 during cell division. Here we investigate the role of DNMT1 in the formation of PMDs in cancer by conducting whole genome bisulfite sequencing (WGBS), repli-seq and ChIP-seq on DNMT1 knockout HCT116 colorectal cancer cells (DNMT1 KO cells). We find that DNMT1 loss leads to preferential hypomethylation in late replicating, heterochromatic PMDs marked by the constitutive heterochromatic mark H3K9me3 or the facultative heterochromatic mark H3K27me3. However, we also observe that a subset of H3K9me3-marked PMDs gain methylation in DNMT1 KO cells. We find that, in DNMT1 KO cells, these hypermethylated PMDs remain late replicating but gain DNMT3A localisation. This is accompanied by loss of heterochromatic H3K9me3 and specific gain of euchromatic H3K36me2. Our observations suggest that hypermethylated PMDs lose their heterochromatic state, enabling their methylation by DNMT3A and the establishment of a hypermethylated, non-PMD state, despite their late replication timing. More generally, our findings suggest that the de novo DNMTs play a key role in establishing domain level DNA methylation patterns in cancer cells.

  171. 171 GSE32399 对人类结直肠肿瘤及相邻正常结肠组织样本进行全基因组亚硫酸盐测序,每个样本包含两个独立库,比较肿瘤与正常组织的DNA甲基化差异。 人源 · 2 例 · GPL10999 · 2011/09/27

    设计对人类结直肠肿瘤及相邻正常结肠组织样本进行全基因组亚硫酸盐测序,每个样本包含两个独立库,比较肿瘤与正常组织的DNA甲基化差异。

    摘要Extensive changes in DNA methylation are common in cancer and may contribute to oncogenesis through transcriptional silencing of tumor suppressor genes. Genome-scale studies have yielded important insights into these changes, but have focused on CpG islands or gene promoters. We used whole-genome bisulfite sequencing (Bisulfite-Seq) to comprehensively profile a primary human colorectal tumor and adjacent-normal colon tissue at single-basepair resolution. Regions of focal hypermethylation in the tumor were located primarily at CpG islands and were concentrated within regions of long-range (>100 kb) hypomethylation. These hypomethylated domains covered nearly half the genome and coincided with late replication and attachment to the nuclear lamina in human cell lines. The confluence of hypermethylation and hypomethylation within these domains was confirmed in 25 diverse colorectal tumors with matched adjacent tissue. We propose that widespread DNA methylation changes in cancer are linked to silencing programs orchestrated by the 3D organization of chromatin within the nucleus. dbGAP study: phs000385

  172. 172 GSE44446 对人类结直肠癌LoVo_S和LoVo_R细胞系进行DNA甲基化芯片分析,比较两者的基因组DNA甲基化模式差异。 人源 · 2 例 · GPL8490 · 2013/11/26

    设计对人类结直肠癌LoVo_S和LoVo_R细胞系进行DNA甲基化芯片分析,比较两者的基因组DNA甲基化模式差异。

    摘要Genome wide DNA methylation profiling of LoVo oxaliplatin sensitive (LoVo_S) and LoVo 10 fold oxaliplatin resistant (LoVo_R) cell lines. The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 27,000 CpGs in cell lines genomic DNA samples.

  173. 173 GSE58695 比较人类HCT116结肠癌细胞与其遗传衍生物DKO1细胞(缺乏DNMT3B和DNMT1活性)的全基因组DNA甲基化和核小体占有率模式,采用NOMe-seq技术,每个细胞系各取1个样本,通过亚硫酸氢盐测序进行基因组比对。 人源 · 2 例 · GPL11154 · 2015/02/06

    设计比较人类HCT116结肠癌细胞与其遗传衍生物DKO1细胞(缺乏DNMT3B和DNMT1活性)的全基因组DNA甲基化和核小体占有率模式,采用NOMe-seq技术,每个细胞系各取1个样本,通过亚硫酸氢盐测序进行基因组比对。

    摘要We compare the global DNA methylation and nucleosome occupancy patterns of HCT116 colon cancer cells with its genetic derivatives DKO1 cells which lack DNMT3B and DNMT1 activity

人源accessibility

Human · accessibility

  1. 01 GSE335210 对人类结直肠癌细胞模型进行 ATAC-seq、RNA-seq 和 CUT&RUN 多组学分析,研究 SOX9 降解/恢复、BAF 亚基扰动、组蛋白标记占据、ARID1A/ARID1B 敲低及 SOX9 变体染色质可及性。主要时间序列使用 HT29-dTAG 细胞,SOX9 变体 ATAC-seq 子集使用 LS180 细胞,检测时间点包括 DMSO、D2、D4、D5、D7、D10 和 D13。 人源 · 173 例 · GPL24676 · 2026/06/16

    设计对人类结直肠癌细胞模型进行 ATAC-seq、RNA-seq 和 CUT&RUN 多组学分析,研究 SOX9 降解/恢复、BAF 亚基扰动、组蛋白标记占据、ARID1A/ARID1B 敲低及 SOX9 变体染色质可及性。主要时间序列使用 HT29-dTAG 细胞,SOX9 变体 ATAC-seq 子集使用 LS180 细胞,检测时间点包括 DMSO、D2、D4、D5、D7、D10 和 D13。

    摘要This study combines matched ATAC-seq, RNA-seq, and CUT&RUN profiling in human colon cancer cell models to track SOX9 degradation/recovery, BAF subunit perturbation, histone-mark occupancy, ARID1A/ARID1B knockdown, and SOX9-variant chromatin accessibility. The main time-course series uses HT29-dTAG cells; the SOX9-variant ATAC-seq subset uses LS180 cells.

  2. 02 GSE223997 对结直肠癌细胞系 DLD-1 的不同基因型与处理条件进行 R-loop 相关检测,采用 CUT&Tag 和 ChIP-Seq 技术分析 DNA-RNA 杂交状态及染色质修饰分布,比较基因型与处理组间的差异。 人源 · 111 例 · GPL24676 · 2023/06/20

    设计对结直肠癌细胞系 DLD-1 的不同基因型与处理条件进行 R-loop 相关检测,采用 CUT&Tag 和 ChIP-Seq 技术分析 DNA-RNA 杂交状态及染色质修饰分布,比较基因型与处理组间的差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  3. 03 GSE205984 研究对象为人类结直肠癌上皮组织,采用HCT-116细胞系进行MED14-dTAG基因型与对照组的比较实验。实验设置DMSO处理组、dTAG处理组、dTAG+I-BET处理组及Triptolide处理组,各组均采集结直肠上皮组织的基因组DNA,通过ChIP-Seq和ATAC-seq技术检测染色质结合状态与可及性变化,主要比较不同处理条件下基因组DNA的结合与可及性差异。 人源 · 109 例 · GPL21697 · 2023/04/13

    设计研究对象为人类结直肠癌上皮组织,采用HCT-116细胞系进行MED14-dTAG基因型与对照组的比较实验。实验设置DMSO处理组、dTAG处理组、dTAG+I-BET处理组及Triptolide处理组,各组均采集结直肠上皮组织的基因组DNA,通过ChIP-Seq和ATAC-seq技术检测染色质结合状态与可及性变化,主要比较不同处理条件下基因组DNA的结合与可及性差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  4. 04 GSE207954 对结直肠癌相关样本(包括结肠组织、结肠癌组织、结肠类器官)和细胞系(HCT116、HPCEC、HT29)进行处理,其中部分样本接受DMSO或JQ1 (500 nM, 24 hr)处理,采集总RNA和基因组DNA,通过RNA-Seq和ATAC-seq检测基因表达与染色质结合特征,比较处理组与相应对照组的差异。 人源 · 104 例 · GPL24676 · 2022/08/27

    设计对结直肠癌相关样本(包括结肠组织、结肠癌组织、结肠类器官)和细胞系(HCT116、HPCEC、HT29)进行处理,其中部分样本接受DMSO或JQ1 (500 nM, 24 hr)处理,采集总RNA和基因组DNA,通过RNA-Seq和ATAC-seq检测基因表达与染色质结合特征,比较处理组与相应对照组的差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  5. 05 GSE201336 对携带或不携带germline APC突变的结肠癌患者,分别采集息肉、正常组织和CRC样本,分离核后进行单细胞RNA测序和单细胞ATAC测序,比较不同疾病状态及APC突变状态下的细胞状态和组成变化。 人源 · 89 例 · GPL24676;20301 · 2022/04/28

    设计对携带或不携带germline APC突变的结肠癌患者,分别采集息肉、正常组织和CRC样本,分离核后进行单细胞RNA测序和单细胞ATAC测序,比较不同疾病状态及APC突变状态下的细胞状态和组成变化。

    摘要To chart cell composition and cell state changes that occur during the transformation of healthy colon to precancerous adenomas to colorectal cancer (CRC), we generated single-cell chromatin accessibility profiles and single-cell transcriptomes from polyps, normal tissues, and CRCs collected from patients with or without germline APC mutations. We find that a large fraction of polyp and CRC cells exhibit a stem-like phenotype, and we define a continuum of epigenetic and transcriptional changes occurring in these stem-like cells as they progress from homeostasis to CRC.

  6. 06 GSE201348 对结肠组织样本(包括正常、腺瘤和结直肠癌)进行单细胞RNA测序和ATAC测序,比较不同疾病阶段的细胞组成与状态变化,同时考虑患者是否携带germline APC突变。 人源 · 72 例 · GPL24676 · 2022/04/28

    设计对结肠组织样本(包括正常、腺瘤和结直肠癌)进行单细胞RNA测序和ATAC测序,比较不同疾病阶段的细胞组成与状态变化,同时考虑患者是否携带germline APC突变。

    摘要To chart cell composition and cell state changes that occur during the transformation of healthy colon to precancerous adenomas to colorectal cancer (CRC), we generated single-cell chromatin accessibility profiles and single-cell transcriptomes from polyps, normal tissues, and CRCs collected from patients with or without germline APC mutations. We find that a large fraction of polyp and CRC cells exhibit a stem-like phenotype, and we define a continuum of epigenetic and transcriptional changes occurring in these stem-like cells as they progress from homeostasis to CRC.

  7. 07 GSE294559 对人类结直肠癌肿瘤组织、相邻正常组织及其衍生的正常和肿瘤患者来源类器官进行单核多组学分析,包括单核 RNA 测序和单核 ATAC 测序,以探究结直肠癌的分子特征。 人源 · 72 例 · GPL24676 · 2025/07/18

    设计对人类结直肠癌肿瘤组织、相邻正常组织及其衍生的正常和肿瘤患者来源类器官进行单核多组学分析,包括单核 RNA 测序和单核 ATAC 测序,以探究结直肠癌的分子特征。

    摘要Colorectal cancer (CRC) arises in the colorectal tissue driven by genetic disorder or the accumulation of somatic mutations, leading to abnormal epithelial cell growth. In this study, we employed single-nucleus multi-omics analysis, including single-nucleus RNA-seq and single-nucleus ATAC-seq, on over 100,000 high-quality nuclei to investigate the molecular landscape of both primary tissue and patient-derived organoids (PDOs). Our analysis showed that normal PDOs (N-PDOs) derived from tissue adjacent to tumors replicate the cellular composition and differentiation trajectory of colorectal crypts. In contrast, tumor PDOs (T-PDOs) showed patient-specific transcriptomic and epigenomic heterogeneity yet consistently maintained a stem cell-like state. T-PDOs retained the somatic mutation profile of the primary tumor while also exhibiting de novo mutations not detected in either the primary tumor or N-PDOs. Notably, inferred cell-cell interaction analysis highlighted the activin signaling pathway as a potential unique feature of fibroblast-epithelial interactions within tumor microenvironment. This study provides a comprehensive view of the transition from normal to malignant colorectal epithelium and underscores the utility of PDOs as faithful model for capturing both conserved and patient-specific features of colorectal cancer.

  8. 08 GSE184482 本研究比较了结直肠癌患者来源模型(PDO、PDX、PDOX)与原始患者肿瘤(PT)的表观组。PT来自6名患者,PDO来自6名患者,PDX来自3名患者,每个样本类型包含3个生物重复。采用Omni-ATAC协议提取核,使用Illumina HiSeq 4000 PE 150bp测序,通过Diffbind分析染色质可及性差异,严格阈值p<0.05和|logFC|>1。 人源 · 63 例 · GPL20301 · 2024/03/01

    设计本研究比较了结直肠癌患者来源模型(PDO、PDX、PDOX)与原始患者肿瘤(PT)的表观组。PT来自6名患者,PDO来自6名患者,PDX来自3名患者,每个样本类型包含3个生物重复。采用Omni-ATAC协议提取核,使用Illumina HiSeq 4000 PE 150bp测序,通过Diffbind分析染色质可及性差异,严格阈值p<0.05和|logFC|>1。

    摘要Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to compare the epigenomes of different patient-derived models of colorectal cancer (PDO, PDX and PDOX) to the original patient tumor. Methods: The Omni-ATAC protocol was utilized for ATAC library preparations. The nulcei were extracted from samples (PT, PDO, PDX and PDOX). For each sample set, three biological replicates were included. The libraries were sequenced using Illumina HiSeq 4000 PE 150bp. Results: Using an optimized data analysis workflow, we achieved high quality ATAC-seq library. Data were mapped to hg19 with over 90% mapping rate, and relative low mitochondria fraction (<30%). We used Diffbind to assess the chromatin accessibility enrichment in each model with a strict threshold of p <0.05 and |logFC|>1. Conclusions: Our study represents the first detailed analysis of CRC PDMC epigenome. CRC cells from all three models share chromatin alterations when compared to PT cells, representing a PT-PDMC epigenetic axis. Chromatin alterations in CRC cells are more similar betweeen PDOX and PDX than between PDOX and PDO, indicating that the growth environment of the model exerts strong influence on chraomtin adaptation in tumor cells.

  9. 09 GSE179064 对 HCT-15 人结直肠癌细胞系进行 Tn5 转座酶切割的 ATAC-seq 和 RNA-Seq 分析,比较 T 处理 6h 与 DMSO 对照组、A 处理 12h 与 DMSO 对照组的染色质可及性及转录组变化。 人源 · 60 例 · GPL24676 · 2022/08/17

    设计对 HCT-15 人结直肠癌细胞系进行 Tn5 转座酶切割的 ATAC-seq 和 RNA-Seq 分析,比较 T 处理 6h 与 DMSO 对照组、A 处理 12h 与 DMSO 对照组的染色质可及性及转录组变化。

    摘要This SuperSeries is composed of the SubSeries listed below.

  10. 10 GSE101966 以人结直肠癌细胞系HCT116及其纯合ARID1A敲除(ARID1A-/-)细胞为研究对象,经慢病毒shRNA分别敲低ARID1B(V3LHS_306691)或表达乱序对照,构成基因型(野生型/ARID1A敲除)×处理(ARID1B敲低/对照)的2×2分组,每种组合在ATAC-seq、H3K4me、H3K4me3、H3K27ac、H3K27me3的ChIP-seq及RNA-seq中均设2个重复,另设ChIP-seq input对照,共52个样本;比较基因型与ARID1B敲低对染色质开放性、组蛋白修饰和基因表达的影响。 人源 · 52 例 · GPL18573;16791 · 2017/09/29

    设计以人结直肠癌细胞系HCT116及其纯合ARID1A敲除(ARID1A-/-)细胞为研究对象,经慢病毒shRNA分别敲低ARID1B(V3LHS_306691)或表达乱序对照,构成基因型(野生型/ARID1A敲除)×处理(ARID1B敲低/对照)的2×2分组,每种组合在ATAC-seq、H3K4me、H3K4me3、H3K27ac、H3K27me3的ChIP-seq及RNA-seq中均设2个重复,另设ChIP-seq input对照,共52个样本;比较基因型与ARID1B敲低对染色质开放性、组蛋白修饰和基因表达的影响。

    摘要ARID1A, a subunit of the SWI/SNF chromatin remodeling complex, is frequently mutated in cancer. Deficiency in its homolog ARID1B is synthetically lethal with ARID1A mutation. However, the functional relationship between these homologs has not been explored. Here we use ATAC-seq, genome-wide histone modification mapping, and expression analysis to examine colorectal cancer cells lacking one or both ARID proteins. We find that ARID1A has a dominant role in maintaining chromatin accessibility at enhancers, while the contribution of ARID1B is evident only in the context of ARID1A mutation. Changes in accessibility are predictive of changes in expression and correlate with loss of H3K4me and H3K27ac marks, nucleosome spacing, and transcription factor binding, particularly at growth pathway genes including MET. We find that ARID1B knockdown in ARID1A mutant ovarian cancer cells causes similar loss of enhancer architecture, suggesting that this is a conserved function underlying the synthetic lethality between ARID1A and ARID1B.

  11. 11 GSE324972 将患者来源的结直肠癌类器官分别培养于Matrigel、结肠脱细胞基质、肝脏脱细胞基质、脑脱细胞基质和肺脱细胞基质中,采用Bulk ATAC-seq和CUT&Tag技术检测染色质可及性变化,比较不同微环境对类器官表观遗传状态的影响。 人源 · 50 例 · GPL24676;34281 · 2026/09/10

    设计将患者来源的结直肠癌类器官分别培养于Matrigel、结肠脱细胞基质、肝脏脱细胞基质、脑脱细胞基质和肺脱细胞基质中,采用Bulk ATAC-seq和CUT&Tag技术检测染色质可及性变化,比较不同微环境对类器官表观遗传状态的影响。

    摘要The extracellular matrix (ECM) plays a central role in regulating tumor progression and metastatic colonization by providing biochemical and mechanical signals that shape cancer cell fate. However, most organoid culture systems rely on basement membrane extracts that fail to reproduce the tissue-specific extracellular environments encountered during metastasis. Here, we develop tissue-derived decellularized matrix hydrogels to reconstruct organ-specific microenvironments and investigate epigenetic adaptation to ECM cues during metastatic colonization. Patient-derived colorectal cancer organoids cultured in colon-derived matrices exhibited enhanced maintenance of stem-like phenotypes and colon-specific chromatin accessibility landscapes compared with cultures grown in basement membrane extracts, demonstrating improved physiological relevance for primary tumor modeling. When exposed to matrices derived from secondary organs, the organoids showed distinct growth phenotypes accompanied by rapid, tissue-dependent chromatin accessibility remodeling, indicating that ECM composition alone can reshape regulatory programs governing metastatic adaptation. Notably, liver-derived matrices selectively activated hepatocyte nuclear factor 4 alpha (HNF4A)–associated transcriptional networks and created a context-specific dependence on c-MET signaling for survival. Functional perturbation of HNF4A or c-MET signaling confirmed that both are required for organoid formation specifically within the liver matrix environment. Together, these findings establish tissue-derived matrix hydrogels as instructive bioactive materials that actively regulate cancer cell epigenetic states and reveal microenvironment-specific therapeutic vulnerabilities during early metastatic colonization.

  12. 12 GSE175651 对 HCT116 人类结直肠癌细胞系在不同甲醛固定浓度条件下进行 OuNicE-seq 染色质可及性测定,比较 0.2%、1% 和 4% 甲醛固定组的可及性图谱差异,并通过免疫荧光检测验证 DNA 损伤标记物的染色质标记效率。 人源 · 46 例 · GPL21697 · 2021/12/01

    设计对 HCT116 人类结直肠癌细胞系在不同甲醛固定浓度条件下进行 OuNicE-seq 染色质可及性测定,比较 0.2%、1% 和 4% 甲醛固定组的可及性图谱差异,并通过免疫荧光检测验证 DNA 损伤标记物的染色质标记效率。

    摘要Accessible chromatin landscape allows remodeling of transcription factors and enhancers during development and molecular subtypes of cancer in patient samples. One-tube universal NicE-seq (OuNicE-seq) is an improved accessible chromatin profiling method that negate DNA purification and incorporate sonication free enzymatic fragmentation before library preparation and is suited to a variety of mammalian cells. OuNicE-seq is versatile, capable of profiling 4% formaldehyde fixed chromatin in 25 fixed cells and opens the possibility for automation. Accessible chromatin profile is more efficient on formaldehyde fixed cells using OuNicE-seq compare to Tn5 transposon mediated methods, demonstrating its versatility.

  13. 13 GSE83968 对结直肠癌相关非编码变异 rs1800734 进行功能研究,采用 CRISPR-CAS9 突变构建 COLO320 等基因型细胞系,通过 TFAP4、ELF1 等转录因子抗体进行 ChIP-seq,结合 DNase I-seq、ATAC-seq、4C-seq 和靶向 DNA/RNA-seq 技术,检测不同基因型细胞系中 TF 结合位点及 DCLK3 表达差异,比较 rs1800734 变异与转录因子相互作用对基因表达的影响。 人源 · 39 例 · GPL11154;18573 · 2017/02/15

    设计对结直肠癌相关非编码变异 rs1800734 进行功能研究,采用 CRISPR-CAS9 突变构建 COLO320 等基因型细胞系,通过 TFAP4、ELF1 等转录因子抗体进行 ChIP-seq,结合 DNase I-seq、ATAC-seq、4C-seq 和靶向 DNA/RNA-seq 技术,检测不同基因型细胞系中 TF 结合位点及 DCLK3 表达差异,比较 rs1800734 变异与转录因子相互作用对基因表达的影响。

    摘要Genome-wide association studies (GWAS) have identified a great number of non-coding risk variants for colorectal cancer (CRC). To date, the majority of these variants have not been functionally studied. Identification of allele-specific transcription factor (TF) binding is of great importance to understand regulatory consequences of such variants. A recently developed proteome-wide analysis of disease-associated SNPs (PWAS) enables identification of DNA-TF interactions in an unbiased fashion. Here, we performed a large-scale PWAS studies to comprehensively characterize TF binding related to CRC, which identified 731 allele-specific TF binding at 116 CRC risk loci. This screen identified rs1800734 within the promoter region of MLH1 as perturbing the binding of TFAP4 and consequently increaseing DCLK3 expression through a long-range interaction, which promotes cancer progression through enhancing expression of the genes related to epithelial-to-mesenchymal transition (EMT).

  14. 14 GSE179059 对BxPC-3(胰腺癌)和HCT-15(结直肠癌)细胞系分别进行T和A两种3-氯哌啶类化合物处理,处理时间分别为6小时和12小时,同时设置DMSO对照组。采用ATAC-seq检测染色质可及性,比较不同处理条件和时间点下的变化。 人源 · 30 例 · GPL24676 · 2022/08/17

    设计对BxPC-3(胰腺癌)和HCT-15(结直肠癌)细胞系分别进行T和A两种3-氯哌啶类化合物处理,处理时间分别为6小时和12小时,同时设置DMSO对照组。采用ATAC-seq检测染色质可及性,比较不同处理条件和时间点下的变化。

    摘要Despite the tremendous advances in the use of omic-based technologies to serve the new paradigm of precision medicine, efforts are still required to expedite their routine use in drug discovery. In this work, we present a case study describing the use of multi-omics to push the development of 3-chloropiperidines (3-CePs), a new class of potential anticancer DNA alkylating agents. The combined analyses of transcriptome and chromatin accessibility efficiently identified proteostasis and DNA repair unbalances as the mechanisms underlying the tropism of 3-CePs against a pancreatic adenocarcinoma cell line. Further on, we implemented a new versatile strategy for the integration of RNA-seq and ATAC-seq information, which could be easily exported to accelerate and extend the separate analyses of omic layers. In addition, this platform offered a new anchor for the construction of a perturbation-informed basal signature able to efficiently predict cell lines sensitivity to 3-CePs and to further direct their development against specific tumor types. Overall, this approach offered a clinically-applicable pipeline to support both the early phases of drug discovery and the correct positioning of therapeutics in the medical practice.

  15. 15 GSE246046 将TP53突变的患者来源结直肠癌类器官分为SAHA 5µM、NKL54 10µM和DMSO处理组,每组进行三次重复,采集组织样本进行ATAC-seq和RNA-Seq检测,比较不同处理组的染色质可及性及转录组变化。 人源 · 30 例 · GPL24676 · 2024/03/04

    设计将TP53突变的患者来源结直肠癌类器官分为SAHA 5µM、NKL54 10µM和DMSO处理组,每组进行三次重复,采集组织样本进行ATAC-seq和RNA-Seq检测,比较不同处理组的染色质可及性及转录组变化。

    摘要This SuperSeries is composed of the SubSeries listed below.

  16. 16 GSE207950 对23例结肠组织样本进行bulk ATAC-seq,样本涵盖不同阶段的结直肠癌(CRC)进展,包括腺瘤性息肉(AdeCa)、息肉(Polyp)和黏膜(Mucosa)状态,分析染色质结构如相互作用条带和环的全局衰减,以及转录水平与对应启动子接触倾向的定量匹配变化。 人源 · 23 例 · GPL24676 · 2022/08/29

    设计对23例结肠组织样本进行bulk ATAC-seq,样本涵盖不同阶段的结直肠癌(CRC)进展,包括腺瘤性息肉(AdeCa)、息肉(Polyp)和黏膜(Mucosa)状态,分析染色质结构如相互作用条带和环的全局衰减,以及转录水平与对应启动子接触倾向的定量匹配变化。

    摘要Although the 3D genome architecture is essential for long-range gene regulation, the significance of physical chromatin interactions is challenged by recent findings of mutual insensitiveness between contact propensity and gene expression. Here we report hundred basepair-resolution profiling of chromatin conformation in 33 colon tissues tracing the formation and malignant transformation of colorectal polyps. We identified progressive genome-wide decays of chromatin structures such as interaction stripes and loops on all types of cis-regulatory elements, particularly promoters, independent to the alterations of DNA methylation and chromatin accessibility. Instead of linearly correlated with degree of structural decays, transcription levels shifted toward correction of their quantitative mismatching with corresponding promoter contact propensity. These observations suggest increasing sensitivity of transcription to regulatory architecture integrity along with its loss during early cancer development, a mechanism which may provide novel insights to the misregulations of cancer driving genes.

  17. 17 GSE207068 将人类工程化结直肠癌(Colorectal cancer)AKPS organoid 类器官单细胞分选为 STAR+ 或 STAR- 细胞,分别在培养 5 天和 12 天后进行 bulk ATAC-seq 测定,比较不同时间点及 STAR 表达状态的染色质可及性差异。 人源 · 21 例 · GPL18573 · 2023/12/01

    设计将人类工程化结直肠癌(Colorectal cancer)AKPS organoid 类器官单细胞分选为 STAR+ 或 STAR- 细胞,分别在培养 5 天和 12 天后进行 bulk ATAC-seq 测定,比较不同时间点及 STAR 表达状态的染色质可及性差异。

    摘要Human engineered CRC organoids were equipped with the intestinal stem cell reporter STAR reflecting transcriptional activity of ASCL2. Bulk ATAC-sequencing was performed on STAR populations after 5 days and after 12 days of plating single STAR+ or STAR- cells.

  18. 18 GSE227941 针对结肠癌组织,使用人类结肠癌细胞系 HCT116,设置 NuMA 基因敲低组与野生型组,分别进行 RNA-Seq、Hi-C 和 ATAC-seq 测定,比较两组间基因表达、染色质三维结构及可及性差异。 人源 · 21 例 · GPL24676;20795 · 2024/03/01

    设计针对结肠癌组织,使用人类结肠癌细胞系 HCT116,设置 NuMA 基因敲低组与野生型组,分别进行 RNA-Seq、Hi-C 和 ATAC-seq 测定,比较两组间基因表达、染色质三维结构及可及性差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  19. 19 GSE306459 对24例结直肠肿瘤及9例相邻非恶性组织样本进行单细胞核ATAC测序,将等量来自2-4个供体的细胞混池制备成15个测序库,比较肿瘤与非恶性组织的染色质可及性差异。 人源 · 15 例 · GPL28038 · 2025/10/31

    设计对24例结直肠肿瘤及9例相邻非恶性组织样本进行单细胞核ATAC测序,将等量来自2-4个供体的细胞混池制备成15个测序库,比较肿瘤与非恶性组织的染色质可及性差异。

    摘要Single-cell ATAC sequencing data were collected from 24 colorectal tumor and 9 adjacent nonmalignant tissues pooled into 15 libraries. This dataset was generated to investigate the global chromatin accessibility profiles of epithelial, stromal, and immune cells in the colorectal cancer microenvironment. Information on the donors, tissues, libraries, and demultiplexed barcodes are provided in the supplementary data of the cited paper.

  20. 20 GSE153016 研究对象为结直肠癌肝转移和结肠原发肿瘤样本,来自体内模型。采用ATAC-seq和RNA-Seq检测基因组DNA和总RNA,比较两组的表观基因组和转录组特征。 人源 · 14 例 · GPL20301 · 2021/06/17

    设计研究对象为结直肠癌肝转移和结肠原发肿瘤样本,来自体内模型。采用ATAC-seq和RNA-Seq检测基因组DNA和总RNA,比较两组的表观基因组和转录组特征。

    摘要Integrative analysis of colorectal cancer (CRC) ATAC-seq and RNA-seq revealed an epigenomic and transcriptomic remodeling during liver metastasis.

  21. 21 GSE97889 对HCT116结直肠癌细胞系进行NicE-seq和ATAC-seq开放染色质测序,同时开展WGBS甲基化测序。HCT116细胞分为Decitabine处理组(6天处理,分两次更换培养基)和对照组,检测开放染色质位点(OCS)与组蛋白修饰标记(H3K4me3、H3K27ac)的关联性,比较处理前后全基因组可及性变化及甲基化差异,重点分析启动子、5’UTR、CpG岛和外显子区域的差异甲基化区域(DMRs)。 人源 · 14 例 · GPL18573 · 2017/05/24

    设计对HCT116结直肠癌细胞系进行NicE-seq和ATAC-seq开放染色质测序,同时开展WGBS甲基化测序。HCT116细胞分为Decitabine处理组(6天处理,分两次更换培养基)和对照组,检测开放染色质位点(OCS)与组蛋白修饰标记(H3K4me3、H3K27ac)的关联性,比较处理前后全基因组可及性变化及甲基化差异,重点分析启动子、5’UTR、CpG岛和外显子区域的差异甲基化区域(DMRs)。

    摘要Mammalian chromatin is dynamic and contains structural information that leads to transcriptional regulation of genes by recruiting transcription factors and altering nucleosome positioning. Here, we describe open chromatin mapping using Nicking Enzyme assisted sequencing (NicE-seq) for integrative epigenomic analysis. NicE-seq captures open chromatin sites in both fixed and native cells and reveals the genomic location of open chromatin sites (OCS) and transcription factor occupancy at single nucleotide resolution, with as few as 250 HCT116 cells. In HCT116 cells a large percentage of the OCS were coincident with DHS (DNaseI hypersensitive site) and ATAC-seq sites. OCSs correlated well with RNA pol II occupancy and transcriptionally active chromatin marks, while displaying a pattern contrasting to CpG methylation. ChIP CTCF peaks common to OCS and DHS displayed a strong correlation with H3K4me3 and H3K27ac marks. Further peaks unique to OCS and ChIP CTCF peaks also correlated strongly with H3K4me3, H3K27ac and higher transcription. Similar results were also obtained for Max and Sp1 transcription factors. Using NicE-seq we have demonstrated that HCT116 cells, treated with anti cancer drug decitabine, displayed time dependent accumulation of OCS coinciding with hypomethylation of the genome, particularly in SINE and satellite repetitive DNA. Differentially methylated regions (DMRs) were more pronounced in promoters, 5’UTR, CpG islands and exons. In summary, sequence specificity offered by a nicking enzyme allows a means to study open chromatin structure and hypomethylation of genomes, revealing the open chromatin landscape in cellular context.

  22. 22 GSE113176 对患者来源的结直肠癌起始细胞进行基线 ChIP-seq 和 ATAC-seq 分析,检测 H3K27me3/H3K4me3 标记启动子及染色质可及性;随后用 UNC1999 处理 7 天后进行 RNA-seq,比较不同处理条件下基因表达差异。所有样本为悬浮培养的 POP92 细胞系,采用 DMSO 或 UNC1999 处理,检测方式包含 RNA-seq、ChIP-seq 和 ATAC-seq。 人源 · 13 例 · GPL16791 · 2019/08/07

    设计对患者来源的结直肠癌起始细胞进行基线 ChIP-seq 和 ATAC-seq 分析,检测 H3K27me3/H3K4me3 标记启动子及染色质可及性;随后用 UNC1999 处理 7 天后进行 RNA-seq,比较不同处理条件下基因表达差异。所有样本为悬浮培养的 POP92 细胞系,采用 DMSO 或 UNC1999 处理,检测方式包含 RNA-seq、ChIP-seq 和 ATAC-seq。

    摘要We profiled changes in gene expression following EZH2 inhibition, in a patient-derived, cancer stem cell enriched model. Cells were treated with UNC1999, an EZH2 inhibitor, for 7 days, prior to processing for RNA-seq. In parallel, we identified H3K27me3 and H3K4me3 marked promoters using ChIP-seq at baseline in the same model, as well as chromatin accessibility using ATAC-seq.

  23. 23 GSE113219 将 HT29/C1 细胞分为 BFT2 处理组(24 小时、48 小时)和未处理对照组,分别在指定时间点收集细胞进行 ATAC-seq 测序,检测染色质可及性变化,并与基因表达、转录因子结合位点及 colorectal cancer 中常见单核苷酸变异(SNVs)和差异甲基化区域(DMRs)的位置进行关联分析。 人源 · 12 例 · GPL11154 · 2018/04/18

    设计将 HT29/C1 细胞分为 BFT2 处理组(24 小时、48 小时)和未处理对照组,分别在指定时间点收集细胞进行 ATAC-seq 测序,检测染色质可及性变化,并与基因表达、转录因子结合位点及 colorectal cancer 中常见单核苷酸变异(SNVs)和差异甲基化区域(DMRs)的位置进行关联分析。

    摘要Purpose: The goal of this study is to determine how BFT2 alters chromatin accessibility at relatively early time points in colon epithelial cells, and to correlate the changes in chromatin accessibility with changes in gene expression, transcription factor binding sites, and the location of common single nucleotide variants (SNVs) and differentially methylated regions (DMRs) in colorectal cancer. Methods: HT29/C1 cells were plated at low density and allowed to grow for 4 days at 37C and 10% CO2. Afterwards, cells were either left untreated or treated with 100ng/mL BFT2 for 24 or 48 hours. After the specified time point, cells were counted and DNA was collected in order to prepare ATAC-seq libraries. ATAC-seq library was prepared as outlined by Buenrostro et al. (2013). The 4nM pooled ATAC-seq library was sequenced using the Illumina HiSeq. For each sample, three biological replicates were sequenced. After sequencing, the data was analyzed using the pipeline developed by the Kundaje lab, as outlined on ENCODE (Lee et al., 2016). Briefly, reads were trimmed, aligned and filtered using Bowtie2, and peaks were called using MACS2. The three replicate peak files were combined in order to create one consensus file for each treatment condition using an irreproducible discovery rate (IDR) threshold of 0.1. For all analyses, the “optimal set” consensus file was used. Results: Our data show that several genes are differentially expressed after BFT treatment and these changes correlate with changes in chromatin accessibility. This correlation is mediated by an increase in chromatin accessibility at particular transcription factor binding sites. Also, sites of increased chromatin accessibility are associated with a lower frequency of common single nucleotide variants (SNVs) in CRC and with a higher frequency of common differentially methylated regions (DMRs) in CRC. Conclusions: This study adds critical knowledge to our understanding of host-microbe interactions in the gut. While scientists have begun to analyze the effect of specific bacteria on the epigenome of colon epithelial cells, to date, no other studies have surveyed the effect of a specific bacterial toxin on chromatin accessibility in colon epithelial cells. We conclude that BFT2 alters chromatin accessibility in colon epithelial cells, and that these changes correlate with subsequent changes in gene expression. Also, sites of BFT2-induced increased chromatin accessibility are associated with a lower frequency of common single nucleotide variants (SNVs) in CRC and with a higher frequency of common differentially methylated regions (DMRs) in CRC.

  24. 24 GSE190951 对结直肠癌耐药细胞系 HCT15-FR 与原始细胞系 HCT15 进行染色质可及性及转录组联合分析,包含 4 个 mRNA+lncRNA-seq 生物重复(HCT15_1、HCT15_2 为对照,HCT15-FR_1、HCT15-FR_2 为处理)和 4 个 smRNA-seq 生物重复(HCT15_1、HCT15_2 为对照,HCT15-FR_1、HCT15-FR_2 为处理),同时进行 2 个 ATAC-seq 生物重复(HCT15_1、HCT15_2 为对照,HCT15-FR_1、HCT15-FR_2 为处理),比较不同组间染色质可及性变化与转录表达差异。 人源 · 12 例 · GPL20795;16791 · 2021/12/17

    设计对结直肠癌耐药细胞系 HCT15-FR 与原始细胞系 HCT15 进行染色质可及性及转录组联合分析,包含 4 个 mRNA+lncRNA-seq 生物重复(HCT15_1、HCT15_2 为对照,HCT15-FR_1、HCT15-FR_2 为处理)和 4 个 smRNA-seq 生物重复(HCT15_1、HCT15_2 为对照,HCT15-FR_1、HCT15-FR_2 为处理),同时进行 2 个 ATAC-seq 生物重复(HCT15_1、HCT15_2 为对照,HCT15-FR_1、HCT15-FR_2 为处理),比较不同组间染色质可及性变化与转录表达差异。

    摘要5-Fluorouracil (5-FU) is one of the most effective and widely used chemotherapeutic drugs in the treatment of colon cancer. Yet chemoresistance is a common feature of colon cancer, resulting in poor prognosis and short survival. Dynamic reprogramming of chromatin accessibility allows rapid access of the gene regulatory machinery to open genomic regions facilitating subsequent gene expression via direct transcription factor activation and regulatory element-binding. To better understand the regulatory network underlying 5-FU resistance in colon cancer cells, we explored the systematic alterations of chromatin accessibility and transcript expression by the assay for transposase-accessible chromatin using sequencing (ATAC-seq) in combination with transcriptome sequencing, followed by integrative analysis to identify potential regulators and their targets associated with differentially accessible regions (DARs) in 5-FU-resistant HCT15 (HCT15-FR) cells. A total of 3175 differentially expressed mRNAs (DEGs), lncRNAs (DELs) and miRNAs (DEMs) related to 5-FU resistance were identified, including dramatically up-regulated IL33, H19, miR-17-5p, significantly down-regulated AKR1B10, LINC01012, miR-125b-5p, and potential chromatin modifiers such as INO80C, HDAC6 and KDM5A. A competitive endogenous RNAs (ceRNAs) regulatory network was established based on information about interactions among DEGs, DELs and DEMs, suggesting that H19, HOXA11-AS and NEAT1 might function as ceRNAs associate with 5-FU resistance in HCT15 cells. By integrating with transcriptome data, 9868 DARs were identified in HCT15-FR cells compared to control, which were positively (r = 0.58) correlated with their nearest DEGs and DELs. The up-regulated genes related to 4937 increased chromatin-accessible regions were significantly enriched in signaling pathways of MAPK, FOX and WNT, while the 4931 decreased chromatin-accessible regions were considered to be involved in declined biosynthesis of amino acids and nucleotide sugars, signaling pathways of Notch, and HIF-1. Analyses of the DAR sequences revealed that, besides AP-1 family, the TF DNA-binding motifs of FOX and KLF family members were highly enriched in hyper- and hypo-accessible regions, respectively. Moreover, relationships of critical TFs and their potential targets associated with DARs were identified, such as FOXA1, RUNX2, KLF3 and GRHL2. These data provided clear insights and valuable resources for an improved understanding of the non-genetic landscape of 5-FU-resistant colon cancer cells based on chromatin accessibility and transcript levels, which allowed for genome-wide detection of TF-binding sites, potential cis-regulatory elements and therapeutic targets.

  25. 25 GSE202072 将HCT116结直肠癌细胞稳定转染空载体对照、EHF、CDX1或EHF加CDX1表达质粒,采用ATAC-seq检测各组细胞染色质可及性变化,比较不同处理条件下的转录因子对染色质重塑的影响。 人源 · 12 例 · GPL18573 · 2022/11/02

    设计将HCT116结直肠癌细胞稳定转染空载体对照、EHF、CDX1或EHF加CDX1表达质粒,采用ATAC-seq检测各组细胞染色质可及性变化,比较不同处理条件下的转录因子对染色质重塑的影响。

    摘要EHF and CDX1 co-operate to drive differentation of CRC cells. To identify the change in chromatin remodelling induced by these transcription factors, EHF and CDX1 were stably re-expressed in poorly differentiated HCT116 CRC cells and ATAC-seq analysis performed.

  26. 26 GSE254604 本研究对BRAFV600E突变型结直肠癌(CRC)患者来源异种移植模型进行ATAC-seq分析。将PDX肿瘤组织分为对照组(磷酸盐缓冲盐水)和5-azacitidine处理组(0.5mg/kg,每周两次腹腔注射),采集组织样本进行染色质可及性测序,比较两组在DNA甲基化水平降低区域的组蛋白修饰差异。 人源 · 12 例 · GPL24676 · 2024/09/01

    设计本研究对BRAFV600E突变型结直肠癌(CRC)患者来源异种移植模型进行ATAC-seq分析。将PDX肿瘤组织分为对照组(磷酸盐缓冲盐水)和5-azacitidine处理组(0.5mg/kg,每周两次腹腔注射),采集组织样本进行染色质可及性测序,比较两组在DNA甲基化水平降低区域的组蛋白修饰差异。

    摘要BRAFV600E-mutated colorectal cancer (CRC) exhibits a strong correlation with DNA hypermethylation suggesting this subgroup of tumors is uniquely presenting epigenomic phenotypes. Nonetheless, the traditional epigenomic therapeutic agent, 5-azacitidine, which inhibits DNA methyltransferase activity, did not yield sufficient improvements in the efficacies of BRAFV600E CRC in vivo. We utilized a patient-derived xenograft model and confirmed an effective reduction of DNA methylation levels upon 5-azacitidine treatment yet failed to restore gene expression patterns. This study unbiasedly explored the adaptive engagement of other epigenomic modifications upon the profound decrease in DNA methylation by azacitidine treatment. A loss of histone acetylation and a gain of histone methylations, including H3K27 and H3K4 trimethylation, were observed around hypomethylated regions. Our findings suggested a compensatory increase in repressive histone mark, H3K27 trimethylation, around treatment-induced hypomethylated regions, which suggests the involvement of polycomb repressive complex (PRC) activity around the genome with lost DNA methylation, therefore maintaining the suppression of key genes. Combined inhibition of PRC activity through EZH2 inhibitor with azacitidine treatment additively improved efficacies in BRAFV600E CRC cells. In conclusion, DNA hypermethylation exhibits a close association with H3K27me3 and PRC activity in BRAFV600E CRC, and simultaneous blockade of DNMT and EZH2 holds promise as a potential therapeutic strategy for patients with BRAFV600E-mutated CRC.

  27. 27 GSE290616 对人类结直肠癌肿瘤组织和正常邻近组织中的 T 细胞进行单细胞多组学分析,采集肿瘤与正常组织的 T 细胞分别进行核 RNA 测序和 ATAC 测序,比较两者在基因表达与染色质可及性上的差异。 人源 · 12 例 · GPL34295 · 2025/12/15

    设计对人类结直肠癌肿瘤组织和正常邻近组织中的 T 细胞进行单细胞多组学分析,采集肿瘤与正常组织的 T 细胞分别进行核 RNA 测序和 ATAC 测序,比较两者在基因表达与染色质可及性上的差异。

    摘要Regulatory T (Treg) cells are considered major contributors to the growth of solid organ tumors, with the notable exception of colorectal cancer (CRC), despite the documented abundance of Treg cells in CRC. Here, we demonstrate that IL-10⁺ and IL-10⁻ Treg cells constitute two distinct subsets with opposing functions: IL-10⁺ Treg cells counteract, while IL-10⁻ Treg cells promote, the growth of genetically engineered CRC tumors. Our findings suggest that the tumor-suppressive function of IL-10⁺ Treg cells is mediated by their suppression of effector CD4⁺ T cell production of IL-17, a cytokine that directly stimulates CRC tumor cell proliferation. Consistently, IL-10⁺ Treg cells were more abundant in both mouse and human CRC tumors than in tumor-adjacent normal colon tissue, whereas IL-10⁻ Treg cells exhibited the opposite distribution. Furthermore, gene expression signatures associated with IL-10⁺ and IL-10⁻ Treg cells correlated with better and worse disease prognoses in human CRC, respectively. This functional dichotomy between Treg subsets provides a rationale for therapeutic strategies aimed at selectively targeting pro-tumoral Treg cells while preserving their anti-tumoral counterparts across various barrier tissue cancers that harbor both subsets.

  28. 28 GSE290891 对结直肠癌患者肿瘤细胞和外周血单核细胞(PBL)进行单细胞ATAC-seq检测染色质可及性及线粒体DNA,同时对健康供体T细胞进行单细胞CITEseq分析抗原特异性TCR。健康供体T细胞分为未刺激(Hashtag #4)和抗原刺激(Hashtag #5)组,通过抗体标记后进行单细胞测序;肿瘤细胞和PBL样本来自4名结直肠癌患者,分别进行ATAC-seq检测,比较不同组别染色质可及性差异。 人源 · 11 例 · GPL24676;32242 · 2025/08/05

    设计对结直肠癌患者肿瘤细胞和外周血单核细胞(PBL)进行单细胞ATAC-seq检测染色质可及性及线粒体DNA,同时对健康供体T细胞进行单细胞CITEseq分析抗原特异性TCR。健康供体T细胞分为未刺激(Hashtag #4)和抗原刺激(Hashtag #5)组,通过抗体标记后进行单细胞测序;肿瘤细胞和PBL样本来自4名结直肠癌患者,分别进行ATAC-seq检测,比较不同组别染色质可及性差异。

    摘要It has been hypothesized that neoantigen-specific T cells play a major role in effective cancer immunotherapy, including neoantigen vaccines, immune checkpoint blockade (ICB) therapy, and adoptive T cell therapy using tumor-infiltrating lymphocytes (TILs). The major source of neoantigens are mutated proteins derived from non-synonymous mutations found in tumor genomic DNA. It’s highly conceivable that non-synonymous mutations found in tumor mitochondrial DNA (mtDNA) can also generate neoantigens that can be recognized by T-cell receptors (TCRs). This project contains two types of single-cell data. One is single-cell CITEseq (5' mRNA plus antibody feature barcode plus TCR) seqeuncing to identify antigen-specific TCRs. The other is single-cell ATAC-seq to detect chromatin accessiblities and mtDNA.

  29. 29 GSE196515 对结直肠癌细胞系 SW480 和 LS174T 及其顺序转移衍生物 LvM1、LvM2 进行 scRNA-seq、scATAC-seq 和 bulk ATAC-seq 测序,比较不同转移谱系的表观遗传特征差异。 人源 · 10 例 · GPL20301 · 2023/02/01

    设计对结直肠癌细胞系 SW480 和 LS174T 及其顺序转移衍生物 LvM1、LvM2 进行 scRNA-seq、scATAC-seq 和 bulk ATAC-seq 测序,比较不同转移谱系的表观遗传特征差异。

    摘要We used a sequential metastasis model of colorectal cancer cell lines and tumours to understand epigenomic regulators of metastasis. We performed scRNA-seq, scATAC-seq, and bulk ATAC-seq on these samples and discovered the deregulation of HMG20B and its regulon.

  30. 30 GSE222766 对10例结直肠癌患者来源的组织样本进行ATAC-seq、H3K27ac ChIP-seq和RNA-seq多组学分析,整合数据以识别与结直肠癌风险相关的增强子-基因调控连接。 人源 · 10 例 · GPL24676 · 2023/01/17

    设计对10例结直肠癌患者来源的组织样本进行ATAC-seq、H3K27ac ChIP-seq和RNA-seq多组学分析,整合数据以识别与结直肠癌风险相关的增强子-基因调控连接。

    摘要Although GWASs have identified thousands of variants associated with human complex traits, most of which reside in the non-coding regions, especially enhancers, and biological mechanisms remain unclear. To created enhancer-gene maps to determine causal variant of CRC risk, we performed multi-omics analyses of ATAC-seq, H3K27ac ChIP-seq and RNA-seq with high quality from our 10 CRC tissues. By computationally integrating these multi-omics data, we identified 34,130 enhancer-gene connections involving 15,121 unique enhancers and 12,351 expressed genes. We demonstrated an ABC regulatory variant rs4810856 that is significantly associated with an increased CRC risk with large-scale population study and biological experiments. Our study provides regulation maps linking enhancers to genes, providing new insights into colorectal cancer etiology.

  31. 31 GSE266742 使用人类结直肠腺癌细胞系 DLD-1,建立 GATA6-AID-IAA7 转基因细胞系及 WT、GATA6-KO 基因型细胞,通过 ATAC-seq 分析染色质可及性变化。GATA6-AID-IAA7 细胞在含 500uM IAA 的培养基中进行 +Auxin 处理,分别在 0h、12h、1h 等时间点采集样本,同时设置 Wash 处理组,比较不同基因型与处理条件下的染色质开放状态差异。 人源 · 10 例 · GPL24676 · 2024/12/19

    设计使用人类结直肠腺癌细胞系 DLD-1,建立 GATA6-AID-IAA7 转基因细胞系及 WT、GATA6-KO 基因型细胞,通过 ATAC-seq 分析染色质可及性变化。GATA6-AID-IAA7 细胞在含 500uM IAA 的培养基中进行 +Auxin 处理,分别在 0h、12h、1h 等时间点采集样本,同时设置 Wash 处理组,比较不同基因型与处理条件下的染色质开放状态差异。

    摘要Colorectal cancer (CRC) is one of the most lethal and prevalent malignancies with elusive molecular causes. While the abnormal activity of transcription factors has been reported as a vital component of cancer progression, the mechanism through which they function remains unclear. Here, through the analysis of primary human CRC tissue data, we identified GATA6 as a CRC specific regulator, whose expression upregulation is potentially associated with promoter hypomethylation. In the human genome, GATA6 showed preferential binding at tumor specific active enhancers. Through both auxin-inducible degron (AID) and CRISPR knockout, we showed that GATA6 depletion severely impaired clonogenicity and proliferation. GATA6 depletion caused the loss of CRC specific open chromatin, suggesting a specific regulatory role of GATA6 in CRC pathogenesis. Interestingly, we also discovered the co-occupancy of GATA6 with CTCF and its direct involvement in promoter enhancer loops, suggesting the possibility that GATA6 mediate transcriptional regulation through 3D genome. The loss of GATA6 led to alterations in E-P chromatin interactions of a panel of oncogenes, accompanied by the oncogene downregulation. Finally, we showed that GATA6 loss is detrimental to the xenograft tumor growth and thereby rescued mice survival. Taken together, we unrevealed a novel mechanism by which GATA6 contributes to CRC.

  32. 32 GSE295009 从结直肠癌腹膜转移患者中生成的患者来源类器官(PDOs)进行ATAC-seq测序,以研究多柔比星反应的机制。 人源 · 9 例 · GPL24676 · 2026/06/16

    设计从结直肠癌腹膜转移患者中生成的患者来源类器官(PDOs)进行ATAC-seq测序,以研究多柔比星反应的机制。

    摘要In this study, we generated patient-derived organoids (PDOs) from patients with colorectal cancer peritoneal mestasis and performed RNA- and ATAC-sequencing to study mechanisms for doxorubicin response.

  33. 33 GSE157949 将 TP53-WT 和 TP53-KO HCT116 细胞分别用 5-FU 处理 0 小时和 24 小时,采集细胞进行 ATAC-seq 和 RNA-seq 测定,比较两组细胞在不同处理时间点的染色质可及性及转录组差异。 人源 · 8 例 · GPL16791 · 2021/02/10

    设计将 TP53-WT 和 TP53-KO HCT116 细胞分别用 5-FU 处理 0 小时和 24 小时,采集细胞进行 ATAC-seq 和 RNA-seq 测定,比较两组细胞在不同处理时间点的染色质可及性及转录组差异。

    摘要5-Fluorouracil (5-FU) is one of the most common drugs used in chemotherapy because of its efficacy and stability. However, 5-FU has been known to work on only 10~15% of colon cancer patients. Therefore, the study of 5-FU sensitivity study is necessary to increase the survival of colon cancer patients. p53 is one of the factors that effect on drug sensitivity. Main function of p53 has been focused on transcription activity in cell death. Numerous drug related studies show that expression of wild-type p53 increases drug sensitivity in various cancer types through inducing apoptotic signaling pathways. Currently, it has been reported that p53 has both transcriptional and non-transcriptional activities in apoptosis. However, most studies about p53 non-transcriptional activities in apoptosis are mainly focused on p53 induced mitochondrial outer membrane permeabilization, triggering the release of pro-apoptotic factors. The chromatin structure and organization have strongly attracted because of their impacts in cellular phenotypes. Recent studies have been shown that changes in chromatin accessibility affect cell phenotypes for external stimuli. Since p53 plays an important role in drug sensitivity and 5-FU is an external stimulus for cancer cells, we hypothesized that p53 may effect on 5-FU sensitivity through different regulation of chromatin accessible regions between TP53-WT and TP53-KO cells. To determine the effect of p53 on chromatin accessibility modification associated with 5-FU sensitivity, ATAC-seq and RNA-seq were performed under 5-FU treatment on TP53-WT as drug sensitive and TP53-KO as drug resistant HCT116 cells. In this study, we found that 5-FU induces chromatin accessibility in both TP53-WT and TP53-KO cells. Moreover, our results show that 5-FU induced chromatin accessibility increases expression of apoptotic genes in TP53-WT HCT116 cells through p53 non-transcriptional activity in nucleus.

  34. 34 GSE234735 对HCT15结直肠癌细胞系进行CUT&Tag检测H3K23 succinylation,结合mRNA-seq和ATAC-seq多组学分析,比较5-FU耐药细胞与DMSO处理对照细胞的表观遗传修饰差异。 人源 · 8 例 · GPL24676 · 2023/06/20

    设计对HCT15结直肠癌细胞系进行CUT&Tag检测H3K23 succinylation,结合mRNA-seq和ATAC-seq多组学分析,比较5-FU耐药细胞与DMSO处理对照细胞的表观遗传修饰差异。

    摘要Although widely used in chemotherapy for colon cancer, 5-fluorouracil (5-FU) resistance is the main reason greatly limiting the efficacy of current therapies, leading to poor patient prognosis and survival. Histone lysine succinylation plays a vital role in various diseases by influencing gene expression and chromatin structure. However, limited information is currently available about the role of H3K23 succinylation associated with 5-FU resistance in colon cancer cells (CCCs). Here we explored the systematic alterations of H3K23s succinylation using the Cleavage Under Targets and Tagmentation (CUT&Tag), followed by integrated analysis of multi-omics data to identify potential regulators and their targets associated with differentially enriched regions (DERs) in the parental and 5-FU-resistant HCT15 colon cancer cells. More than 60,000 high-quality peaks were obtained from each sample with higher signal enriched at gene promoter regions. A total of 13,622 H3K23su DERs were identified in 5-FU-resistant HCT15 cells compared to control, which was positively (r = 0.68) correlated with their nearest differentially expressed genes (DEGs). The up-regulated DEGs associated with H3K23su GAIN regions are mainly involved in colorectal cancer, MAPK, Ras, and p53 signaling pathways, while the down-regulated DEGs related to H3K23su LOSS regions significantly enriched in the signaling pathways of Wnt and HIF-1. DNA motif analyses of the DER sequences showed that, besides AP-1, the members of FOX, GATA, and TEAD transcription factor (TF) families were potentially enriched in GAIN or LOSS regions with different preferences. Moreover, differentially expressed TFs and their potential targets associated with H3K23su DERs were identified, including FOSL21, FOXA1 and HNF1B, and known and predicted interactions among these critical TFs were further illustrated. These data provided clear insights and resources for an improved understanding of the role of H3K23su related to 5-FU resistance in colon cancer cells based on the multi-omics data, which allowed for the detection of epigenomic profiles, potential regulatory TFs, cis-regulatory elements, and therapeutic targets.

  35. 35 GSE268978 将HT29细胞系与原发性结直肠癌细胞分别进行PTEN敲低(KD)和空载(EV)处理,并在有无EZH2抑制剂条件下进行ATAC-seq检测,分析染色质可及性变化及H3K27me3水平差异。 人源 · 8 例 · GPL18573 · 2024/11/27

    设计将HT29细胞系与原发性结直肠癌细胞分别进行PTEN敲低(KD)和空载(EV)处理,并在有无EZH2抑制剂条件下进行ATAC-seq检测,分析染色质可及性变化及H3K27me3水平差异。

    摘要Epithelial-to-mesenchymal (EMT) transition is one of the best-known examples of tumor cell plasticity. EMT enhances cancer cell metastasis, which is the main cause of colorectal cancer (CRC)-related mortality. Therefore, understanding underlying molecular mechanisms contributing to the EMT process is crucial to finding druggable targets and more effective therapeutic approaches in CRC. In this study, we demonstrated that activation of AKT induces EMT in epithelial CRC. Activation of AKT through Phosphatase and tensin homolog (PTEN) knockdown (KD) modulated chromatin accessibility and reprogrammed gene transcription to mediate EMT in epithelial CRC cells. Active AKT can phosphorylate EZH2 on serine 21, which switches EZH2 from a transcriptional repressor to an activator. Interestingly, PTEN KD reduced the global level of trimethylation of histone 3 at lysine 27(H3K27me3) in an EZH2-phosphorylation-dependent manner. Additionally, EZH2 phosphorylation at serine 21 reduced the interaction of EZH2 with another polycomb repressive complex 2 (PRC2) component, the Suppressor of Zeste 12 (SUZ12), suggesting that the reduced H3K27me3 levels in PTEN KD cells were due to a disruption of the PRC2 complex. Overall, we demonstrated that PTEN KD modulates changes in gene expression to induce the EMT process in epithelial CRC cells by phosphorylating EZH2 and activating different transcription factors such as activator protein 1 (AP1).

  36. 36 GSE298524 将HCT116结肠上皮细胞分别以0.5 uM(LD)、5 uM(MD)和80 uM(HD)剂量处理72小时后换用无药培养基,经10个周期亚培养后获取ATAC-seq样本,同时设置未处理对照组。采用ATAC-seq技术检测各组细胞核膜染色质可及性变化,比较不同剂量处理组与对照组的染色质可及性差异。 人源 · 8 例 · GPL24676 · 2025/07/15

    设计将HCT116结肠上皮细胞分别以0.5 uM(LD)、5 uM(MD)和80 uM(HD)剂量处理72小时后换用无药培养基,经10个周期亚培养后获取ATAC-seq样本,同时设置未处理对照组。采用ATAC-seq技术检测各组细胞核膜染色质可及性变化,比较不同剂量处理组与对照组的染色质可及性差异。

    摘要Drug resistance and distant metastases are leading causes of mortality in colorectal cancer (CRC), yet the molecular mechanisms linking these processes remain elusive. In this study, we demonstrate that acquired resistance to oxaliplatin, a first-line chemotherapeutic in CRC, enhances metastatic potential through transcriptional reprogramming. Using a clinically relevant dosing regimen, we generated oxaliplatin-resistant CRC cells that displayed increased metastatic potential. Integrated transcriptomic and phenotypic analyses revealed that dysregulated cholesterol biogenesis amplifies TGF-b signaling, which in turn drives expression of SERPINE1, that serves as a key effector of both oxaliplatin resistance and metastasis. Furthermore, we uncovered a SERPINE1-associated nine-gene expression signature, RESIST-M, that robustly predicts overall and relapse-free survival across distinct patient cohorts. Notably, RESIST-M stratifies a high-risk subtype of CMS4/iCMS3-fibrotic patients that display the poorest prognosis, underscoring its clinical relevance. Targeting of SERPINE1 or cholesterol biosynthesis re-sensitized resistant, pro-metastatic cells to oxaliplatin in mouse xenograft models. Altogether, this study uncovers a mechanistic link between metabolic rewiring and transcriptional plasticity underlying therapy-induced metastasis in primary CRC. Additionally, it also reveals actionable vulnerabilities that offer both prognostic value and therapeutic potential.

  37. 37 GSE113608 对YB5结直肠癌细胞系进行DMSO或10uM HH1处理,采集处理后细胞样本进行ATAC-seq分析,比较两种处理条件下的基因组可及性差异。 人源 · 6 例 · GPL16791 · 2018/10/26

    设计对YB5结直肠癌细胞系进行DMSO或10uM HH1处理,采集处理后细胞样本进行ATAC-seq分析,比较两种处理条件下的基因组可及性差异。

    摘要ATAC-seq was performed after YB5 cells were treated with DMSO or HH1

  38. 38 GSE140456 对Caco2细胞系、人类肠道类器官(HIOs)和Caco2类器官进行ATAC-seq分析,比较其开放染色质特征。每个组别包含2个独立重复,共6个样本。 人源 · 6 例 · GPL16791 · 2020/05/19

    设计对Caco2细胞系、人类肠道类器官(HIOs)和Caco2类器官进行ATAC-seq分析,比较其开放染色质特征。每个组别包含2个独立重复,共6个样本。

    摘要Organoids are a valuable 3D model to study the differentiated functions of the human intestinal epithelium. They are a particularly powerful tool to measure epithelial transport processs in health and disease. Though biological assays such as organoid swelling and intraluminal pH measurements are well established, their underlying functional genomics are not well characterized. Here we combine genome-wide analysis of open chromatin by ATAC-seq with transcriptome mapping by RNA-seq to define the genomic signature of human intestinal organoids (HIOs). These data provide an important tool for investigating key physiological and biochemical processes in the intestinal epithelium. We next compared the transcriptome and open chromatin profiles of HIOs with equivalent datasets from the Caco2 colorectal carcinoma line, which is an important 2D model of the intestinal epithelium. Our results define common features of the intestinal epithelium in HIO and Caco2 and further illustrate the cancer-associated program of the cell line. Generation of Caco2 organoids enabled interrogation of the molecular divergence of the 2D and 3D cultures. Over-represented motif analysis of open chromatin peaks identified Caudal Type Homeobox 2 (CDX2) as a key activating transcription factor in HIO, but not in monolayer cultures of Caco2. However, the CDX2 motif becomes overrepresented in open chromatin from Caco2 organoids, reinforcing the importance of this factor in intestinal epithelial differentiation and function. Intersection of the HIO and Caco2 transcriptomes further showed functional overlap in pathways of ion transport and tight junction integrity among others. These data make an important contribution to understanding human intestinal organoid biology.

  39. 39 GSE156552 将人源结直肠癌细胞系 RKO 分为 DMSO 处理组与 aphidicolin (0.2µM) 处理组,两组均在 16h 时间点采集细胞进行 ATAC-seq 测定,比较低剂量 aphidicolin 诱导的复制应激对染色质可及性的影响。 人源 · 6 例 · GPL18573 · 2021/05/19

    设计将人源结直肠癌细胞系 RKO 分为 DMSO 处理组与 aphidicolin (0.2µM) 处理组,两组均在 16h 时间点采集细胞进行 ATAC-seq 测定,比较低剂量 aphidicolin 诱导的复制应激对染色质可及性的影响。

    摘要RKO cells were treated with low doses of aphidicolin (0.2µM) that inhibit replicative DNA polymerases and induce a mild replication stress. ATAC-seq data were analysed on control cells (DMSO) and after 16h of treatment with aphidicolin

  40. 40 GSE163075 对人源结直肠癌细胞进行 ATAC-seq 染色质可及性分析,每个样本包含 2 个技术重复,检测 WT-hTERT 启动子区域的染色质结构变化。 人源 · 6 例 · GPL18573 · 2023/01/08

    设计对人源结直肠癌细胞进行 ATAC-seq 染色质可及性分析,每个样本包含 2 个技术重复,检测 WT-hTERT 启动子区域的染色质结构变化。

    摘要Transcriptional reactivation of hTERT is the limiting step in tumorigenesis. While mutations in hTERT promoter in 19% of cancers are recognized as key drivers of hTERT reactivation, mechanisms by which wildtype hTERT (WT-hTERT) promoter is reactivated, in majority of human cancers, remain unknown. Using primary colorectal cancers (CRC) we identify, Tert INTeracting region 2 (T-INT2), the critical chromatin region essential for reactivating WT-hTERT promoter in CRCs. T-INT2 is essential for the formation of a unique chromatin architecture needed for the reactivation of WT-hTERT. This cancer-cell-specific WT-hTERT reactivation is mediated by -catenin and JunD signalling via T-INT2. Pharmacological screens uncovered Salinomycin, which inhibits WT-hTERT reactivation by blocking T-INT2 mediated formation of chromatin architecture essential for WT-hTERT promoter reactivation. Our results provide a framework for therapeutic targeting of WT-hTERT, specifically in cancer cells and explain, for the first time how known CRC alterations, such as APC lead to WT-hTERT promoter reactivation during oncogene-induced stepwise-transformation.

  41. 41 GSE200813 对小鼠源性结直肠癌细胞的单细胞ATAC-seq分析,采集3只Balb/c nude小鼠的配对原发性结直肠癌与肝转移性肿瘤样本,比较两组肿瘤细胞在染色质可及性上的差异。 人源 · 6 例 · GPL24676 · 2023/04/01

    设计对小鼠源性结直肠癌细胞的单细胞ATAC-seq分析,采集3只Balb/c nude小鼠的配对原发性结直肠癌与肝转移性肿瘤样本,比较两组肿瘤细胞在染色质可及性上的差异。

    摘要Chromatin regulatory networks that maintain differentiated cell states are frequently dysregulated in and thus contribute to cancer metastasis. Here, we reveal the dynamic transitions of regulatory states of colorectal cancer (CRC) cells during metastasizing to liver by profiling single-cell chromatin accessibility of paired primary and metastatic CRC tumors in mouse. We discover CRC subclones, which are characterized by losing chromatin accessibility around colon-tissue specific genes and gain that around liver-specific genes,including transcription factors in FOXA family and HNF family we discovered in our previous study, might partially mimic types of liver cells across the liver development. A particular subclone with stem-like state, which is highly enriched in metastases but not primary tumors , clearly shows poor prognosis.

  42. 42 GSE220209 对人类结直肠癌细胞系 SW620 及猪肾细胞系 PK15、猪睾丸细胞系 ST 进行 ATAC-seq 测序,分析其基因组中 G4 结构的分布特征、进化保守性、动态变化及对基因表达的调控作用。样本包括 SW620-rep1、SW620-rep2、PK15-rep1、PK15-rep2、ST-rep1、ST-rep2 共 6 个生物重复,采用 Cleavage Under Targets and Tagmentation 技术绘制 eG4s 的基因组图谱。 人源 · 6 例 · GPL24676;26351 · 2025/08/06

    设计对人类结直肠癌细胞系 SW620 及猪肾细胞系 PK15、猪睾丸细胞系 ST 进行 ATAC-seq 测序,分析其基因组中 G4 结构的分布特征、进化保守性、动态变化及对基因表达的调控作用。样本包括 SW620-rep1、SW620-rep2、PK15-rep1、PK15-rep2、ST-rep1、ST-rep2 共 6 个生物重复,采用 Cleavage Under Targets and Tagmentation 技术绘制 eG4s 的基因组图谱。

    摘要G4s are non-canonical four-stranded structures and emerge as novel genetic regulatory elements. Endogenous G4s (eG4s) can form quadruplex structures and induce double strand breaking during DNA replication, and thus contributing to genomic instability and genome evolution. Besides, eG4s are closely associated with gene expression regulation, and both their stimulative and repressive roles in the genome have been elucidated. Although functions of several specific G4s have been reported, a systematical identification and characterization of eG4s is still unconducted. Here we applied Cleavage Under Targets and Tagmentation (CUT&Tag) for mapping eG4s across human, mouse, and pig at high resolution and low background. We analyzed their genomics distribution, evolutionary conservation, dynamics, regulation, and impacts on gene expression in a single framework. ATAC-seq

  43. 43 GSE226300 对结直肠癌相关Epithelial Tumor Colon组织及HCT-116人结肠癌细胞系进行ATAC-seq检测,比较MED14-dTAG转基因处理组与DMSO对照组的染色质可及性差异。研究采用快速蛋白耗竭技术结合高分辨率MNase-based染色体构象捕获方法,分析Mediator复合体对增强子-启动子相互作用的影响,同时观察CTCF结合位点相互作用变化及Cohesin复合体在染色质上的分布差异。 人源 · 6 例 · GPL21697 · 2023/04/13

    设计对结直肠癌相关Epithelial Tumor Colon组织及HCT-116人结肠癌细胞系进行ATAC-seq检测,比较MED14-dTAG转基因处理组与DMSO对照组的染色质可及性差异。研究采用快速蛋白耗竭技术结合高分辨率MNase-based染色体构象捕获方法,分析Mediator复合体对增强子-启动子相互作用的影响,同时观察CTCF结合位点相互作用变化及Cohesin复合体在染色质上的分布差异。

    摘要Enhancer-mediated gene activation generally requires physical proximity between enhancers and their target gene promoters. However, the molecular mechanisms by which interactions between enhancers and promoters are formed are not well understood. Here, we investigate the function of the Mediator complex in the regulation of enhancer-promoter interactions, by combining rapid protein depletion and high-resolution MNase-based chromosome conformation capture approaches. We show that depletion of Mediator leads to reduced enhancer-promoter interaction frequencies, which are associated with a strong decrease in gene expression. In addition, we find increased interactions between CTCF-binding sites upon Mediator depletion. These changes in chromatin architecture are associated with a re-distribution of the Cohesin complex on chromatin and a reduction in Cohesin occupancy specifically at enhancers. Our results indicate that enhancer-promoter interactions are dependent on an interplay between the Mediator and Cohesin complexes and provide new insights into the molecular mechanisms by which communication between enhancers and promoters is regulated.

  44. 44 GSE239642 对人类结直肠癌细胞系HCT116进行ATAC-seq分析,比较ARID1A敲低组(shARID1A; n=3)与对照组(shCtrl; n=3)的染色质可及性差异。 人源 · 6 例 · GPL24676 · 2026/01/29

    设计对人类结直肠癌细胞系HCT116进行ATAC-seq分析,比较ARID1A敲低组(shARID1A; n=3)与对照组(shCtrl; n=3)的染色质可及性差异。

    摘要ARID1A functions as a vital tumor suppressor whose activity usually depends on the SWI/SNF chromatin remodeling complex. ARID1A is highly mutated across human cancers, and its deficiency has been found to promote immunogenicity through impaired mismatch repair and elevated tumor mutation burden. However, little is known about the SWI/SNF-independent function of ARID1A and the subsequent consequences. Here, we report a novel mechanism of action that ARID1A maintains heterochromatin integrity and silences endogenous satellite/retroelements, independent of SWI/SNF and microsatellite instability. Mechanistically, ARID1A recruits TRIM28 to keep the rigidity of heterochromatin. Loss of ARID1A displaces SETDB1 from TRIM28-contraining heterochromatin complex to induce the derepression of H3K9me3 at endogenous satellite/retroelement regions. The unleashed satellites and retroelements resulting from impaired ARID1A-TRIM28 interaction trigger type-I interferon immune responses, promoting tumor progression and sensitivity to PD1 blockade through both RNA- and DNA-sensing pathways. Our results shed light on the SWI/SNF-independent function of ARID1A to necessarily maintain heterochromatin integrity and safeguard the immunogenicity, potentiating the disruption of ARID1A-TRIM28 interaction as a strategy to convert ARID1A-wildtype tumors into hot to strengthen the therapeutic efficacies.

  45. 45 GSE253011 研究对象为结直肠癌细胞,采用DLD-1 NELFC-AID细胞系,设置DMSO处理组、IAA处理4小时组和IAA处理24小时组,每组包含两个生物重复。通过ATAC-seq技术检测基因组DNA结合情况,比较不同处理条件下DNA结合模式的差异。 人源 · 6 例 · GPL24676 · 2025/12/13

    设计研究对象为结直肠癌细胞,采用DLD-1 NELFC-AID细胞系,设置DMSO处理组、IAA处理4小时组和IAA处理24小时组,每组包含两个生物重复。通过ATAC-seq技术检测基因组DNA结合情况,比较不同处理条件下DNA结合模式的差异。

    摘要Regulation of RNA polymerase II (Pol II) transcription is closely associated with cell proliferation. However, it remains unclear how the Pol II transcription program is rewired in cancer to promote uncontrolled growth. Here, we find that gene expression of NELFCD, a known negative elongation factor, is up-regulated in colorectal tumours. To dissect the direct role of NELF-C on Pol II transcription in such cancer, we employed an auxin-dependent protein degradation system for NELF-C in combination with nascent transcript sequencing technologies. Strikingly, we demonstrate that the acute loss of NELF-C protein globally redistributes termination factors and perturbs Pol II transcription termination. These changes drive pervasive Pol II transcription into DNA replication zones leading to transcription-replication conflict that may block the cell cycle in G1 or early S phase. Our findings reveal a previously unrecognised role of NELF in transcription termination and highlight NELF as a potential therapeutic target in colorectal cancer.

  46. 46 GSE192905 对CHD7敲低与对照组RKO结肠癌细胞系进行ATAC-seq检测,分析染色质可及性变化。研究对象为人类结肠癌细胞,材料取自结肠组织,分组依据基因型(CHD7 knockdown与control),处理通过shRNA2实现,检测方式为ATAC-seq,主要比较两组染色质可及性差异。 人源 · 4 例 · GPL24676 · 2022/01/04

    设计对CHD7敲低与对照组RKO结肠癌细胞系进行ATAC-seq检测,分析染色质可及性变化。研究对象为人类结肠癌细胞,材料取自结肠组织,分组依据基因型(CHD7 knockdown与control),处理通过shRNA2实现,检测方式为ATAC-seq,主要比较两组染色质可及性差异。

    摘要We experimentally demonstrated that CHD7 promotes the growth of colorectal cancer cells in vitro and in vivo. Mechanistically, RNA-seq and ATAC-seq approaches together with ChIP assays indicated that CHD7 can bind to the promoters of target genes to maintain chromatin accessibility and facilitate transcription. We found that CHD7 knockdown downregulates AK4 expression and activates AMPK phosphorylation, thereby promoting the phosphorylation and stability of p53 and leading to the inhibition of the colorectal cancer growth. Our genomic analyses of ATPCRs across large-scale cancer specimens identified potential therapeutic targets and our experimental studies revealed a novel CHD7-AK4-AMPK-p53 axis that plays an oncogenic role in colorectal cancer.

  47. 47 GSE240039 对SKBR3、T47D、HCT116和RKO细胞系进行ATAC-seq分析,以鉴定开放染色质区域。检测采用60-bp单端测序,数据通过Bowtie2比对至hg19基因组,样本类型为人类基因组DNA,未见明确分组或处理条件。 人源 · 4 例 · GPL16791 · 2023/08/10

    设计对SKBR3、T47D、HCT116和RKO细胞系进行ATAC-seq分析,以鉴定开放染色质区域。检测采用60-bp单端测序,数据通过Bowtie2比对至hg19基因组,样本类型为人类基因组DNA,未见明确分组或处理条件。

    摘要Nectin-4 or PVRL4 is a promising therapeutic target because its augmented expression has been found in a wide range of human cancers. It is of note that Enfortumab Vedotin, an ADC for PVRL4 is clinically used for the treatment of urothelial bladder cancer. In addition, rMV-SLAMblind, a genetically engineered oncolytic measles virus, can infect cancer cells and induce apoptosis through an interaction with PVRL4. Although the transcripts of PVRL4 are elevated in breast, lung and ovarian cancer, the mechanism(s) of its overexpression has not been uncovered. To clarify the regulatory mechanism(s) of its elevated expression in breast cancer cells, we searched for its regulatory region(s) using ATAC-seq and ChIP-seq data. Using breast cancer cells, we identified an enhancer region. Additional analyses disclosed that FOS interacted with the enhancer region, and the alterations of the FOS-binding motifs decreased the reporter activity. Consistent with these data, exogenous expression of FOS enhanced not only the reporter activity but also PVRL4 expression in breast cancer cells. Furthermore, RNA-seq analysis using breast cancer cells treated with PVRL4-siRNA revealed its possible involvement in cytokine response and immune systems. These data suggest that FOS is involved, at least partly, in the regulation of PVRL4 expression in breast cancer cells, and that elevated PVRL4 expression may regulate response of the cancer cells to cytokines and immune systems.

  48. 48 GSE289006 对结直肠癌患者血浆样本进行肽组学分析,筛选出候选生物活性肽YG-22,并在HCT116细胞中通过ATAC-seq检测其对染色质可及性的影响,比较化疗单独处理与化疗联合Jianpi中药方处理组的差异。 人源 · 4 例 · GPL24676 · 2025/03/26

    设计对结直肠癌患者血浆样本进行肽组学分析,筛选出候选生物活性肽YG-22,并在HCT116细胞中通过ATAC-seq检测其对染色质可及性的影响,比较化疗单独处理与化疗联合Jianpi中药方处理组的差异。

    摘要Colorectal cancer (CRC) is a prevalent malignancy worldwide, often treated with chemotherapy despite its limitations, including adverse effects and resistance. Chemotherapy combined with the traditional Chinese medicine (TCM) Jianpi formula has been demonstrated to improve efficacy. In this study, we aim to screen bioactive peptides derived from the blood of CRC patients through peptidomics and explore the molecular mechanisms of the candidate peptides in HCT116 cells using multi-omics analysis. Differential peptides were identified in plasma samples from patients treated with chemotherapy alone and those receiving the combined therapy. Among these, YG-22 exhibited the strongest cytotoxic effect on HCT116 cells, reducing viability in a dose- and time-dependent manner. Transcriptome analysis highlighted the modulation of key pathways involved in lysosome-mediated degradation and apoptosis, while metabolomic profiling indicated disruptions in tumor-supportive metabolic pathways. Additionally, chromatin accessibility and histone modifications suggested epigenetic reprogramming induced by YG-22. These findings demonstrate that combining chemotherapy with TCM enriches the molecular landscape and generates bioactive peptides with strong antitumor activity. Furthermore, this study also lays the foundation for further development of peptide-based therapies and highlights the value of combining traditional and modern therapeutic strategies for CRC management.

  49. 49 GSE321026 对Homo sapiens HCT116细胞系的基因组DNA进行DNase超敏反应测序,未见明确分组或比较信息。 人源 · 4 例 · GPL24676 · 2026/02/28

    设计对Homo sapiens HCT116细胞系的基因组DNA进行DNase超敏反应测序,未见明确分组或比较信息。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  50. 50 GSE321299 对结直肠癌相关的HCT116细胞系进行DNase-Hypersensitivity测序,分析染色质可及性。 人源 · 4 例 · GPL24676 · 2026/02/28

    设计对结直肠癌相关的HCT116细胞系进行DNase-Hypersensitivity测序,分析染色质可及性。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  51. 51 GSE321390 对 Homo sapiens HCT116 细胞系的基因组 DNA 进行 DNase-Hypersensitivity 测序分析,采集 4 个样本,未明确分组或比较关系。 人源 · 4 例 · GPL24676 · 2026/02/28

    设计对 Homo sapiens HCT116 细胞系的基因组 DNA 进行 DNase-Hypersensitivity 测序分析,采集 4 个样本,未明确分组或比较关系。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  52. 52 GSE122583 一例结直肠腺癌患者的细胞谱系示踪研究,本记录为其ATAC-seq部分:取该患者结肠肿瘤组织及2个癌旁健康组织样本,组织解离后按EPCAM+表面标志物分选原代细胞,进行ATAC测序检测染色质可及性;整体设计中细胞还用于单细胞RNA测序,但本系列仅展示ATAC-seq数据;研究旨在以体细胞线粒体DNA突变作为天然条码同时追踪细胞谱系与细胞状态;主要比较肿瘤组织与癌旁健康组织的染色质可及性。 人源 · 3 例 · GPL18573 · 2019/02/28

    设计一例结直肠腺癌患者的细胞谱系示踪研究,本记录为其ATAC-seq部分:取该患者结肠肿瘤组织及2个癌旁健康组织样本,组织解离后按EPCAM+表面标志物分选原代细胞,进行ATAC测序检测染色质可及性;整体设计中细胞还用于单细胞RNA测序,但本系列仅展示ATAC-seq数据;研究旨在以体细胞线粒体DNA突变作为天然条码同时追踪细胞谱系与细胞状态;主要比较肿瘤组织与癌旁健康组织的染色质可及性。

    摘要Lineage tracing provides unprecedented insights into the fate of individual cells and their progeny in complex organisms. While effective genetic approaches have been developed in vitro and in animal models, these cannot be used to interrogate human physiology in vivo. Instead, naturally occurring somatic mutations have been utilized to infer clonality and lineal relationships between cells in human tissues, but current approaches are limited by high error rates and scale, and provide little information about the state or function of the cells. Here, we show how somatic mutations in mitochondrial DNA (mtDNA) can be tracked by current single cell RNA-Seq (scRNA-Seq) or single cell ATAC-Seq (scATAC-Seq) for simultaneous analysis of single cell lineage and state. We leverage somatic mtDNA mutations as natural genetic barcodes and demonstrate their use as clonal markers to infer lineal relationships. We trace the lineage of human cells by somatic mtDNA mutations in a native context both in vitro and in vivo, and relate it to expression profiles and chromatin accessibility. Our approach should allow lineage tracing at a 100- to 1,000-fold greater scale than with single cell whole genome sequencing, while providing information on cell state, opening the way to chart detailed cell lineage and fate maps in human health and disease.

  53. 53 GSE197009 对结直肠癌来源的LoVo、HEK293和HepG2细胞系进行批量OMNI ATAC-seq,检测染色质可及性,所有样本均未处理。 人源 · 3 例 · GPL24676 · 2022/02/21

    设计对结直肠癌来源的LoVo、HEK293和HepG2细胞系进行批量OMNI ATAC-seq,检测染色质可及性,所有样本均未处理。

    摘要Transcription factors read the genome, fundamentally connecting DNA sequence to gene expression across diverse cell types. Determining how, where, and when TFs bind chromatin will advance our understanding of gene regulatory networks and cellular behavior. The 2017 ENCODE-DREAM in vivo Transcription-Factor Binding Site (TFBS) Prediction Challenge highlighted the value of chromatin accessibility data to TFBS prediction, establishing state-of-the-art methods. Yet, while Assay-for-Transposase-Accessible-Chromatin (ATAC)-seq datasets grow exponentially, suboptimal motif scanning is commonly used for TFBS prediction from ATAC-seq. Here, we present “maxATAC”, a suite of user-friendly, deep neural network models for genome-wide TFBS prediction from ATAC-seq in any cell type. With models available for 127 human TFs, maxATAC is the largest collection of state-of-the-art TFBS models to date. maxATAC performance extends to primary cells and single-cell ATAC-seq, enabling state-of-the-art TFBS prediction in vivo. We demonstrate maxATAC’s capabilities by identifying TFBS associated with allele-dependent chromatin accessibility at atopic dermatitis genetic risk loci.

  54. 54 GSE307697 对colorectal cancer患者来源异种移植(PDX)肿瘤模型PDX-1和PDX-2,分别采用PBS对照与脾细胞(7SL1敲入)携带FAP-CAR mRNA-LNPs的处理,采集肿瘤组织进行ATAC测序,比较不同治疗组与对照组的染色质可及性差异。 人源 · 3 例 · GPL24676 · 2025/12/10

    设计对colorectal cancer患者来源异种移植(PDX)肿瘤模型PDX-1和PDX-2,分别采用PBS对照与脾细胞(7SL1敲入)携带FAP-CAR mRNA-LNPs的处理,采集肿瘤组织进行ATAC测序,比较不同治疗组与对照组的染色质可及性差异。

    摘要This study investigates the therapeutic potential of an mRNA–lipid nanoparticle (LNP)-based strategy to deliver fibroblast activation protein (FAP)-specific chimeric antigen receptor (CAR) mRNA in colorectal cancer. Patient-derived xenograft (PDX) tumor models (PDX-1 and PDX-2) were treated by splenocytes (7SL1 knock-in) with FAP-CAR mRNA-LNPs, in comparison with PBS controls. ATAC sequencing of the tumor tissues was performed to profile transcriptional responses associated with treatment efficacy or resistance. Analysis revealed distinct chromatin accessibility programs, including activation of HOX gene clusters in resistant tumors, highlighting potential epigenetic mechanisms of therapeutic escape.

  55. 55 GSE320634 对 Homo sapiens HCT116 结直肠癌细胞系进行 DNase I 消化构建文库的 DNase-seq,共 3 个样本。 人源 · 3 例 · GPL24676 · 2026/02/28

    设计对 Homo sapiens HCT116 结直肠癌细胞系进行 DNase I 消化构建文库的 DNase-seq,共 3 个样本。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  56. 56 GSE321520 以男性、48 岁供体来源的人结直肠癌细胞系 HCT116 为材料,建立 3 个独立 Biosample 重复样本,未设置处理组或对照组;提取基因组 DNA 进行 DNase-seq 高通量测序,检测 DNase 超敏感位点以反映染色质可及性;数据产出 BED、BIGWIG、BIGBED 格式文件。该记录属 ENCODE 项目实验 ENCSR933DDO,仅含 HCT116 单一细胞系的 DNase-seq 数据,不涉及疾病-对照或不同条件间的比较。 人源 · 3 例 · GPL24676 · 2026/02/28

    设计以男性、48 岁供体来源的人结直肠癌细胞系 HCT116 为材料,建立 3 个独立 Biosample 重复样本,未设置处理组或对照组;提取基因组 DNA 进行 DNase-seq 高通量测序,检测 DNase 超敏感位点以反映染色质可及性;数据产出 BED、BIGWIG、BIGBED 格式文件。该记录属 ENCODE 项目实验 ENCSR933DDO,仅含 HCT116 单一细胞系的 DNase-seq 数据,不涉及疾病-对照或不同条件间的比较。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  57. 57 GSE321705 对人类结直肠癌HCT116细胞系进行DNase超敏反应测序,检测基因组DNA的DNase敏感位点。 人源 · 3 例 · GPL24676 · 2026/02/28

    设计对人类结直肠癌HCT116细胞系进行DNase超敏反应测序,检测基因组DNA的DNase敏感位点。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  58. 58 GSE322091 对结直肠癌相关的人类 HCT116 细胞系进行 DNase-seq 测序,检测基因组 DNA 的 DNase 超敏反应特征。 人源 · 3 例 · GPL24676 · 2026/02/28

    设计对结直肠癌相关的人类 HCT116 细胞系进行 DNase-seq 测序,检测基因组 DNA 的 DNase 超敏反应特征。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  59. 59 GSE322407 对人类结直肠癌 HCT116 细胞系进行 DNase 超敏反应测序,分析基因组 DNA 的 DNase 敏感位点,共包含 3 个样本。 人源 · 3 例 · GPL24676 · 2026/02/28

    设计对人类结直肠癌 HCT116 细胞系进行 DNase 超敏反应测序,分析基因组 DNA 的 DNase 敏感位点,共包含 3 个样本。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  60. 60 GSE130205 以人结肠癌细胞系HCT116为研究对象,细胞培养于含10% FBS和青霉素-链霉素的Mccoys培养基,在70%汇合的10 cm培养皿中分别以10 μl DMSO(溶剂对照)或10 μM Nutlin-3A(原文标注为p53抑制剂)处理;提取开放染色质DNA进行ATAC-seq测序,2个样本覆盖上述两种处理条件,比较处理组与溶剂对照的染色质开放区域差异;该数据旨在探讨将ATAC-seq信号与基因组序列结合、以循环神经网络识别具有转录活动峰的分类模型。 人源 · 2 例 · GPL18573 · 2020/04/30

    设计以人结肠癌细胞系HCT116为研究对象,细胞培养于含10% FBS和青霉素-链霉素的Mccoys培养基,在70%汇合的10 cm培养皿中分别以10 μl DMSO(溶剂对照)或10 μM Nutlin-3A(原文标注为p53抑制剂)处理;提取开放染色质DNA进行ATAC-seq测序,2个样本覆盖上述两种处理条件,比较处理组与溶剂对照的染色质开放区域差异;该数据旨在探讨将ATAC-seq信号与基因组序列结合、以循环神经网络识别具有转录活动峰的分类模型。

    摘要We explore different uses of machine learning classifiers, including neural networks, to combine the “signal” from ATAC-seq with its underlying genome sequence in order to classify ATAC-seq peaks on the presence or absence of transcription. We show how a hybrid signal/sequence representation, classified using recurrent neural networks (RNNs), yields the best performance across different cell types.

  61. 61 GSE138656 对结直肠癌相关 HCT116 细胞及其奥沙利铂耐药变种 HCT116OxR 进行 ATAC-seq 测序,分析染色质连接性变化并比较两者的差异。 人源 · 2 例 · GPL11154 · 2021/10/01

    设计对结直肠癌相关 HCT116 细胞及其奥沙利铂耐药变种 HCT116OxR 进行 ATAC-seq 测序,分析染色质连接性变化并比较两者的差异。

    摘要Numerous studies have highlighted the critical role of genetic and epigenetic modifications in the regulation of oxaliplatin resistance, but whether changes involving chromatin structure have not been fully investigated. We have integrated a variety of techniques to explore a comprehensive overview of chromatin changes in oxaliplatin-resistant processes.

  62. 62 GSE187099 对结直肠癌相关的人类 HCT116 细胞系进行 ATAC-seq 测序,检测 CRISPR 插入 O. sativa LOC4335696 基因后的染色质可及性变化,比较药物处理组与未处理对照组的差异。 人源 · 2 例 · GPL24676 · 2021/11/04

    设计对结直肠癌相关的人类 HCT116 细胞系进行 ATAC-seq 测序,检测 CRISPR 插入 O. sativa LOC4335696 基因后的染色质可及性变化,比较药物处理组与未处理对照组的差异。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  63. 63 GSE187214 对人类结直肠癌HCT116细胞系进行ATAC-seq分析,设置处理组与对照组,处理组用1 μM 5-Phenyl-1H-indole-3-acetic acid处理6小时,比较处理组与对照组的染色质可及性差异。 人源 · 2 例 · GPL24676 · 2021/11/04

    设计对人类结直肠癌HCT116细胞系进行ATAC-seq分析,设置处理组与对照组,处理组用1 μM 5-Phenyl-1H-indole-3-acetic acid处理6小时,比较处理组与对照组的染色质可及性差异。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  64. 64 GSE187226 对结直肠癌状态的人类 HCT116 细胞系进行 ATAC-seq,检测基因组 DNA 可及性。 人源 · 2 例 · GPL24676 · 2021/11/04

    设计对结直肠癌状态的人类 HCT116 细胞系进行 ATAC-seq,检测基因组 DNA 可及性。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  65. 65 GSE187240 对结直肠癌相关的HCT116细胞系进行ATAC-seq分析,处理包括CRISPR插入O. sativa LOC4335696、CRISPR靶向H. sapiens POLR2A及1 μM 5-Phenyl-1H-indole-3-acetic acid处理6小时,检测基因组DNA结合状态,但未明确分组与比较结构。 人源 · 2 例 · GPL24676 · 2021/11/04

    设计对结直肠癌相关的HCT116细胞系进行ATAC-seq分析,处理包括CRISPR插入O. sativa LOC4335696、CRISPR靶向H. sapiens POLR2A及1 μM 5-Phenyl-1H-indole-3-acetic acid处理6小时,检测基因组DNA结合状态,但未明确分组与比较结构。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  66. 66 GSE187411 对人类结直肠癌相关的HCT116细胞系进行ATAC-seq分析,该细胞系经CRISPR插入水稻LOC4335696和人类SMARCA5基因。检测方式为高通量测序的基因组结合/占据分析,样本为基因组DNA。 人源 · 2 例 · GPL24676 · 2021/11/04

    设计对人类结直肠癌相关的HCT116细胞系进行ATAC-seq分析,该细胞系经CRISPR插入水稻LOC4335696和人类SMARCA5基因。检测方式为高通量测序的基因组结合/占据分析,样本为基因组DNA。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  67. 67 GSE187412 对人类结直肠癌相关 HCT116 细胞系进行 ATAC-seq 测序,该细胞系经 CRISPR 技术插入水稻 LOC4335696 基因并靶向敲除人类 RAD21 基因,采集基因组 DNA 用于染色质可及性分析,未明确对照组设置及比较关系。 人源 · 2 例 · GPL24676 · 2021/11/04

    设计对人类结直肠癌相关 HCT116 细胞系进行 ATAC-seq 测序,该细胞系经 CRISPR 技术插入水稻 LOC4335696 基因并靶向敲除人类 RAD21 基因,采集基因组 DNA 用于染色质可及性分析,未明确对照组设置及比较关系。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  68. 68 GSE187668 对HCT116细胞系进行CRISPR插入O. sativa LOC4335696和靶向H. sapiens CDK7的基因组修饰,采集基因组DNA进行ATAC-seq分析,比较不同处理条件下的染色质可及性。 人源 · 2 例 · GPL24676 · 2021/11/04

    设计对HCT116细胞系进行CRISPR插入O. sativa LOC4335696和靶向H. sapiens CDK7的基因组修饰,采集基因组DNA进行ATAC-seq分析,比较不同处理条件下的染色质可及性。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  69. 69 GSE187951 对人类结直肠癌相关 HCT116 细胞系进行 ATAC-seq 分析,检测基因组 DNA 可及性变化。该细胞系经 CRISPR 插入 O. sativa LOC4335696 和 H. sapiens BRD4 基因,与未转基因对照组比较基因组开放区域特征。 人源 · 2 例 · GPL24676 · 2021/11/04

    设计对人类结直肠癌相关 HCT116 细胞系进行 ATAC-seq 分析,检测基因组 DNA 可及性变化。该细胞系经 CRISPR 插入 O. sativa LOC4335696 和 H. sapiens BRD4 基因,与未转基因对照组比较基因组开放区域特征。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  70. 70 GSE188041 对人类结直肠癌相关 HCT116 细胞系进行 ATAC-seq 分析,该细胞系经 CRISPR 插入 O. sativa LOC4335696 和 CRISPR 靶向 H. sapiens BRD4 处理,并在 1 μM 5-Phenyl-1H-indole-3-acetic 酸作用下培养 6 小时,采集基因组 DNA 用于高通量测序。 人源 · 2 例 · GPL24676 · 2021/11/04

    设计对人类结直肠癌相关 HCT116 细胞系进行 ATAC-seq 分析,该细胞系经 CRISPR 插入 O. sativa LOC4335696 和 CRISPR 靶向 H. sapiens BRD4 处理,并在 1 μM 5-Phenyl-1H-indole-3-acetic 酸作用下培养 6 小时,采集基因组 DNA 用于高通量测序。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  71. 71 GSE215527 对HCT116细胞系进行基因编辑插入O. sativa LOC4335696和靶向H. sapiens CDK7的CRISPR处理,并用1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时,采集基因组DNA进行DNase-Hypersensitivity测序。 人源 · 2 例 · GPL24676 · 2022/10/16

    设计对HCT116细胞系进行基因编辑插入O. sativa LOC4335696和靶向H. sapiens CDK7的CRISPR处理,并用1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时,采集基因组DNA进行DNase-Hypersensitivity测序。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  72. 72 GSE215542 对人类结直肠癌相关 HCT116 细胞系进行 DNase-seq 分析,检测基因组 DNA 的敏感性,样本量为 2 个独立单位。 人源 · 2 例 · GPL24676 · 2022/10/16

    设计对人类结直肠癌相关 HCT116 细胞系进行 DNase-seq 分析,检测基因组 DNA 的敏感性,样本量为 2 个独立单位。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  73. 73 GSE215550 对人类结直肠癌HCT116细胞系进行DNase-seq检测,分析基因组DNA的DNase超敏反应位点特征。 人源 · 2 例 · GPL24676 · 2022/10/16

    设计对人类结直肠癌HCT116细胞系进行DNase-seq检测,分析基因组DNA的DNase超敏反应位点特征。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  74. 74 GSE215564 对HCT116细胞系进行DNase-seq分析,采用CRISPR插入O. sativa LOC4335696和H. sapiens MED14基因,并在1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时后采集样本,检测基因组DNA的DNase超敏反应特征。 人源 · 2 例 · GPL24676 · 2022/10/16

    设计对HCT116细胞系进行DNase-seq分析,采用CRISPR插入O. sativa LOC4335696和H. sapiens MED14基因,并在1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时后采集样本,检测基因组DNA的DNase超敏反应特征。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  75. 75 GSE215626 对人类结直肠癌HCT116细胞系进行DNase-seq分析,检测其基因组结合/占据特征。该细胞系经CRISPR插入O. sativa LOC4335696和H. sapiens MED14基因,采集样本进行高通量测序。 人源 · 2 例 · GPL24676 · 2022/10/16

    设计对人类结直肠癌HCT116细胞系进行DNase-seq分析,检测其基因组结合/占据特征。该细胞系经CRISPR插入O. sativa LOC4335696和H. sapiens MED14基因,采集样本进行高通量测序。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  76. 76 GSE215632 对HCT116结直肠癌细胞系进行CRISPR插入O. sativa LOC4335696和H. sapiens CTCF基因处理,并用1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时,采集基因组DNA进行DNase超敏反应测序,比较不同处理条件下的基因组DNA差异。 人源 · 2 例 · GPL24676 · 2022/10/16

    设计对HCT116结直肠癌细胞系进行CRISPR插入O. sativa LOC4335696和H. sapiens CTCF基因处理,并用1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时,采集基因组DNA进行DNase超敏反应测序,比较不同处理条件下的基因组DNA差异。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  77. 77 GSE215740 对人类结直肠癌HCT116细胞系进行CRISPR插入处理,使用1 uM 5-Phenyl-1H-indole-3-acetic acid药物处理6小时,采集基因组DNA进行DNase-Hypersensitivity测序分析。 人源 · 2 例 · GPL24676 · 2022/10/16

    设计对人类结直肠癌HCT116细胞系进行CRISPR插入处理,使用1 uM 5-Phenyl-1H-indole-3-acetic acid药物处理6小时,采集基因组DNA进行DNase-Hypersensitivity测序分析。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  78. 78 GSE307935 对PKM2野生型(WT)与K206R突变型HCT116结直肠癌细胞进行ATAC-seq分析,检测抗H3K27ac抗体处理下的基因组DNA结合特征,比较两种基因型细胞的转录调控差异。 人源 · 2 例 · GPL24676 · 2026/02/14

    设计对PKM2野生型(WT)与K206R突变型HCT116结直肠癌细胞进行ATAC-seq分析,检测抗H3K27ac抗体处理下的基因组DNA结合特征,比较两种基因型细胞的转录调控差异。

    摘要Despite the clinical utility of bevacizumab in advanced colorectal cancer (CRC), resistance remains a major challenge. Here, we unveiled a lactate-mediated mechanism driving vasculogenic mimicry (VM) and bevacizumab resistance through PKM2 lactylation. PKM2 lactylation at K206 by AARS1 promoted PKM2 nuclear translocation and interaction with FOSL1. PKM2 binding facilitated FOSL1-dependent super-enhancer formation and target gene transcription, which contributed to CRC cell VM. Genetic or pharmacological inhibition of PKM2 lactylation disrupted VM and synergized with bevacizumab in patient-derived pre-clinical models, significantly improving therapeutic efficacy. Together, this study reveals lactylation as a metabolic switch linking cancer glycolytic reprogramming to transcriptional rewiring and proposes targeting PKM2 lactylation to enhance the anti-tumor activity of bevacizumab in CRC.

  79. 79 GSE320937 对 HCT116 人类结直肠癌细胞系进行 DNase I 消化后高通量测序的染色质可及性测定。 人源 · 2 例 · GPL24676 · 2026/02/28

    设计对 HCT116 人类结直肠癌细胞系进行 DNase I 消化后高通量测序的染色质可及性测定。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  80. 80 GSE321011 对HCT116结直肠癌细胞系进行DNase超敏反应测序,检测基因组DNA的可及性特征。 人源 · 2 例 · GPL24676 · 2026/02/28

    设计对HCT116结直肠癌细胞系进行DNase超敏反应测序,检测基因组DNA的可及性特征。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  81. 81 GSE321088 对Homo sapiens HCT116细胞系的基因组DNA进行DNase超敏位点测序分析,检测DNase-Hypersensitivity特征。 人源 · 2 例 · GPL24676 · 2026/02/28

    设计对Homo sapiens HCT116细胞系的基因组DNA进行DNase超敏位点测序分析,检测DNase-Hypersensitivity特征。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  82. 82 GSE321273 对Homo sapiens HCT116细胞系进行DNase超敏反应测序,分析DNA可及性。 人源 · 2 例 · GPL24676 · 2026/02/28

    设计对Homo sapiens HCT116细胞系进行DNase超敏反应测序,分析DNA可及性。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  83. 83 GSE333941 对结直肠癌相关 RKO 细胞系中 GSK3B 基因野生型与敲除型样本进行 ATAC 测序,比较两种基因型细胞的可及性差异。研究对象为 RKO 细胞,被测材料为基因组 DNA,检测方式为 ATAC 测序,分组依据为 GSK3B 基因型(野生型与敲除型),主要比较两组细胞的染色质可及性特征。 人源 · 2 例 · GPL24676 · 2026/06/19

    设计对结直肠癌相关 RKO 细胞系中 GSK3B 基因野生型与敲除型样本进行 ATAC 测序,比较两种基因型细胞的可及性差异。研究对象为 RKO 细胞,被测材料为基因组 DNA,检测方式为 ATAC 测序,分组依据为 GSK3B 基因型(野生型与敲除型),主要比较两组细胞的染色质可及性特征。

    摘要This study focuses on the epigenomics and transcriptomic changes driven by the GSK3B gene in colon cancer, offering valuable insights into tumor biology and its progression. Gaining a deeper understanding of these processes may contribute to developing more effective therapeutic strategies and enhance prognostic outcomes.

  84. 84 GSE215594 对人类结直肠癌HCT116细胞系进行DNase-seq,检测基因组DNA的DNase超敏反应。 人源 · 1 例 · GPL24676 · 2022/10/16

    设计对人类结直肠癌HCT116细胞系进行DNase-seq,检测基因组DNA的DNase超敏反应。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  85. 85 GSE215612 对HCT116细胞系基因组DNA进行DNase超敏性分析,检测开放染色质区域。 人源 · 1 例 · GPL24676 · 2022/10/16

    设计对HCT116细胞系基因组DNA进行DNase超敏性分析,检测开放染色质区域。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  86. 86 GSE215646 以人结直肠癌来源的 HCT116 细胞系为实验材料,该细胞系经 CRISPR 插入改造:插入水稻 LOC4335696 序列,并以 CRISPR 靶向人 BRD4 基因进行插入改造;以基因组 DNA 为对象开展 DNase 超敏感位点测序,检测该细胞系的染色质开放区域;当前记录仅含 1 个样本,未见分组、处理或对照设置,未记录组间比较结构。 人源 · 1 例 · GPL24676 · 2022/10/16

    设计以人结直肠癌来源的 HCT116 细胞系为实验材料,该细胞系经 CRISPR 插入改造:插入水稻 LOC4335696 序列,并以 CRISPR 靶向人 BRD4 基因进行插入改造;以基因组 DNA 为对象开展 DNase 超敏感位点测序,检测该细胞系的染色质开放区域;当前记录仅含 1 个样本,未见分组、处理或对照设置,未记录组间比较结构。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  87. 87 GSE215661 对结直肠癌相关的HCT116细胞系进行5-Phenyl-1H-indole-3-acetic acid处理,采集基因组DNA进行DNase超敏反应测序,未见明确对照组比较信息。 人源 · 1 例 · GPL24676 · 2022/10/16

    设计对结直肠癌相关的HCT116细胞系进行5-Phenyl-1H-indole-3-acetic acid处理,采集基因组DNA进行DNase超敏反应测序,未见明确对照组比较信息。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  88. 88 GSE215674 对人类结直肠癌HCT116细胞系进行CRISPR插入O. sativa LOC4335696和靶向H. sapiens SMARCA5的基因组修饰,并用1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时,采集基因组DNA进行DNase超敏反应测序分析。 人源 · 1 例 · GPL24676 · 2022/10/16

    设计对人类结直肠癌HCT116细胞系进行CRISPR插入O. sativa LOC4335696和靶向H. sapiens SMARCA5的基因组修饰,并用1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时,采集基因组DNA进行DNase超敏反应测序分析。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  89. 89 GSE284934 对 HCT116 人源结直肠癌细胞系进行 DNase I 消化构建文库的 DNase-seq 测定。 人源 · 1 例 · GPL24676 · 2025/01/14

    设计对 HCT116 人源结直肠癌细胞系进行 DNase I 消化构建文库的 DNase-seq 测定。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  90. 90 GSE321790 对结直肠癌 HCT116 细胞系进行 DNase-Hypersensitivity 测序,分析其基因组 DNA 的可及性。 人源 · 1 例 · GPL24676 · 2026/02/28

    设计对结直肠癌 HCT116 细胞系进行 DNase-Hypersensitivity 测序,分析其基因组 DNA 的可及性。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  91. 91 GSE339713 对HCT116细胞系进行snATAC-seq分析,未见明确分组或对照组描述。 人源 · 1 例 · GPL24676 · 2026/07/24

    设计对HCT116细胞系进行snATAC-seq分析,未见明确分组或对照组描述。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  92. 92 GSE340494 对人类结直肠癌HCT116细胞系进行ATAC-seq分析,该细胞系经CRISPR插入O. sativa LOC4335696及靶向H. sapiens POLR2A的基因组修饰,随后在1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时后采集样本,检测基因组DNA可及性变化。 人源 · 1 例 · GPL24676 · 2026/07/24

    设计对人类结直肠癌HCT116细胞系进行ATAC-seq分析,该细胞系经CRISPR插入O. sativa LOC4335696及靶向H. sapiens POLR2A的基因组修饰,随后在1 uM 5-Phenyl-1H-indole-3-acetic acid处理6小时后采集样本,检测基因组DNA可及性变化。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

  93. 93 GSE340653 对HCT116细胞系进行CRISPR基因插入(O. sativa LOC4335696和H. sapiens CTCF)并化学处理(1 uM 5-Phenyl-1H-indole-3-acetic acid持续6小时),采集基因组DNA进行ATAC-seq,比较处理组与相应未处理对照组的染色质可及性差异。 人源 · 1 例 · GPL24676 · 2026/07/24

    设计对HCT116细胞系进行CRISPR基因插入(O. sativa LOC4335696和H. sapiens CTCF)并化学处理(1 uM 5-Phenyl-1H-indole-3-acetic acid持续6小时),采集基因组DNA进行ATAC-seq,比较处理组与相应未处理对照组的染色质可及性差异。

    摘要For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

人源·鼠源甲基化

Human · Mouse · Methylation

  1. 01 GSE140270 对结直肠癌相关 Apc Min 小鼠和人类 Sw620 细胞系的肠类器官与结肠癌组织样本进行甲基化测序和 RNA 测序,比较不同培养基(control medium、Low Glutamine medium)及 DM-aKG 治疗组与对照组间的基因表达与甲基化差异。 人源·鼠源 · 44 例 · GPL17021;23976 · 2020/03/23

    设计对结直肠癌相关 Apc Min 小鼠和人类 Sw620 细胞系的肠类器官与结肠癌组织样本进行甲基化测序和 RNA 测序,比较不同培养基(control medium、Low Glutamine medium)及 DM-aKG 治疗组与对照组间的基因表达与甲基化差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  2. 02 GSE98534 对人类和小鼠的结直肠腺癌组织及相邻非肿瘤组织进行基因组 DNA 甲基化分析,比较肿瘤组织与正常组织的差异。同时,对 Caco2 和 Colo320 细胞系分别进行 BRAFV600E 过表达或 GFP 对照处理,提取基因组 DNA 后进行甲基化分析,比较不同处理条件下的甲基化特征。 人源·鼠源 · 33 例 · GPL8490;13534;16446;23976 · 2019/12/18

    设计对人类和小鼠的结直肠腺癌组织及相邻非肿瘤组织进行基因组 DNA 甲基化分析,比较肿瘤组织与正常组织的差异。同时,对 Caco2 和 Colo320 细胞系分别进行 BRAFV600E 过表达或 GFP 对照处理,提取基因组 DNA 后进行甲基化分析,比较不同处理条件下的甲基化特征。

    摘要This SuperSeries is composed of the SubSeries listed below.

  3. 03 GSE79838 对HCT116结直肠癌细胞系DNA及患者来源的异种移植瘤(PDXs)血浆cfDNA进行MeDIP-seq和cfMeDIP-seq甲基组分析。第一实验中,不同起始量的HCT116细胞系DNA(100 ng、10 ng、5 ng、1 ng)经剪切模拟细胞游离DNA后,分别行MeDIP-seq和cfMeDIP-seq检测。第二实验中,使用HCT116与MM1.S细胞系DNA(剪切模拟细胞游离DNA)按不同比例(100% HCT116、10% HCT116、1% HCT116、0.1% HCT116、0.01% HCT116、0.001% HCT116、100% MM1.S)进行cfMeDIP-seq检测,起始DNA量均被填充至100 ng。第三实验中,对两例结直肠癌患者的PDXs小鼠血浆cfDNA行cfMeDIP-seq检测,并与输入对照样本进行比较。所有样本均采用5-甲基胞嘧啶抗体进行免疫沉淀,测序数据对齐至hg19和mm9参考基因组。 人源·鼠源 · 24 例 · GPL11154;13112 · 2018/04/01

    设计对HCT116结直肠癌细胞系DNA及患者来源的异种移植瘤(PDXs)血浆cfDNA进行MeDIP-seq和cfMeDIP-seq甲基组分析。第一实验中,不同起始量的HCT116细胞系DNA(100 ng、10 ng、5 ng、1 ng)经剪切模拟细胞游离DNA后,分别行MeDIP-seq和cfMeDIP-seq检测。第二实验中,使用HCT116与MM1.S细胞系DNA(剪切模拟细胞游离DNA)按不同比例(100% HCT116、10% HCT116、1% HCT116、0.1% HCT116、0.01% HCT116、0.001% HCT116、100% MM1.S)进行cfMeDIP-seq检测,起始DNA量均被填充至100 ng。第三实验中,对两例结直肠癌患者的PDXs小鼠血浆cfDNA行cfMeDIP-seq检测,并与输入对照样本进行比较。所有样本均采用5-甲基胞嘧啶抗体进行免疫沉淀,测序数据对齐至hg19和mm9参考基因组。

    摘要Three separate experiments were carried out using MeDIP-seq and cfMeDIP-seq for methylome analysis. For the first experiment, different starting amounts of HCT116 cell line DNA, sheared to mimic cell-free DNA, were analyzed using MeDIP-seq and cfMeDIP-seq. In the second experiment the limit of detection of cfMeDIP-seq was tested using varying dilutions of colorectal cancer cell line DNA (HCT116) with multiple myeloma cell line DNA (MM1.S). For both cell line DNA samples, the DNA was sheared to mimic cell-free DNA. In the final experiment, we tested the enrichment of human ctDNA using cfMeDIP-seq performed on plasma collected from patient-derived xenografts (PDXs) generated in mice from two colorectal cancer patients.

  4. 04 GSE28254 收集结直肠癌患者肿瘤组织与配对癌旁黏膜,以及 HCT116 结直肠癌细胞和野生型小鼠胚胎干细胞(ES cells)与 Dnmt 三重敲除(TKO)小鼠 ES cells,行 ChIP-bisulfite 与 MethylCap-bisulfite 深度测序(ChIP-BS-seq 和 MethylCap-BS-seq)以直接评估染色质修饰与 DNA 甲基化之间的相互作用。研究对象包括正常结肠组织、肿瘤结肠组织、HCT116 细胞和小鼠 ES cells,采用 H3K27me3 抗体进行 ChIP-BS-seq,同时使用 His6-GST-MBD 蛋白进行 MethylCap-BS-seq,比较不同组别间 DNA 甲基化模式与 H3K27me3 沉积情况的差异。 人源·鼠源 · 15 例 · GPL10999;13112;11002 · 2012/03/27

    设计收集结直肠癌患者肿瘤组织与配对癌旁黏膜,以及 HCT116 结直肠癌细胞和野生型小鼠胚胎干细胞(ES cells)与 Dnmt 三重敲除(TKO)小鼠 ES cells,行 ChIP-bisulfite 与 MethylCap-bisulfite 深度测序(ChIP-BS-seq 和 MethylCap-BS-seq)以直接评估染色质修饰与 DNA 甲基化之间的相互作用。研究对象包括正常结肠组织、肿瘤结肠组织、HCT116 细胞和小鼠 ES cells,采用 H3K27me3 抗体进行 ChIP-BS-seq,同时使用 His6-GST-MBD 蛋白进行 MethylCap-BS-seq,比较不同组别间 DNA 甲基化模式与 H3K27me3 沉积情况的差异。

    摘要Cross-talk between DNA methylation and histone modifications drives the establishment of composite epigenetic signatures and is traditionally studied using correlative rather than direct approaches. Here we present sequential ChIP-bisulfite-sequencing (ChIP- BS-seq) as an approach to quantitatively assess DNA methylation patterns associated with chromatin modifications or chromatin-associated factors directly. A chromatin- immunoprecipitation (ChIP)-capturing step is used to obtain a restricted representation of the genome occupied by the epigenetic feature of interest, for which a single-base resolution DNA methylation map is then generated. When applied to H3 lysine 27 tri- methylation (H3K27me3), we found that H3K27me3 and DNA methylation are compatible throughout most of the genome, except for CpG islands, where these two marks are mutually exclusive. Further ChIP-BS-seq-based analysis in Dnmt triple- knock-out (TKO) embryonic stem cells revealed that total loss of CpG methylation is associated with alteration of H3K27me3 levels throughout the genome: H3K27me3 in localized peaks is decreased while broad local enrichments (BLOCs) of H3K27me3 are formed. At an even broader scale, these BLOCs correspond to regions of high DNA methylation in wild-type ES cells, suggesting that DNA methylation prevents H3K27me3 deposition locally and at megabase scale. Our strategy provides an unique way of investigating global interdependencies between DNA methylation and other chromatin features.

  5. 05 GSE192745 对人源和小鼠来源的结直肠癌肿瘤组织及 CT26 细胞系进行 DAC 处理与未处理分组,采用 RNA 测序和亚硫酸盐测序检测基因表达与甲基化状态,比较处理组与对照组的差异。 人源·鼠源 · 8 例 · GPL21290;21493 · 2022/01/03

    设计对人源和小鼠来源的结直肠癌肿瘤组织及 CT26 细胞系进行 DAC 处理与未处理分组,采用 RNA 测序和亚硫酸盐测序检测基因表达与甲基化状态,比较处理组与对照组的差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

人源·鼠源accessibility

Human · Mouse · accessibility

  1. 01 GSE266750 研究对象为结直肠癌相关的人类 DLD-1 细胞系、CACO-2 细胞系、患者样本及异种移植小鼠,采用 ATAC-seq、Hi-C、RNA-Seq 和 CUT&Tag 技术检测基因组 DNA 与总 RNA 的表观遗传修饰及三维基因组结构。样本按基因型(GATA6-AID-IAA7、WT、GATA6-KO、TP53 mutant、BRAF mutant、GATA6 CRISPR KO)和处理条件(+Auxin、-Auxin、Wash、IAA 诱导蛋白降解)分组,时间点包括 0h、12h、24h、72h。检测覆盖不同基因型与处理时间点的比较,以及特定抗体(GATA6、CTCF、H3K27ac、RAD21)介导的染色质结合分析。 人源·鼠源 · 75 例 · GPL24676;24247 · 2024/12/19

    设计研究对象为结直肠癌相关的人类 DLD-1 细胞系、CACO-2 细胞系、患者样本及异种移植小鼠,采用 ATAC-seq、Hi-C、RNA-Seq 和 CUT&Tag 技术检测基因组 DNA 与总 RNA 的表观遗传修饰及三维基因组结构。样本按基因型(GATA6-AID-IAA7、WT、GATA6-KO、TP53 mutant、BRAF mutant、GATA6 CRISPR KO)和处理条件(+Auxin、-Auxin、Wash、IAA 诱导蛋白降解)分组,时间点包括 0h、12h、24h、72h。检测覆盖不同基因型与处理时间点的比较,以及特定抗体(GATA6、CTCF、H3K27ac、RAD21)介导的染色质结合分析。

    摘要This SuperSeries is composed of the SubSeries listed below.

  2. 02 GSE345464 对小鼠和人类来源的CD45+结直肠肿瘤浸润淋巴细胞、脾细胞、肠上皮类器官及CD8+T细胞进行单细胞RNA测序和ATAC测序,评估PPARδ在不同组织和细胞类型中的活性对肿瘤-免疫细胞竞争及免疫治疗效果的影响。CD8+T细胞分别来自野生型小鼠、PPARδ免疫特异性获得功能小鼠及肿瘤引流淋巴结,部分样本经4-OHT处理后进行批量RNA测序,比较不同处理条件下细胞转录状态与染色质可及性差异。 人源·鼠源 · 58 例 · GPL37305;37309 · 2026/08/31

    设计对小鼠和人类来源的CD45+结直肠肿瘤浸润淋巴细胞、脾细胞、肠上皮类器官及CD8+T细胞进行单细胞RNA测序和ATAC测序,评估PPARδ在不同组织和细胞类型中的活性对肿瘤-免疫细胞竞争及免疫治疗效果的影响。CD8+T细胞分别来自野生型小鼠、PPARδ免疫特异性获得功能小鼠及肿瘤引流淋巴结,部分样本经4-OHT处理后进行批量RNA测序,比较不同处理条件下细胞转录状态与染色质可及性差异。

    摘要Most patients with solid tumors fail to sustain anti-tumor immunity, in part because immune cells cannot outcompete cancer cells inside the immunosuppressive tumor microenvironment. Here, we identify the lipid-sensing transcription factor PPARδ as a compartment-specific determinant of cancer-immune fitness balance and immunotherapy efficacy. Activating PPARδ in cancer cells promotes their growth and impairs anti-tumor immunity, whereas activating it in immune cells drives tumor suppression and overrides tumor-promoting effects of cancer-intrinsic activation.Mechanistically, PPARδ enhances CD8+ T cell fitness against cancer through effector-associated chromatin and remodeling and Cpt1a-mediated fatty acid oxidation, which is partly necessary but not sufficient.Therapeutically, PPARδ-activated CD8+ T cells sensitize immunotherapy resistant microsatellite stable (MSS) metastatic colorectal cancer to checkpoint blockade in mice, and pharmacologic or genetic PPARδ activation enhances human CAR-T cell function. These findings identify compartment-specific PPARδ activity as a targetable driver of immune cell fitness that can be harnessed to improve outcomes in immunotherapy-resistant tumors.

  3. 03 GSE181856 将 RKO 结肠癌细胞系稳定表达 ZNF280C 靶向 shRNA(由四环素诱导型启动子调控)与未处理细胞进行比较,同时比较 Zfp280c 敲除小鼠与野生型小鼠的结肠组织转录组特征。采用 RNA-Seq 和 ChIP-Seq 技术检测基因表达及染色质结合状态,使用 H3K27ac、H3K27me3、SMCHD1、H2AK119Ub、Rad21、H3K4me1、H3K4me3、ZNF280C、CTCF 等抗体进行染色质免疫沉淀,分析 H3K27me3 标记位点的表观遗传调控机制。 人源·鼠源 · 41 例 · GPL23227;23479;20795;30209 · 2022/05/19

    设计将 RKO 结肠癌细胞系稳定表达 ZNF280C 靶向 shRNA(由四环素诱导型启动子调控)与未处理细胞进行比较,同时比较 Zfp280c 敲除小鼠与野生型小鼠的结肠组织转录组特征。采用 RNA-Seq 和 ChIP-Seq 技术检测基因表达及染色质结合状态,使用 H3K27ac、H3K27me3、SMCHD1、H2AK119Ub、Rad21、H3K4me1、H3K4me3、ZNF280C、CTCF 等抗体进行染色质免疫沉淀,分析 H3K27me3 标记位点的表观遗传调控机制。

    摘要This SuperSeries is composed of the SubSeries listed below.

  4. 04 GSE140276 对结直肠癌细胞系 HCT116 和结直肠组织样本,采用不同处理条件(5mC 和 C,onBead 与 offBead,2.5U、50U 酶量)进行 UniNicE-seq 测序,比较各处理组间开放染色质特征差异。样本按固定(fixed)或非固定(nonfixed)状态处理,部分样本在福尔马林固定后测序,其余为原生状态。检测通过高通量测序实现,使用 Illumina RTA 软件和 Picard 工具生成 fastq 文件,所有样本均未进行额外优化步骤。 人源·鼠源 · 28 例 · GPL18573;19057;24676 · 2020/10/02

    设计对结直肠癌细胞系 HCT116 和结直肠组织样本,采用不同处理条件(5mC 和 C,onBead 与 offBead,2.5U、50U 酶量)进行 UniNicE-seq 测序,比较各处理组间开放染色质特征差异。样本按固定(fixed)或非固定(nonfixed)状态处理,部分样本在福尔马林固定后测序,其余为原生状态。检测通过高通量测序实现,使用 Illumina RTA 软件和 Picard 工具生成 fastq 文件,所有样本均未进行额外优化步骤。

    摘要Accessible chromatin plays a central role in gene expression and chromatin architecture. Current accessible chromatin approaches depend on limited digestion/cutting and pasting adaptors at the accessible DNA, thus requiring additional materials and time for optimization. Universal NicE-seq (UniNicE-seq) is an improved accessible chromatin profiling method that negate the optimization step and is suited to a variety of mammalian cells and tissues. Addition of 5-methyldeoxycytidine triphosphate during accessible chromatin labeling and an on-bead library making step substantially improved the signal to noise ratio while protecting the accessible regions from repeated nicking in cell lines, mouse T cells, mouse kidney, and human frozen and FFPE tissue sections. These refinements allowed reliable mapping of accessible chromatin for high resolution genomic feature studies.

  5. 05 GSE252652 对人结直肠癌细胞系 SW480 和 CT26 以及小鼠肠道组织进行短链脂肪酸处理,采用 ATAC-seq 技术检测染色质可及性变化。SW480 细胞分别以 0 mM、1 mM 和 10 mM NaBu 或 NaPr 处理,CT26 细胞以 0 mM、10 mM NaPr 或 1 mM NaBu 处理,每组设置 2-4 个实验重复。同时比较处理组与未处理对照组的染色质可及性差异,分析短链脂肪酸对结直肠癌及正常细胞的调控作用。 人源·鼠源 · 20 例 · GPL24676;21103 · 2024/01/10

    设计对人结直肠癌细胞系 SW480 和 CT26 以及小鼠肠道组织进行短链脂肪酸处理,采用 ATAC-seq 技术检测染色质可及性变化。SW480 细胞分别以 0 mM、1 mM 和 10 mM NaBu 或 NaPr 处理,CT26 细胞以 0 mM、10 mM NaPr 或 1 mM NaBu 处理,每组设置 2-4 个实验重复。同时比较处理组与未处理对照组的染色质可及性差异,分析短链脂肪酸对结直肠癌及正常细胞的调控作用。

    摘要The short-chain fatty acids (SCFA) propionate and butyrate are produced in large amounts by microbial metabolism and have been identified as unique acyl lysine histone marks. In order to better understand the function of these modifications we used ChIP-Seq to map the genome-wide location of four short-chain acyl histone marks H3K18pr/bu and H4K12pr/bu in treated and untreated colorectal cancer (CRC) and normal cells, as well as in mouse intestines in vivo. We correlate these marks with open chromatin regions along with gene expression to access the function of the target regions. Our data demonstrate that propionate and butyrate act as promoters of growth, differentiation as well as ion transport. We propose a mechanism involving direct modification of specific genomic regions, resulting in increased chromatin accessibility, and in case of butyrate, opposing effects on the proliferation of normal versus CRC cells.

鼠源甲基化

Mouse · Methylation

  1. 01 GSE38983 对Apc-Min/+突变小鼠的肠腺瘤及正常肠组织、Apc-+/+野生型小鼠的正常肠组织进行MeDIP-seq和RNA-seq分析,比较腺瘤与正常组织、不同基因型间差异甲基化区域(DMRs)及基因表达特征。 鼠源 · 21 例 · GPL11002 · 2013/04/03

    设计对Apc-Min/+突变小鼠的肠腺瘤及正常肠组织、Apc-+/+野生型小鼠的正常肠组织进行MeDIP-seq和RNA-seq分析,比较腺瘤与正常组织、不同基因型间差异甲基化区域(DMRs)及基因表达特征。

    摘要Aberrant CpG methylation is a universal trait of cancer cell genomes and can result in epigenetic modulation of gene activity; however, at which stages tumour-specific epigenetic patterns arise is unknown. Here, we analyse the methylome of APCM in mouse intestinal adenoma as a model of intestinal cancer initiation, and inventory a map of over 13,000 adenoma-specific recurrent differentially methylated regions (DMRs). We find that multiple genes coding for Polycomb proteins are upregulated in adenoma, and concomitantly, hypermethylated DMRs form preferentially at Polycomb target sites. We establish that DMRs are absent from proliferating intestinal epithelial cells or intestinal stem cells, and thus arise de novo after loss of APC. Importantly, a core set of DMRs is conserved in human colon cancer, defining a class of early epigenetic alterations that are distinct from known sets of epigenetically silenced tumour suppressors. The data presented suggests a sequence of events that leads to an altered methylome of colon cancer cells, and may allow more specific selection of clinical epigenetic biomarkers.

  2. 02 GSE102648 将18周龄小鼠的结肠上皮细胞分为对照组、AOM/DSS诱导组及诱导组加姜黄素组,采用RNA-Seq与Bisulfite-Seq技术检测转录组和甲基组变化,比较三组间差异。 鼠源 · 18 例 · GPL19057 · 2018/06/11

    设计将18周龄小鼠的结肠上皮细胞分为对照组、AOM/DSS诱导组及诱导组加姜黄素组,采用RNA-Seq与Bisulfite-Seq技术检测转录组和甲基组变化,比较三组间差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  3. 03 GSE123004 对Apc基因不同突变型小鼠的Lgr5+-GFP+肠干细胞进行RNA-seq和RRBS检测,比较三种基因型(Apc+/+、ApcFlox/+、ApcFlox/Flox)在Cre重组酶激活15天后的转录组与DNA甲基化差异。 鼠源 · 12 例 · GPL21103 · 2020/03/22

    设计对Apc基因不同突变型小鼠的Lgr5+-GFP+肠干细胞进行RNA-seq和RRBS检测,比较三种基因型(Apc+/+、ApcFlox/+、ApcFlox/Flox)在Cre重组酶激活15天后的转录组与DNA甲基化差异。

    摘要Loss of APC is the main driving alteration associated with colorectal cancer (CRC) development. We investigate the immediate outcome of this genetic event on the transcriptomic and DNA methylation profiles of Lgr5+ intestinal stem cells (ISCs), considered as the cell-of-origin of CRC. RNA-seq analyses show that the sequential deletion of Apc alleles has a rapid impact on the transcriptional profiles of ISCs. Indeed, Apc loss-of-function dictates an altered cell fate program at transcriptional level, resuting in an impaired commitment of those cells to differentiation. Reduced-representation bisufite sequencing (RRBS) on the genomic DNA (gDNA) also shows that focal alterations occur in the DNA methylations profiles of ISCs at this stage, and functionally contribute to altered cell fate in those cells. This study sheds light on the earliest events in CRC development, proving evidences on the role exerted by DNA methylation changes associated with Apc inactivation in the homeostatic rupture at CRC initation.

  4. 04 GSE179313 以 Apc-Min 小鼠肠腺瘤为对象,通过杂交构建四种基因型组:Tet1+/+ Tdg+/+ ApcMin/+(对照)、Tet1-/- Tdg+/+ ApcMin/+、Tet1+/- TdgN151A/+ ApcMin/+ 和 Tet1+/+ TdgN151A/+ ApcMin/+。小鼠于 150-160 日龄处死,解剖结肠腺瘤并提取基因组 DNA,每组取 3 个腺瘤(按 12 个样本与 4 组估计)。采用 DREAM(甲基化限制性酶数字分析)检测甲基化:DNA 依次经甲基化敏感的 SmaI 与甲基化不敏感的 XmaI 酶切,产生区分甲基化状态的末端特征,再经高通量测序定位 CCCGGG 位点,并按甲基化与未甲基化读数比例计算各位点甲基化率,用内标校正酶切效率差异。主要比较四种基因型腺瘤的甲基化谱差异,以 Tet1/Tdg 野生型 ApcMin 腺瘤为对照。 鼠源 · 12 例 · GPL17021 · 2024/07/01

    设计以 Apc-Min 小鼠肠腺瘤为对象,通过杂交构建四种基因型组:Tet1+/+ Tdg+/+ ApcMin/+(对照)、Tet1-/- Tdg+/+ ApcMin/+、Tet1+/- TdgN151A/+ ApcMin/+ 和 Tet1+/+ TdgN151A/+ ApcMin/+。小鼠于 150-160 日龄处死,解剖结肠腺瘤并提取基因组 DNA,每组取 3 个腺瘤(按 12 个样本与 4 组估计)。采用 DREAM(甲基化限制性酶数字分析)检测甲基化:DNA 依次经甲基化敏感的 SmaI 与甲基化不敏感的 XmaI 酶切,产生区分甲基化状态的末端特征,再经高通量测序定位 CCCGGG 位点,并按甲基化与未甲基化读数比例计算各位点甲基化率,用内标校正酶切效率差异。主要比较四种基因型腺瘤的甲基化谱差异,以 Tet1/Tdg 野生型 ApcMin 腺瘤为对照。

    摘要Aberrant DNA methylation is frequent in colorectal cancer (CRC), but the underlying mechanisms and pathological consequences are poorly understood. Ten-Eleven Translocation (TET) dioxygenases and Thymine DNA Glycosylase (TDG) mediate active DNA demethylation by generating and removing oxidized cytosine species. TET1 and TDG mutations, and altered levels of oxidized cytosines have been identified in human CRC. To investigate the TET-TDG demethylation axis in intestinal tumorigenesis, we generated ApcMin mice that are devoid of Tet1 and/or Tdg, and characterized the methylome and transcriptome of intestinal adenomas. There were increased numbers (>30) of adenomas in ApcMin mice expressing the dominant-negative TdgN151A allele, whereas Tet1-deficient and Tet1/Tdg-double heterozygous ApcMin adenomas were larger and displayed features of erosion and invasion. Methylome analysis revealed reduction in global DNA hypomethylation in colonic adenomas from Tet1- and Tdg-mutant ApcMin mice, and hypermethylation of CpG islands in Tet1-mutant ApcMin mice. In addition, RNA sequencing showed upregulation of inflammatory, immune and interferon response genes in Tet1- and Tdg-mutant colonic adenomas compared to control ApcMin adenomas. The corresponding 127-gene inflammatory signature separated human colonic adenocarcinomas in four groups, closely aligned with their microsatellite or chromosomal instability, and characterized by different levels of DNA methylation and DNMT1 expression that anti-correlated with TET1 expression. These findings demonstrate a novel mechanism of epigenetic regulation during intestinal tumorigenesis by which TET1-TDG-mediated DNA demethylation may decrease methylation levels and inflammatory/interferon/immune responses, and is linked to the type of genomic instability.

  5. 05 GSE57527 对小鼠远端结肠上皮细胞进行全基因组亚硫酸盐测序,比较未处理对照组、DSS处理炎症组及DSS后AOM处理癌变组的甲基化特征。所有组别均包含三个独立样本,检测对象为genomic DNA,采用Bisulfite-Seq策略,通过GPL13112平台分析三种状态下的甲基化差异。 鼠源 · 9 例 · GPL13112 · 2015/06/17

    设计对小鼠远端结肠上皮细胞进行全基因组亚硫酸盐测序,比较未处理对照组、DSS处理炎症组及DSS后AOM处理癌变组的甲基化特征。所有组别均包含三个独立样本,检测对象为genomic DNA,采用Bisulfite-Seq策略,通过GPL13112平台分析三种状态下的甲基化差异。

    摘要This study uses whole-genome bisulfite sequencing to characterize the methylomes of the AOM/DSS mouse model at single-base resolution. In this model, mice are treated with dextran sodium sulfate (DSS) to induce colitis. When this treatment is preceded by injections of the weak carcinogen azoxymethane (AOM) the mice develop intestinal tumors. Our results identify hypermethylated DMVs as a prominent feature of the colitis methylome that is conserved in intestinal adenocarcinomas. Further analyses reveal a subset of DMV-associated genes, expressed in normal intestinal epithelial cells, that were silenced and hypermethylated in inflamed and cancerous intestinal cells. Together, these findings provide strong support for the hypothesis that inflammatory signals induce a higher risk for cancer development by manipulating the epigenome. .

  6. 06 GSE102645 对18周龄C57BL/6小鼠结肠上皮细胞进行DNA甲基化分析,包含对照组、AOM和DSS诱导组及AOM和DSS诱导后加curcumin处理组三个分组。采用Bisulfite-Seq策略获取甲基化数据,比较三组间DNA CpG甲基化模式差异。 鼠源 · 6 例 · GPL19057 · 2018/06/11

    设计对18周龄C57BL/6小鼠结肠上皮细胞进行DNA甲基化分析,包含对照组、AOM和DSS诱导组及AOM和DSS诱导后加curcumin处理组三个分组。采用Bisulfite-Seq策略获取甲基化数据,比较三组间DNA CpG甲基化模式差异。

    摘要Inflammation is highly associated with colon carcinogenesis. Epigenetic mechanisms play an important role in the initiation and progression of colon cancer. Curcumin is a dietary cancer preventive phytochemical with promising effect in suppressing colitis-associated colon cancer (CAC) in azoxymethane (AOM) and dextran sulfate sodium (DSS) mouse model. In the present study, we confirmed the effect of curcumin in suppressing colon cancer. Using Agilent SureSelect Methyl-seq and RNA-seq, we obtained single-base methylation profile and transcriptome analyses of epithelial cells from control group, AOM and DSS induced group (AOM+DSS), and AOM and DSS induced plus curcumin treated group (AOM+DSS+Curcumin) in a 18 weeks long-term colon cancer mouse model. The average DNA methylation levels of the three groups are significantly different also. Based on differential methylation patterns of three groups, several pathways of genes were identified including IL-8 signaling, LPS-stimulated MAPK signaling and colorectal cancer metastasis signaling. Among these methylated pathways and genes, Tnf, an inflammatory gene stood out with decreased DNA CpG methylation in the AOM-DSS as compared to the control group and interestingly curcumin reversed the CpG methylation (validated by pyrosequencing). The functional role of DNA methylation of Tnf was confirmed by in vitro luciferase transcriptional activity assay. In addition, we found that a group of genes associated with the inflammatory responses and their methylation level was decreased in AOM+DSS group but restored in the curcumin treated group. Taken together, in this study, aberrant DNA CpG methylation of the inflammatory response was found in colitis-associated colon cancer and curcumin restored their CpG methlyation, which could potentially explain the inflammatory and cancer protective effects of curcumin. (Note this GEO/dataset is the DNA methyl-seq part of the study.)

鼠源accessibility

Mouse · accessibility

  1. 01 GSE222713 研究对象为结直肠癌相关材料,包括结肠癌类器官、体内肿瘤衍生AKP类器官、结肠癌组织及正常结肠上皮。分组基于基因型(AKP、Control、SOX17KO、WT)和肿瘤状态(C57Bl6、AKPVT),其中AKPVT代表自发性肿瘤模型。检测方式为RNA-seq和ATAC-seq,分别用于转录组和染色质可及性分析。主要比较不同基因型下肿瘤组织与正常组织的差异,以及肿瘤存在与否的条件差异。 鼠源 · 53 例 · GPL19057 · 2024/02/28

    设计研究对象为结直肠癌相关材料,包括结肠癌类器官、体内肿瘤衍生AKP类器官、结肠癌组织及正常结肠上皮。分组基于基因型(AKP、Control、SOX17KO、WT)和肿瘤状态(C57Bl6、AKPVT),其中AKPVT代表自发性肿瘤模型。检测方式为RNA-seq和ATAC-seq,分别用于转录组和染色质可及性分析。主要比较不同基因型下肿瘤组织与正常组织的差异,以及肿瘤存在与否的条件差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  2. 02 GSE290756 对小鼠结肠癌类器官及AKP类器官进行ATAC-seq和RNA-Seq测序,包含Control、GATA6KO、GATA6KO_AKP、Gata6KO_AKP四个基因型,每个基因型设3个复制品,同时检测H3K27ac和H3K4me3标记,比较不同基因型间染色质可及性与转录组差异。 鼠源 · 50 例 · GPL19057;30172 · 2026/06/22

    设计对小鼠结肠癌类器官及AKP类器官进行ATAC-seq和RNA-Seq测序,包含Control、GATA6KO、GATA6KO_AKP、Gata6KO_AKP四个基因型,每个基因型设3个复制品,同时检测H3K27ac和H3K4me3标记,比较不同基因型间染色质可及性与转录组差异。

    摘要This SuperSeries is composed of the SubSeries listed below.

  3. 03 GSE211526 对CT26小鼠结直肠癌细胞系进行ATAC-seq测定,包含WT型与Phf8敲除型细胞,其中Phf8敲除型细胞进一步分为未处理组和20 ng/mL IFN-γ处理24小时组,所有样本均采用Tn5转座酶切割建库,每组设两个生物学重复。 鼠源 · 32 例 · GPL24247 · 2023/05/24

    设计对CT26小鼠结直肠癌细胞系进行ATAC-seq测定,包含WT型与Phf8敲除型细胞,其中Phf8敲除型细胞进一步分为未处理组和20 ng/mL IFN-γ处理24小时组,所有样本均采用Tn5转座酶切割建库,每组设两个生物学重复。

    摘要This SuperSeries is composed of the SubSeries listed below.

  4. 04 GSE290751 通过连续同源移植建立结直肠癌肝转移来源与原发肿瘤来源的类器官库,采集类器官进行ATAC-seq分析,比较肝转移类器官与原发肿瘤类器官的染色质可及性差异。 鼠源 · 15 例 · GPL19057 · 2026/06/22

    设计通过连续同源移植建立结直肠癌肝转移来源与原发肿瘤来源的类器官库,采集类器官进行ATAC-seq分析,比较肝转移类器官与原发肿瘤类器官的染色质可及性差异。

    摘要Colorectal cancer (CRC) liver metastases are the leading cause of CRC-related mortality, yet the specific genetic and epigenetic drivers that promote this process remain poorly understood. Here, we established a pro-metastatic CRC organoid library through serial orthotopic transplantation of organoids derived from mouse liver metastases. Integrative RNA-seq and ATAC-seq analyses of these organoids uncovered distinct transcriptomic and chromatin accessibility profiles correlating with metastatic potential. These pro-metastatic epigenetic changes were characterized by reactivation of fetal-like programs and downregulation of LGR5+ intestinal stem cell signatures. Notably, they converged on the silencing of the transcription factor GATA6, which occurs in liver metastases in both mice and humans. Genetic ablation of GATA6 in mouse models significantly enhanced liver metastasis while having minimal impact on primary tumor growth. Mechanistically, the loss of GATA6 induced the pro-metastatic epigenetic state and promoted the generation of LGR5- cancer cells. Together, these findings demonstrate that GATA6 loss drives liver metastatic progression by reprogramming cancer cells into a pro-metastatic epigenetic state through the hijacking of developmental programs.

  5. 05 GSE285872 对小鼠结肠organoids在高脂肪饮食(HFD)、对照饮食(CD)、对照组(Control)和PA处理条件下进行ATAC-seq测定,采用Tn5转座酶切割建库,比较各处理组间的染色质可及性差异。 鼠源 · 12 例 · GPL19057 · 2026/01/01

    设计对小鼠结肠organoids在高脂肪饮食(HFD)、对照饮食(CD)、对照组(Control)和PA处理条件下进行ATAC-seq测定,采用Tn5转座酶切割建库,比较各处理组间的染色质可及性差异。

    摘要We demonstrate that tumor-intrinsic ceramide metabolism is crucial in initiating colorectal cancer (CRC) metastasis, a process further enhanced by dietary fat intake

  6. 06 GSE211525 以小鼠结直肠癌细胞系CT26为材料,设置野生型对照与Phf8敲除(sgPhf8)细胞,分别以20 ng/mL IFN-γ处理24小时或不处理,构成基因型与处理两因素的2×2分组,每组2个重复,共8个样本;对各组合细胞进行ATAC-seq染色质可及性检测,比较Phf8敲除与野生型、IFN-γ处理与未处理之间的染色质开放性差异,旨在探讨PHF8调控内源逆转录元件与肿瘤免疫逃逸的染色质机制。 鼠源 · 8 例 · GPL24247 · 2023/05/24

    设计以小鼠结直肠癌细胞系CT26为材料,设置野生型对照与Phf8敲除(sgPhf8)细胞,分别以20 ng/mL IFN-γ处理24小时或不处理,构成基因型与处理两因素的2×2分组,每组2个重复,共8个样本;对各组合细胞进行ATAC-seq染色质可及性检测,比较Phf8敲除与野生型、IFN-γ处理与未处理之间的染色质开放性差异,旨在探讨PHF8调控内源逆转录元件与肿瘤免疫逃逸的染色质机制。

    摘要Immunotherapy is currently a prime approach to cancer treatment. Despite the promise of immunotherapies such as immune checkpoint blockade on multiple cancers, most patients do not have a response or become resistant to treatment. Recent work indicate that epigenetic therapies converge with cancer immunotherapy through ‘viral mimicry’, the antiviral response triggered by endogenous nuclei acids that derived from aberrantly transcribed endogenous retrotransposons. However, epigenetic factors that regulate endogenous retrotransposons and further modulate the immune sensitivity of tumor cells is largely unknown. Here we identified the histone demethylase PHD finger protein 8 (PHF8, KDM7B), a Jumonji C domain-containing protein that erases repressive histone marks as an essential mediator of immune escape. We found that depletion of PHF8 abrogates tumor growth, induces immune memory and augments sensitivity to immune checkpoint blockade in multiple tumor models without directly affecting tumor cell proliferation.

  7. 07 GSE221298 对结直肠癌相关肠道肿瘤病变样本进行 ATAC-seq 分析,比较不同细胞系来源的染色质可及性差异。研究对象为遗传工程小鼠模型和家族性腺瘤性息肉病患者样本,材料包括 Lgr5-Apcf/f-tdT、Lgr5-Apcf/f-Sox9f/+-tdT 和 Lgr5-tdT 细胞系来源的肠道肿瘤病变组织,检测方式为 ATAC-seq,主要比较各细胞系间染色质可及性变化及 Sox9 抑制对再生与胎儿基因位点的影响。 鼠源 · 6 例 · GPL24247 · 2023/04/03

    设计对结直肠癌相关肠道肿瘤病变样本进行 ATAC-seq 分析,比较不同细胞系来源的染色质可及性差异。研究对象为遗传工程小鼠模型和家族性腺瘤性息肉病患者样本,材料包括 Lgr5-Apcf/f-tdT、Lgr5-Apcf/f-Sox9f/+-tdT 和 Lgr5-tdT 细胞系来源的肠道肿瘤病变组织,检测方式为 ATAC-seq,主要比较各细胞系间染色质可及性变化及 Sox9 抑制对再生与胎儿基因位点的影响。

    摘要Cell state (phenotypic) plasticity is a carefully regulated feature of adult epithelial cells that enables adaptive responses to injury, inflammation, and other forms of stress.Aberrant expansion of the normally restricted capability for cell state plasticity to escape terminal differentiation is a critical aspect of neoplasia. The nongenetic factors and specific programs that mediate aberrant cell state plasticity and impaired differentiationrequire deeper characterization to understand this elusive aspect ofcancer pathogenesis. Using genetically engineered andcarcinogen-induced murine models of intestinal neoplasia, wedemonstrate that impaired differentiation is a conserved eventpreceding cancer development. Single cell RNA-sequencing (scRNA-seq)of neoplastic intestinal lesions from both mouse models and a patientwith familial adenomatous polyposis revealed that cancer initiates byadopting an aberrant transcriptional state characterized bynonoverlapping expression of a regenerative pathway, marked by Ly6a(Sca-1), and a fetal intestinal program, positive for Tacstd2 (Trop2).Genetic inactivation of Sox9 prevented adenoma formation in ApcKOmice, obstructed emergence of aberrant regenerative and fetalintestinal programs, and restored multi-lineage differentiation byscRNA-seq. Expanded chromatin accessibility at regeneration and fetalgenes upon Apc inactivation was reduced by concomitant Sox9suppression. These studies indicate that aberrant cell stateplasticity mediated by unabated regenerative activity anddevelopmental reprogramming precedes cancer development.

  8. 08 GSE222712 将naïve AKP结肠癌类器官原位移植至免疫 competent 小鼠,从原发肿瘤生成类器官并传代多次直至培养物中仅含癌细胞,采集组织进行ATAC-seq分析,比较不同传代阶段的表观基因组特征。 鼠源 · 6 例 · GPL19057 · 2024/02/28

    设计将naïve AKP结肠癌类器官原位移植至免疫 competent 小鼠,从原发肿瘤生成类器官并传代多次直至培养物中仅含癌细胞,采集组织进行ATAC-seq分析,比较不同传代阶段的表观基因组特征。

    摘要In addition to accumulation of step-wise genetic mutations, epigenetic alterations play critical roles in the evolution of colon cancers. However, distinct mutational patterns and patient backgrounds render it challenging to distinguish driver epigenetic alterations from passenger epigenetic alterations. To address this, we combined the colon cancer organoid orthotopic transplantation approach with comprehensive epigenomic and transcriptomic analyses. We found that an in vivo environment induces epigenetic alterations with fetal intestinal features that converge on SOX17, a transcription factor that is required for endoderm development. Surprisingly, SOX17 knockout leads to tumour rejection in immunocompetent mice, but not in immunodeficient mice, by turning immune cold tumours into hot with robust infiltration of activated CD8+ T cells. Mechanistically, SOX17 suppresses Ifngr1-mediated MHC-I expression to evade CD8+ T cell-mediated tumour cell killing. At the tumour initiation, SOX17 expression is induced by APC loss, and SOX17 facilitates the production of LGR5- cells with low MHC-I expression to evade immune surveillance. Together, our result reveals that SOX17 is a master transcriptional factor that induces in vivo epigenetic reprograming of tumours, which provides fundamental understanding of how an immune evasion program is initiated at the early stages of colon cancer development.

  9. 09 GSE239752 将野生型肠上皮类器官(WT)、ApcKO(A)和ApcKO::KrasG12D::Smad4KO::Trp53KO(AKSP)肿瘤类器官分别按两份重复样本进行ATAC-seq检测,比较不同基因型类器官的染色质可及性差异。所有样本在达到汇合状态时收集,采用核提取缓冲液处理后经Tn5转座酶作用,再通过Qiagen MinElute PCR纯化试剂盒纯化DNA。检测数据来自GSM编号WT-Rep1、WT-Rep2、CRC-A-Rep1、CRC-A-Rep2、CRC-AKSP-Rep1、CRC-AKSP-Rep2的批量ATAC测序结果。 鼠源 · 6 例 · GPL24247 · 2024/10/17

    设计将野生型肠上皮类器官(WT)、ApcKO(A)和ApcKO::KrasG12D::Smad4KO::Trp53KO(AKSP)肿瘤类器官分别按两份重复样本进行ATAC-seq检测,比较不同基因型类器官的染色质可及性差异。所有样本在达到汇合状态时收集,采用核提取缓冲液处理后经Tn5转座酶作用,再通过Qiagen MinElute PCR纯化试剂盒纯化DNA。检测数据来自GSM编号WT-Rep1、WT-Rep2、CRC-A-Rep1、CRC-A-Rep2、CRC-AKSP-Rep1、CRC-AKSP-Rep2的批量ATAC测序结果。

    摘要To characterize changes in chromatin accessibility acorss the CRC malignancy continum, wild type organoids (WT), ApcKO (A) and ApcKO::KrasG12D::Smad4KO::Trp53KO (AKSP) tumoroids were subjected to bulk ATAC-seq. We then performed differential accessibility analysis using data obtained from ATAC-seq of the indicated organoid lines.

  10. 10 GSE244935 对小鼠结直肠癌细胞系 CMT-93 的 PLC-β3 缺陷(KO)组与 scramble sgRNA 处理组进行 ATAC-seq 测定,比较两组间染色质可及性的差异。 鼠源 · 6 例 · GPL17021 · 2024/10/06

    设计对小鼠结直肠癌细胞系 CMT-93 的 PLC-β3 缺陷(KO)组与 scramble sgRNA 处理组进行 ATAC-seq 测定,比较两组间染色质可及性的差异。

    摘要Crohn’s disease is a chronic, debilitating inflammatory bowel disease. Here we report a critical role for phospholipase C-β3 (PLC-β3) in intestinal homeostasis. In PLC-β3- deficient mice, exposure to oral dextran sodium sulfate induced lethality and severe inflammation in the small intestine. The lethality was due to PLC-3 deficiency in multiple non-hematopoietic cell types. PLC-β3 deficiency resulted in reduced Wnt/-catenin signaling, which is essential for homeostasis and regeneration of the intestinal epithelium. PLC-β3 regulated the Wnt/β-catenin pathway in small intestinal epithelial cells (IECs) at transcriptional, epigenetic, and potentially protein-protein interaction levels. PLC-β3- deficient IECs were unable to respond to stimulation by R-spondin 1, an enhancer of Wnt/β-catenin signaling. Reduced expression of PLC-β3 and its signature genes was found in biopsies of ileal Crohn’s disease patients. PLC-β regulation of Wnt signaling was evolutionally conserved in Drosophila. Our data indicate that reduction of PLC-β3- mediated Wnt/β-catenin signaling contributes to the pathogenesis of ileal Crohn’s disease.

  11. 11 GSE278871 对小鼠结肠隐窝细胞进行ATAC-seq测序,比较CDX2P-CreERT2Apcfl/fl Hmga1+/+、CDX2P-CreERT2Apcfl/fl Hmga1+/-及CDX2P-CreERT2Apcfl/fl Hmga1-/-三组的染色质可及性差异,其中Hmga1+/+组作为对照,Hmga1+/-和Hmga1-/-组均接受tamoxifen诱导处理,样本采集于12周龄小鼠。 鼠源 · 6 例 · GPL24247 · 2025/02/05

    设计对小鼠结肠隐窝细胞进行ATAC-seq测序,比较CDX2P-CreERT2Apcfl/fl Hmga1+/+、CDX2P-CreERT2Apcfl/fl Hmga1+/-及CDX2P-CreERT2Apcfl/fl Hmga1-/-三组的染色质可及性差异,其中Hmga1+/+组作为对照,Hmga1+/-和Hmga1-/-组均接受tamoxifen诱导处理,样本采集于12周龄小鼠。

    摘要Mutated cells undergo changes in chromatin accessibility and gene expression, resulting in aberrant proliferation and differentiation, although how this occurs is unclear. HMGA1 chromatin regulators are abundant in stem cells and oncogenic in diverse tissues; however, their role in colon tumorigenesis is only beginning to emerge. Here, we uncover a previously unknown epigenetic program whereby HMGA1 amplifies Wnt signaling during colon tumorigenesis driven by inflammatory microbiota and/or Adenomatous polyposis coli (Apc) inactivation. Mechanistically, HMGA1 “opens” chromatin to up-regulate the stem cell regulator, Ascl2, and downstream Wnt effectors, promoting stem and Paneth-like cell states while depleting differentiated enterocytes. Loss of just one Hmga1 allele within colon epithelium restrains tumorigenesis and Wnt signaling driven by mutant Apc and inflammatory microbiota. However, HMGA1 deficiency has minimal effects in colon epithelium under homeostatic conditions. In human colon cancer cells, HMGA1 directly induces ASCL2 by recruiting activating histone marks. Silencing HMGA1 disrupts oncogenic properties, whereas re-expression of ASCL2 partially rescues these phenotypes. Further, HMGA1 and ASCL2 are co-expressed and up-regulated in human colorectal cancer. Together, our results establish HMGA1 as an epigenetic gatekeeper of Wnt signals and cell state under conditions of APC inactivation, illuminating HMGA1 as a potential therapeutic target in colon cancer.

  12. 12 GSE262237 利用CRISPR-Cas9构建Sun1敲除的CT26小鼠结肠癌细胞系,将Sun1敲除与野生型CT26细胞分别皮下注射至BALB/c小鼠右侧胁部建立同基因移植瘤模型,接种后第14天采集肿瘤,消化并制备单细胞核,用10x Chromium Single Cell Multiome ATAC+Gene Expression试剂盒行单核多组学测序,同时获得基因表达与染色质可及性数据,比较Sun1敲除与野生型两组肿瘤,以探讨Sun1对肿瘤细胞在体基因调控网络的影响。 鼠源 · 4 例 · GPL24247 · 2024/03/29

    设计利用CRISPR-Cas9构建Sun1敲除的CT26小鼠结肠癌细胞系,将Sun1敲除与野生型CT26细胞分别皮下注射至BALB/c小鼠右侧胁部建立同基因移植瘤模型,接种后第14天采集肿瘤,消化并制备单细胞核,用10x Chromium Single Cell Multiome ATAC+Gene Expression试剂盒行单核多组学测序,同时获得基因表达与染色质可及性数据,比较Sun1敲除与野生型两组肿瘤,以探讨Sun1对肿瘤细胞在体基因调控网络的影响。

    摘要T cell infiltration is essential for immune checkpoint inhibitors to be effective in treating solid cancers. Through a bioinformatic pipeline, we identified a target gene SUN1 that might relate to modulating immune cell infiltration and immune response. Thus, we generated one Sun1_knockout CT26 cell line (Sun1_KO) using CRISPR-Cas9. By performing multiome single nuclei sequencing using tumors grown in syngeneic model, we set out to understand how mouse Sun1 can affect the regulatory network in tumor cells in vivo.

  13. 13 GSE290618 对小鼠移植后4周的AKP肿瘤组织及相邻正常组织分选T细胞,采用单细胞ATAC-seq和核RNA-seq检测其多组学特征,比较肿瘤与正常组织间T细胞的基因组开放状态及转录组差异。 鼠源 · 4 例 · GPL19057 · 2025/12/15

    设计对小鼠移植后4周的AKP肿瘤组织及相邻正常组织分选T细胞,采用单细胞ATAC-seq和核RNA-seq检测其多组学特征,比较肿瘤与正常组织间T细胞的基因组开放状态及转录组差异。

    摘要Regulatory T (Treg) cells are considered major contributors to the growth of solid organ tumors, with the notable exception of colorectal cancer (CRC), despite the documented abundance of Treg cells in CRC. Here, we demonstrate that IL-10⁺ and IL-10⁻ Treg cells constitute two distinct subsets with opposing functions: IL-10⁺ Treg cells counteract, while IL-10⁻ Treg cells promote, the growth of genetically engineered CRC tumors. Our findings suggest that the tumor-suppressive function of IL-10⁺ Treg cells is mediated by their suppression of effector CD4⁺ T cell production of IL-17, a cytokine that directly stimulates CRC tumor cell proliferation. Consistently, IL-10⁺ Treg cells were more abundant in both mouse and human CRC tumors than in tumor-adjacent normal colon tissue, whereas IL-10⁻ Treg cells exhibited the opposite distribution. Furthermore, gene expression signatures associated with IL-10⁺ and IL-10⁻ Treg cells correlated with better and worse disease prognoses in human CRC, respectively. This functional dichotomy between Treg subsets provides a rationale for therapeutic strategies aimed at selectively targeting pro-tumoral Treg cells while preserving their anti-tumoral counterparts across various barrier tissue cancers that harbor both subsets.

  14. 14 GSE313944 对PHF8敲除与野生型CT26细胞的染色质开放概况进行高灵敏度ATAC-seq分析,每组设置两个生物重复。CT26细胞经消化计数后重悬于20μL含1×10⁵细胞的悬浮液,使用High-Sensitivity Open Chromatin Profile Kit处理,提取DNA并经Tagment DNA Extract Beads纯化,最终在Illumina NovaSeq X Plus平台进行测序。 鼠源 · 4 例 · GPL34328 · 2026/01/01

    设计对PHF8敲除与野生型CT26细胞的染色质开放概况进行高灵敏度ATAC-seq分析,每组设置两个生物重复。CT26细胞经消化计数后重悬于20μL含1×10⁵细胞的悬浮液,使用High-Sensitivity Open Chromatin Profile Kit处理,提取DNA并经Tagment DNA Extract Beads纯化,最终在Illumina NovaSeq X Plus平台进行测序。

    摘要CT26 cells with or without PHF8 knockout were processed using the High-Sensitivity Open Chromatin Profile Kit according to the manufacturer’s instructions.DNA was extracted using Tagment DNA Extract Beads, purified with NovoNGS DNA Clean Beads, and amplified by PCR. Libraries that passed quality control were sequenced on an Illumina NovaSeq X Plus platform.

  15. 15 GSE333943 采用AOM/DSS诱导的结肠癌模型小鼠,在肠上皮特异性敲除Gsk3b构建Gsk3b IEC-/-小鼠,以IEC+/+小鼠为对照;分别取两组小鼠的结肠肿瘤组织,各构建2个ATAC-Seq文库(共4个样本)检测染色质可及性,比较肠上皮Gsk3b敲除与野生型对照结肠肿瘤组织染色质可及性的差异。 鼠源 · 4 例 · GPL28330 · 2026/06/19

    设计采用AOM/DSS诱导的结肠癌模型小鼠,在肠上皮特异性敲除Gsk3b构建Gsk3b IEC-/-小鼠,以IEC+/+小鼠为对照;分别取两组小鼠的结肠肿瘤组织,各构建2个ATAC-Seq文库(共4个样本)检测染色质可及性,比较肠上皮Gsk3b敲除与野生型对照结肠肿瘤组织染色质可及性的差异。

    摘要This study focuses on the epigenomics and transcriptomic changes driven by the GSK3B gene in colon cancer, offering valuable insights into tumor biology and its progression. Gaining a deeper understanding of these processes may contribute to developing more effective therapeutic strategies and enhance prognostic outcomes.

  16. 16 GSE192672 以BALB/c背景的小鼠结直肠癌细胞系CT26为材料,设置WT、Whsc1 KO与Nlrc5 KO三种基因型细胞,共3个样本,对各基因型细胞提取基因组DNA进行ATAC-seq染色质可及性测序,考察染色质状态,主要比较WT与Whsc1 KO或Nlrc5 KO细胞的染色质状态差异,以探讨Whsc1与Nlrc5缺失对染色质状态的影响为目的。 鼠源 · 3 例 · GPL24247 · 2022/01/03

    设计以BALB/c背景的小鼠结直肠癌细胞系CT26为材料,设置WT、Whsc1 KO与Nlrc5 KO三种基因型细胞,共3个样本,对各基因型细胞提取基因组DNA进行ATAC-seq染色质可及性测序,考察染色质状态,主要比较WT与Whsc1 KO或Nlrc5 KO细胞的染色质状态差异,以探讨Whsc1与Nlrc5缺失对染色质状态的影响为目的。

    摘要Histone dimethyl transferase WHSC1 drives the transcription of MHC-I machinery in mouse and human colorectal cancer cells (CRCs); thus, WHSC1 downregulation potentiates CRCs to escape from cytotoxic CD8+ T cell responses. WHSC1 directly interacts with MHC-I transactivator, NLRC5 to selectively stimulate MHC-I gene expression. Thus, silencing Whsc1 diminished MHC-I level, impaired anti-tumor immunity and blunted immunotherapy efficacy.

  17. 17 GSE197227 将MC38移植瘤小鼠按接种后第18天分组,PBS组与CAG(50mg/kg)组通过灌胃给药处理,采集肿瘤组织制备单细胞悬液进行10x scRNA-seq和scATAC-seq分析,比较两组肿瘤细胞的基因组特征差异。 鼠源 · 2 例 · GPL21103 · 2023/02/22

    设计将MC38移植瘤小鼠按接种后第18天分组,PBS组与CAG(50mg/kg)组通过灌胃给药处理,采集肿瘤组织制备单细胞悬液进行10x scRNA-seq和scATAC-seq分析,比较两组肿瘤细胞的基因组特征差异。

    摘要Purpose:We want to elaborate the specific mechanism of CAG inhibiting the growth of transplanted mouse colon cancer cell MC38. Methods:After MC38 cells were inoculated into C57BL/6 mice for 6 days, the mice were evenly divided into PBS group and CAG group, and PBS and CAG (50mg / kg) were administered by gavage every day. On the 18th day, the mouse tumors were removed, and one tumor was selected to prepare single cell suspension for 10x-scRNA-seq and 10x-scATAC-seq. Results:We found that CAG promoted the antigen-presenting function of tumor cells and enhanced the killing ability of CD8 T cells. Conclusions:CAG enhances the antitumor immunity of CD8 T cells by promoting the antigen presentation of tumor cells.

  18. 18 GSE237938 对AKSP肿瘤类器官进行单细胞ATAC-seq和3' RNA-seq分析,以表征其调控转录因子的细胞状态。 鼠源 · 2 例 · GPL19057 · 2024/10/17

    设计对AKSP肿瘤类器官进行单细胞ATAC-seq和3' RNA-seq分析,以表征其调控转录因子的细胞状态。

    摘要To characterize transcription factors (TFs) that govern the various cellular states in CRC, AKSP tumoroids were subjected to Mutliome analysis combining s.c ATAC-seq and s.c 3' RNA-seq.

  19. 19 GSE278081 对ARID1A野生型和敲除型CT26小鼠结直肠癌细胞系进行ATAC-seq分析,比较两种基因型细胞的基因组DNA结合特征差异。 鼠源 · 2 例 · GPL24247 · 2024/11/26

    设计对ARID1A野生型和敲除型CT26小鼠结直肠癌细胞系进行ATAC-seq分析,比较两种基因型细胞的基因组DNA结合特征差异。

    摘要ARID1A, a core constituent of SWI/SNF complex, is mutated in about 10% of colorectal cancer (CRC). This study demonstrates a synergistic effect of arachidonic acid metabolism inhibitors with immune checkpoint inhibitors (ICIs) by regulating functionality of CD8+ T cells and vasculogenic mimicry (VM) formation in ARID1A-deficient CRC. Mechanistically, ATAC-seq and ChIP-qPCR demonstrated that the lack of ARID1A results in reduced levels of the key enzymes PTGS1 and PTGS2, which control the arachidonic acid pathway. This reduction generated a reliance on the remaining functionality of arachidonic acid pathway in ARID1A-deficient cells.

猕猴甲基化

Macaque · Methylation

  1. 01 GSE178383 收集结直肠癌患者肿瘤组织与配对癌旁正常结肠黏膜样本,行全基因组 DNA 甲基化 Bisulfite-Seq 测定,比较肿瘤与正常组织的甲基化模式。研究对象为 Rhesus Macaque 模型的结直肠癌样本,包含 MSI-H、MSS、MSI-L 三类微卫星不稳定性状态,以及男性和女性个体。样本通过宏解剖分离并采用 QIAGEN AllPrep DNA/RNA FFPE Kit 提取 DNA/RNA,部分样本使用 ZYMO RESEARCH 提取试剂盒处理新鲜冷冻组织。测定覆盖全基因组 DNA 甲基化,采用双链 DNA 测序策略,通过随机选择和 cDNA 选择进行文库构建,检测材料为基因组 DNA 和转录组 RNA。 猕猴 · 69 例 · GPL21326;27943;23949 · 2022/03/31

    设计收集结直肠癌患者肿瘤组织与配对癌旁正常结肠黏膜样本,行全基因组 DNA 甲基化 Bisulfite-Seq 测定,比较肿瘤与正常组织的甲基化模式。研究对象为 Rhesus Macaque 模型的结直肠癌样本,包含 MSI-H、MSS、MSI-L 三类微卫星不稳定性状态,以及男性和女性个体。样本通过宏解剖分离并采用 QIAGEN AllPrep DNA/RNA FFPE Kit 提取 DNA/RNA,部分样本使用 ZYMO RESEARCH 提取试剂盒处理新鲜冷冻组织。测定覆盖全基因组 DNA 甲基化,采用双链 DNA 测序策略,通过随机选择和 cDNA 选择进行文库构建,检测材料为基因组 DNA 和转录组 RNA。

    摘要This SuperSeries is composed of the SubSeries listed below. NIH grant(s): Grant ID: 5 P30 CA016672-44 Grant title: Cancer Center Support Grant Affiliation: The University of Texas MD Anderson Cancer Center Grantor: NCI

  2. 02 GSE178377 对恒河猴结直肠肿瘤组织与匹配的正常粘膜样本进行减少表征亚硫酸氢盐测序(RRBS),比较两者甲基化特征差异。研究对象为14例肿瘤样本及14例对应正常样本,共28个GSM记录。 猕猴 · 28 例 · GPL21326;27943 · 2022/03/31

    设计对恒河猴结直肠肿瘤组织与匹配的正常粘膜样本进行减少表征亚硫酸氢盐测序(RRBS),比较两者甲基化特征差异。研究对象为14例肿瘤样本及14例对应正常样本,共28个GSM记录。

    摘要Colorectal cancer (CRC) remains the third most common cancer in the US, with 15% of cases displaying Microsatellite Instability (MSI) secondary to Lynch Syndrome (LS) or somatic hypermethylation of the MLH1 promoter. A cohort of rhesus macaques from our institution developed spontaneous mismatch repair deficient (MMRd) CRC with a notable fraction harboring a pathogenic germline mutation in MLH1. DNA methylation and transcriptome analysis was performed to evaluate the rhesus macaque as a model organism to study carcinogenesis, develop immunotherapies and vaccines, and implement chemoprevention approaches pertinent to sporadic MSI-H and LS CRC in humans. NIH grant(s): Grant ID: 5 P30 CA016672-44 Grant title: Cancer Center Support Grant Affiliation: The University of Texas MD Anderson Cancer Center Grantor: NCI

微信二维码

课题合作 · 扫码加微信

bioinformaticsboy